assays_assay_id,assays_assay_organism,assays_tissue_id,assays_chembl_id,assays_description,assays_assay_test_type,assays_doc_id,assays_assay_tissue,assays_tid,assays_variant_id,assays_assay_category,assays_bao_format,assays_src_assay_id,assays_curated_by,assays_assay_subcellular_fraction,assays_assay_tax_id,assays_relationship_type,assays_confidence_score,assays_src_id,assays_cell_id
7524,Rattus norvegicus,2113.0,CHEMBL618647,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,In vivo,9866,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7525,Rattus norvegicus,2113.0,CHEMBL618648,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,In vivo,9866,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7526,Rattus norvegicus,2113.0,CHEMBL618649,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,In vivo,9866,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7527,Rattus norvegicus,2107.0,CHEMBL618650,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,In vivo,9866,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7528,Rattus norvegicus,2107.0,CHEMBL618651,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,In vivo,9866,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7529,Rattus norvegicus,2107.0,CHEMBL876497,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,In vivo,9866,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7530,Rattus norvegicus,2048.0,CHEMBL618652,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,In vivo,9866,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7531,Rattus norvegicus,2048.0,CHEMBL618653,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,In vivo,9866,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7532,Rattus norvegicus,2048.0,CHEMBL618654,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,In vivo,9866,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7533,Rattus norvegicus,,CHEMBL618655,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,,6351,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7534,Rattus norvegicus,,CHEMBL618656,Compound was tested for solubility in water,,1465,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7535,,,CHEMBL618657,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),,5182,,22229,,,BAO_0000100,,Intermediate,,,U,0,1,
7536,Rattus norvegicus,,CHEMBL618658,Solubility was determined,,17847,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7537,Rattus norvegicus,,CHEMBL618659,solubility in water (ug/mL) at 37 degree C.,,15339,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7538,Rattus norvegicus,,CHEMBL618660,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,,5202,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7539,Rattus norvegicus,,CHEMBL618661,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,,1088,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7540,Rattus norvegicus,,CHEMBL873807,Half life in rats,,3169,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7541,Rattus norvegicus,,CHEMBL618662,Half life in Dawley rat,,5353,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7542,Rattus norvegicus,,CHEMBL618663,Half life period after 3 mg/kg iv administration,In vivo,2864,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7543,Rattus norvegicus,,CHEMBL618664,Half life period after 3 mg/kg iv administration in rat,In vivo,2864,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7544,Rattus norvegicus,,CHEMBL618665,Half life period after 3 mg/kg iv administration in the rat,In vivo,2864,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7545,Rattus norvegicus,,CHEMBL876498,Half life period in female Sprague-Dawley rats,,6362,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7546,Rattus norvegicus,,CHEMBL618666,Half life period in rat,,6249,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7547,Rattus norvegicus,,CHEMBL620440,Half-life in rats was determined,,3169,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7548,Rattus norvegicus,,CHEMBL620441,Half-life in rats with metabolic oxidation,,3169,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7549,Rattus norvegicus,,CHEMBL620442,Half-life in rats,,3169,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7550,Rattus norvegicus,,CHEMBL620443,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,In vivo,17260,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7551,Rattus norvegicus,,CHEMBL620444,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,In vivo,17260,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7552,Rattus norvegicus,,CHEMBL620445,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,In vivo,17260,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7553,Rattus norvegicus,,CHEMBL620446,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,In vivo,17260,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7554,Rattus norvegicus,1969.0,CHEMBL620447,Biological half-life measured in plasma of rat,,2879,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7555,Rattus norvegicus,1969.0,CHEMBL621129,Biological half-life measured in plasma of rat; 22-25,,2879,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7556,Rattus norvegicus,1969.0,CHEMBL621130,Biological half-life measured in plasma of rat; 9-16,,2879,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7557,Rattus norvegicus,,CHEMBL873808,Compound was evaluated for its half life when administered intravenously in rat,In vivo,3184,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7558,Rattus norvegicus,,CHEMBL876598,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,In vivo,4891,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7559,Rattus norvegicus,,CHEMBL621131,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,In vivo,429,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7560,Rattus norvegicus,,CHEMBL621132,Half life (T1/2) after oral administration in rat,In vivo,5656,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7561,Rattus norvegicus,,CHEMBL621133,Half life of compound after iv administration of 20 mg/kg dose in rat,In vivo,4413,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7562,Rattus norvegicus,,CHEMBL621312,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,In vivo,3598,,50597,,,BAO_0000218,,Expert,,10116.0,N,1,1,
7563,Rattus norvegicus,,CHEMBL621313,Half life of compound was determined in rat,,17267,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7564,Rattus norvegicus,178.0,CHEMBL621314,Half life of compound was determined in rat blood,,4727,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7565,Rattus norvegicus,,CHEMBL621315,Half life at 1 mg/kg was determined in rat,In vivo,17651,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7566,Rattus norvegicus,,CHEMBL621316,Half life at 10 mg/kg was determined in rat,In vivo,17651,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7567,Rattus norvegicus,,CHEMBL621317,Half life in rats,,401,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7568,Rattus norvegicus,,CHEMBL621318,Half life in rats in hours,,4942,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7569,Rattus norvegicus,,CHEMBL621319,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,In vivo,17735,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7570,Rattus norvegicus,,CHEMBL621377,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,In vivo,6056,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7571,Rattus norvegicus,,CHEMBL621378,Half life was determined,,5213,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7572,Rattus norvegicus,,CHEMBL876599,Half life after i.v. administration,In vivo,6616,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7573,Rattus norvegicus,,CHEMBL621379,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,In vivo,5937,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7574,Rattus norvegicus,1969.0,CHEMBL621380,Half life in rat plasma,,5819,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7575,Rattus norvegicus,1969.0,CHEMBL621381,Half life in rat plasma; Not detected,,5819,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7576,Rattus norvegicus,,CHEMBL618515,Half life in rats,,6803,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7577,Rattus norvegicus,,CHEMBL618516,Half life period of compound was determined after peroral administration,In vivo,17804,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7578,Rattus norvegicus,,CHEMBL618517,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,In vivo,17804,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7579,Rattus norvegicus,,CHEMBL618518,Half life period in rat,,5948,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7580,Rattus norvegicus,,CHEMBL618519,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,In vivo,1916,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7581,Rattus norvegicus,,CHEMBL618698,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,In vivo,1916,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7582,Rattus norvegicus,,CHEMBL618862,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,In vivo,1916,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7583,Rattus norvegicus,,CHEMBL618863,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,In vivo,4890,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7584,Rattus norvegicus,,CHEMBL618864,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,In vivo,17764,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7585,Rattus norvegicus,,CHEMBL618865,Half life time in rat the dose of 2 mg/kg,In vivo,4727,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7586,Rattus norvegicus,,CHEMBL618866,Half-life 24 hr after 10 mg/kg iv administration in rats,In vivo,17509,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7587,Rattus norvegicus,,CHEMBL618867,Half-life 24 hr after 2 mg/kg iv administration in rats,In vivo,17509,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7588,Rattus norvegicus,,CHEMBL875828,Half-life consistent with the observed metabolic steady state in rats,,6597,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7589,Rattus norvegicus,,CHEMBL618868,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,In vivo,17735,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7590,Rattus norvegicus,,CHEMBL618869,Half-life for oxidative metabolic stability was determined using male human,,6597,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7591,Rattus norvegicus,,CHEMBL618870,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",In vivo,17670,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7592,Rattus norvegicus,1969.0,CHEMBL618871,Half-life in rat plasma,,1696,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7593,Rattus norvegicus,1969.0,CHEMBL618872,Half-life in rat plasma was determined,,1742,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7594,Rattus norvegicus,,CHEMBL873816,Half-life in rats was determined,,17800,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7595,,,CHEMBL618873,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,,12923,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
7596,,,CHEMBL621602,Area under curve after oral dose of 0.1 mg//kg,,11954,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
7597,,,CHEMBL621603,Area under curve after oral dose of 0.3 mg/kg,,11954,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
7598,,,CHEMBL621604,Area under curve after oral dose of 1 mg/kg,,11954,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
7599,,,CHEMBL621605,Area under curve after oral dose of 10 mg/kg,,11954,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
7600,,,CHEMBL621606,Area under curve after oral dose of 23.4 mg/kg,,11954,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
7601,,,CHEMBL621607,Area under curve after oral dose of 3 mg/kg,,11954,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
7602,,,CHEMBL621608,Area under curve after oral dose of 3.87 mg/kg,,11954,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
7603,,,CHEMBL621609,Area under curve was determined,,5237,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
7604,,,CHEMBL621610,Area under curve at a dose of 10 mg/kg,,4026,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
7605,Rattus norvegicus,,CHEMBL621611,Area under curve was determined; ND=No data,,5237,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7606,Rattus norvegicus,,CHEMBL621612,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,14793,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7607,Rattus norvegicus,,CHEMBL622308,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,14793,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7608,Rattus norvegicus,,CHEMBL622309,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,14793,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7609,Rattus norvegicus,,CHEMBL622310,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,,14793,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7610,Rattus norvegicus,,CHEMBL622311,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,14793,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7611,Rattus norvegicus,,CHEMBL622312,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,,14793,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7612,Rattus norvegicus,,CHEMBL622931,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,14793,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7613,Rattus norvegicus,,CHEMBL622932,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,,14793,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7614,Rattus norvegicus,1969.0,CHEMBL622736,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,14793,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7615,Rattus norvegicus,1969.0,CHEMBL622737,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,14793,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7616,Rattus norvegicus,1969.0,CHEMBL622738,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,14793,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7617,Rattus norvegicus,1969.0,CHEMBL622739,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,,14793,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7618,Rattus norvegicus,1969.0,CHEMBL622740,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,14793,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7619,Rattus norvegicus,1969.0,CHEMBL622741,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,,14793,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7620,Rattus norvegicus,1969.0,CHEMBL622742,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,14793,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7621,Rattus norvegicus,1969.0,CHEMBL622743,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,,14793,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7622,Mus musculus,1969.0,CHEMBL622744,AUC in mice,,11637,Plasma,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
7623,,,CHEMBL624134,Area under curve was measured from the graph obtained from concentration Vs time,,11149,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
7624,,,CHEMBL624135,Area under curve value of compound per hour after oral administration,,10016,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
7625,Rattus norvegicus,,CHEMBL624136,Area under curve was determined after oral administration in rats,,17796,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7626,Rattus norvegicus,,CHEMBL624137,Area under curve was determined after oral administration in rats; No data,,17796,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7627,Rattus norvegicus,,CHEMBL624320,Area under curve was determined after oral administration in rats;No data,,17796,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7628,Canis lupus familiaris,,CHEMBL624321,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,12923,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
7629,Rattus norvegicus,,CHEMBL624322,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,,15372,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7630,Rattus norvegicus,,CHEMBL624323,Area under curve was determined for the compound after iv dose of 5.06 in rats,,15372,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7631,Rattus norvegicus,,CHEMBL624324,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,,15372,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7632,Rattus norvegicus,,CHEMBL624325,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,,15372,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7633,Rattus norvegicus,,CHEMBL624326,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,,15372,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7634,Rattus norvegicus,,CHEMBL624327,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,,15372,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7635,Rattus norvegicus,,CHEMBL624328,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,,15372,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7636,Canis lupus familiaris,,CHEMBL627848,Area under curve was determined in Dogs after peroral administration,,14169,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
7637,Rattus norvegicus,,CHEMBL627849,Area under curve was determined in Rats after peroral administration,,14169,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7638,Rattus norvegicus,,CHEMBL627850,Area under curve was determined in carotid blood of rat when administered intradermally,,14258,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7639,Rattus norvegicus,,CHEMBL627851,Area under curve was determined in portal blood of rat when administered intradermally,,14258,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7640,Mus musculus,,CHEMBL627852,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,15011,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
7641,Mus musculus,,CHEMBL627853,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,15011,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
7642,Mus musculus,,CHEMBL627854,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,15011,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
7643,Mus musculus,,CHEMBL627855,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,15011,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
7644,Mus musculus,,CHEMBL627856,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),,15011,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
7645,Mus musculus,,CHEMBL875339,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,15011,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
7646,Mus musculus,,CHEMBL627857,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),,15011,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
7647,Rattus norvegicus,2106.0,CHEMBL627858,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,In vivo,11195,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7648,Rattus norvegicus,178.0,CHEMBL627859,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,,10130,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7649,Rattus norvegicus,955.0,CHEMBL627860,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,,10130,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7650,Rattus norvegicus,948.0,CHEMBL627019,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,,10130,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7651,Rattus norvegicus,2107.0,CHEMBL627020,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,,10130,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7652,Rattus norvegicus,2048.0,CHEMBL627021,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,,10130,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7653,Rattus norvegicus,2385.0,CHEMBL627022,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,,10130,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7654,Rattus norvegicus,,CHEMBL627023,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,,10130,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7655,Rattus norvegicus,2106.0,CHEMBL627024,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,,10130,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7656,Rattus norvegicus,2046.0,CHEMBL627025,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,,10130,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7657,Rattus norvegicus,2113.0,CHEMBL627026,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,,10130,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7658,Rattus norvegicus,178.0,CHEMBL627027,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,,10130,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7659,Rattus norvegicus,955.0,CHEMBL627028,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,,10130,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7660,Rattus norvegicus,948.0,CHEMBL627029,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,,10130,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7661,Rattus norvegicus,2113.0,CHEMBL627030,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,,10130,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7662,Rattus norvegicus,2107.0,CHEMBL627031,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,,10130,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7663,Rattus norvegicus,2048.0,CHEMBL627032,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,,10130,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7664,Rattus norvegicus,2385.0,CHEMBL627033,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,,10130,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7665,Rattus norvegicus,,CHEMBL627034,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,,10130,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7666,Rattus norvegicus,2106.0,CHEMBL627035,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,,10130,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7667,Rattus norvegicus,2046.0,CHEMBL627036,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,,10130,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7668,Rattus norvegicus,178.0,CHEMBL875340,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,,10130,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7669,Rattus norvegicus,948.0,CHEMBL627037,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,,10130,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7670,Rattus norvegicus,2113.0,CHEMBL627038,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,,10130,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7671,Rattus norvegicus,2107.0,CHEMBL627039,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,,10130,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7672,Rattus norvegicus,2385.0,CHEMBL627040,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,,10130,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7673,Rattus norvegicus,2106.0,CHEMBL624663,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,,10130,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7674,Rattus norvegicus,2046.0,CHEMBL625963,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,,10130,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7675,Rattus norvegicus,955.0,CHEMBL876799,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,,10130,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7676,Rattus norvegicus,2048.0,CHEMBL626133,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,,10130,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7677,Rattus norvegicus,,CHEMBL626134,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,,10130,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7678,Rattus norvegicus,,CHEMBL626135,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,6295,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7679,Rattus norvegicus,,CHEMBL626136,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,6296,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7680,Rattus norvegicus,,CHEMBL626137,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,,6296,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7681,Rattus norvegicus,,CHEMBL626138,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,6295,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7682,Rattus norvegicus,,CHEMBL626139,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,6296,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7683,Rattus norvegicus,,CHEMBL626140,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,In vivo,17260,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7684,Rattus norvegicus,,CHEMBL626141,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,In vivo,17260,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7685,Rattus norvegicus,,CHEMBL626142,C24h in rat p.o. at 20 mg/kg concentration,,17686,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7686,Rattus norvegicus,2385.0,CHEMBL627930,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,In vivo,9866,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7687,Rattus norvegicus,2385.0,CHEMBL627931,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,In vivo,9866,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7688,Rattus norvegicus,2385.0,CHEMBL627932,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,In vivo,9866,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7689,Rattus norvegicus,2106.0,CHEMBL627933,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,In vivo,9866,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7690,Rattus norvegicus,2106.0,CHEMBL627934,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,In vivo,9866,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7691,Rattus norvegicus,2106.0,CHEMBL627935,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,In vivo,9866,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7692,Rattus norvegicus,178.0,CHEMBL627936,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,In vivo,9866,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7693,Rattus norvegicus,178.0,CHEMBL627937,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,In vivo,9866,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7694,Rattus norvegicus,178.0,CHEMBL627938,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,In vivo,9866,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7695,Rattus norvegicus,178.0,CHEMBL627939,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,In vivo,9866,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7696,Rattus norvegicus,178.0,CHEMBL627940,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,In vivo,9866,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7697,Rattus norvegicus,178.0,CHEMBL627941,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,In vivo,9866,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7698,Rattus norvegicus,178.0,CHEMBL876800,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,In vivo,9866,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7699,Rattus norvegicus,178.0,CHEMBL627942,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,In vivo,9866,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7700,Rattus norvegicus,178.0,CHEMBL627943,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,In vivo,9866,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7701,Rattus norvegicus,178.0,CHEMBL627944,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,In vivo,9866,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7702,Rattus norvegicus,178.0,CHEMBL627945,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,In vivo,9866,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7703,Rattus norvegicus,178.0,CHEMBL628584,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,In vivo,9866,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7704,Rattus norvegicus,178.0,CHEMBL628585,Biodistribution in rat blood in the presence of GdDTPA at 15 min,In vivo,9866,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7705,Rattus norvegicus,178.0,CHEMBL628586,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,In vivo,9866,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7706,Rattus norvegicus,178.0,CHEMBL628587,Biodistribution in rat blood in the presence of GdDTPA at 30 min,In vivo,9866,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7707,Rattus norvegicus,178.0,CHEMBL628588,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,In vivo,9866,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7708,Rattus norvegicus,178.0,CHEMBL628589,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,In vivo,9866,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7709,Rattus norvegicus,178.0,CHEMBL625304,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,In vivo,9866,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7710,Rattus norvegicus,178.0,CHEMBL625305,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,In vivo,9866,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7711,Rattus norvegicus,178.0,CHEMBL625306,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,In vivo,9866,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7712,Rattus norvegicus,178.0,CHEMBL625307,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,In vivo,9866,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7713,Rattus norvegicus,178.0,CHEMBL625308,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,In vivo,9866,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7714,Rattus norvegicus,178.0,CHEMBL627740,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,In vivo,9866,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7715,Rattus norvegicus,178.0,CHEMBL627741,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,In vivo,9866,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7716,Rattus norvegicus,178.0,CHEMBL627742,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,In vivo,9866,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7717,Rattus norvegicus,178.0,CHEMBL627743,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,In vivo,9866,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7718,Rattus norvegicus,178.0,CHEMBL627744,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,In vivo,9866,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7719,Rattus norvegicus,10000001.0,CHEMBL627745,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,In vivo,9866,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7720,Rattus norvegicus,10000001.0,CHEMBL627746,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,In vivo,9866,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7721,Rattus norvegicus,10000001.0,CHEMBL627747,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,In vivo,9866,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7722,Rattus norvegicus,10000001.0,CHEMBL876810,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,In vivo,9866,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7723,Rattus norvegicus,10000001.0,CHEMBL627748,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,In vivo,9866,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7724,Rattus norvegicus,10000001.0,CHEMBL627749,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,In vivo,9866,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7725,Rattus norvegicus,10000001.0,CHEMBL627750,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,In vivo,9866,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7726,Rattus norvegicus,10000001.0,CHEMBL618728,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,In vivo,9866,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7727,Rattus norvegicus,10000001.0,CHEMBL618729,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,In vivo,9866,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7728,Rattus norvegicus,10000001.0,CHEMBL618730,Biodistribution in rat bone in the presence of GdDTPA at 15 min,In vivo,9866,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7729,Rattus norvegicus,10000001.0,CHEMBL618731,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,In vivo,9866,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7730,Rattus norvegicus,10000001.0,CHEMBL618732,Biodistribution in rat bone in the presence of GdDTPA at 30 min,In vivo,9866,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7731,Rattus norvegicus,10000001.0,CHEMBL618733,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,In vivo,9866,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7732,Rattus norvegicus,10000001.0,CHEMBL618734,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,In vivo,9866,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7733,Rattus norvegicus,10000001.0,CHEMBL618735,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,In vivo,9866,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7734,Rattus norvegicus,10000001.0,CHEMBL876602,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,In vivo,9866,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7735,Rattus norvegicus,10000001.0,CHEMBL618736,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,In vivo,9866,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7736,Rattus norvegicus,10000001.0,CHEMBL618737,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,In vivo,9866,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7737,Rattus norvegicus,10000001.0,CHEMBL618738,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,In vivo,9866,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7738,Rattus norvegicus,10000001.0,CHEMBL618739,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,In vivo,9866,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7739,Rattus norvegicus,10000001.0,CHEMBL618740,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,In vivo,9866,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7740,Rattus norvegicus,10000001.0,CHEMBL618741,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,In vivo,9866,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7741,Rattus norvegicus,10000001.0,CHEMBL618742,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,In vivo,9866,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7742,Rattus norvegicus,10000001.0,CHEMBL618743,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,In vivo,9866,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7743,Rattus norvegicus,1969.0,CHEMBL618744,Half-life from rat plasma at a single oral dose of 25 mg/kg,In vivo,17752,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7744,Rattus norvegicus,,CHEMBL618745,Half-life in male rat,,5610,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7745,Rattus norvegicus,,CHEMBL620479,Half-life in rat after peroral administration at 10 mg/kg concentration,In vivo,5939,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7746,Rattus norvegicus,,CHEMBL620480,Half-life in rat after peroral administration at 5 mg/kg concentration,In vivo,5939,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7747,Rattus norvegicus,,CHEMBL620481,Half-life in rat at a dose of 3 mg/kg,In vivo,17771,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7748,Rattus norvegicus,,CHEMBL620482,Half-life was evaluated in rats,,1974,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7749,Rattus norvegicus,,CHEMBL876603,Half-life was measured in rat,,4239,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7750,Rattus norvegicus,,CHEMBL620483,Half-life period for the compound was determined in rats at 50 mg/kg dose,In vivo,6681,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7751,Rattus norvegicus,,CHEMBL620484,Half-life period in rats after intravenous administration at 5 mg/kg,In vivo,17752,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7752,Rattus norvegicus,,CHEMBL620485,Half-life period in rat at 10 mg/kg,In vivo,6046,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7753,Rattus norvegicus,,CHEMBL620486,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",In vivo,6685,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7754,Rattus norvegicus,,CHEMBL620487,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",In vivo,6685,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7755,Rattus norvegicus,,CHEMBL620488,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",In vivo,6685,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7756,Rattus norvegicus,,CHEMBL620489,Half-life time in rat the dose of 2 mg/kg,In vivo,4727,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7757,Rattus norvegicus,,CHEMBL620490,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,In vivo,1088,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7758,Rattus norvegicus,,CHEMBL620491,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,In vivo,5610,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7759,Rattus norvegicus,1969.0,CHEMBL876604,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",In vivo,3032,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7760,Rattus norvegicus,,CHEMBL620492,Oral half life was determined,In vivo,5199,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7761,Rattus norvegicus,,CHEMBL620493,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",In vivo,14941,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7762,Rattus norvegicus,,CHEMBL620494,Pharmacokinetic property (t1/2) in rat,In vivo,4408,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7763,Rattus norvegicus,1969.0,CHEMBL620495,Plasma elimination half-life was determined,,2552,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7764,Rattus norvegicus,1969.0,CHEMBL620496,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,In vivo,5199,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7765,Rattus norvegicus,1969.0,CHEMBL620497,Plasma half life was observed after intravenous administration in rat,In vivo,15662,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7766,Rattus norvegicus,1969.0,CHEMBL620498,Plasma half-life was determined,,1465,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7767,Rattus norvegicus,1969.0,CHEMBL620499,Plasma half-life following oral administration in Fisher rats,In vivo,1446,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7768,Rattus norvegicus,1969.0,CHEMBL620500,Plasma half-life in rat,,6824,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7769,Rattus norvegicus,1969.0,CHEMBL873809,Plasmatic Half-life after intravenous administration to rat,In vivo,17533,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7770,Rattus norvegicus,,CHEMBL620501,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,In vivo,5979,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7771,Rattus norvegicus,,CHEMBL620502,Terminal half life after intravenous administration (1 mg/kg) in rat,In vivo,4689,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7772,Rattus norvegicus,,CHEMBL620503,Terminal half life in Rat at a oral dose of 5 mg/kg,In vivo,4689,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7773,Rattus norvegicus,,CHEMBL620504,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,In vivo,2463,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7774,Rattus norvegicus,,CHEMBL876605,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,In vivo,4883,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7775,Rattus norvegicus,,CHEMBL620505,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,In vivo,4883,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7776,Rattus norvegicus,1969.0,CHEMBL873811,plasma half life was observed after intravenous administration in rat,In vivo,15662,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7777,Rattus norvegicus,,CHEMBL624016,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,In vivo,3598,,50597,,,BAO_0000218,,Expert,,10116.0,N,1,1,
7778,Rattus norvegicus,,CHEMBL624017,Half life of compound determined in rat,,4576,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7779,Rattus norvegicus,,CHEMBL624018,Mean residence time determined in rat,,4576,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7780,Rattus norvegicus,,CHEMBL624019,Plasma half life determined in rat,,4576,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7781,Rattus norvegicus,955.0,CHEMBL624020,Compound was evaluated for Tmax in brain after intravenous administration in male rats,In vivo,4910,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7782,Rattus norvegicus,,CHEMBL624201,Compound was evaluated for pharmacokinetic parameter maximum time period,In vivo,4891,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7783,Rattus norvegicus,,CHEMBL872528,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,In vivo,429,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7784,Rattus norvegicus,,CHEMBL624202,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,In vivo,5974,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7785,Rattus norvegicus,,CHEMBL624203,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,In vivo,5974,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7786,Rattus norvegicus,,CHEMBL624350,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,In vivo,5974,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7787,Rattus norvegicus,,CHEMBL621320,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,In vivo,5974,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7788,Rattus norvegicus,,CHEMBL621321,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,In vivo,17582,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7789,Rattus norvegicus,,CHEMBL621322,Maximum time (Tmax) required to reach Cmax in rats,,4026,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7790,Rattus norvegicus,,CHEMBL621323,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,In vivo,4890,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7791,Rattus norvegicus,,CHEMBL621324,Maximum time of clearance of compound in rats after peroral administration,In vivo,6571,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7792,Rattus norvegicus,,CHEMBL621325,Maximum time at the dose of 2 mg/kg in rat,,4727,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7793,Rattus norvegicus,1969.0,CHEMBL875837,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,In vivo,17651,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7794,Rattus norvegicus,1969.0,CHEMBL621326,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,In vivo,17651,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7795,Rattus norvegicus,,CHEMBL621327,Tmax in Guinea pig (PO dose),In vivo,14465,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7796,Rattus norvegicus,,CHEMBL621328,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",In vivo,14941,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7797,Rattus norvegicus,,CHEMBL621329,Pharmacokinetic parameter (Tmax) in rat,In vivo,5960,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7798,Rattus norvegicus,,CHEMBL621330,Pharmacokinetic parameter (Tmax) was estimated,In vivo,5022,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7799,Rattus norvegicus,,CHEMBL621331,Pharmacokinetic property (Tmax) in rat,In vivo,4408,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7800,Rattus norvegicus,,CHEMBL621332,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,In vivo,5983,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7801,Rattus norvegicus,,CHEMBL621333,T max in Rat at a oral dose of 5 mg/kg,In vivo,4689,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7802,Rattus norvegicus,,CHEMBL621334,T max was determined at 10 mg/kg po dose in rats,In vivo,2792,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7803,Mus musculus,,CHEMBL621335,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),,15011,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
7804,Canis lupus familiaris,,CHEMBL621336,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,,14180,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
7805,Rattus norvegicus,,CHEMBL621337,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,,14180,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7806,Canis lupus familiaris,,CHEMBL621338,Area under curve was measured after i.v. administration into Beagle dog.,,14599,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
7807,Canis lupus familiaris,,CHEMBL875838,Area under curve was measured after iv administration into Beagle dog,,14599,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
7808,Canis lupus familiaris,,CHEMBL621339,Area under curve was measured after po administration into Beagle dog,,14599,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
7809,Canis lupus familiaris,,CHEMBL621340,Area under curve was measured after po administration into Beagle dog.,,14599,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
7810,,,CHEMBL621341,Area under curve was measured at peroral dose of 3 mg/kg,,15675,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
7811,,,CHEMBL621342,Area under curve was measured by using concentration Vs time,,12706,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
7812,,,CHEMBL621343,Area under curve was measured by using concentration Vs time; not tested,,12706,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
7813,Mus musculus,,CHEMBL621344,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),,9750,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
7814,Mus musculus,,CHEMBL621345,Area under curve(AUC) was measured in mice after oral administration.,,9750,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
7815,,,CHEMBL621346,Area under curve(AUC) value of the compound,,14691,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
7816,,,CHEMBL621347,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,,14691,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
7817,Canis lupus familiaris,,CHEMBL621348,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,,14691,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
7818,,178.0,CHEMBL621349,Area under curve(carotid artery) was determined by the availability in blood,,2939,Blood,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
7819,,178.0,CHEMBL621350,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,,2939,Blood,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
7820,,178.0,CHEMBL875839,Area under curve(carotid artery) was determined by the availability in blood; No data,,2939,Blood,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
7821,,178.0,CHEMBL620211,Area under curve(portal vein) was determined by the availability in blood,,2939,Blood,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
7822,,178.0,CHEMBL620212,Area under curve(portal vein) was determined by the availability in blood; ND means no data,,2939,Blood,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
7823,,178.0,CHEMBL620213,Area under curve(portal vein) was determined by the availability in blood; No data,,2939,Blood,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
7824,Macaca mulatta,1969.0,CHEMBL620214,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,9552,Plasma,50797,,,BAO_0000218,,Intermediate,,9544.0,N,1,1,
7825,Macaca mulatta,1969.0,CHEMBL620215,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,9552,Plasma,50797,,,BAO_0000218,,Intermediate,,9544.0,N,1,1,
7826,Macaca mulatta,1969.0,CHEMBL620216,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,,9552,Plasma,50797,,,BAO_0000218,,Intermediate,,9544.0,N,1,1,
7827,Canis lupus familiaris,1969.0,CHEMBL620888,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",,9552,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
7828,Canis lupus familiaris,1969.0,CHEMBL620889,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",,9552,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
7829,,1969.0,CHEMBL620890,Area under plasma concentration vs time curve observed in rats for 0-3 h,,9552,Plasma,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
7830,Rattus norvegicus,1969.0,CHEMBL620891,Area under plasma time curve determined in male rat,,11911,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7831,,,CHEMBL620892,Area under the MAP curve measured over 5 min.,,16618,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
7832,Mus musculus,,CHEMBL621079,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,,14387,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
7833,Mus musculus,,CHEMBL621080,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,,14387,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
7834,Canis lupus familiaris,,CHEMBL621081,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,,12836,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
7835,Cricetinae,,CHEMBL621082,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,,12836,,100712,,,BAO_0000218,,Intermediate,,10026.0,N,1,1,
7836,Rattus norvegicus,,CHEMBL621083,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,,12836,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7837,Canis lupus familiaris,,CHEMBL621084,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,,14339,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
7838,Canis lupus familiaris,,CHEMBL621085,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,,14339,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
7839,Canis lupus familiaris,,CHEMBL621086,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,,14339,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
7840,Canis lupus familiaris,,CHEMBL621087,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,10524,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
7841,Canis lupus familiaris,,CHEMBL622607,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),,9994,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
7842,Canis lupus familiaris,,CHEMBL622608,Serum AUC in marmosets (IV dose),,11325,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
7843,,,CHEMBL624481,Area under the curve after intravenous administration at a dose of 10 umol/kg,,12536,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
7844,,,CHEMBL624482,Area under the curve after intravenous administration at a dose of 2 umol/kg,,12536,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
7845,,,CHEMBL624483,Area under the curve after intravenous administration at a dose of 4 umol/kg,,12536,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
7846,,,CHEMBL624484,Area under the curve after intravenous administration at a dose of 40 umol/kg,,12536,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
7847,,,CHEMBL624485,Area under the curve after intravenous administration at a dose of 5 umol/kg,,12536,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
7848,Rattus norvegicus,,CHEMBL624486,Area under the curve for fumarate salt was evaluated in F344 Rats.,,15556,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7849,,,CHEMBL624487,Area under the curve for the compound was calculated.,,2809,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
7850,,,CHEMBL624488,Area under the curve in concentration/ time,,9511,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
7851,Rattus norvegicus,,CHEMBL624489,Area under the curve administered intraintestinal in rats.,,12818,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7852,Rattus norvegicus,,CHEMBL625184,Area under the curve administered intravenously in rats.,,12818,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7853,,,CHEMBL625185,Area under the curve during intravenous administration,,15118,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
7854,,,CHEMBL875954,Area under the curve during intravenous administration; Not determined,,15118,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
7855,,,CHEMBL625186,Area under the curve during systemic administration,,15118,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
7856,,,CHEMBL625187,Area under the curve during systemic administration; Not determined,,15118,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
7857,,,CHEMBL625188,Area under the curve was calculated for the compound.,,2632,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
7858,Canis lupus familiaris,,CHEMBL625189,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,,14346,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
7859,Canis lupus familiaris,,CHEMBL625190,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,,14346,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
7860,Rattus norvegicus,,CHEMBL621733,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,,14346,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7861,Rattus norvegicus,,CHEMBL621734,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,,14346,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7862,Rattus norvegicus,,CHEMBL621735,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,,11149,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7863,Rattus norvegicus,1969.0,CHEMBL621736,Clearance of the drug was measured in the plasma of rat; No data,,17796,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7864,Rattus norvegicus,1969.0,CHEMBL621737,The pharmacokinetic parameter plasma clearance in vivo in rats,,5247,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7865,Rattus norvegicus,,CHEMBL621738,Plasma clearance at the dose of 2 mg/kg in rat,,4727,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7866,Rattus norvegicus,,CHEMBL622806,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,In vivo,5654,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7867,Rattus norvegicus,,CHEMBL623519,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,In vivo,5654,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7868,Rattus norvegicus,,CHEMBL623520,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,In vivo,17260,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7869,Rattus norvegicus,,CHEMBL623521,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,In vivo,17065,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7870,Rattus norvegicus,,CHEMBL623522,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,In vivo,17671,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7871,Rattus norvegicus,,CHEMBL623523,Clearance rate in rat,In vivo,6672,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7872,Rattus norvegicus,,CHEMBL623690,Clearance rate in rat,In vivo,6673,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7873,Rattus norvegicus,,CHEMBL623691,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,5978,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7874,Rattus norvegicus,,CHEMBL623692,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,5978,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7875,Rattus norvegicus,,CHEMBL623693,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,5978,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7876,Rattus norvegicus,,CHEMBL623694,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,5978,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7877,Rattus norvegicus,,CHEMBL623695,Clearance of compound after iv administration of 20 mg/kg dose in rat,In vivo,4413,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7878,Rattus norvegicus,,CHEMBL623696,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,In vivo,2661,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7879,Rattus norvegicus,,CHEMBL623697,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,In vivo,2661,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7880,Macaca mulatta,1969.0,CHEMBL623698,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,In vivo,5005,Plasma,22224,,,BAO_0000218,,Intermediate,,9544.0,U,0,1,
7881,Rattus norvegicus,1969.0,CHEMBL623699,Compound was tested for its plasma clearance rate in Sprague Dawley rats,In vivo,5005,Plasma,22224,,,BAO_0000218,,Intermediate,,10116.0,U,0,1,
7882,Rattus norvegicus,,CHEMBL623700,Mean (%CV) PK parameters for CL(mL/min/kg).,In vivo,15765,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7883,Rattus norvegicus,,CHEMBL623701,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,In vivo,3747,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7884,Rattus norvegicus,1969.0,CHEMBL623702,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,In vivo,16366,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7885,Rattus norvegicus,,CHEMBL623703,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,In vivo,4199,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7886,Rattus norvegicus,,CHEMBL623704,Plasma clearance in rat was determined,In vivo,17267,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7887,Rattus norvegicus,,CHEMBL623705,Plasma clearance in rat after administration of 2 mg/kg iv,In vivo,6535,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7888,Rattus norvegicus,,CHEMBL623706,Plasma clearance in rat after administration of 2 mg/kg iv,In vivo,6535,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7889,Rattus norvegicus,,CHEMBL623707,Plasma clearance was determined,In vivo,5041,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7890,Rattus norvegicus,,CHEMBL623708,Plasma clearance in rat,In vivo,5960,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7891,Rattus norvegicus,,CHEMBL623709,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,In vivo,5937,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7892,Rattus norvegicus,,CHEMBL623710,Plasma clearance in rat by iv administration,In vivo,5871,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7893,Rattus norvegicus,,CHEMBL623711,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,In vivo,5874,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7894,Rattus norvegicus,,CHEMBL623712,Plasma clearance in rat p.o.,In vivo,6504,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7895,Rattus norvegicus,,CHEMBL623713,Plasma clearance in rats,In vivo,6803,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7896,Rattus norvegicus,,CHEMBL623714,Plasma clearance was determined; ND denotes no data,In vivo,5041,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7897,Rattus norvegicus,,CHEMBL623715,Plasma clearance was determined; ND denotes not determined,In vivo,5041,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7898,Rattus norvegicus,,CHEMBL623716,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,In vivo,1916,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7899,Rattus norvegicus,,CHEMBL622980,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,In vivo,5199,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7900,Rattus norvegicus,,CHEMBL622981,Plasma administration to rats,In vivo,16367,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7901,Rattus norvegicus,,CHEMBL622982,Plasma clearance of the compound in female Sprague-Dawley rats,In vivo,6362,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7902,Rattus norvegicus,,CHEMBL622983,Plasma clearance was observed after intravenous administration in rat,In vivo,15662,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7903,Rattus norvegicus,,CHEMBL622984,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,In vivo,6215,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7904,Rattus norvegicus,,CHEMBL622985,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,In vivo,1466,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7905,Rattus norvegicus,1969.0,CHEMBL623631,plasma clearance was observed after intravenous administration in rat,In vivo,15662,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7906,Rattus norvegicus,,CHEMBL623632,In vivo CL/F determined,In vivo,4723,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7907,Rattus norvegicus,1969.0,CHEMBL623633,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,In vivo,2792,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7908,Rattus norvegicus,1969.0,CHEMBL623634,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,In vivo,2792,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7909,Rattus norvegicus,,CHEMBL623635,Compound was tested for the lower blood clearance in rat,In vivo,5213,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7910,Rattus norvegicus,,CHEMBL621195,Evaluated for the low clearance in rat (in vivo),In vivo,4687,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7911,Rattus norvegicus,,CHEMBL621196,Pharmacokinetic property (CLb)of the compound was determined in rat,In vivo,3371,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7912,Rattus norvegicus,,CHEMBL875287,Rapid clearance after intravenous administration in rat was determined,In vivo,4690,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7913,Rattus norvegicus,,CHEMBL621197,Clearance measured in rat,In vivo,5702,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7914,Rattus norvegicus,1969.0,CHEMBL621198,Compound was evaluated for plasma clearance in rat,In vivo,740,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7915,Rattus norvegicus,1969.0,CHEMBL621199,Low plasma clearance was calculated in rat,In vivo,4853,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7916,Rattus norvegicus,,CHEMBL621200,Pharmacokinetic property (Clp) in rat,In vivo,5789,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7917,Rattus norvegicus,,CHEMBL621201,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,In vivo,4527,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7918,Rattus norvegicus,,CHEMBL621202,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,In vivo,4527,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7919,Rattus norvegicus,,CHEMBL621203,Plasma clearance after IV dosing at 0.5 mg/kg in rat,In vivo,6518,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7920,Rattus norvegicus,,CHEMBL621204,Plasma clearance after IV dosing at 1 mg/kg in rat,In vivo,6518,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7921,Rattus norvegicus,948.0,CHEMBL621205,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,In vivo,9866,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7922,Rattus norvegicus,948.0,CHEMBL621206,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,In vivo,9866,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7923,Rattus norvegicus,948.0,CHEMBL621207,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,In vivo,9866,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7924,Rattus norvegicus,948.0,CHEMBL621208,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,In vivo,9866,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7925,Rattus norvegicus,948.0,CHEMBL621209,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,In vivo,9866,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7926,Rattus norvegicus,948.0,CHEMBL876484,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,In vivo,9866,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7927,Rattus norvegicus,948.0,CHEMBL621210,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,In vivo,9866,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7928,Rattus norvegicus,948.0,CHEMBL621211,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,In vivo,9866,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7929,Rattus norvegicus,948.0,CHEMBL621212,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,In vivo,9866,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7930,Rattus norvegicus,948.0,CHEMBL621213,Biodistribution in rat heart in the presence of GdDTPA at 15 min,In vivo,9866,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7931,Rattus norvegicus,948.0,CHEMBL621214,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,In vivo,9866,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7932,Rattus norvegicus,948.0,CHEMBL621215,Biodistribution in rat heart in the presence of GdDTPA at 30 min,In vivo,9866,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7933,Rattus norvegicus,948.0,CHEMBL621216,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,In vivo,9866,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7934,Rattus norvegicus,948.0,CHEMBL621217,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,In vivo,9866,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7935,Rattus norvegicus,948.0,CHEMBL621218,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,In vivo,9866,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7936,Rattus norvegicus,948.0,CHEMBL621219,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,In vivo,9866,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7937,Rattus norvegicus,948.0,CHEMBL621220,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,In vivo,9866,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7938,Rattus norvegicus,948.0,CHEMBL621221,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,In vivo,9866,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7939,Rattus norvegicus,948.0,CHEMBL621222,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,In vivo,9866,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7940,Rattus norvegicus,948.0,CHEMBL621223,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,In vivo,9866,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7941,Rattus norvegicus,948.0,CHEMBL876485,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,In vivo,9866,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7942,Rattus norvegicus,948.0,CHEMBL621224,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,In vivo,9866,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7943,Rattus norvegicus,948.0,CHEMBL621225,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,In vivo,9866,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7944,Rattus norvegicus,948.0,CHEMBL621226,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,In vivo,9866,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7945,Rattus norvegicus,2113.0,CHEMBL621227,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,In vivo,9866,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7946,Rattus norvegicus,2113.0,CHEMBL621228,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,In vivo,9866,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7947,Rattus norvegicus,2113.0,CHEMBL621229,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,In vivo,9866,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7948,Rattus norvegicus,2113.0,CHEMBL621230,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,In vivo,9866,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7949,Rattus norvegicus,2113.0,CHEMBL621231,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,In vivo,9866,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7950,Rattus norvegicus,2113.0,CHEMBL621232,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,In vivo,9866,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7951,Rattus norvegicus,2113.0,CHEMBL621233,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,In vivo,9866,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7952,Rattus norvegicus,2113.0,CHEMBL621234,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,In vivo,9866,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7953,Rattus norvegicus,2113.0,CHEMBL621235,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,In vivo,9866,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7954,Rattus norvegicus,2113.0,CHEMBL621236,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,In vivo,9866,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7955,Rattus norvegicus,2113.0,CHEMBL621237,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,In vivo,9866,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7956,Rattus norvegicus,2113.0,CHEMBL876486,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,In vivo,9866,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7957,Rattus norvegicus,160.0,CHEMBL622436,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,In vivo,9866,Intestine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7958,Rattus norvegicus,160.0,CHEMBL622437,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,In vivo,9866,Intestine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7959,Rattus norvegicus,160.0,CHEMBL622438,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,In vivo,9866,Intestine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7960,Rattus norvegicus,2107.0,CHEMBL622439,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,In vivo,9866,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7961,Rattus norvegicus,2107.0,CHEMBL622440,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,In vivo,9866,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7962,Rattus norvegicus,2107.0,CHEMBL622441,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,In vivo,9866,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7963,Rattus norvegicus,2107.0,CHEMBL622442,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,In vivo,9866,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7964,Rattus norvegicus,2107.0,CHEMBL622443,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,In vivo,9866,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7965,Rattus norvegicus,2107.0,CHEMBL622444,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,In vivo,9866,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7966,Rattus norvegicus,2107.0,CHEMBL622445,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,In vivo,9866,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7967,Rattus norvegicus,2107.0,CHEMBL622446,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,In vivo,9866,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7968,Rattus norvegicus,2107.0,CHEMBL622447,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,In vivo,9866,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7969,Rattus norvegicus,2107.0,CHEMBL622448,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,In vivo,9866,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7970,Rattus norvegicus,2107.0,CHEMBL622449,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,In vivo,9866,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7971,Rattus norvegicus,2107.0,CHEMBL622450,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,In vivo,9866,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7972,Rattus norvegicus,2107.0,CHEMBL622451,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,In vivo,9866,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7973,Rattus norvegicus,2107.0,CHEMBL622452,Biodistribution in rat liver in the presence of GdDTPA at 15 min,In vivo,9866,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7974,Rattus norvegicus,2107.0,CHEMBL622453,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,In vivo,9866,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7975,Rattus norvegicus,2107.0,CHEMBL622454,Biodistribution in rat liver in the presence of GdDTPA at 30 min,In vivo,9866,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7976,Rattus norvegicus,2107.0,CHEMBL622455,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,In vivo,9866,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7977,Rattus norvegicus,2107.0,CHEMBL876024,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,In vivo,9866,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7978,Rattus norvegicus,,CHEMBL622456,T max was determined at 3 mg/kg po dose in rats,In vivo,2792,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7979,Rattus norvegicus,,CHEMBL622457,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",In vivo,15078,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7980,Rattus norvegicus,,CHEMBL622458,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",In vivo,15078,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7981,Rattus norvegicus,,CHEMBL622459,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,,15022,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7982,Rattus norvegicus,,CHEMBL873343,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,,15022,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7983,Rattus norvegicus,,CHEMBL622460,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,,15022,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7984,Rattus norvegicus,1969.0,CHEMBL622461,Time for maximum plasma concentration determined in rat,,4576,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7985,Rattus norvegicus,1969.0,CHEMBL622462,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,In vivo,6681,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7986,Rattus norvegicus,,CHEMBL622463,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,In vivo,16365,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7987,Rattus norvegicus,,CHEMBL622464,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,In vivo,16365,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7988,Rattus norvegicus,,CHEMBL622465,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,In vivo,16365,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7989,Rattus norvegicus,,CHEMBL622466,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,In vivo,16365,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7990,Rattus norvegicus,,CHEMBL622467,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,In vivo,16365,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7991,Rattus norvegicus,1969.0,CHEMBL622468,Time of maximum plasma concentration in rat,,6824,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7992,Rattus norvegicus,1969.0,CHEMBL876025,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,6685,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7993,Rattus norvegicus,1969.0,CHEMBL622469,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,6685,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7994,Rattus norvegicus,1969.0,CHEMBL622470,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,6685,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7995,Rattus norvegicus,,CHEMBL622471,Time required to reach maximum concentration (Cmax) after oral administration in rat,In vivo,15662,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7996,Rattus norvegicus,1969.0,CHEMBL622472,Time required to reach maximum concentration in rat plasma,,1742,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7997,Rattus norvegicus,1969.0,CHEMBL622473,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,In vivo,2774,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7998,Rattus norvegicus,1969.0,CHEMBL624282,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,In vivo,5199,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
7999,Rattus norvegicus,1969.0,CHEMBL624283,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,In vivo,12873,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8000,Rattus norvegicus,1969.0,CHEMBL624284,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,In vivo,12873,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8001,Rattus norvegicus,1969.0,CHEMBL624285,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,In vivo,1916,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8002,Rattus norvegicus,,CHEMBL624286,Time to reach Cmax after oral administration to rats,In vivo,16367,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8003,Rattus norvegicus,,CHEMBL624287,Time to reach Cmax when a dose of 1 mg/kg is administered orally,In vivo,16366,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8004,Rattus norvegicus,,CHEMBL624288,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,,216,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8005,Rattus norvegicus,1969.0,CHEMBL624289,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,In vivo,6410,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8006,Rattus norvegicus,1969.0,CHEMBL873344,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,In vivo,6410,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8007,Rattus norvegicus,,CHEMBL619623,Tmax after peroral administration (10 mg/kg) was determined in rat,In vivo,6215,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8008,Rattus norvegicus,,CHEMBL621399,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,In vivo,3598,,50597,,,BAO_0000218,,Expert,,10116.0,N,1,1,
8009,Rattus norvegicus,,CHEMBL621400,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,In vivo,4527,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8010,Rattus norvegicus,,CHEMBL621401,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",In vivo,17670,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8011,Rattus norvegicus,,CHEMBL621402,Tmax was determined,,1465,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8012,Rattus norvegicus,,CHEMBL621403,Tmax was determined,,2552,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8013,Rattus norvegicus,,CHEMBL621121,Tmax after oral administration in rat,In vivo,5656,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8014,Rattus norvegicus,,CHEMBL872525,Tmax after peroral administration in rats at 2.4 uM/kg,In vivo,17764,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8015,Rattus norvegicus,,CHEMBL621122,Tmax in male rat,,5610,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8016,Rattus norvegicus,,CHEMBL621123,Tmax in rat at 10 mg/kg,In vivo,6046,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8017,Rattus norvegicus,,CHEMBL621124,Tmax in rat by po administration at a dose of 40 mg/kg,In vivo,5874,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8018,Rattus norvegicus,,CHEMBL621125,Tmax in rats,,17596,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8019,Rattus norvegicus,,CHEMBL621126,Tmax was measured in rats after peroral administration at 5 mg/kg,In vivo,17804,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8020,Rattus norvegicus,,CHEMBL621127,Tmax value after oral dose at a dose of 10 mg/kg in rats.,In vivo,1908,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8021,Rattus norvegicus,,CHEMBL621128,Tmax value after administration of 20 mg/Kg oral dose in rat,In vivo,2959,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8022,Rattus norvegicus,,CHEMBL618263,Tmax value at a dose of 10 mg/kg in male SD rats,In vivo,6757,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8023,Rattus norvegicus,,CHEMBL618264,Tmax value at a dose of 100 mg/kg in male SD rats,In vivo,6757,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8024,Rattus norvegicus,,CHEMBL618265,Tmax value at a dose of 50 mg/kg in male SD rats,In vivo,6757,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8025,Rattus norvegicus,1969.0,CHEMBL618266,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,In vivo,4186,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8026,Rattus norvegicus,,CHEMBL618267,time required to reach maximum concentration (Cmax) after oral administration in rat,In vivo,15662,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8027,Rattus norvegicus,1088.0,CHEMBL618450,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),,429,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8028,Rattus norvegicus,1088.0,CHEMBL618451,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),,429,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8029,Rattus norvegicus,,CHEMBL618452,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,5546,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8030,Rattus norvegicus,1088.0,CHEMBL618453,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,,3173,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8031,Rattus norvegicus,1088.0,CHEMBL618454,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,,3173,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8032,Rattus norvegicus,1088.0,CHEMBL618455,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,,3173,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8033,Rattus norvegicus,,CHEMBL618456,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,In vivo,4257,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8034,Rattus norvegicus,,CHEMBL618457,Compound distribution in rat tissues was determined,In vivo,6011,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8035,Rattus norvegicus,,CHEMBL618458,Volume of distribution was evaluated in rat,In vivo,5472,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8036,Rattus norvegicus,,CHEMBL618459,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,,14346,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8037,Rattus norvegicus,,CHEMBL876733,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,,14346,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8038,Canis lupus familiaris,,CHEMBL618460,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,,14346,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
8039,Rattus norvegicus,,CHEMBL618461,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,,14346,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8040,,,CHEMBL618462,Area under the curve was determined after oral administration (300 uM/Kg),,15469,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
8041,Rattus norvegicus,,CHEMBL618463,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,,14346,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8042,Rattus norvegicus,,CHEMBL618464,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,,14346,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8043,Rattus norvegicus,,CHEMBL618465,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,,14346,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8044,Rattus norvegicus,,CHEMBL618466,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,,14346,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8045,Rattus norvegicus,,CHEMBL618467,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,,14346,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8046,Rattus norvegicus,,CHEMBL618468,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,,15372,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8047,Canis lupus familiaris,1969.0,CHEMBL618469,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,,12935,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
8048,Canis lupus familiaris,1969.0,CHEMBL618470,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,,12935,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
8049,,,CHEMBL618471,Plasma drug AUC in rat (PO dose),,14813,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
8050,Mus musculus,,CHEMBL618472,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,,15792,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8051,,,CHEMBL618473,Area under was determined at a dose of 30 mg/kg,,3579,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
8052,Mustela putorius furo,,CHEMBL621699,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,,12487,,50506,,,BAO_0000218,,Intermediate,,9669.0,N,1,1,
8053,Rattus norvegicus,,CHEMBL621700,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,,12487,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8054,Rattus norvegicus,,CHEMBL621701,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,,12487,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8055,Mustela putorius furo,,CHEMBL621702,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,,12487,,50506,,,BAO_0000218,,Intermediate,,9669.0,N,1,1,
8056,Canis lupus familiaris,,CHEMBL621703,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,,12487,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
8057,Canis lupus familiaris,,CHEMBL621704,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,,12487,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
8058,Rattus norvegicus,,CHEMBL624259,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",,12902,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8059,Rattus norvegicus,,CHEMBL624260,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",,12902,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8060,Rattus norvegicus,,CHEMBL624430,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",,12902,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8061,Rattus norvegicus,,CHEMBL624431,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",,12902,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8062,Rattus norvegicus,,CHEMBL624432,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",,12902,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8063,Rattus norvegicus,,CHEMBL624433,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",,12902,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8064,Rattus norvegicus,,CHEMBL624434,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",,12902,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8065,Rattus norvegicus,,CHEMBL624435,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",,12902,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8066,Mus musculus,,CHEMBL618570,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,,12745,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8067,Mus musculus,,CHEMBL618571,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,12745,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8068,Mus musculus,,CHEMBL618572,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,,12745,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8069,Mus musculus,,CHEMBL618573,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,12745,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8070,Mus musculus,,CHEMBL619267,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,,12745,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8071,Mus musculus,,CHEMBL619431,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,12745,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8072,Mus musculus,,CHEMBL619432,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,,12745,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8073,Mus musculus,,CHEMBL619433,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,12745,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8074,,1969.0,CHEMBL619434,AUC in mice after oral dose (50 mg/kg),,13298,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
8075,Mus musculus,1977.0,CHEMBL619435,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,,12226,Serum,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8076,,1969.0,CHEMBL619436,AUC (0-4 hr) ug/ml/h,,12634,Plasma,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
8077,Rattus norvegicus,,CHEMBL619437,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,,14810,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8078,,,CHEMBL619438,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,,13889,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
8079,Mus musculus,,CHEMBL619439,Compound was evaluated for Area under curve in mice,,10018,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8080,Rattus norvegicus,,CHEMBL619440,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,8758,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8081,,,CHEMBL619441,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,8758,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
8082,Rattus norvegicus,,CHEMBL619442,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,8758,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8083,,,CHEMBL875156,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,,2249,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
8084,,,CHEMBL619443,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,,2249,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
8085,,,CHEMBL619444,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,,2249,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
8086,,,CHEMBL623464,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,,2249,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
8087,Mus musculus,,CHEMBL623465,Compound was evaluated for area under curve when administered through oral route in mouse,,15115,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8088,Rattus norvegicus,,CHEMBL623466,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,In vivo,6518,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8089,Rattus norvegicus,,CHEMBL623467,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,In vivo,6518,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8090,Rattus norvegicus,,CHEMBL623468,Plasma clearance in rat,In vivo,6249,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8091,Rattus norvegicus,,CHEMBL622660,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,In vivo,2463,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8092,Rattus norvegicus,,CHEMBL622661,Plasma clearance rate in Sprague-Dawley rats,In vivo,4969,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8093,Rattus norvegicus,,CHEMBL622662,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,In vivo,17720,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8094,Rattus norvegicus,,CHEMBL622663,Pharmacokinetic property (total body clearance) in rat,In vivo,3457,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8095,Rattus norvegicus,,CHEMBL622664,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,In vivo,5983,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8096,Rattus norvegicus,,CHEMBL622665,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,6295,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8097,Rattus norvegicus,,CHEMBL622666,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,6296,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8098,Rattus norvegicus,,CHEMBL621615,Cl in rat i.v. at 2 mg/kg concentration,In vivo,17686,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8099,Rattus norvegicus,,CHEMBL621616,Clearance of compound after intravenous administration in rats at 24 uM/kg,In vivo,17764,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8100,Rattus norvegicus,,CHEMBL621617,Clearance was determined,In vivo,5503,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8101,Rattus norvegicus,,CHEMBL621618,Clearance by intravenous administration of 3.4 mg/kg in rat,In vivo,4368,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8102,Rattus norvegicus,,CHEMBL621619,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,In vivo,6005,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8103,Rattus norvegicus,,CHEMBL621620,Clearance rate after i.v. administration in rats,In vivo,5031,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8104,Rattus norvegicus,,CHEMBL621786,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,In vivo,4890,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8105,Rattus norvegicus,,CHEMBL621787,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,In vivo,5182,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8106,Rattus norvegicus,,CHEMBL621788,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,In vivo,5979,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8107,Rattus norvegicus,,CHEMBL621789,Clearance (Cl) after oral administration in rat,In vivo,5656,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8108,Rattus norvegicus,,CHEMBL621790,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,In vivo,17804,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8109,Rattus norvegicus,1969.0,CHEMBL621791,Compound was tested for plasma clearance in rat,In vivo,4839,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8110,Rattus norvegicus,,CHEMBL621792,In vitro microsome metabolism clearance in rat was determined,In vitro,5041,,50597,,,BAO_0000218,,Intermediate,Microsomes,10116.0,N,1,1,
8111,Rattus norvegicus,,CHEMBL621793,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,In vitro,5041,,50597,,,BAO_0000218,,Intermediate,Microsomes,10116.0,N,1,1,
8112,Rattus norvegicus,,CHEMBL621794,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,In vivo,5974,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8113,Rattus norvegicus,1969.0,CHEMBL621795,In vivo plasma clearance was determined,In vivo,5496,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8114,Rattus norvegicus,,CHEMBL621796,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,In vivo,5739,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8115,Rattus norvegicus,2107.0,CHEMBL621797,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,In vivo,5676,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,401.0
8116,Rattus norvegicus,,CHEMBL621798,Pharmacokinetic property (Plasma clearance) was measured in rat,In vivo,4239,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8117,Rattus norvegicus,,CHEMBL621799,Pharmacokinetic property (clearance) in rat i.v.,In vivo,5676,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8118,Rattus norvegicus,,CHEMBL621800,"Plasma Clearance was evaluated in rats, iv",In vivo,1918,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8119,Rattus norvegicus,,CHEMBL621801,Plasma clearance (in vivo) in rats was determined,In vivo,17800,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8120,Rattus norvegicus,,CHEMBL621802,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,In vivo,6056,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8121,Rattus norvegicus,,CHEMBL618596,Plasma clearance was determined,In vivo,5496,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8122,Rattus norvegicus,,CHEMBL618597,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,In vivo,5939,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8123,Rattus norvegicus,,CHEMBL618598,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,In vivo,5939,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8124,Rattus norvegicus,,CHEMBL618599,Plasma clearance in rats,In vivo,17752,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8125,Rattus norvegicus,,CHEMBL618600,Plasma clearance rate determined in rat,In vivo,4576,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8126,Rattus norvegicus,,CHEMBL618601,Plasma clearance was determined in rat,In vivo,6011,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8127,Rattus norvegicus,,CHEMBL618602,Plasma clearance was determined,In vivo,5510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8128,Rattus norvegicus,,CHEMBL618603,Plasma clearance value in rat,In vivo,5948,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8129,Rattus norvegicus,2107.0,CHEMBL618604,Clearance rate constant using isolated perfused rat liver (IPRL) assay,Ex vivo,6125,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8130,Rattus norvegicus,,CHEMBL618605,Clearance in rat,In vivo,4839,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8131,Rattus norvegicus,,CHEMBL618606,Total body clearance in rat i.v. at 2 mg/kg concentration,In vivo,17686,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8132,Rattus norvegicus,,CHEMBL618607,Clearance of compound in rats after intravenous administration,In vivo,6571,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8133,Rattus norvegicus,,CHEMBL618608,Clearance after iv administration to rats,In vivo,3364,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8134,Rattus norvegicus,,CHEMBL618609,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,In vivo,13569,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8135,Rattus norvegicus,,CHEMBL618610,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,In vivo,13569,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8136,Rattus norvegicus,,CHEMBL618611,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,In vivo,13569,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8137,Rattus norvegicus,,CHEMBL618612,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,In vivo,13569,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8138,Rattus norvegicus,,CHEMBL618613,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,In vivo,13569,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8139,Rattus norvegicus,,CHEMBL621076,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,In vivo,13569,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8140,Rattus norvegicus,,CHEMBL621077,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,In vivo,13569,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8141,Rattus norvegicus,,CHEMBL621078,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",In vivo,17670,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8142,Rattus norvegicus,,CHEMBL621251,Clearance in rat,In vivo,5970,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8143,Rattus norvegicus,,CHEMBL621252,Clearance in rat after oral administration at 10 mg/kg,In vivo,6495,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8144,Rattus norvegicus,,CHEMBL621253,Clearance in rat.,In vivo,4590,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8145,Rattus norvegicus,,CHEMBL621254,Clearance rate following an oral dose of 20 mg/kg in rats,In vivo,6193,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8146,Rattus norvegicus,,CHEMBL621255,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,In vivo,2832,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8147,Rattus norvegicus,1969.0,CHEMBL621256,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,In vivo,1052,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8148,Rattus norvegicus,2107.0,CHEMBL621257,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,In vivo,9866,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8149,Rattus norvegicus,2107.0,CHEMBL621258,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,In vivo,9866,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8150,Rattus norvegicus,2107.0,CHEMBL621259,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,In vivo,9866,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8151,Rattus norvegicus,2107.0,CHEMBL621260,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,In vivo,9866,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8152,Rattus norvegicus,2107.0,CHEMBL876494,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,In vivo,9866,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8153,Rattus norvegicus,2107.0,CHEMBL621261,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,In vivo,9866,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8154,Rattus norvegicus,2107.0,CHEMBL621262,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,In vivo,9866,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8155,Rattus norvegicus,2107.0,CHEMBL621263,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,In vivo,9866,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8156,Rattus norvegicus,2107.0,CHEMBL621264,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,In vivo,9866,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8157,Rattus norvegicus,2385.0,CHEMBL621265,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,In vivo,9866,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8158,Rattus norvegicus,2385.0,CHEMBL621266,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,In vivo,9866,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8159,Rattus norvegicus,2385.0,CHEMBL621267,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,In vivo,9866,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8160,Rattus norvegicus,2385.0,CHEMBL621268,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,In vivo,9866,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8161,Rattus norvegicus,2385.0,CHEMBL621269,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,In vivo,9866,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8162,Rattus norvegicus,2385.0,CHEMBL621270,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,In vivo,9866,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8163,Rattus norvegicus,2385.0,CHEMBL621271,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,In vivo,9866,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8164,Rattus norvegicus,2385.0,CHEMBL621272,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,In vivo,9866,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8165,Rattus norvegicus,2385.0,CHEMBL621273,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,In vivo,9866,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8166,Rattus norvegicus,2385.0,CHEMBL621274,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,In vivo,9866,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8167,Rattus norvegicus,2385.0,CHEMBL876495,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,In vivo,9866,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8168,Rattus norvegicus,2385.0,CHEMBL621275,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,In vivo,9866,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8169,Rattus norvegicus,2385.0,CHEMBL621276,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,In vivo,9866,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8170,Rattus norvegicus,2385.0,CHEMBL621277,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,In vivo,9866,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8171,Rattus norvegicus,160.0,CHEMBL621278,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,In vivo,9866,Intestine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8172,Rattus norvegicus,160.0,CHEMBL621279,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,In vivo,9866,Intestine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8173,Rattus norvegicus,160.0,CHEMBL621280,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),In vivo,9866,Intestine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8174,Rattus norvegicus,2106.0,CHEMBL621281,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,In vivo,9866,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8175,Rattus norvegicus,2106.0,CHEMBL621282,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,In vivo,9866,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8176,Rattus norvegicus,2106.0,CHEMBL621283,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,In vivo,9866,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8177,Rattus norvegicus,2106.0,CHEMBL621284,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,In vivo,9866,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8178,Rattus norvegicus,2106.0,CHEMBL621285,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,In vivo,9866,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8179,Rattus norvegicus,2106.0,CHEMBL621286,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,In vivo,9866,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8180,Rattus norvegicus,2106.0,CHEMBL623220,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,In vivo,9866,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8181,Rattus norvegicus,2106.0,CHEMBL623221,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,In vivo,9866,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8182,Rattus norvegicus,2106.0,CHEMBL876029,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,In vivo,9866,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8183,Rattus norvegicus,945.0,CHEMBL623222,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,In vivo,9866,Stomach,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8184,Rattus norvegicus,945.0,CHEMBL623223,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,In vivo,9866,Stomach,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8185,Rattus norvegicus,945.0,CHEMBL621445,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,In vivo,9866,Stomach,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8186,Rattus norvegicus,178.0,CHEMBL621446,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8187,Rattus norvegicus,178.0,CHEMBL621447,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8188,Rattus norvegicus,178.0,CHEMBL619681,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8189,Rattus norvegicus,178.0,CHEMBL619682,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8190,Rattus norvegicus,178.0,CHEMBL619683,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8191,Rattus norvegicus,955.0,CHEMBL619684,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8192,Rattus norvegicus,955.0,CHEMBL619685,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8193,Rattus norvegicus,955.0,CHEMBL619686,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8194,Rattus norvegicus,955.0,CHEMBL619687,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8195,Rattus norvegicus,955.0,CHEMBL619688,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8196,Rattus norvegicus,948.0,CHEMBL619689,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8197,Rattus norvegicus,948.0,CHEMBL619690,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8198,Rattus norvegicus,948.0,CHEMBL619691,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8199,Rattus norvegicus,,CHEMBL619692,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,In vivo,6062,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8200,Rattus norvegicus,,CHEMBL619693,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,,3598,,50597,,,BAO_0000218,,Expert,,10116.0,N,1,1,
8201,Rattus norvegicus,,CHEMBL619694,Vc value after IV dose at a dose of 5 mg/kg in rats.,In vivo,1908,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8202,Rattus norvegicus,,CHEMBL619695,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,In vivo,17596,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8203,Rattus norvegicus,,CHEMBL619696,Compound was evaluated for pharmacokinetic parameter volume of distribution,In vivo,4891,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8204,Rattus norvegicus,,CHEMBL619697,Compound was evaluated for volume of distribution in rat,In vivo,740,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8205,Rattus norvegicus,,CHEMBL619698,Steady state volume distribution was determined; steady state(ss),In vivo,16366,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8206,Rattus norvegicus,,CHEMBL619699,Steady state volume of distribution after iv administration to rats,In vivo,3364,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8207,Rattus norvegicus,,CHEMBL619700,Steady state volume of distribution dosing at 3 mg/kg iv,In vivo,2552,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8208,Rattus norvegicus,,CHEMBL619701,The compound was evaluated for volume of distribution in rat,In vivo,406,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8209,Rattus norvegicus,,CHEMBL619702,The compound was tested for volume of distribution in rat,In vivo,12500,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8210,Rattus norvegicus,,CHEMBL620335,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,In vivo,12500,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8211,Rattus norvegicus,,CHEMBL620336,Volume distribution (VD) after oral administration in rat,In vivo,5656,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8212,Rattus norvegicus,,CHEMBL620337,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,In vivo,17671,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8213,Rattus norvegicus,,CHEMBL620520,Volume distribution in rat,In vivo,1094,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8214,Rattus norvegicus,,CHEMBL620521,Volume distribution in rat,In vivo,5833,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8215,Rattus norvegicus,,CHEMBL875825,Volume distribution in rat after peroral administration at 10 mg/kg,In vivo,5939,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8216,Rattus norvegicus,,CHEMBL620522,Volume distribution in rat after peroral administration at 5 mg/kg,In vivo,5939,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8217,Rattus norvegicus,,CHEMBL620523,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,In vivo,6005,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8218,Rattus norvegicus,,CHEMBL620524,Volume of distribution in rat.,In vivo,1696,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8219,Rattus norvegicus,,CHEMBL620525,Volume of distribution in rat,In vivo,6672,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8220,Rattus norvegicus,,CHEMBL620526,Volume of distribution in rat,In vivo,6673,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8221,Rattus norvegicus,,CHEMBL620527,Volume of distribution in rat by iv administration,In vivo,5871,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8222,Rattus norvegicus,,CHEMBL620528,Volume of distribution in rats,In vivo,6803,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8223,Rattus norvegicus,,CHEMBL620529,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,In vivo,5199,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8224,Rattus norvegicus,,CHEMBL620530,Volume distribution at the dose of 2 mg/kg in rat,,4727,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8225,Rattus norvegicus,,CHEMBL620531,Steady state volume of distribution was determined,In vivo,16367,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8226,Macaca mulatta,,CHEMBL620532,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,In vivo,5005,,22224,,,BAO_0000218,,Intermediate,,9544.0,U,0,1,
8227,Rattus norvegicus,,CHEMBL620533,Compound was tested for its plasma volume distribution in Sprague Dawley rats,In vivo,5005,,22224,,,BAO_0000218,,Intermediate,,10116.0,U,0,1,
8228,Rattus norvegicus,,CHEMBL620534,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,In vivo,5005,,22224,,,BAO_0000218,,Intermediate,,10116.0,U,0,1,
8229,Rattus norvegicus,,CHEMBL620535,Mean (%CV) PK parameters for Vdss(mL/kg).,In vivo,15765,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8230,Rattus norvegicus,,CHEMBL875826,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,In vivo,2792,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8231,Rattus norvegicus,,CHEMBL620536,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,In vivo,2792,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8232,Rattus norvegicus,,CHEMBL620537,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,In vivo,5334,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8233,Rattus norvegicus,,CHEMBL618526,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,In vivo,5334,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8234,Rattus norvegicus,,CHEMBL618527,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,In vivo,5739,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8235,Rattus norvegicus,,CHEMBL618528,Pharmacokinetic property (Vdss) in rat,In vivo,5789,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8236,Rattus norvegicus,,CHEMBL618529,Pharmacokinetic property (vdss) was measured in rat,In vivo,4239,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8237,Rattus norvegicus,,CHEMBL618530,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,In vivo,4709,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8238,Rattus norvegicus,,CHEMBL618531,Volume of distribution in rat,In vivo,6642,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8239,Rattus norvegicus,,CHEMBL618532,The pharmacokinetic parameter volume of distribution in vivo in rats,In vivo,5247,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8240,Rattus norvegicus,,CHEMBL618533,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,In vivo,17720,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8241,Rattus norvegicus,,CHEMBL618534,Vdss in rat i.v. at 2 mg/kg concentration,In vivo,17686,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8242,Rattus norvegicus,,CHEMBL618535,Volume distribution after intravenous administration (1 mg/kg) in rat,In vivo,4689,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8243,Rattus norvegicus,,CHEMBL618536,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,In vivo,5654,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8244,Rattus norvegicus,,CHEMBL618537,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,In vivo,5654,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8245,Rattus norvegicus,,CHEMBL618538,Volume distribution at a dose of 10 uM/kg in rat was determined,In vivo,4527,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8246,Rattus norvegicus,,CHEMBL618539,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,In vivo,4521,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8247,Rattus norvegicus,,CHEMBL618540,Volume distribution was calculated in rat,In vivo,6057,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8248,Rattus norvegicus,,CHEMBL618541,Volume distribution was determined,In vivo,5510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8249,Rattus norvegicus,,CHEMBL618542,Volume of distribution after intravenous administration was evaluated in rat,In vivo,2938,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8250,Rattus norvegicus,,CHEMBL622544,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,In vivo,6679,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8251,Rattus norvegicus,,CHEMBL622545,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",In vivo,6685,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8252,Rattus norvegicus,,CHEMBL622546,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",In vivo,6685,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8253,Rattus norvegicus,,CHEMBL622547,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",In vivo,6685,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8254,Rattus norvegicus,,CHEMBL622548,Volume of distribution in steady state was determined in rat,In vivo,5145,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8255,Rattus norvegicus,,CHEMBL622549,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,In vivo,6467,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8256,Rattus norvegicus,,CHEMBL622550,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,In vivo,6467,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8257,Mus musculus,,CHEMBL622551,Compound was evaluated for area under curve when administered through oral route to mouse,,15115,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8258,Rattus norvegicus,,CHEMBL622552,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,8758,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8259,Rattus norvegicus,,CHEMBL622553,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,8758,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8260,,,CHEMBL622554,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,In vivo,8267,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
8261,Canis lupus familiaris,,CHEMBL622555,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,,8267,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
8262,Mus musculus,,CHEMBL622556,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,,14239,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8263,Mus musculus,,CHEMBL622557,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,,14239,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8264,Mus musculus,178.0,CHEMBL622558,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,,10754,Blood,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8265,Mus musculus,178.0,CHEMBL622559,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,,10754,Blood,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8266,Canis lupus familiaris,,CHEMBL622560,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,,10754,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
8267,Rattus norvegicus,,CHEMBL622561,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,,14681,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8268,Rattus norvegicus,,CHEMBL622562,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,,14681,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8269,Rattus norvegicus,,CHEMBL622563,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,14681,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8270,,,CHEMBL622564,Concentration of compound in Central nervous system,,13118,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
8271,,,CHEMBL622565,Concentration of compound in Central nervous system; Not detectable,,13118,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
8272,Mus musculus,,CHEMBL622566,"Concentration of diester in the blood, following oral administration in mice",,13318,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8273,Mus musculus,,CHEMBL624515,"Concentration of monoester in the blood, following oral administration in mice",,13318,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8274,Mus musculus,,CHEMBL624516,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,,13318,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8275,,,CHEMBL624517,Evaluated for Pharmacokinetic property: Area under the curve,,15692,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
8276,Mus musculus,,CHEMBL624518,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,,14839,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8277,Macaca fascicularis,,CHEMBL624519,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,,14839,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
8278,Macaca fascicularis,,CHEMBL624520,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,,14839,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
8279,Macaca fascicularis,,CHEMBL624521,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,,14839,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
8280,Macaca fascicularis,,CHEMBL624522,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,,14839,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
8281,Macaca fascicularis,,CHEMBL624523,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,,14839,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
8282,Macaca fascicularis,,CHEMBL624409,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,14839,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
8283,Macaca fascicularis,,CHEMBL624410,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",,14839,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
8284,Macaca fascicularis,,CHEMBL624411,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,14839,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
8285,Macaca fascicularis,,CHEMBL623531,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",,14839,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
8286,Macaca fascicularis,,CHEMBL623532,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",,14839,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
8287,Macaca fascicularis,,CHEMBL623533,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",,14839,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
8288,Macaca fascicularis,,CHEMBL623534,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,14839,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
8289,Mus musculus,,CHEMBL623535,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,,14839,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8290,Mus musculus,,CHEMBL623536,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,,14839,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8291,Mus musculus,,CHEMBL623537,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,,14839,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8292,Mus musculus,,CHEMBL623538,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,,14839,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8293,Mus musculus,,CHEMBL623539,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,,14839,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8294,Mus musculus,,CHEMBL623540,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,,14839,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8295,Mus musculus,,CHEMBL623541,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",,14839,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8296,Mus musculus,,CHEMBL623542,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",,14839,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8297,Mus musculus,,CHEMBL623543,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",,14839,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8298,Mus musculus,,CHEMBL623544,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",,14839,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8299,Mus musculus,,CHEMBL623545,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",,14839,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8300,Mus musculus,,CHEMBL623546,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",,14839,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8301,Rattus norvegicus,1969.0,CHEMBL623547,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,In vivo,5408,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8302,Rattus norvegicus,,CHEMBL623548,High i.v. clearance in Dawley rats,In vivo,6827,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8303,Rattus norvegicus,2107.0,CHEMBL623549,In vitro clearance in rat liver microsomes,In vitro,17538,Liver,50597,,,BAO_0000218,,Intermediate,Microsomes,10116.0,N,1,1,
8304,Rattus norvegicus,2107.0,CHEMBL623550,Intrinsic clearance in rat liver microsomes was determined,In vitro,6331,Liver,50597,,,BAO_0000218,,Intermediate,Microsomes,10116.0,N,1,1,
8305,Rattus norvegicus,2107.0,CHEMBL875276,Intrinsic clearance in rat hepatocytes was determined,In vitro,5948,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,401.0
8306,Rattus norvegicus,,CHEMBL621872,Plasma Clearance was determined,In vivo,4026,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8307,Rattus norvegicus,,CHEMBL621873,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,In vivo,6647,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8308,Rattus norvegicus,,CHEMBL621874,Plasma clearance in rat.,In vivo,1696,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8309,Rattus norvegicus,,CHEMBL621875,Plasma clearance in rats,In vivo,6597,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8310,Rattus norvegicus,,CHEMBL621876,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,In vivo,347,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8311,Rattus norvegicus,,CHEMBL621877,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,In vivo,16423,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8312,Rattus norvegicus,,CHEMBL621878,Plasma clearance was measured in rat,In vivo,2879,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8313,Rattus norvegicus,,CHEMBL621879,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,In vivo,4883,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8314,Rattus norvegicus,1969.0,CHEMBL621880,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",In vivo,5328,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8315,Rattus norvegicus,,CHEMBL621881,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,In vivo,5160,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8316,Rattus norvegicus,,CHEMBL621882,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,In vivo,17582,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8317,Rattus norvegicus,,CHEMBL875283,Total clearance at 1 mg/kg was determined in rat,In vivo,17651,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8318,Rattus norvegicus,,CHEMBL621883,Total clearance at 10 mg/kg was determined in rat,In vivo,17651,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8319,Rattus norvegicus,,CHEMBL621884,Clearance in rat,In vivo,6596,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8320,Rattus norvegicus,,CHEMBL621885,Plasma clearance rate determined in rats,In vivo,4796,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8321,Rattus norvegicus,,CHEMBL621886,Clearance of compound in rat was evaluated,In vivo,6850,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8322,Rattus norvegicus,1969.0,CHEMBL621887,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,In vivo,5932,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8323,Rattus norvegicus,,CHEMBL621888,Pharmacokinetic property (blood clearance) in rat,In vivo,3371,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8324,Rattus norvegicus,,CHEMBL621889,Plasma clearance in rat,In vivo,2083,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8325,Rattus norvegicus,,CHEMBL621890,Plasma clearance in rats,In vivo,4942,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8326,Rattus norvegicus,2107.0,CHEMBL621891,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,In vitro,6838,Liver,50597,,,BAO_0000218,,Intermediate,Microsomes,10116.0,N,1,1,
8327,Rattus norvegicus,,CHEMBL621892,Clearance in Dawley rat,In vivo,5353,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8328,Rattus norvegicus,,CHEMBL621893,Clearance rat,In vivo,6641,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8329,Rattus norvegicus,,CHEMBL621894,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),In vivo,6641,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8330,Rattus norvegicus,,CHEMBL621895,Clearance rat; Not determined,In vivo,6641,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8331,Rattus norvegicus,,CHEMBL875284,Clearance rate was determined in rat at a dose of 1 mpk i.v.,In vivo,6444,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8332,Rattus norvegicus,,CHEMBL618699,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,In vivo,6444,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8333,Rattus norvegicus,,CHEMBL618700,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,In vivo,6444,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8334,Rattus norvegicus,,CHEMBL618701,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,In vivo,6211,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8335,Rattus norvegicus,1969.0,CHEMBL876600,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",In vivo,12873,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8336,Rattus norvegicus,,CHEMBL618702,Clearance of compound in rat after 1 mg/kg i.v. administration,In vivo,6570,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8337,Rattus norvegicus,,CHEMBL618703,Compound was evaluated for Hepatic clearance in rat,In vivo,3341,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8338,Rattus norvegicus,,CHEMBL618704,In vivo clearance after 5 mg/kg dose,In vivo,4891,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8339,Rattus norvegicus,1969.0,CHEMBL618705,Compound was tested for plasma clearance in rats,In vivo,1094,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8340,Rattus norvegicus,,CHEMBL618706,Hepatic clearance after intravenous administration was evaluated in rat,In vivo,2938,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8341,Rattus norvegicus,,CHEMBL618707,Lower clearance in rat (i.v.) at 0.5 mpk,In vivo,17853,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8342,Rattus norvegicus,1969.0,CHEMBL618708,Pharmacokinetic parameter expressed as plasma clearance in rat,In vivo,6049,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8343,Rattus norvegicus,,CHEMBL618709,Pharmacokinetic property (Clp) in rat,In vivo,5789,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8344,Rattus norvegicus,,CHEMBL618710,Plasma clearance in Sprague-Dawley rats,In vivo,4514,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8345,Rattus norvegicus,,CHEMBL618711,Plasma clearance (Clp) in rat,In vivo,6448,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8346,Rattus norvegicus,,CHEMBL618712,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,In vivo,6062,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8347,Rattus norvegicus,,CHEMBL618713,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,In vivo,5710,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8348,Rattus norvegicus,,CHEMBL618714,Plasma clearance after intravenous administration of 1 mg/kg in rat,In vivo,4709,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8349,Rattus norvegicus,,CHEMBL618715,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,In vivo,4521,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8350,Rattus norvegicus,,CHEMBL618716,Plasma clearance in rat was determined,In vivo,1742,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8351,Rattus norvegicus,,CHEMBL876601,Plasma clearance measured in rat,In vivo,6057,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8352,Rattus norvegicus,,CHEMBL618717,Plasma clearance was calculated in rat,In vivo,6057,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8353,Rattus norvegicus,,CHEMBL618718,Plasma clearance in rat,In vivo,5145,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8354,Rattus norvegicus,,CHEMBL618719,Plasma clearance in rat,In vivo,5833,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8355,Rattus norvegicus,,CHEMBL618720,Plasma clearance in rat,In vivo,6453,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8356,Rattus norvegicus,,CHEMBL618721,Plasma clearance in rat,In vivo,6640,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8357,Rattus norvegicus,,CHEMBL621477,Plasma clearance in rats,In vivo,6305,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8358,Rattus norvegicus,,CHEMBL621478,Plasma clearance in rat,In vivo,6642,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8359,Rattus norvegicus,,CHEMBL621479,Plasma clearance was evaluated in rat,In vivo,5472,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8360,Rattus norvegicus,,CHEMBL621480,Plasma clearance was evaluated in rat; Not tested,In vivo,5472,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8361,Rattus norvegicus,,CHEMBL621481,Plasma clearance rate was determined for the compound in rat,In vivo,5144,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8362,Rattus norvegicus,,CHEMBL621482,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",In vivo,6685,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8363,Rattus norvegicus,,CHEMBL621483,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",In vivo,6685,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8364,Rattus norvegicus,,CHEMBL621484,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",In vivo,6685,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8365,Rattus norvegicus,948.0,CHEMBL621485,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8366,Rattus norvegicus,948.0,CHEMBL621486,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8367,Rattus norvegicus,160.0,CHEMBL621487,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Intestine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8368,Rattus norvegicus,160.0,CHEMBL621488,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Intestine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8369,Rattus norvegicus,160.0,CHEMBL621489,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Intestine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8370,Rattus norvegicus,160.0,CHEMBL621490,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Intestine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8371,Rattus norvegicus,160.0,CHEMBL621491,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Intestine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8372,Rattus norvegicus,2113.0,CHEMBL621492,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8373,Rattus norvegicus,2113.0,CHEMBL621493,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,In vivo,13950,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8374,Rattus norvegicus,2113.0,CHEMBL621494,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8375,Rattus norvegicus,2113.0,CHEMBL621495,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8376,Rattus norvegicus,2113.0,CHEMBL621496,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8377,Rattus norvegicus,2107.0,CHEMBL621497,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8378,Rattus norvegicus,2107.0,CHEMBL621498,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8379,Rattus norvegicus,2107.0,CHEMBL621499,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8380,Rattus norvegicus,2107.0,CHEMBL618634,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,In vivo,13950,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8381,Rattus norvegicus,2107.0,CHEMBL618635,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8382,Rattus norvegicus,2048.0,CHEMBL618636,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8383,Rattus norvegicus,2048.0,CHEMBL619737,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8384,Rattus norvegicus,2048.0,CHEMBL619738,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8385,Rattus norvegicus,2048.0,CHEMBL624329,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8386,Rattus norvegicus,2048.0,CHEMBL624330,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8387,Rattus norvegicus,2385.0,CHEMBL624331,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8388,Rattus norvegicus,2385.0,CHEMBL624332,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8389,Rattus norvegicus,2385.0,CHEMBL624333,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8390,Rattus norvegicus,2385.0,CHEMBL624334,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8391,Rattus norvegicus,2385.0,CHEMBL624335,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8392,Rattus norvegicus,2106.0,CHEMBL620016,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8393,Rattus norvegicus,2106.0,CHEMBL620169,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8394,Rattus norvegicus,2106.0,CHEMBL620170,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8395,Rattus norvegicus,2106.0,CHEMBL620171,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,In vivo,13950,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8396,Rattus norvegicus,2106.0,CHEMBL620172,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8397,Rattus norvegicus,945.0,CHEMBL620173,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Stomach,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8398,Rattus norvegicus,945.0,CHEMBL620174,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,In vivo,13950,Stomach,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8399,Rattus norvegicus,945.0,CHEMBL620175,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Stomach,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8400,Rattus norvegicus,945.0,CHEMBL620176,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Stomach,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8401,Rattus norvegicus,945.0,CHEMBL620177,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,In vivo,13950,Stomach,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8402,Rattus norvegicus,2037.0,CHEMBL620178,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,13950,Cerebellum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8403,Rattus norvegicus,2037.0,CHEMBL620179,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,13950,Cerebellum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8404,Rattus norvegicus,,CHEMBL620180,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,,13950,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8405,Rattus norvegicus,,CHEMBL620181,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,In vivo,6570,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8406,Rattus norvegicus,,CHEMBL620182,Volume of distribution of compound in rats after intravenous administration,In vivo,6571,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8407,Rattus norvegicus,,CHEMBL620183,Volume of distribution in rat,In vivo,6453,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8408,Rattus norvegicus,,CHEMBL620184,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,In vivo,6444,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8409,Rattus norvegicus,,CHEMBL620185,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,In vivo,6444,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8410,Rattus norvegicus,,CHEMBL620186,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,In vivo,6444,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8411,Rattus norvegicus,,CHEMBL620187,Volume of distribution was determined in Dawley rat,In vivo,5353,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8412,Rattus norvegicus,,CHEMBL620188,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,In vivo,5334,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8413,Rattus norvegicus,,CHEMBL620189,Volume of distribution was reported in Sprague-Dawley rat,In vivo,5334,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8414,Rattus norvegicus,,CHEMBL620190,Volumes of distribution in rat after peroral administration,In vivo,6641,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8415,Rattus norvegicus,,CHEMBL620191,Volumes of distribution in rat after po administration,In vivo,6641,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8416,Rattus norvegicus,,CHEMBL620192,Volumes of distribution in rat after po administration; Not determined,In vivo,6641,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8417,Rattus norvegicus,,CHEMBL620193,Pharmacokinetic property (Volume) in rat i.v.,In vivo,5676,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8418,Rattus norvegicus,,CHEMBL620194,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,In vivo,6410,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8419,Rattus norvegicus,,CHEMBL876730,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",In vivo,17670,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8420,Rattus norvegicus,,CHEMBL620195,Volume distribution in rat after oral administration at 10 mg/kg,In vivo,6495,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8421,Rattus norvegicus,,CHEMBL620196,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,In vivo,5408,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8422,Rattus norvegicus,,CHEMBL620197,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,In vivo,4883,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8423,Rattus norvegicus,,CHEMBL620198,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,In vivo,6647,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8424,Rattus norvegicus,,CHEMBL620199,Volume of distribution in rats,In vivo,6495,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8425,Rattus norvegicus,,CHEMBL620200,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,In vivo,2661,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8426,Rattus norvegicus,,CHEMBL620201,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,In vivo,2661,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8427,Rattus norvegicus,,CHEMBL620202,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,In vivo,5974,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8428,Rattus norvegicus,,CHEMBL620203,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,In vivo,5974,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8429,Rattus norvegicus,,CHEMBL620204,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,In vivo,5974,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8430,Rattus norvegicus,,CHEMBL620205,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,In vivo,5974,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8431,Rattus norvegicus,,CHEMBL624664,Pharmacokinetic parameter (Vss) in rat,In vivo,5960,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8432,Rattus norvegicus,,CHEMBL624665,Pharmacokinetic property (Volume) in rat i.v.,In vivo,5676,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8433,Rattus norvegicus,,CHEMBL624666,Pharmacokinetic property (Vss) in rat,,5948,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8434,Rattus norvegicus,,CHEMBL624667,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,In vivo,5979,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8435,Rattus norvegicus,,CHEMBL624668,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,In vivo,5978,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8436,Rattus norvegicus,,CHEMBL624669,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,5978,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8437,Rattus norvegicus,,CHEMBL624670,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,5978,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8438,Rattus norvegicus,,CHEMBL624671,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,5978,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8439,Rattus norvegicus,,CHEMBL624672,Steady state volume distribution in rat,In vivo,6448,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8440,Rattus norvegicus,1969.0,CHEMBL624673,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",In vivo,12873,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8441,Rattus norvegicus,,CHEMBL624674,Steady state volume of distribution determined in rat,In vivo,4576,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8442,Rattus norvegicus,,CHEMBL624675,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,In vivo,17582,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8443,Rattus norvegicus,,CHEMBL621728,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,In vivo,1466,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8444,Rattus norvegicus,,CHEMBL621729,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,,5182,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8445,Rattus norvegicus,,CHEMBL621730,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,,5182,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8446,Rattus norvegicus,,CHEMBL621731,Volume distribution in rat after administration of 2 mg/kg iv,In vivo,6535,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8447,Rattus norvegicus,,CHEMBL621732,Volume distribution in rat after administration of 2 mg/kg iv,In vivo,6535,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8448,Rattus norvegicus,,CHEMBL621908,Volume in steady state distribution value was determined,In vivo,5041,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8449,Rattus norvegicus,,CHEMBL875347,Volume in steady state distribution value was determined; ND denotes no data,In vivo,5041,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8450,Rattus norvegicus,,CHEMBL621909,Volume in steady state distribution value was determined; ND denotes not determined,In vivo,5041,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8451,Rattus norvegicus,,CHEMBL621910,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,In vivo,17065,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8452,Rattus norvegicus,,CHEMBL621911,Volume of distribution at steady state was evaluated in rats,In vivo,6597,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8453,Rattus norvegicus,,CHEMBL621912,Volume of distribution at steady state was observed after intravenous administration in rat,In vivo,15662,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8454,Rattus norvegicus,,CHEMBL621913,Volume of distribution in steady state was determined in rat,In vivo,6485,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8455,Rattus norvegicus,,CHEMBL621914,Volume of distribution in steady state was determined in rat,In vivo,17655,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8456,Rattus norvegicus,,CHEMBL621915,Volume of distribution after i.v. administration,In vivo,6616,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8457,Rattus norvegicus,,CHEMBL621916,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,In vivo,1916,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8458,Mus musculus,2107.0,CHEMBL621917,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",In vivo,16438,Liver,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8459,Mus musculus,2107.0,CHEMBL621918,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",In vivo,16438,Liver,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8460,Mus musculus,2106.0,CHEMBL621919,Biodistribution of compound (oxidized form) in spleen tissue,In vivo,16438,Spleen,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8461,Mus musculus,2106.0,CHEMBL621920,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",In vivo,16438,Spleen,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8462,Mus musculus,2106.0,CHEMBL621921,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",In vivo,16438,Spleen,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8463,Mus musculus,2106.0,CHEMBL622401,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",In vivo,16438,Spleen,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8464,Mus musculus,2106.0,CHEMBL875348,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",In vivo,16438,Spleen,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8465,Mus musculus,2106.0,CHEMBL622402,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",In vivo,16438,Spleen,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8466,Mus musculus,178.0,CHEMBL622403,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,In vivo,16438,Blood,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8467,Mus musculus,178.0,CHEMBL622404,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",In vivo,16438,Blood,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8468,Mus musculus,955.0,CHEMBL622405,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,In vivo,16438,Brain,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8469,Mus musculus,955.0,CHEMBL622406,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",In vivo,16438,Brain,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8470,Mus musculus,955.0,CHEMBL622407,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",In vivo,16438,Brain,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8471,Mus musculus,948.0,CHEMBL622408,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,In vivo,16438,Heart,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8472,Mus musculus,948.0,CHEMBL622409,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",In vivo,16438,Heart,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8473,Mus musculus,948.0,CHEMBL622410,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",In vivo,16438,Heart,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8474,Mus musculus,2113.0,CHEMBL622411,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,In vivo,16438,Kidney,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8475,Mus musculus,2113.0,CHEMBL627864,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",In vivo,16438,Kidney,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8476,Mus musculus,2113.0,CHEMBL627865,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",In vivo,16438,Kidney,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8477,Mus musculus,2107.0,CHEMBL627866,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,In vivo,16438,Liver,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8478,Mus musculus,2107.0,CHEMBL627751,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",In vivo,16438,Liver,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8479,Mus musculus,2106.0,CHEMBL627752,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,In vivo,16438,Spleen,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8480,Mus musculus,2106.0,CHEMBL627753,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",In vivo,16438,Spleen,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8481,Mus musculus,2106.0,CHEMBL627754,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",In vivo,16438,Spleen,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8482,Mus musculus,,CHEMBL627755,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,,12467,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8483,Mus musculus,955.0,CHEMBL627756,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,17208,Brain,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8484,Mus musculus,955.0,CHEMBL627757,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,17208,Brain,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8485,Mus musculus,955.0,CHEMBL627758,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,17208,Brain,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8486,Mus musculus,955.0,CHEMBL627759,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,17208,Brain,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8487,Mus musculus,955.0,CHEMBL627760,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,17208,Brain,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8488,Mus musculus,955.0,CHEMBL627761,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,17208,Brain,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8489,Mus musculus,948.0,CHEMBL876811,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,17208,Heart,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8490,Mus musculus,948.0,CHEMBL627762,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,17208,Heart,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8491,Mus musculus,948.0,CHEMBL627763,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,17208,Heart,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8492,Mus musculus,948.0,CHEMBL627764,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,17208,Heart,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8493,Mus musculus,948.0,CHEMBL627765,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,17208,Heart,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8494,Mus musculus,948.0,CHEMBL627766,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,17208,Heart,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8495,Mus musculus,2113.0,CHEMBL627767,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,17208,Kidney,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8496,Mus musculus,2113.0,CHEMBL627768,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,17208,Kidney,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8497,Mus musculus,2113.0,CHEMBL628422,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,17208,Kidney,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8498,Mus musculus,2113.0,CHEMBL628423,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,17208,Kidney,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8499,Rattus norvegicus,,CHEMBL628424,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,In vivo,5089,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8500,Rattus norvegicus,,CHEMBL628425,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,In vivo,5089,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8501,Rattus norvegicus,,CHEMBL628426,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,In vivo,4257,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8502,Rattus norvegicus,,CHEMBL628427,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,In vivo,6679,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8503,Rattus norvegicus,,CHEMBL626938,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,In vivo,5546,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8504,Rattus norvegicus,,CHEMBL626939,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,In vivo,6141,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8505,Rattus norvegicus,,CHEMBL626940,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,In vivo,5334,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8506,Rattus norvegicus,,CHEMBL626941,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,In vivo,5334,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8507,Rattus norvegicus,,CHEMBL626942,Plasma clearance was reported in Sprague-Dawley rat,In vivo,5334,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8508,Rattus norvegicus,,CHEMBL876812,Plasma clearance after intravenous administration (1 mg/kg) in rat,In vivo,4689,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8509,Rattus norvegicus,,CHEMBL626943,Plasma clearance of compound in rats was evaluated,In vivo,6848,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8510,Rattus norvegicus,,CHEMBL626944,Plasma clearance of compound in rats was evaluated; ND indicates not determined,In vivo,6848,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8511,Rattus norvegicus,,CHEMBL626945,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,In vivo,6467,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8512,Rattus norvegicus,,CHEMBL626946,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,In vivo,6467,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8513,Rattus norvegicus,,CHEMBL626856,Plasma clearance rate in Sprague-Dawley rats,In vivo,4956,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8514,Rattus norvegicus,,CHEMBL626857,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),In vivo,5529,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8515,Rattus norvegicus,1969.0,CHEMBL626858,The compound was evaluated for plasma clearance in rat,In vivo,406,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8516,Rattus norvegicus,1969.0,CHEMBL627018,Total plasma clearance in rat,In vivo,17655,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8517,Rattus norvegicus,178.0,CHEMBL625331,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,In vivo,3293,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8518,Rattus norvegicus,178.0,CHEMBL625332,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,In vivo,4075,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8519,Rattus norvegicus,,CHEMBL877590,C max was determined at 10 mg/kg po dose in rats,In vivo,2792,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8520,Rattus norvegicus,,CHEMBL625333,C max was determined at 3 mg/kg po dose in rats,In vivo,2792,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8521,Rattus norvegicus,,CHEMBL625334,Cmax after repeated oral dose of compound at 1 mg/kg in rats,In vivo,17594,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8522,Rattus norvegicus,,CHEMBL625335,Cmax after single intravenous bolus of 1 mg/kg in rats,In vivo,17594,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8523,Rattus norvegicus,,CHEMBL625336,Cmax of compound at 5 mg/kg after po administration was determined in rat,In vivo,4762,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8524,Rattus norvegicus,,CHEMBL625337,Cmax 24 hr after 10 mg/kg oral administration in rats,In vivo,17509,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8525,Rattus norvegicus,,CHEMBL625338,Cmax 24 hr after 2 mg/kg oral administration in rats,In vivo,17509,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8526,Rattus norvegicus,1969.0,CHEMBL625339,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,In vivo,1466,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8527,Rattus norvegicus,,CHEMBL625340,Cmax in rat after administration of 2 mg/kg iv,In vivo,6535,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8528,Rattus norvegicus,,CHEMBL625341,Cmax in rat after administration of 2 mg/kg iv,In vivo,6535,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8529,Rattus norvegicus,,CHEMBL622687,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,In vivo,3169,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8530,Rattus norvegicus,1969.0,CHEMBL622688,Cmax wa determined in rat plasma at 30 mg/kg after po administration,In vivo,6515,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8531,Rattus norvegicus,178.0,CHEMBL622689,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,In vivo,11149,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8532,Rattus norvegicus,178.0,CHEMBL620295,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,In vivo,11149,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8533,Rattus norvegicus,,CHEMBL620296,Cmax after 10 mg/kg oral administration in rat,In vivo,17858,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8534,Rattus norvegicus,,CHEMBL620297,Cmax after IV dosing at 0.5 mg/kg in rat; no data,In vivo,6518,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8535,Rattus norvegicus,,CHEMBL620298,Cmax after IV dosing at 1 mg/kg in rat; no data,In vivo,6518,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8536,Rattus norvegicus,,CHEMBL620299,Cmax after oral administration at 20 mpk in rats,In vivo,4426,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8537,Rattus norvegicus,,CHEMBL620300,Cmax after oral administration at 20 mpk in rats; Not performed.,In vivo,4426,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8538,Rattus norvegicus,,CHEMBL620301,Cmax after oral administration at 20 mpk in rats d; Not performed.,In vivo,4426,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8539,Rattus norvegicus,,CHEMBL620302,Cmax after oral administration in rat,In vivo,5656,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8540,Rattus norvegicus,,CHEMBL620303,Cmax after oral administration at a dose of 2 mg/kg in rat,In vivo,6518,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8541,Rattus norvegicus,,CHEMBL620304,Cmax after oral administration at a dose of 4 mg/kg in rat,In vivo,6518,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8542,Rattus norvegicus,,CHEMBL620305,Cmax in rats after 20 mg/kg oral dose,In vivo,6113,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8543,Rattus norvegicus,,CHEMBL620306,Cmax after peroral administration in rats at 2.4 uM/kg,In vivo,17764,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8544,Rattus norvegicus,,CHEMBL620307,Cmax at the dose of 2 mg/Kg administered perorally in rats,In vivo,4756,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8545,Rattus norvegicus,,CHEMBL620308,Cmax at the dose of 5 mg/Kg administered perorally in rats,In vivo,4756,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8546,Rattus norvegicus,,CHEMBL620309,Cmax by administering at 20 mg/kg p.o. in rats,In vivo,6402,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8547,Rattus norvegicus,,CHEMBL620310,Cmax in male rat,In vivo,5610,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8548,Rattus norvegicus,,CHEMBL620311,Cmax in rat,In vivo,5207,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8549,Rattus norvegicus,,CHEMBL620312,Cmax in rat,In vivo,6011,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8550,Rattus norvegicus,,CHEMBL620313,Cmax in rat,In vivo,6504,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8551,Rattus norvegicus,,CHEMBL620314,Cmax in rat at 10 mg/kg,In vivo,6046,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8552,Rattus norvegicus,,CHEMBL620315,Cmax in rat at the dose of 1 mg/kg i.v.,In vivo,6504,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8553,Rattus norvegicus,,CHEMBL620316,Cmax in rat by po administration at a dose of 40 mg/kg,In vivo,5874,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8554,Rattus norvegicus,,CHEMBL620317,Cmax in rat p.o. at 20 mg/kg concentration,In vivo,17686,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8555,Rattus norvegicus,,CHEMBL620318,Cmax in rats,In vivo,5836,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8556,Rattus norvegicus,,CHEMBL620319,Cmax in rats,In vivo,17596,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8557,Rattus norvegicus,,CHEMBL620320,Cmax was evaluated after 20 uM/kg of peroral administration,In vivo,16423,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8558,Rattus norvegicus,,CHEMBL620321,Cmax was measured in rats after peroral administration at 3 mg/kg,In vivo,17804,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8559,Rattus norvegicus,,CHEMBL620322,Cmax value after oral dose at a dose of 10 mg/kg in rats.,In vivo,1908,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8560,Rattus norvegicus,,CHEMBL620323,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,,13950,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8561,Rattus norvegicus,1870.0,CHEMBL620324,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,13950,Frontal cortex,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8562,Rattus norvegicus,1870.0,CHEMBL620325,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,13950,Frontal cortex,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8563,Rattus norvegicus,10000000.0,CHEMBL620326,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,,13950,Hippocampus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8564,Rattus norvegicus,10000000.0,CHEMBL620327,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,,13950,Hippocampus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8565,Rattus norvegicus,,CHEMBL620328,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,,13950,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8566,Rattus norvegicus,,CHEMBL620329,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,,13950,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8567,Rattus norvegicus,1891.0,CHEMBL620330,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,,13950,Midbrain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8568,Rattus norvegicus,1891.0,CHEMBL875286,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,,13950,Midbrain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8569,Rattus norvegicus,,CHEMBL620331,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,13950,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8570,Rattus norvegicus,,CHEMBL620332,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,13950,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8571,Rattus norvegicus,2435.0,CHEMBL620333,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,13950,Striatum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8572,Rattus norvegicus,2435.0,CHEMBL620334,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,13950,Striatum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8573,Rattus norvegicus,178.0,CHEMBL621015,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,16434,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8574,Rattus norvegicus,178.0,CHEMBL621016,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,16434,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8575,Rattus norvegicus,178.0,CHEMBL621191,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,16434,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8576,Rattus norvegicus,178.0,CHEMBL621192,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,16434,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8577,Rattus norvegicus,178.0,CHEMBL621193,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,16434,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8578,Rattus norvegicus,178.0,CHEMBL621194,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,16434,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8579,Rattus norvegicus,178.0,CHEMBL624204,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,16434,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8580,Rattus norvegicus,178.0,CHEMBL624205,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,16434,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8581,Rattus norvegicus,178.0,CHEMBL624206,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,16435,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8582,Rattus norvegicus,178.0,CHEMBL624207,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,16435,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8583,Rattus norvegicus,178.0,CHEMBL624208,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,16435,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8584,Rattus norvegicus,178.0,CHEMBL624209,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,16435,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8585,Rattus norvegicus,178.0,CHEMBL624210,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,16435,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8586,Rattus norvegicus,178.0,CHEMBL624211,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,16435,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8587,Rattus norvegicus,178.0,CHEMBL624212,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,16435,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8588,Rattus norvegicus,178.0,CHEMBL624213,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,16435,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8589,Rattus norvegicus,178.0,CHEMBL876611,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,16434,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8590,Rattus norvegicus,178.0,CHEMBL624214,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,16434,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8591,Rattus norvegicus,178.0,CHEMBL624215,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,16434,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8592,Rattus norvegicus,178.0,CHEMBL624216,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,16435,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8593,Rattus norvegicus,178.0,CHEMBL624217,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,16435,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8594,Rattus norvegicus,178.0,CHEMBL624218,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,16435,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8595,Rattus norvegicus,178.0,CHEMBL624219,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,16435,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8596,Rattus norvegicus,178.0,CHEMBL624220,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,16435,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8597,Rattus norvegicus,178.0,CHEMBL624221,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,16435,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8598,Rattus norvegicus,,CHEMBL624222,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8599,Rattus norvegicus,,CHEMBL624223,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8600,Rattus norvegicus,,CHEMBL624224,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8601,Rattus norvegicus,,CHEMBL624225,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8602,Rattus norvegicus,,CHEMBL622420,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,In vivo,17764,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8603,Rattus norvegicus,,CHEMBL622421,Volume of steady state distribution after i.v. administration in rats,In vivo,5031,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8604,Rattus norvegicus,,CHEMBL622422,Vss after intravenous administration (5.0 mg/kg) was determined in rat,In vivo,6215,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8605,Rattus norvegicus,,CHEMBL622423,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,In vivo,17671,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8606,Rattus norvegicus,,CHEMBL622424,Vss was determined,In vivo,17752,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8607,Rattus norvegicus,,CHEMBL622425,Vss in rat,In vivo,6596,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8608,Rattus norvegicus,,CHEMBL876612,Vss was evaluated after 10 uM/kg of intra arterial administration,In vivo,16423,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8609,Rattus norvegicus,,CHEMBL622426,volume of distribution at steady state was observed after intravenous administration in rat,In vivo,15662,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8610,Rattus norvegicus,,CHEMBL622427,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,In vivo,6062,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8611,Rattus norvegicus,,CHEMBL622428,Pharmacokinetic (PK) parameter Vz in rat,In vivo,5874,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8612,Rattus norvegicus,,CHEMBL622429,Volume distribution in rats,In vivo,4942,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8613,Rattus norvegicus,,CHEMBL622430,Volume of distribution in rat; No data,In vivo,17796,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8614,Rattus norvegicus,,CHEMBL622431,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,In vivo,4890,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8615,Rattus norvegicus,2116.0,CHEMBL622432,% absorption predicted from in vitro rat ileum transport studies,,15765,Ileum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8616,Rattus norvegicus,,CHEMBL622433,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,In vivo,13569,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8617,Rattus norvegicus,,CHEMBL622434,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,In vivo,13569,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8618,Rattus norvegicus,,CHEMBL622435,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,In vivo,13569,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8619,Rattus norvegicus,,CHEMBL618748,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),In vivo,13569,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8620,Rattus norvegicus,,CHEMBL618749,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,In vivo,13569,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8621,Rattus norvegicus,,CHEMBL618750,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,In vivo,13569,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8622,Rattus norvegicus,,CHEMBL618751,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,In vivo,13569,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8623,Rattus norvegicus,,CHEMBL618752,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,In vivo,13569,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8624,Rattus norvegicus,,CHEMBL618753,Oral bioavailability in rat,In vivo,4576,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8625,Rattus norvegicus,1969.0,CHEMBL618754,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,In vivo,750,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8626,Rattus norvegicus,,CHEMBL618755,Oral bioavailability in rat,In vivo,750,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8627,Rattus norvegicus,,CHEMBL618756,Oral bioavailability in rat,In vivo,4590,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8628,Rattus norvegicus,,CHEMBL618757,Oral bioavailability in rat,In vivo,1716,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8629,Rattus norvegicus,,CHEMBL618758,Bioavailability in rat,In vivo,1974,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8630,Rattus norvegicus,,CHEMBL621088,Oral bioavailability in rat (dose 30 mg/kg),In vivo,4502,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8631,Rattus norvegicus,,CHEMBL621089,Pharmacokinetic property (cLogP) in rat,,3371,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8632,Rattus norvegicus,178.0,CHEMBL621090,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,,9099,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8633,Rattus norvegicus,178.0,CHEMBL621091,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,,9099,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8634,Rattus norvegicus,,CHEMBL876731,Clearance in rat.,In vivo,4590,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8635,Rattus norvegicus,,CHEMBL621092,Compound was evaluated for its clearance when administered intravenously in rat,In vivo,3184,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8636,Rattus norvegicus,,CHEMBL621093,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,In vivo,16456,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8637,Rattus norvegicus,,CHEMBL621094,Blood: Brain distribution ratio is determined in rat,,4199,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8638,Rattus norvegicus,,CHEMBL621095,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,,4199,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8639,Rattus norvegicus,,CHEMBL621096,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,,4199,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8640,Rattus norvegicus,2113.0,CHEMBL621097,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,8677,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8641,Rattus norvegicus,,CHEMBL621098,Percent dose excreted in 0-48 hours administered ip to male rat,,7449,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8642,Rattus norvegicus,2037.0,CHEMBL621099,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,11977,Cerebellum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8643,Rattus norvegicus,2037.0,CHEMBL621100,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,11977,Cerebellum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8644,Rattus norvegicus,2037.0,CHEMBL621101,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,11977,Cerebellum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8645,Rattus norvegicus,2037.0,CHEMBL621102,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,11977,Cerebellum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8646,Rattus norvegicus,2037.0,CHEMBL876732,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,11977,Cerebellum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8647,Rattus norvegicus,,CHEMBL621103,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,11977,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8648,Rattus norvegicus,,CHEMBL621104,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,11977,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8649,Rattus norvegicus,,CHEMBL621105,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,11977,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8650,Rattus norvegicus,,CHEMBL621106,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,11977,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8651,Rattus norvegicus,,CHEMBL621107,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,11977,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8652,Rattus norvegicus,,CHEMBL621108,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,11977,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8653,Rattus norvegicus,,CHEMBL621109,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,11977,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8654,Mus musculus,2113.0,CHEMBL621110,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,17208,Kidney,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8655,Mus musculus,2113.0,CHEMBL621111,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,17208,Kidney,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8656,Mus musculus,2107.0,CHEMBL622541,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,17208,Liver,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8657,Mus musculus,2107.0,CHEMBL622542,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,17208,Liver,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8658,Mus musculus,2107.0,CHEMBL622543,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,17208,Liver,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8659,Mus musculus,2107.0,CHEMBL624412,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,17208,Liver,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8660,Mus musculus,2107.0,CHEMBL624413,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,17208,Liver,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8661,Mus musculus,2107.0,CHEMBL624414,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,17208,Liver,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8662,Mus musculus,2048.0,CHEMBL624415,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,17208,Lung,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8663,Mus musculus,2048.0,CHEMBL624416,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,17208,Lung,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8664,Mus musculus,2048.0,CHEMBL624417,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,17208,Lung,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8665,Mus musculus,2048.0,CHEMBL624418,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,17208,Lung,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8666,Mus musculus,2048.0,CHEMBL624419,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,17208,Lung,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8667,Mus musculus,2048.0,CHEMBL624420,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,17208,Lung,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8668,Mus musculus,2385.0,CHEMBL624421,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),In vivo,17208,Muscle tissue,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8669,Mus musculus,2385.0,CHEMBL624422,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,17208,Muscle tissue,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8670,Mus musculus,2385.0,CHEMBL624423,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,17208,Muscle tissue,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8671,Mus musculus,2385.0,CHEMBL625123,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,17208,Muscle tissue,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8672,Mus musculus,2385.0,CHEMBL625124,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,17208,Muscle tissue,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8673,Mus musculus,2385.0,CHEMBL625125,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,17208,Muscle tissue,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8674,Mus musculus,14.0,CHEMBL625126,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,17208,Zone of skin,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8675,Mus musculus,14.0,CHEMBL626947,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,17208,Zone of skin,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8676,Mus musculus,14.0,CHEMBL626948,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,17208,Zone of skin,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8677,Mus musculus,14.0,CHEMBL626949,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,17208,Zone of skin,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8678,Mus musculus,14.0,CHEMBL626950,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,17208,Zone of skin,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8679,Mus musculus,14.0,CHEMBL626951,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,17208,Zone of skin,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8680,Mus musculus,2106.0,CHEMBL626952,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,17208,Spleen,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8681,Mus musculus,2106.0,CHEMBL626953,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,17208,Spleen,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8682,Mus musculus,2106.0,CHEMBL626954,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,17208,Spleen,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8683,Mus musculus,2106.0,CHEMBL626955,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,17208,Spleen,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8684,Mus musculus,2106.0,CHEMBL626956,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,17208,Spleen,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8685,Mus musculus,2106.0,CHEMBL626957,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,17208,Spleen,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8686,Mus musculus,178.0,CHEMBL626958,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),In vivo,17208,Blood,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8687,Mus musculus,178.0,CHEMBL626959,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),In vivo,17208,Blood,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8688,Mus musculus,178.0,CHEMBL626960,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),In vivo,17208,Blood,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8689,Mus musculus,178.0,CHEMBL626961,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),In vivo,17208,Blood,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8690,Mus musculus,178.0,CHEMBL627589,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),In vivo,17208,Blood,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8691,Mus musculus,178.0,CHEMBL627590,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),In vivo,17208,Blood,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8692,Mus musculus,,CHEMBL627591,Time taken for EC90 was determined when tested in mouse,,3132,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8693,Mus musculus,,CHEMBL627592,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,,3132,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8694,Mus musculus,,CHEMBL627593,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),In vivo,16597,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8695,Mus musculus,,CHEMBL627594,Half life in mice,,5727,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8696,Mus musculus,,CHEMBL876813,Half life period in mouse after 10 mg/Kg dose,In vivo,5302,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8697,Mus musculus,,CHEMBL627595,Half life period in mouse after 10 mg/kg dose,In vivo,5302,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8698,Mus musculus,,CHEMBL627596,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,In vivo,6348,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8699,Rattus norvegicus,,CHEMBL627597,Cmax value at 5 mg/kg po was determined in rat,In vivo,5964,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8700,Rattus norvegicus,,CHEMBL627598,Cmax value evaluated in rat,In vivo,6078,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8701,Rattus norvegicus,955.0,CHEMBL627599,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,In vivo,5206,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8702,Rattus norvegicus,,CHEMBL627600,Cmax value after administration of 20 mg/Kg oral dose in rat,In vivo,2959,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8703,Rattus norvegicus,,CHEMBL627601,Cmax value at 1 mg/kg po in rat,In vivo,5964,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8704,Rattus norvegicus,,CHEMBL627776,Cmax value at 5 mg/kg po in rat,In vivo,5964,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8705,Rattus norvegicus,,CHEMBL627777,Cmax value at a dose of 10 mg/kg in male SD rats,In vivo,6757,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8706,Rattus norvegicus,,CHEMBL627778,Cmax value at a dose of 100 mg/kg in male SD rats,In vivo,6757,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8707,Rattus norvegicus,,CHEMBL627779,Cmax value at a dose of 50 mg/kg in male SD rats,In vivo,6757,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8708,Rattus norvegicus,,CHEMBL876814,Cmax value in rats at 10 mg/kg,In vivo,17617,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8709,Rattus norvegicus,,CHEMBL627780,Cmax value was evaluated in rats at a dose of 20 mg/kg,In vivo,1445,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8710,Rattus norvegicus,,CHEMBL627781,Cmax value was determined after peroral administration of 20 mg/kg in rat,In vivo,6082,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8711,Rattus norvegicus,,CHEMBL627782,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,In vivo,1446,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8712,Rattus norvegicus,1969.0,CHEMBL627783,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,In vivo,5407,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8713,Rattus norvegicus,1969.0,CHEMBL627784,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,In vivo,2690,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8714,Rattus norvegicus,,CHEMBL627785,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,In vivo,2661,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8715,Rattus norvegicus,,CHEMBL627786,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,In vivo,2661,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8716,Rattus norvegicus,1969.0,CHEMBL627787,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,In vivo,4891,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8717,Rattus norvegicus,1969.0,CHEMBL627788,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,In vivo,2807,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8718,Rattus norvegicus,1969.0,CHEMBL626579,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,In vivo,2807,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8719,Rattus norvegicus,1969.0,CHEMBL626580,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,In vivo,2807,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8720,Rattus norvegicus,,CHEMBL876815,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,In vivo,3634,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8721,Rattus norvegicus,1969.0,CHEMBL626581,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,In vivo,1881,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8722,Rattus norvegicus,1969.0,CHEMBL626582,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,In vivo,1881,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8723,Rattus norvegicus,,CHEMBL626583,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,In vivo,429,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8724,Rattus norvegicus,,CHEMBL626205,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,In vivo,5974,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8725,Rattus norvegicus,,CHEMBL626206,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,In vivo,5974,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8726,Rattus norvegicus,,CHEMBL626207,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,In vivo,5974,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8727,Rattus norvegicus,,CHEMBL623882,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,In vivo,5974,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8728,Rattus norvegicus,,CHEMBL623883,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,In vivo,17582,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8729,Rattus norvegicus,,CHEMBL623884,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,In vivo,17582,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8730,Rattus norvegicus,1969.0,CHEMBL623885,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",In vivo,3032,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8731,Rattus norvegicus,1969.0,CHEMBL623886,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,In vivo,6295,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8732,Rattus norvegicus,,CHEMBL623887,Maximal concentration in rat was determined,In vivo,6619,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8733,Rattus norvegicus,,CHEMBL623888,Maximal concentration after i.v. administration,In vivo,6616,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8734,Rattus norvegicus,1969.0,CHEMBL623889,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,In vivo,3249,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8735,Rattus norvegicus,1969.0,CHEMBL623890,Maximal plasma concentration in rat after oral administration at 50 mg/kg,In vivo,17791,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8736,Rattus norvegicus,1969.0,CHEMBL623891,Cmax in rat plasma after oral dose (50 mg/Kg),In vivo,17791,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8737,Rattus norvegicus,1969.0,CHEMBL623892,Maximal plasma concentration was determined.,In vivo,1360,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8738,Rattus norvegicus,1969.0,CHEMBL623893,Maximal plasma drug concentration was determined,In vivo,2552,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8739,Rattus norvegicus,,CHEMBL877616,Maximal concentration in rats after peroral administration,In vivo,6571,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8740,Rattus norvegicus,,CHEMBL623894,Maximum concentration in rat after 2 mg/kg peroral administration,In vivo,6570,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8741,Rattus norvegicus,1969.0,CHEMBL623895,Maximum concentration in rat plasma after 5 mg/kg oral gavage,In vivo,6567,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8742,Rattus norvegicus,,CHEMBL623896,Maximum concentration of compound in rat was evaluated.,In vivo,3031,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8743,Rattus norvegicus,,CHEMBL623897,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,In vivo,3436,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8744,Rattus norvegicus,,CHEMBL623898,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,In vivo,3436,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8745,Rattus norvegicus,,CHEMBL623899,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,In vivo,2083,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8746,Rattus norvegicus,,CHEMBL623900,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,In vivo,3436,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8747,Rattus norvegicus,,CHEMBL623901,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,In vivo,4527,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8748,Rattus norvegicus,,CHEMBL623902,Maximum concentration was evaluated in rats,In vivo,1974,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8749,Rattus norvegicus,1359.0,CHEMBL623903,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,In vivo,3307,Cerebrospinal fluid,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8750,Rattus norvegicus,1969.0,CHEMBL623904,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,In vivo,3307,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8751,Rattus norvegicus,1969.0,CHEMBL877617,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,In vivo,1916,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8752,Rattus norvegicus,,CHEMBL623905,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,In vivo,1500,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8753,Rattus norvegicus,,CHEMBL623906,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,In vivo,1500,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8754,Rattus norvegicus,1969.0,CHEMBL623907,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,In vivo,4186,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8755,Rattus norvegicus,,CHEMBL623908,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8756,Rattus norvegicus,,CHEMBL623909,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8757,Rattus norvegicus,,CHEMBL623910,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8758,Rattus norvegicus,,CHEMBL623911,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8759,Rattus norvegicus,,CHEMBL623912,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8760,Rattus norvegicus,,CHEMBL624616,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8761,Rattus norvegicus,,CHEMBL624617,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8762,Rattus norvegicus,,CHEMBL624618,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8763,Rattus norvegicus,,CHEMBL624619,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8764,Rattus norvegicus,,CHEMBL624794,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8765,Rattus norvegicus,,CHEMBL624795,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8766,Rattus norvegicus,,CHEMBL623921,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8767,Rattus norvegicus,,CHEMBL623922,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8768,Rattus norvegicus,,CHEMBL623923,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8769,Rattus norvegicus,,CHEMBL623924,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8770,Rattus norvegicus,,CHEMBL623925,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8771,Rattus norvegicus,,CHEMBL623926,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8772,Rattus norvegicus,,CHEMBL623927,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8773,Rattus norvegicus,,CHEMBL623928,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8774,Rattus norvegicus,,CHEMBL623929,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8775,Rattus norvegicus,,CHEMBL623930,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8776,Rattus norvegicus,955.0,CHEMBL623931,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,16434,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8777,Rattus norvegicus,955.0,CHEMBL622165,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,16434,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8778,Rattus norvegicus,955.0,CHEMBL621249,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,16434,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8779,Rattus norvegicus,955.0,CHEMBL621250,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,16434,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8780,Rattus norvegicus,955.0,CHEMBL621448,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,16434,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8781,Rattus norvegicus,955.0,CHEMBL621449,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,16434,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8782,Rattus norvegicus,955.0,CHEMBL621450,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,16434,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8783,Rattus norvegicus,955.0,CHEMBL621451,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,16434,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8784,Rattus norvegicus,955.0,CHEMBL621452,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,16435,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8785,Rattus norvegicus,955.0,CHEMBL621453,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,16435,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8786,Rattus norvegicus,955.0,CHEMBL621454,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,16435,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8787,Rattus norvegicus,955.0,CHEMBL621455,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,16435,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8788,Rattus norvegicus,955.0,CHEMBL621456,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,16435,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8789,Rattus norvegicus,955.0,CHEMBL625145,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,16435,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8790,Rattus norvegicus,955.0,CHEMBL875847,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,16435,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8791,Rattus norvegicus,955.0,CHEMBL625146,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,16435,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8792,Rattus norvegicus,955.0,CHEMBL625147,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,16434,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8793,Rattus norvegicus,955.0,CHEMBL625148,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,16434,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8794,Rattus norvegicus,955.0,CHEMBL625149,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,16434,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8795,Rattus norvegicus,955.0,CHEMBL625150,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,16435,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8796,Rattus norvegicus,955.0,CHEMBL625151,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,16435,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8797,Rattus norvegicus,955.0,CHEMBL625152,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,16435,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8798,Rattus norvegicus,955.0,CHEMBL625153,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,16435,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8799,Rattus norvegicus,955.0,CHEMBL625154,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,16435,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8800,Rattus norvegicus,955.0,CHEMBL625155,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,16435,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8801,Rattus norvegicus,,CHEMBL625156,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,11977,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8802,Rattus norvegicus,,CHEMBL624354,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,11977,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8803,Rattus norvegicus,10000000.0,CHEMBL624355,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,11977,Hippocampus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8804,Rattus norvegicus,10000000.0,CHEMBL624356,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,11977,Hippocampus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8805,Rattus norvegicus,10000000.0,CHEMBL624357,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,11977,Hippocampus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8806,Rattus norvegicus,10000000.0,CHEMBL624358,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,11977,Hippocampus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8807,Rattus norvegicus,2435.0,CHEMBL624359,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,11977,Striatum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8808,Rattus norvegicus,2435.0,CHEMBL624360,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,11977,Striatum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8809,Rattus norvegicus,2435.0,CHEMBL624361,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,11977,Striatum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8810,Rattus norvegicus,2435.0,CHEMBL624362,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,11977,Striatum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8811,Rattus norvegicus,2435.0,CHEMBL624363,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,11977,Striatum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8812,Rattus norvegicus,178.0,CHEMBL624364,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8813,Rattus norvegicus,178.0,CHEMBL624365,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8814,Rattus norvegicus,178.0,CHEMBL624366,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8815,Rattus norvegicus,178.0,CHEMBL624367,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8816,Rattus norvegicus,955.0,CHEMBL624368,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8817,Rattus norvegicus,955.0,CHEMBL624369,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8818,Rattus norvegicus,955.0,CHEMBL624370,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,11977,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8819,Rattus norvegicus,955.0,CHEMBL625069,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8820,Rattus norvegicus,955.0,CHEMBL625070,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8821,Rattus norvegicus,948.0,CHEMBL626051,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8822,Rattus norvegicus,948.0,CHEMBL626052,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8823,Rattus norvegicus,948.0,CHEMBL626053,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,11977,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8824,Rattus norvegicus,948.0,CHEMBL626054,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8825,Rattus norvegicus,948.0,CHEMBL626055,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8826,Rattus norvegicus,2113.0,CHEMBL626056,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8827,Rattus norvegicus,2113.0,CHEMBL626057,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8828,Rattus norvegicus,2113.0,CHEMBL625193,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8829,Rattus norvegicus,2113.0,CHEMBL625194,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8830,Rattus norvegicus,2107.0,CHEMBL625195,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8831,Rattus norvegicus,2107.0,CHEMBL625196,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8832,Rattus norvegicus,2107.0,CHEMBL625197,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,11977,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8833,Rattus norvegicus,2107.0,CHEMBL625198,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8834,Rattus norvegicus,2107.0,CHEMBL627929,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8835,Rattus norvegicus,2048.0,CHEMBL627074,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8836,Rattus norvegicus,2048.0,CHEMBL627075,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8837,Rattus norvegicus,2048.0,CHEMBL627076,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,11977,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8838,Rattus norvegicus,2048.0,CHEMBL627077,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8839,Rattus norvegicus,2048.0,CHEMBL627078,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8840,Rattus norvegicus,2385.0,CHEMBL627079,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),In vivo,11977,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8841,Mus musculus,,CHEMBL873824,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,In vivo,4573,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8842,Mus musculus,1969.0,CHEMBL627080,Half life in mouse plasma was determined at dose 25 mg/kg,In vivo,3132,Plasma,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8843,Mus musculus,,CHEMBL627081,Half life was determined,,17718,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8844,Mus musculus,,CHEMBL627082,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,In vivo,17728,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8845,Mus musculus,,CHEMBL627083,Half-life in male mice after 1 mg/kg intravenous dose,In vivo,5961,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8847,Mus musculus,1969.0,CHEMBL627085,Half life in mice plasma,,17731,Plasma,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8848,Mus musculus,,CHEMBL627086,Half life in mouse,,17592,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8849,Mus musculus,1969.0,CHEMBL627087,Half life in mouse plasma at dose 25 mg/kg,In vivo,3132,Plasma,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8850,Mus musculus,,CHEMBL627088,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,In vivo,17729,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8851,Mus musculus,,CHEMBL627089,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,In vivo,17729,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8852,Mus musculus,,CHEMBL627090,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,In vivo,17729,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8853,Mus musculus,,CHEMBL627091,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),In vivo,3277,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8854,Mus musculus,,CHEMBL627092,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",In vivo,3760,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8855,Mus musculus,,CHEMBL876785,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",In vivo,3760,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8856,Mus musculus,,CHEMBL627093,Half-life by iv administration in mouse,In vivo,2862,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8857,Mus musculus,,CHEMBL627094,Half-life by oral administration in mouse,In vivo,2862,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8858,Mus musculus,,CHEMBL627095,Half-life in mice,,5980,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8859,Mus musculus,955.0,CHEMBL627096,Half-life using mouse brain homogenate,,6159,Brain,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8860,Mus musculus,,CHEMBL627097,Half-life was measured in mice,,6254,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8861,Mus musculus,,CHEMBL627098,Half-life was measured in mouse after an iv dose of 1 mg/kg,In vivo,6062,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8862,Mus musculus,178.0,CHEMBL627099,Half-life period was determined in mouse blood,,1574,Blood,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8863,Mus musculus,955.0,CHEMBL627100,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",,56,Brain,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8864,Mus musculus,1969.0,CHEMBL627101,Plasma half life in mouse,,993,Plasma,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8865,Mus musculus,,CHEMBL627102,Stability of the peptide in the presence of mouse serum,,6652,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8866,Mus musculus,,CHEMBL627103,Terminal half life of compound was determined in mouse,,17852,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8867,Mus musculus,,CHEMBL627104,Terminal half life was evaluated in mice after intravenous administration,In vivo,2675,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8868,Mus musculus,,CHEMBL627105,Terminal half life was evaluated in mice after oral administration,In vivo,2675,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8869,Mus musculus,,CHEMBL876786,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,,499,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8870,Mus musculus,,CHEMBL873825,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,,499,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8871,Mus musculus,,CHEMBL627106,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,,499,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8872,Mus musculus,,CHEMBL626336,half life period is evaluated by administering intravenously at 25 mg/kg in mice,In vivo,14239,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8873,Mus musculus,,CHEMBL877462,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",In vivo,5506,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8874,Mus musculus,,CHEMBL626337,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",In vivo,5506,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8875,Mus musculus,,CHEMBL626338,Half life after intraperitoneal administration of 100 mg/kg in mice,,17734,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8876,Mus musculus,,CHEMBL626339,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,In vivo,17728,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8877,Mus musculus,,CHEMBL626340,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,In vivo,17728,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8878,Mus musculus,,CHEMBL625377,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,In vivo,17728,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8879,Mus musculus,,CHEMBL625378,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,In vivo,17728,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8880,Mus musculus,,CHEMBL625379,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,In vivo,17728,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
8881,Sus scrofa,,CHEMBL625380,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),,14294,,22224,,,BAO_0000251,,Autocuration,Microsomes,9823.0,U,0,1,
8882,Sus scrofa,,CHEMBL625381,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),,14294,,22224,,,BAO_0000251,,Autocuration,Microsomes,9823.0,U,0,1,
8883,Sus scrofa,,CHEMBL625382,Stability to porcine renal DHP-I,,6056,,22224,,,BAO_0000019,,Autocuration,,9823.0,U,0,1,
8884,Sus scrofa,,CHEMBL873828,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,In vivo,1317,,22224,,,BAO_0000218,,Autocuration,,9823.0,U,0,1,
8885,Sus scrofa,,CHEMBL625383,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,In vivo,1317,,22224,,,BAO_0000218,,Autocuration,,9823.0,U,0,1,
8886,Sus scrofa,,CHEMBL625384,Half-life of the parent prodrug in porcine esterase solution,,5229,,22224,,,BAO_0000019,,Autocuration,,9823.0,U,0,1,
8887,Sus scrofa,,CHEMBL625385,"First order rate constant, k was determined in in pig liver Esterase",,4231,,22224,,,BAO_0000019,,Autocuration,,9823.0,U,0,1,
8888,Sus scrofa,2107.0,CHEMBL625386,Half life of the in pig liver Esterase,,4231,Liver,22224,,,BAO_0000221,,Autocuration,,9823.0,U,0,1,
8889,Sus scrofa,2107.0,CHEMBL623571,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,,5318,Liver,22224,,,BAO_0000221,,Autocuration,,9823.0,U,0,1,
8890,Sus scrofa,2107.0,CHEMBL623572,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,,5318,Liver,22224,,,BAO_0000221,,Autocuration,,9823.0,U,0,1,
8891,Sus scrofa,2107.0,CHEMBL623573,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,,5318,Liver,22224,,,BAO_0000221,,Autocuration,,9823.0,U,0,1,
8892,Sus scrofa,2107.0,CHEMBL623574,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,,3305,Liver,22224,,,BAO_0000221,,Autocuration,,9823.0,U,0,1,
8893,Sus scrofa,2107.0,CHEMBL623575,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,,3305,Liver,22224,,,BAO_0000221,,Autocuration,,9823.0,U,0,1,
8894,Sus scrofa,2107.0,CHEMBL623749,Half-life in the presence of pig liver esterase(PLE) was evaluated.,,2842,Liver,22224,,,BAO_0000221,,Autocuration,,9823.0,U,0,1,
8895,Sus scrofa,2107.0,CHEMBL623750,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,,2842,Liver,22224,,,BAO_0000221,,Autocuration,,9823.0,U,0,1,
8896,Sus scrofa,2107.0,CHEMBL623751,Half-life in vitro in pig liver,In vitro,889,Liver,22224,,,BAO_0000221,,Autocuration,,9823.0,U,0,1,
8897,Sus scrofa,2107.0,CHEMBL623752,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,,1904,Liver,22224,,,BAO_0000221,,Autocuration,,9823.0,U,0,1,
8898,Rattus norvegicus,1969.0,CHEMBL623753,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,In vivo,4186,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8899,Rattus norvegicus,1969.0,CHEMBL623754,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,In vivo,2774,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8900,Rattus norvegicus,1969.0,CHEMBL623755,Maximum concentration in rat plasma was determined,In vivo,1742,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8901,Rattus norvegicus,,CHEMBL623756,Maximum concentration in rats,In vivo,3169,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8902,Rattus norvegicus,,CHEMBL623757,Maximum concentration in rats at 1-2 hours,In vivo,3169,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8903,Rattus norvegicus,,CHEMBL623758,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,In vivo,2081,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8904,Rattus norvegicus,955.0,CHEMBL623759,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,In vivo,3307,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8905,Rattus norvegicus,,CHEMBL623760,Maximum concentration at the dose of 2 mg/kg in rat,In vivo,4727,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8906,Rattus norvegicus,,CHEMBL623761,Maximum concentration was evaluated in rats,In vivo,6597,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8907,Rattus norvegicus,1969.0,CHEMBL623762,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,In vivo,16365,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8908,Rattus norvegicus,1969.0,CHEMBL877594,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,In vivo,16365,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8909,Rattus norvegicus,1969.0,CHEMBL623763,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,In vivo,16365,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8910,Rattus norvegicus,1969.0,CHEMBL623764,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,In vivo,16365,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8911,Rattus norvegicus,1969.0,CHEMBL623765,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,In vivo,16365,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8912,Rattus norvegicus,178.0,CHEMBL623766,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,In vivo,2591,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8913,Rattus norvegicus,178.0,CHEMBL623767,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,In vivo,2591,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8914,Rattus norvegicus,178.0,CHEMBL623768,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,In vivo,2591,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8915,Rattus norvegicus,1969.0,CHEMBL623769,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,In vivo,5978,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8916,Rattus norvegicus,1969.0,CHEMBL623770,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,In vivo,5978,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8917,Rattus norvegicus,1969.0,CHEMBL623771,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,In vivo,5978,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8918,Rattus norvegicus,1969.0,CHEMBL623772,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,In vivo,5978,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8919,Rattus norvegicus,1969.0,CHEMBL623773,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,In vivo,5978,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8920,Rattus norvegicus,1969.0,CHEMBL623774,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,In vivo,5978,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8921,Rattus norvegicus,1969.0,CHEMBL623775,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,In vivo,5978,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8922,Rattus norvegicus,,CHEMBL623776,Cmax in rat (PO dose),In vivo,14465,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8923,Rattus norvegicus,1969.0,CHEMBL622191,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,In vivo,4723,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8924,Rattus norvegicus,1969.0,CHEMBL622192,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,In vivo,4723,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8925,Rattus norvegicus,1969.0,CHEMBL622193,Maximum plasma concentration determined in rat,In vivo,4576,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8926,Rattus norvegicus,1969.0,CHEMBL622194,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,In vivo,12873,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8927,Rattus norvegicus,1969.0,CHEMBL622195,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,In vivo,12873,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8928,Rattus norvegicus,1969.0,CHEMBL622196,Maximum plasma concentration in rat,In vivo,6824,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8929,Rattus norvegicus,1969.0,CHEMBL622197,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,In vivo,17065,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8930,Rattus norvegicus,1969.0,CHEMBL622198,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,In vivo,2932,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8931,Rattus norvegicus,1969.0,CHEMBL622199,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,In vivo,2932,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8932,Rattus norvegicus,1969.0,CHEMBL622200,Maximum plasma concentration of compound was measured in rat,In vivo,2879,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8933,Rattus norvegicus,1969.0,CHEMBL622201,Maximum plasma concentration after 20 mg/kg oral administration in rat,In vivo,2864,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8934,Rattus norvegicus,1969.0,CHEMBL623990,Maximum plasma concentration after oral administration to rats,In vivo,16367,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8935,Rattus norvegicus,1969.0,CHEMBL623991,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,In vivo,17717,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8936,Rattus norvegicus,1969.0,CHEMBL623992,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",In vivo,17717,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8937,Rattus norvegicus,1969.0,CHEMBL623993,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,In vivo,17717,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8938,Rattus norvegicus,1969.0,CHEMBL623994,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,In vivo,17717,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8939,Rattus norvegicus,1969.0,CHEMBL623995,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,In vivo,17720,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8940,Rattus norvegicus,1969.0,CHEMBL623996,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,In vivo,17720,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8941,Rattus norvegicus,1969.0,CHEMBL623997,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,In vivo,17720,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8942,Rattus norvegicus,1969.0,CHEMBL623998,Maximum plasma concentration dosed orally in rats,In vivo,4516,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8943,Rattus norvegicus,1969.0,CHEMBL623999,Maximum plasma concentration dosed orally in rats after 6 hours,In vivo,4516,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8944,Rattus norvegicus,1969.0,CHEMBL624000,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,In vivo,4516,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8945,Rattus norvegicus,1969.0,CHEMBL624001,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,In vivo,5199,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8946,Rattus norvegicus,1969.0,CHEMBL624002,Maximum plasma concentration in rat after po administration,In vivo,17538,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8947,Rattus norvegicus,1969.0,CHEMBL624003,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",In vivo,6685,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8948,Rattus norvegicus,1969.0,CHEMBL624004,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",In vivo,6685,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8949,Rattus norvegicus,948.0,CHEMBL624005,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,16434,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8950,Rattus norvegicus,948.0,CHEMBL624006,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,16434,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8951,Rattus norvegicus,948.0,CHEMBL624007,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,16434,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8952,Rattus norvegicus,948.0,CHEMBL624008,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,16434,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8953,Rattus norvegicus,948.0,CHEMBL624009,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,16434,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8954,Rattus norvegicus,948.0,CHEMBL874387,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,16434,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8955,Rattus norvegicus,948.0,CHEMBL624010,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,16434,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8956,Rattus norvegicus,948.0,CHEMBL624011,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,16434,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8957,Rattus norvegicus,948.0,CHEMBL624012,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,16435,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8958,Rattus norvegicus,948.0,CHEMBL624013,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,16435,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8959,Rattus norvegicus,948.0,CHEMBL624736,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,16435,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8960,Rattus norvegicus,948.0,CHEMBL624737,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,16435,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8961,Rattus norvegicus,948.0,CHEMBL624738,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,16434,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8962,Rattus norvegicus,948.0,CHEMBL624739,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,16434,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8963,Rattus norvegicus,948.0,CHEMBL624740,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,16434,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8964,Rattus norvegicus,948.0,CHEMBL624896,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,16435,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8965,Rattus norvegicus,948.0,CHEMBL624897,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,16435,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8966,Rattus norvegicus,948.0,CHEMBL624108,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,16435,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8967,Rattus norvegicus,948.0,CHEMBL624109,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,16435,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8968,Rattus norvegicus,948.0,CHEMBL624110,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,16435,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8969,Rattus norvegicus,948.0,CHEMBL624111,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,16435,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8970,Rattus norvegicus,948.0,CHEMBL624112,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,16435,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8971,Rattus norvegicus,948.0,CHEMBL624113,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,16435,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8972,Rattus norvegicus,948.0,CHEMBL619709,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,16435,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8973,Rattus norvegicus,948.0,CHEMBL619710,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,16435,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8974,Rattus norvegicus,2113.0,CHEMBL619711,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,16434,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8975,Rattus norvegicus,2113.0,CHEMBL619712,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,16434,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8976,Rattus norvegicus,2113.0,CHEMBL619713,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,16434,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8977,Rattus norvegicus,2113.0,CHEMBL619714,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,16434,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8978,Rattus norvegicus,2113.0,CHEMBL619715,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,16434,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8979,Rattus norvegicus,2113.0,CHEMBL619716,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,16434,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8980,Rattus norvegicus,2113.0,CHEMBL619717,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,16434,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8981,Rattus norvegicus,2113.0,CHEMBL619718,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,16434,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8982,Rattus norvegicus,2113.0,CHEMBL619719,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,16435,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8983,Rattus norvegicus,2113.0,CHEMBL875329,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,16435,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8984,Rattus norvegicus,2113.0,CHEMBL619720,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,16435,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8985,Rattus norvegicus,2113.0,CHEMBL619721,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,16435,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8986,Rattus norvegicus,2113.0,CHEMBL619722,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,16435,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8987,Rattus norvegicus,2113.0,CHEMBL619723,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,16435,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8988,Rattus norvegicus,2113.0,CHEMBL619724,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,16435,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8989,Rattus norvegicus,2113.0,CHEMBL619725,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,16435,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8990,Rattus norvegicus,2113.0,CHEMBL619726,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,16434,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8991,Rattus norvegicus,2113.0,CHEMBL619727,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,16434,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8992,Rattus norvegicus,2113.0,CHEMBL619728,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,16434,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8993,Rattus norvegicus,2113.0,CHEMBL619729,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,16435,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8994,Rattus norvegicus,2385.0,CHEMBL619730,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8995,Rattus norvegicus,2385.0,CHEMBL619731,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8996,Rattus norvegicus,2385.0,CHEMBL619732,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,11977,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8997,Rattus norvegicus,2385.0,CHEMBL619733,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8998,Rattus norvegicus,2385.0,CHEMBL619734,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
8999,Rattus norvegicus,14.0,CHEMBL619735,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Zone of skin,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9000,Rattus norvegicus,14.0,CHEMBL875330,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Zone of skin,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9001,Rattus norvegicus,14.0,CHEMBL628465,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,11977,Zone of skin,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9002,Rattus norvegicus,14.0,CHEMBL628466,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Zone of skin,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9003,Rattus norvegicus,14.0,CHEMBL628467,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Zone of skin,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9004,Rattus norvegicus,2106.0,CHEMBL628468,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9005,Rattus norvegicus,2106.0,CHEMBL628469,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9006,Rattus norvegicus,2106.0,CHEMBL628470,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,11977,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9007,Rattus norvegicus,2106.0,CHEMBL628471,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9008,Rattus norvegicus,2106.0,CHEMBL628472,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9009,Rattus norvegicus,2046.0,CHEMBL625191,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9010,Rattus norvegicus,2046.0,CHEMBL625192,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9011,Rattus norvegicus,2046.0,CHEMBL875337,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),In vivo,11977,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9012,Rattus norvegicus,2046.0,CHEMBL626341,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9013,Rattus norvegicus,2046.0,CHEMBL626342,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9014,Rattus norvegicus,2107.0,CHEMBL621943,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),In vivo,11977,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9015,Rattus norvegicus,,CHEMBL621944,Half life in rats,,3748,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9016,Rattus norvegicus,,CHEMBL621945,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,,15765,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9017,Rattus norvegicus,,CHEMBL621946,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),,4871,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9018,Rattus norvegicus,,CHEMBL621947,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,,4871,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9019,Rattus norvegicus,,CHEMBL621948,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),,4872,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9020,Rattus norvegicus,,CHEMBL621949,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,,4872,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9021,Rattus norvegicus,,CHEMBL621950,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),,5413,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9022,Rattus norvegicus,,CHEMBL621951,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,,5413,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9023,Rattus norvegicus,178.0,CHEMBL621952,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,In vivo,15272,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9024,Rattus norvegicus,2107.0,CHEMBL621953,Stability (%) in rat liver microsomes,,4689,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9025,Rattus norvegicus,,CHEMBL621954,Area under curve was calculated after intravenous administration,,6057,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9026,Rattus norvegicus,,CHEMBL621955,Area under the curve was calculated after iv administration in rat,,6057,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9027,Rattus norvegicus,,CHEMBL621956,Area under the curve was calculated in rat after peroral administration,,6057,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9028,Rattus norvegicus,,CHEMBL621957,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,6211,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9029,Rattus norvegicus,,CHEMBL621958,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,,5710,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9030,Rattus norvegicus,,CHEMBL621959,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,,5710,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9031,Rattus norvegicus,,CHEMBL621960,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,,17853,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9032,Rattus norvegicus,,CHEMBL621961,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,,17853,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9033,Rattus norvegicus,,CHEMBL621962,p value of the compound,,15765,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9034,Rattus norvegicus,,CHEMBL876787,p value of the compound,,15765,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9035,Rattus norvegicus,,CHEMBL621963,p value of the compound,,15765,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9036,Rattus norvegicus,945.0,CHEMBL622637,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,6175,Stomach,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9037,Rattus norvegicus,945.0,CHEMBL622638,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,6175,Stomach,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9038,Rattus norvegicus,945.0,CHEMBL626561,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,6175,Stomach,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9039,Oryctolagus cuniculus,,CHEMBL626562,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),,7991,,22224,,,BAO_0000019,,Autocuration,,9986.0,U,0,1,
9040,Oryctolagus cuniculus,,CHEMBL626563,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),,429,,22224,,,BAO_0000218,,Autocuration,,9986.0,U,0,1,
9041,Oryctolagus cuniculus,,CHEMBL626564,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),,429,,22224,,,BAO_0000218,,Autocuration,,9986.0,U,0,1,
9042,Oryctolagus cuniculus,,CHEMBL626565,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,In vivo,6253,,22224,,,BAO_0000218,,Autocuration,,9986.0,U,0,1,
9043,Oryctolagus cuniculus,,CHEMBL626566,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,In vivo,6253,,22224,,,BAO_0000218,,Autocuration,,9986.0,U,0,1,
9044,Oryctolagus cuniculus,,CHEMBL626567,Clearance rate in rabbits,In vivo,3615,,22224,,,BAO_0000218,,Autocuration,,9986.0,U,0,1,
9045,Oryctolagus cuniculus,,CHEMBL626568,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,In vivo,4059,,22224,,,BAO_0000218,,Autocuration,,9986.0,U,0,1,
9046,Oryctolagus cuniculus,,CHEMBL626569,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,In vivo,5124,,22224,,,BAO_0000218,,Autocuration,,9986.0,U,0,1,
9047,Oryctolagus cuniculus,,CHEMBL626570,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,In vivo,5124,,22224,,,BAO_0000218,,Autocuration,,9986.0,U,0,1,
9048,Oryctolagus cuniculus,,CHEMBL626571,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,In vivo,5124,,22224,,,BAO_0000218,,Autocuration,,9986.0,U,0,1,
9049,Oryctolagus cuniculus,,CHEMBL626572,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,In vivo,429,,22224,,,BAO_0000218,,Autocuration,,9986.0,U,0,1,
9050,Oryctolagus cuniculus,1969.0,CHEMBL626573,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,In vivo,4059,Plasma,22224,,,BAO_0000218,,Autocuration,,9986.0,U,0,1,
9051,Oryctolagus cuniculus,2107.0,CHEMBL626574,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,,9659,Liver,22224,,,BAO_0000251,,Autocuration,Microsomes,9986.0,U,0,1,
9052,Oryctolagus cuniculus,2107.0,CHEMBL626575,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,,9659,Liver,22224,,,BAO_0000251,,Autocuration,Microsomes,9986.0,U,0,1,
9053,Oryctolagus cuniculus,,CHEMBL626576,Dose at which bioavailability of intravenously administered compound was tested in rabbit,,3639,,22224,,,BAO_0000218,,Autocuration,,9986.0,U,0,1,
9054,Oryctolagus cuniculus,,CHEMBL626577,Dose at which bioavailability of perorally administered compound was tested in rabbit,,3639,,22224,,,BAO_0000218,,Autocuration,,9986.0,U,0,1,
9055,Oryctolagus cuniculus,,CHEMBL626578,The compound was tested for its bioavailability in rabbit (by oral dosage).,In vivo,3639,,22224,,,BAO_0000218,,Autocuration,,9986.0,U,0,1,
9056,Oryctolagus cuniculus,,CHEMBL625263,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,In vivo,5124,,22224,,,BAO_0000218,,Autocuration,,9986.0,U,0,1,
9057,Oryctolagus cuniculus,,CHEMBL625264,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,In vivo,5124,,22224,,,BAO_0000218,,Autocuration,,9986.0,U,0,1,
9058,Oryctolagus cuniculus,,CHEMBL625265,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,In vivo,5124,,22224,,,BAO_0000218,,Autocuration,,9986.0,U,0,1,
9059,Oryctolagus cuniculus,,CHEMBL625266,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),,14294,,22224,,,BAO_0000251,,Autocuration,Microsomes,9986.0,U,0,1,
9060,Oryctolagus cuniculus,,CHEMBL876796,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),,14294,,22224,,,BAO_0000251,,Autocuration,Microsomes,9986.0,U,0,1,
9061,Oryctolagus cuniculus,,CHEMBL625267,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,In vivo,429,,22224,,,BAO_0000218,,Autocuration,,9986.0,U,0,1,
9062,Oryctolagus cuniculus,1969.0,CHEMBL625268,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,In vivo,5124,Plasma,22224,,,BAO_0000218,,Autocuration,,9986.0,U,0,1,
9063,Oryctolagus cuniculus,1969.0,CHEMBL625269,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,In vivo,5124,Plasma,22224,,,BAO_0000218,,Autocuration,,9986.0,U,0,1,
9064,Oryctolagus cuniculus,1969.0,CHEMBL624689,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,In vivo,5124,Plasma,22224,,,BAO_0000218,,Autocuration,,9986.0,U,0,1,
9065,Oryctolagus cuniculus,,CHEMBL624690,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,In vivo,429,,22224,,,BAO_0000218,,Autocuration,,9986.0,U,0,1,
9066,Oryctolagus cuniculus,1088.0,CHEMBL624691,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),,429,Urine,22224,,,BAO_0000218,,Autocuration,,9986.0,U,0,1,
9067,Oryctolagus cuniculus,1088.0,CHEMBL624692,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),,429,Urine,22224,,,BAO_0000218,,Autocuration,,9986.0,U,0,1,
9068,Oryctolagus cuniculus,,CHEMBL624693,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,In vivo,4059,,22224,,,BAO_0000218,,Autocuration,,9986.0,U,0,1,
9069,Oryctolagus cuniculus,,CHEMBL624694,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,In vivo,4137,,22224,,,BAO_0000218,,Autocuration,,9986.0,U,0,1,
9070,Oryctolagus cuniculus,,CHEMBL877596,In vitro Biological half-life in crude homogenate of rabbit renal cortex,In vitro,11672,,22224,,,BAO_0000221,,Autocuration,,9986.0,U,0,1,
9071,Oryctolagus cuniculus,,CHEMBL624695,Time within which only 10% of the drug was degraded,,12886,,22224,,,BAO_0000019,,Autocuration,,9986.0,U,0,1,
9072,Oryctolagus cuniculus,2107.0,CHEMBL624696,Half life period in rabbit liver homogenate,,3853,Liver,22224,,,BAO_0000221,,Autocuration,,9986.0,U,0,1,
9073,Oryctolagus cuniculus,,CHEMBL624697,Half life value in rabbits,,3615,,22224,,,BAO_0000019,,Autocuration,,9986.0,U,0,1,
9074,Oryctolagus cuniculus,178.0,CHEMBL624698,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,In vivo,6253,Blood,22224,,,BAO_0000218,,Autocuration,,9986.0,U,0,1,
9075,Oryctolagus cuniculus,178.0,CHEMBL624699,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,In vivo,6253,Blood,22224,,,BAO_0000218,,Autocuration,,9986.0,U,0,1,
9076,Oryctolagus cuniculus,,CHEMBL624700,Half-life period in rabbits following intravenous administration at 2 mg/kg,In vivo,6077,,22224,,,BAO_0000218,,Autocuration,,9986.0,U,0,1,
9077,Rattus norvegicus,1969.0,CHEMBL622903,AUC 0-8 hr value in rats at 10 mg/kg,,17617,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9078,Rattus norvegicus,1969.0,CHEMBL622904,AUC after administration at 2000 mg/kg/day in rats,,17594,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9079,Rattus norvegicus,1969.0,CHEMBL622905,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,,6149,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9080,Rattus norvegicus,1969.0,CHEMBL622906,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,17260,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9081,Rattus norvegicus,1969.0,CHEMBL622907,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,17260,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9082,Rattus norvegicus,1969.0,CHEMBL622908,AUC in rat after oral administration at 10.5 mg/kg dose,,6644,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9083,Rattus norvegicus,1969.0,CHEMBL622909,AUC in rat after oral administration at 11.2 mg/kg dose,,6644,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9084,Rattus norvegicus,1969.0,CHEMBL622910,AUC in rat after oral administration at 9.7 mg/kg dose,,6644,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9085,Rattus norvegicus,955.0,CHEMBL622911,AUC in rat brain after oral administration at 10 mg/kg,,6495,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9086,Rattus norvegicus,1969.0,CHEMBL622912,AUC in rat p.o.,,6504,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9087,Rattus norvegicus,1969.0,CHEMBL622913,AUC in rat p.o. at 20 mg/kg concentration,,17686,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9088,Rattus norvegicus,1969.0,CHEMBL622914,AUC in rat plasma after oral administration at 10 mg/kg,,6495,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9089,Rattus norvegicus,1969.0,CHEMBL622915,AUC in rats,,216,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9090,Rattus norvegicus,1969.0,CHEMBL622916,AUC value after IV dose at a dose of 5 mg/kg in rats.,,1908,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9091,Rattus norvegicus,1969.0,CHEMBL622917,AUC value after oral dose at a dose of 10 mg/kg in rats.,,1908,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9092,Rattus norvegicus,1969.0,CHEMBL622918,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",In vivo,6685,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9093,Rattus norvegicus,1969.0,CHEMBL622919,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,In vivo,216,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9094,Rattus norvegicus,1969.0,CHEMBL622920,Maximum plasma concentration was evaluated in rat,In vivo,6049,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9095,Rattus norvegicus,1969.0,CHEMBL622921,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,In vivo,2463,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9096,Rattus norvegicus,1969.0,CHEMBL622922,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,In vivo,6679,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9097,Rattus norvegicus,1969.0,CHEMBL622923,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,In vivo,6681,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9098,Rattus norvegicus,1969.0,CHEMBL877604,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,In vivo,4890,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9099,Rattus norvegicus,1969.0,CHEMBL622924,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,In vivo,6410,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9100,Rattus norvegicus,1969.0,CHEMBL622925,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,In vivo,6410,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9101,Rattus norvegicus,1969.0,CHEMBL622926,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,In vivo,16366,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9102,Rattus norvegicus,1969.0,CHEMBL623625,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,In vivo,6227,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9103,Rattus norvegicus,1969.0,CHEMBL623626,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,In vivo,3598,Plasma,50597,,,BAO_0000218,,Expert,,10116.0,N,1,1,
9104,Rattus norvegicus,1969.0,CHEMBL623627,Maximum plasma drug concentration was determined,In vivo,1465,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9105,Rattus norvegicus,,CHEMBL623628,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,In vivo,4368,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9106,Rattus norvegicus,1969.0,CHEMBL623629,Mean peak plasma concentration was observed after intravenous administration in rat,In vivo,15662,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9107,Rattus norvegicus,1969.0,CHEMBL623630,Mean peak plasma concentration was observed after oral administration in rat,In vivo,15662,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9108,Rattus norvegicus,,CHEMBL623804,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,In vivo,5355,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9109,Rattus norvegicus,,CHEMBL623805,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,In vivo,5355,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9110,Rattus norvegicus,1969.0,CHEMBL623806,Peak oral plasma concentration was determined in rats by oral administration,In vivo,1567,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9111,Rattus norvegicus,1969.0,CHEMBL623807,Peak plasma concentration (Cmax) was determined,In vivo,4026,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9112,Rattus norvegicus,1969.0,CHEMBL623808,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,In vivo,6193,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9113,Rattus norvegicus,1969.0,CHEMBL623809,Peak plasma concentration (Cmax) in rats,In vivo,4026,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9114,Rattus norvegicus,1969.0,CHEMBL623810,Peak plasma concentration at 1 mg/kg peroral administration,In vivo,6485,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9115,Rattus norvegicus,1969.0,CHEMBL623811,Peak plasma concentration in rat,In vivo,17655,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9116,Rattus norvegicus,1969.0,CHEMBL623812,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",In vivo,14941,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9117,Rattus norvegicus,,CHEMBL877605,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,In vivo,5394,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9118,Rattus norvegicus,,CHEMBL623813,Pharmacokinetic property (Cmax) in rat,In vivo,4408,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9119,Rattus norvegicus,,CHEMBL623814,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,In vivo,5983,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9120,Rattus norvegicus,,CHEMBL623815,Cmax in rat after 3mg/kg oral dose,In vivo,4878,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9121,Rattus norvegicus,,CHEMBL623816,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,In vivo,5862,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9122,Rattus norvegicus,,CHEMBL623145,Cmax in rats after 20 mg/kg oral dose,In vivo,4517,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9123,Rattus norvegicus,1969.0,CHEMBL623146,Cmax in rat plasma after 30mg/kg oral dose,In vivo,5932,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9124,Rattus norvegicus,1969.0,CHEMBL623147,Plasma concentration after oral administration of 100 mg/kg to rats,In vivo,5436,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9125,Rattus norvegicus,955.0,CHEMBL623042,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,In vivo,4910,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9126,Rattus norvegicus,,CHEMBL623043,Tested for the Cmax in rat at 10 mg/kg per orally,In vivo,4950,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9127,Rattus norvegicus,,CHEMBL623044,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",In vivo,15078,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9128,Rattus norvegicus,,CHEMBL623045,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",In vivo,15078,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9129,Rattus norvegicus,,CHEMBL623046,Bioavailability as oral Cmax in rats at 30 mins,In vivo,3360,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9130,Rattus norvegicus,,CHEMBL623226,Bioavailability as oral Cmax in rats at 6hr,In vivo,3360,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9131,Rattus norvegicus,,CHEMBL623227,The maximum concentration of compound was measured at the dose of 100 umol/kg,In vivo,15022,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9132,Rattus norvegicus,,CHEMBL623228,The maximum concentration of compound was measured at the dose of 300 umol/kg,In vivo,15022,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9133,Rattus norvegicus,,CHEMBL623229,The maximum concentration of compound was measured at the dose of 30 umol/kg,In vivo,15022,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9134,Rattus norvegicus,1969.0,CHEMBL623230,The maximum plasma levels for the compounds were determined by LC-MS.,In vivo,5160,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9135,Rattus norvegicus,1969.0,CHEMBL623231,mean peak plasma concentration was observed after intravenous administration in rat,In vivo,15662,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9136,Rattus norvegicus,1969.0,CHEMBL623232,mean peak plasma concentration was observed after oral administration in rat,In vivo,15662,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9137,Rattus norvegicus,,CHEMBL623233,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,,4709,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9138,Rattus norvegicus,,CHEMBL623234,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,,3535,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9139,Rattus norvegicus,,CHEMBL623235,Concentration in plasma (portal) following oral dose in rats at 1 hr,,3535,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9140,Rattus norvegicus,,CHEMBL623236,Concentration in plasma (portal) following oral dose in rats at 2 hr,,3535,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9141,Rattus norvegicus,,CHEMBL623237,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,,3535,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9142,Rattus norvegicus,,CHEMBL623238,Concentration in plasma (systemic) following oral dose in rats at 1 hr,,3535,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9143,Rattus norvegicus,,CHEMBL623239,Concentration in plasma (systemic) following oral dose in rats at 2 hr,,3535,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9144,Rattus norvegicus,1969.0,CHEMBL623240,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,In vivo,5005,Plasma,22224,,,BAO_0000218,,Intermediate,,10116.0,U,0,1,
9145,Rattus norvegicus,1898.0,CHEMBL623241,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",,6326,Hypothalamus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9146,Rattus norvegicus,1898.0,CHEMBL623242,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",,6326,Hypothalamus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9147,Rattus norvegicus,,CHEMBL874394,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",,6326,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9148,Rattus norvegicus,,CHEMBL623243,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",,6326,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9149,Rattus norvegicus,,CHEMBL623244,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,17411,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9150,Rattus norvegicus,2113.0,CHEMBL623245,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,16435,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9151,Rattus norvegicus,2113.0,CHEMBL623246,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,16435,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9152,Rattus norvegicus,2113.0,CHEMBL623247,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,16435,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9153,Rattus norvegicus,2113.0,CHEMBL623248,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,16435,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9154,Rattus norvegicus,2113.0,CHEMBL623249,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,16435,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9155,Rattus norvegicus,2107.0,CHEMBL625072,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,16434,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9156,Rattus norvegicus,2107.0,CHEMBL625073,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,16434,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9157,Rattus norvegicus,2107.0,CHEMBL625074,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,16434,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9158,Rattus norvegicus,2107.0,CHEMBL625075,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,16434,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9159,Rattus norvegicus,2107.0,CHEMBL625076,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,,16434,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9160,Rattus norvegicus,2107.0,CHEMBL625077,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,16434,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9161,Rattus norvegicus,2107.0,CHEMBL625078,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,16434,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9162,Rattus norvegicus,2107.0,CHEMBL874395,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,16434,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9163,Rattus norvegicus,2107.0,CHEMBL625079,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,16435,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9164,Rattus norvegicus,2107.0,CHEMBL625080,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,16435,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9165,Rattus norvegicus,2107.0,CHEMBL625081,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,16435,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9166,Rattus norvegicus,2107.0,CHEMBL625082,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,16435,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9167,Rattus norvegicus,2107.0,CHEMBL625083,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,16435,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9168,Rattus norvegicus,2107.0,CHEMBL625084,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,16435,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9169,Rattus norvegicus,2107.0,CHEMBL625085,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,16435,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9170,Rattus norvegicus,2107.0,CHEMBL625086,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,16435,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9171,Rattus norvegicus,2107.0,CHEMBL625087,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,16434,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9172,Rattus norvegicus,2107.0,CHEMBL625088,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,16434,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9173,Rattus norvegicus,2107.0,CHEMBL622205,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,16434,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9174,Rattus norvegicus,2107.0,CHEMBL622206,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,16435,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9175,Rattus norvegicus,2107.0,CHEMBL622207,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,16435,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9176,Rattus norvegicus,2107.0,CHEMBL622366,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,16435,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9177,Rattus norvegicus,2107.0,CHEMBL622367,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,16435,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9178,Rattus norvegicus,2107.0,CHEMBL875331,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,16435,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9179,Rattus norvegicus,2107.0,CHEMBL622368,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,16435,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9180,Rattus norvegicus,2048.0,CHEMBL622369,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,16434,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9181,Rattus norvegicus,2048.0,CHEMBL622370,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,16434,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9182,Rattus norvegicus,2048.0,CHEMBL622371,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,16434,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9183,Rattus norvegicus,2048.0,CHEMBL622372,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,16434,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9184,Rattus norvegicus,2048.0,CHEMBL622373,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,16434,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9185,Rattus norvegicus,2048.0,CHEMBL622374,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,16434,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9186,Rattus norvegicus,2048.0,CHEMBL622375,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,16434,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9187,Rattus norvegicus,2048.0,CHEMBL622376,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,16434,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9188,Rattus norvegicus,2048.0,CHEMBL622377,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,16435,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9189,Rattus norvegicus,2048.0,CHEMBL622378,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,16435,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9190,Rattus norvegicus,2048.0,CHEMBL622379,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,16435,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9191,Rattus norvegicus,2048.0,CHEMBL622380,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,16435,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9192,Rattus norvegicus,2048.0,CHEMBL622381,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,16435,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9193,Rattus norvegicus,2048.0,CHEMBL622382,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,16435,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9194,Rattus norvegicus,2048.0,CHEMBL622383,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,,16434,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9195,Rattus norvegicus,945.0,CHEMBL875332,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,6175,Stomach,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9196,Rattus norvegicus,945.0,CHEMBL622384,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,6175,Stomach,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9197,Rattus norvegicus,945.0,CHEMBL622385,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,6175,Stomach,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9198,Rattus norvegicus,945.0,CHEMBL622386,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,6175,Stomach,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9199,Rattus norvegicus,,CHEMBL622387,The compound was tested for the plasma binding in rat,,10839,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9200,Rattus norvegicus,,CHEMBL622388,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",,16459,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9201,Rattus norvegicus,,CHEMBL622389,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",,16459,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9202,Rattus norvegicus,,CHEMBL622390,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",,16459,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9203,Rattus norvegicus,,CHEMBL622391,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),,16459,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9204,Rattus norvegicus,,CHEMBL622392,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),,16459,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9205,Rattus norvegicus,,CHEMBL622393,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),,16459,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9206,Rattus norvegicus,,CHEMBL622394,Plasma level at 2 hr after administration of the compound,,3278,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9207,Rattus norvegicus,,CHEMBL622395,plasma level at 2 hr after administration of the compound,,3278,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9208,Rattus norvegicus,1977.0,CHEMBL622396,Stability in rat serum measured as % recovery at 1 min,,4684,Serum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9209,Rattus norvegicus,1977.0,CHEMBL624894,Stability in rat serum measured as % recovery at 10 min,,4684,Serum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9210,Rattus norvegicus,1977.0,CHEMBL624895,Stability in rat serum measured as % recovery at 10 mins,,4684,Serum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9211,Rattus norvegicus,1977.0,CHEMBL624058,Stability in rat serum measured as % recovery at 2 hr,,4684,Serum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9212,Rattus norvegicus,1977.0,CHEMBL624059,Stability in rat serum measured as % recovery at 3 min,,4684,Serum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9213,Rattus norvegicus,1977.0,CHEMBL624060,Stability in rat serum measured as % recovery at 3 mins,,4684,Serum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9214,Rattus norvegicus,1977.0,CHEMBL624061,Stability in rat serum measured as % recovery at 5 min,,4684,Serum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9215,Rattus norvegicus,1977.0,CHEMBL624062,Stability in rat serum measured as % recovery at 5 mins,,4684,Serum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9216,Rattus norvegicus,,CHEMBL624063,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,In vivo,16456,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9217,Rattus norvegicus,,CHEMBL624064,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,In vivo,16456,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9218,Rattus norvegicus,1969.0,CHEMBL624065,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,,723,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9219,Rattus norvegicus,1969.0,CHEMBL624066,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,,723,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9220,Rattus norvegicus,,CHEMBL877490,Half life tested in mature male rat at a dose of 30 mg/kg,In vivo,5160,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9221,Rattus norvegicus,,CHEMBL874442,Half life after intravenous administration of 1 mg/kg in rat,In vivo,4709,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9222,Rattus norvegicus,,CHEMBL626890,Half life period after administration (30 mg/kg) in rat,In vivo,5633,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9223,Rattus norvegicus,,CHEMBL626891,Half life period in rat after 5 mg/Kg dose,In vivo,5302,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9224,Rattus norvegicus,,CHEMBL626892,Half life period in rat after 5 mg/kg dose,In vivo,5302,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9225,Rattus norvegicus,,CHEMBL626893,Half life period was determined,,17791,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9226,Rattus norvegicus,,CHEMBL626894,Half life period was evaluated in rat,,17791,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9227,Rattus norvegicus,,CHEMBL626895,Half life period was evaluated in rat; 0.5-1.0,,17791,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9228,Rattus norvegicus,,CHEMBL626896,Half life period was evaluated in rat; 5.9-7.5,,17791,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9229,Rattus norvegicus,1969.0,CHEMBL626897,Half-life in rat plasma,,14512,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9230,Rattus norvegicus,,CHEMBL626898,Half-life time in rat was determined,,6230,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9231,Rattus norvegicus,,CHEMBL626899,Terminal half-life after iv administration to rats,In vivo,3364,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9232,Rattus norvegicus,,CHEMBL626900,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,In vivo,6874,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9233,Rattus norvegicus,,CHEMBL626901,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,,857,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9234,Rattus norvegicus,,CHEMBL626902,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),In vivo,858,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9235,Rattus norvegicus,,CHEMBL626903,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),In vivo,858,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9236,Rattus norvegicus,,CHEMBL874443,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,In vivo,5355,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9237,Rattus norvegicus,,CHEMBL626904,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,In vivo,5355,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9238,Rattus norvegicus,,CHEMBL626905,Half life in rats,,6305,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9239,Rattus norvegicus,1969.0,CHEMBL873830,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,In vivo,13501,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9240,Rattus norvegicus,,CHEMBL626906,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,In vivo,17594,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9241,Rattus norvegicus,1969.0,CHEMBL631076,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,In vivo,4186,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9242,Rattus norvegicus,1969.0,CHEMBL631077,Biological half-life was measured in plasma of rats,,2932,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9243,Rattus norvegicus,,CHEMBL631078,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,In vivo,17065,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9244,Rattus norvegicus,,CHEMBL631079,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,In vivo,15765,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9245,Rattus norvegicus,,CHEMBL631080,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,In vivo,2713,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9246,Rattus norvegicus,,CHEMBL631081,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,In vivo,2661,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9247,Rattus norvegicus,,CHEMBL631239,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,In vivo,2661,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9248,Rattus norvegicus,1969.0,CHEMBL631240,Compound was evaluated for plasma half life in rat,,740,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9249,Rattus norvegicus,1969.0,CHEMBL631241,AUC value at a dose of 5 mg/kg (p.o.) in rats,,6597,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9250,Rattus norvegicus,1969.0,CHEMBL631242,AUC value after administration of 20 mg/Kg oral dose in rat,,2959,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9251,Rattus norvegicus,1969.0,CHEMBL631243,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,,17594,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9252,Rattus norvegicus,1969.0,CHEMBL874444,AUC0-96 after administration at 50 mg/kg,,17596,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9253,Rattus norvegicus,1969.0,CHEMBL631244,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,,17594,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9254,Rattus norvegicus,,CHEMBL631245,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",,3293,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9255,Rattus norvegicus,,CHEMBL627162,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,,6757,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9256,Rattus norvegicus,,CHEMBL627163,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,,6757,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9257,Rattus norvegicus,,CHEMBL627164,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,,6757,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9258,Rattus norvegicus,2113.0,CHEMBL627165,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,,5979,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9259,Rattus norvegicus,,CHEMBL627166,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,,5979,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9260,Rattus norvegicus,,CHEMBL627167,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,,5979,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9261,Rattus norvegicus,,CHEMBL627822,Area under curve (AUC) at a dose of 30 mg/kg in rats,,4026,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9262,Rattus norvegicus,,CHEMBL627823,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,5355,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9263,Rattus norvegicus,,CHEMBL627824,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,,5355,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9264,Rattus norvegicus,,CHEMBL627825,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,5355,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9265,Rattus norvegicus,,CHEMBL627826,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,,5633,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9266,Rattus norvegicus,,CHEMBL627827,Area under curve (Pharmacokinetic property) was determined,,1716,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9267,Rattus norvegicus,,CHEMBL627828,Area under curve (Pharmacokinetic property) of the compound; Not determined,,1716,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9268,Rattus norvegicus,,CHEMBL627829,Area under curve after intravenous administration (1 mg/kg) in rat,,4689,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9269,Rattus norvegicus,,CHEMBL627830,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,,4527,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9270,Rattus norvegicus,,CHEMBL627831,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,,4527,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9271,Rattus norvegicus,,CHEMBL627832,Area under curve in male SD rats was observed after oral administration in rat,,15662,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9272,Rattus norvegicus,,CHEMBL627833,Area under curve of compound after iv administration of 20 mg/kg dose in rat,,4413,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9273,Rattus norvegicus,,CHEMBL627834,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,,3598,,50597,,,BAO_0000218,,Expert,,10116.0,N,1,1,
9274,Rattus norvegicus,,CHEMBL628004,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,,3598,,50597,,,BAO_0000218,,Expert,,10116.0,N,1,1,
9275,Rattus norvegicus,,CHEMBL628005,Area under curve at 5 mg/kg po was determined in rat,,5964,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9276,Rattus norvegicus,,CHEMBL628006,Area under curve in Rat at a oral dose of 5 mg/kg,,4689,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9277,Rattus norvegicus,,CHEMBL628007,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,4186,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9278,Rattus norvegicus,,CHEMBL625676,Area under curve was determined,,5510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9279,Rattus norvegicus,,CHEMBL631309,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,,17858,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9280,Rattus norvegicus,,CHEMBL631310,Area under curve after intravenous administration at 3 mg/kg,,17804,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9281,Rattus norvegicus,,CHEMBL631311,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,,6106,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9282,Rattus norvegicus,,CHEMBL631312,Area under curve at 4 hr in rat,,5964,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9283,Rattus norvegicus,,CHEMBL631313,Area under curve at a dose of 30 mg/kg,,4026,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9284,Rattus norvegicus,,CHEMBL631314,Area under curve at the dose of 2 mg/Kg administered perorally in rats,,4756,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9285,Rattus norvegicus,,CHEMBL631315,Area under curve at the dose of 5 mg/Kg administered perorally in rats,,4756,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9286,Rattus norvegicus,,CHEMBL631316,Area under curve for a 2-mpk po dose in SD rats,,5862,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9287,Rattus norvegicus,,CHEMBL631317,Area under curve in SD rats,,5862,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9288,Rattus norvegicus,,CHEMBL874471,Area under curve in rat after oral administration at 13 mg/kg dose,,6644,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9289,Rattus norvegicus,,CHEMBL631318,Area under curve in rat by po administration at 0-24 hr,,5871,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9290,Rattus norvegicus,1969.0,CHEMBL631319,Area under curve in rat plasma,,5919,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9291,Rattus norvegicus,,CHEMBL631320,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,,5939,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9292,Rattus norvegicus,,CHEMBL631321,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,,5939,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9293,Rattus norvegicus,,CHEMBL631322,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,,10,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9294,Rattus norvegicus,,CHEMBL631323,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,,11149,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9295,Rattus norvegicus,,CHEMBL631324,Area under curve value in rat at a dose of 5 mg/kg,,5302,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9296,Rattus norvegicus,,CHEMBL631325,Area under curve was determined after oral administration in rats,,17796,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9297,Rattus norvegicus,,CHEMBL631326,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,4890,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9298,Rattus norvegicus,,CHEMBL631327,Area under curve was determined after peroral administration in rat,,6011,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9299,Rattus norvegicus,,CHEMBL631328,Area under curve was determined at a dose 30 mpk administered orally.,,5375,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9300,Rattus norvegicus,,CHEMBL631329,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,,17764,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9301,Rattus norvegicus,,CHEMBL627217,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,,4368,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9302,Rattus norvegicus,,CHEMBL626352,Area under curve was determined in male rat,,5610,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9303,Rattus norvegicus,,CHEMBL626353,Area under curve was determined in rat after PO administration,,5833,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9304,Rattus norvegicus,,CHEMBL626354,Area under curve was determined in rat after a 3 mg/kg of oral dose,,4257,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9305,Rattus norvegicus,,CHEMBL626355,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,,5937,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9306,Rattus norvegicus,,CHEMBL626356,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,,5932,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9307,Rattus norvegicus,,CHEMBL626357,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,,5932,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9308,Rattus norvegicus,,CHEMBL626358,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,17411,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9309,Rattus norvegicus,,CHEMBL626359,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,17411,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9310,Rattus norvegicus,1969.0,CHEMBL626360,Peak plasma concentration in rat at a dose of 3 mg/kg,,17771,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9311,Rattus norvegicus,,CHEMBL626361,Plasma concentration at 2 hr in rats was evaluated.,,1628,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9312,Rattus norvegicus,,CHEMBL626362,Plasma concentration at 2 hr in rats was evaluated; Not available,,1628,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9313,Rattus norvegicus,,CHEMBL626363,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,17411,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9314,Rattus norvegicus,,CHEMBL626970,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,4910,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9315,Rattus norvegicus,,CHEMBL626971,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,,4910,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9316,Rattus norvegicus,1969.0,CHEMBL626972,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,4910,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9317,Rattus norvegicus,1969.0,CHEMBL626973,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,,4910,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9318,Rattus norvegicus,1969.0,CHEMBL626974,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,4910,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9319,Rattus norvegicus,1969.0,CHEMBL874592,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,,4910,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9320,Rattus norvegicus,,CHEMBL626975,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,,5510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9321,Rattus norvegicus,,CHEMBL626976,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,,5510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9322,Rattus norvegicus,,CHEMBL626977,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,,5510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9323,Rattus norvegicus,,CHEMBL626978,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,,5510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9324,Rattus norvegicus,,CHEMBL626979,PK study was carried to determine the relative absorption ranking in rat.,,16427,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9325,Rattus norvegicus,1969.0,CHEMBL626980,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,In vivo,4689,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9326,Rattus norvegicus,178.0,CHEMBL626981,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",,11450,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9327,Rattus norvegicus,178.0,CHEMBL626982,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",,11450,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9328,Rattus norvegicus,178.0,CHEMBL626983,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",,11450,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9329,Rattus norvegicus,178.0,CHEMBL622522,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",,11450,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9330,Rattus norvegicus,178.0,CHEMBL622523,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",,11450,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9331,Rattus norvegicus,178.0,CHEMBL622524,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",,11450,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9332,Rattus norvegicus,955.0,CHEMBL622525,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",,11450,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9333,Rattus norvegicus,955.0,CHEMBL622526,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",,11450,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9334,Rattus norvegicus,955.0,CHEMBL619849,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",,11450,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9335,Rattus norvegicus,955.0,CHEMBL619850,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",,11450,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9336,Rattus norvegicus,955.0,CHEMBL623864,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",,11450,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9337,Rattus norvegicus,955.0,CHEMBL623865,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",,11450,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9338,Rattus norvegicus,948.0,CHEMBL623866,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",,11450,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9339,Rattus norvegicus,948.0,CHEMBL623867,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",,11450,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9340,Rattus norvegicus,948.0,CHEMBL877615,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",,11450,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9341,Rattus norvegicus,948.0,CHEMBL623868,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",,11450,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9342,Rattus norvegicus,948.0,CHEMBL623869,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",,11450,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9343,Rattus norvegicus,948.0,CHEMBL623870,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",,11450,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9344,Rattus norvegicus,2048.0,CHEMBL623871,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,16434,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9345,Rattus norvegicus,2048.0,CHEMBL623872,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,16434,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9346,Rattus norvegicus,2048.0,CHEMBL622129,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,16435,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9347,Rattus norvegicus,2048.0,CHEMBL622130,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,16435,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9348,Rattus norvegicus,2048.0,CHEMBL622131,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,16435,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9349,Rattus norvegicus,2048.0,CHEMBL622132,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,16435,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9350,Rattus norvegicus,2048.0,CHEMBL622133,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,16435,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9351,Rattus norvegicus,2048.0,CHEMBL622134,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,16435,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9352,Rattus norvegicus,2048.0,CHEMBL622135,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,16435,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9353,Rattus norvegicus,2048.0,CHEMBL622136,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,16435,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9354,Rattus norvegicus,2385.0,CHEMBL622137,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,16434,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9355,Rattus norvegicus,2385.0,CHEMBL622138,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,16434,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9356,Rattus norvegicus,2385.0,CHEMBL623017,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,16434,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9357,Rattus norvegicus,2385.0,CHEMBL623018,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,16434,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9358,Rattus norvegicus,2385.0,CHEMBL623019,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,16434,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9359,Rattus norvegicus,2385.0,CHEMBL623020,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,16434,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9360,Rattus norvegicus,2385.0,CHEMBL623021,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,,16434,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9361,Rattus norvegicus,2385.0,CHEMBL623022,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,16434,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9362,Rattus norvegicus,2385.0,CHEMBL623023,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,16435,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9363,Rattus norvegicus,2385.0,CHEMBL623024,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,16435,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9364,Rattus norvegicus,2385.0,CHEMBL623025,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,16435,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9365,Rattus norvegicus,2385.0,CHEMBL620545,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,16435,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9366,Rattus norvegicus,2385.0,CHEMBL620546,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,16435,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9367,Rattus norvegicus,2385.0,CHEMBL620547,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,16435,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9368,Rattus norvegicus,2385.0,CHEMBL620548,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,16435,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9369,Rattus norvegicus,2385.0,CHEMBL620549,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,16435,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9370,Rattus norvegicus,2385.0,CHEMBL620550,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,16434,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9371,Rattus norvegicus,2385.0,CHEMBL620551,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,16434,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9372,Rattus norvegicus,2385.0,CHEMBL620552,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,16434,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9373,Rattus norvegicus,2385.0,CHEMBL620553,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,16435,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9374,Rattus norvegicus,2385.0,CHEMBL620554,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,16435,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9375,Rattus norvegicus,2385.0,CHEMBL875845,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,16435,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9376,Rattus norvegicus,2385.0,CHEMBL620555,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,16435,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9377,Rattus norvegicus,2385.0,CHEMBL620556,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,16435,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9378,Rattus norvegicus,2385.0,CHEMBL620557,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,16435,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9379,Rattus norvegicus,,CHEMBL620558,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9380,Rattus norvegicus,,CHEMBL620559,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9381,Rattus norvegicus,,CHEMBL622939,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9382,Rattus norvegicus,,CHEMBL622940,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9383,Rattus norvegicus,,CHEMBL622941,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9384,Rattus norvegicus,,CHEMBL622942,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9385,Rattus norvegicus,,CHEMBL622943,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9386,Rattus norvegicus,,CHEMBL622944,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9387,Rattus norvegicus,,CHEMBL622945,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9388,Rattus norvegicus,,CHEMBL622946,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9389,Rattus norvegicus,,CHEMBL622947,Compound was evaluated for terminal half life in rat,,3341,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9390,Rattus norvegicus,1969.0,CHEMBL622948,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,In vivo,3634,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9391,Rattus norvegicus,1969.0,CHEMBL622949,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,In vivo,3634,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9392,Rattus norvegicus,,CHEMBL622950,Compound was tested for its half life in rat,,4839,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9393,Macaca mulatta,1969.0,CHEMBL622951,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,In vivo,5005,Plasma,22224,,,BAO_0000218,,Intermediate,,9544.0,U,0,1,
9394,Rattus norvegicus,1969.0,CHEMBL622952,Compound was tested for its plasma half life in Sprague Dawley rats,,5005,Plasma,22224,,,BAO_0000366,,Intermediate,,10116.0,U,0,1,
9395,Rattus norvegicus,1969.0,CHEMBL622953,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,,5005,Plasma,22224,,,BAO_0000366,,Intermediate,,10116.0,U,0,1,
9396,Rattus norvegicus,1969.0,CHEMBL873818,Compound was tested for plasma half-life period in rat,,1094,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9397,Rattus norvegicus,,CHEMBL622954,Elimination half life after i.v. administration of compound in rats,In vivo,5031,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9398,Rattus norvegicus,,CHEMBL622955,Elimination half-life after IV dosing at 0.5 mg/kg in rat,In vivo,6518,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9399,Rattus norvegicus,,CHEMBL875229,Elimination half-life after IV dosing at 1 mg/kg in rat,In vivo,6518,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9400,Rattus norvegicus,,CHEMBL622956,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,In vivo,6518,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9401,Rattus norvegicus,,CHEMBL622957,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,In vivo,6518,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9402,Rattus norvegicus,955.0,CHEMBL622958,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,In vivo,5408,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9403,Rattus norvegicus,1969.0,CHEMBL622959,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,In vivo,5408,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9404,Rattus norvegicus,955.0,CHEMBL622960,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,In vivo,5408,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9405,Rattus norvegicus,1969.0,CHEMBL622961,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,In vivo,5408,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9406,Rattus norvegicus,,CHEMBL622962,Evaluated for the half life in rat (in vivo),In vivo,4687,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9407,Rattus norvegicus,,CHEMBL622963,Hafl life in rat,,6640,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9408,Rattus norvegicus,,CHEMBL622964,Hafl life rat,,6640,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9409,Rattus norvegicus,,CHEMBL622965,Hafl life rat,,6641,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9410,Rattus norvegicus,,CHEMBL622966,Hafl life rat; Not determined,,6640,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9411,Rattus norvegicus,,CHEMBL622967,Hafl life rat; Not determined,,6641,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9412,Rattus norvegicus,2113.0,CHEMBL622968,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,In vivo,17411,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9413,Rattus norvegicus,2107.0,CHEMBL622969,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,In vivo,17411,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9414,Rattus norvegicus,2048.0,CHEMBL875327,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,In vivo,17411,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9415,Rattus norvegicus,,CHEMBL628638,Half life in rat after 1 mg/kg i.v. administration,In vivo,6570,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9416,Rattus norvegicus,,CHEMBL628639,Half life in rat after 2 mg/kg peroral administration,In vivo,6570,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9417,Rattus norvegicus,,CHEMBL625840,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,In vivo,17411,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9418,Rattus norvegicus,,CHEMBL625841,Half life of 10 mg/kg oral dose determined in rats,In vivo,4722,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9419,Rattus norvegicus,,CHEMBL625842,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,5978,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9420,Rattus norvegicus,,CHEMBL625843,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,5978,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9421,Rattus norvegicus,,CHEMBL625844,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,5978,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9422,Rattus norvegicus,,CHEMBL873822,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,5978,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9423,Rattus norvegicus,,CHEMBL625845,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,5978,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9424,Rattus norvegicus,,CHEMBL627059,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,5978,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9425,Rattus norvegicus,,CHEMBL627060,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,5978,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9426,Rattus norvegicus,,CHEMBL627061,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,In vivo,5978,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9427,Rattus norvegicus,,CHEMBL627709,Half life of compound at 5 mg/kg after po administration was determined in rat,In vivo,4762,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9428,Rattus norvegicus,,CHEMBL627710,Half life of compound determined after intravenous administration to rat,In vivo,5327,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9429,Rattus norvegicus,,CHEMBL627711,Half life of compound was determined in rat,,4847,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9430,Rattus norvegicus,1969.0,CHEMBL627712,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,In vivo,17720,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9431,Rattus norvegicus,,CHEMBL627713,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,In vivo,4723,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9432,Rattus norvegicus,,CHEMBL627714,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,In vivo,4723,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9433,Macaca fascicularis,,CHEMBL627889,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,In vivo,4256,,22224,,,BAO_0000218,,Intermediate,,9541.0,U,0,1,
9434,Rattus norvegicus,,CHEMBL627890,Half life determined in rat by intravenous administration,In vivo,4256,,22224,,,BAO_0000218,,Intermediate,,10116.0,U,0,1,
9435,Rattus norvegicus,,CHEMBL627891,Half life determined in rats after iv administration,In vivo,4722,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9436,Rattus norvegicus,1969.0,CHEMBL627892,Half life in rat plasma after administration of 2 mg/kg iv,In vivo,6535,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9437,Rattus norvegicus,1969.0,CHEMBL627893,Half life in rat plasma after administration of 2 mg/kg iv,In vivo,6535,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9438,Rattus norvegicus,1969.0,CHEMBL627894,Half life in rat plasma was determined,,1435,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9439,Rattus norvegicus,1969.0,CHEMBL627895,Half life in rat plasma was determined; NA means not applicable,,1435,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9440,Rattus norvegicus,,CHEMBL627896,Half life in rat was tested,,5206,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9441,Rattus norvegicus,1969.0,CHEMBL627897,Half life measured in rat plasma,,6080,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9442,Rattus norvegicus,,CHEMBL627898,Half life recorded in rats,,4449,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9443,Rattus norvegicus,,CHEMBL627899,Half life was calculated,,6057,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9444,Rattus norvegicus,,CHEMBL873823,Half life was calculated in rat,,6057,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9445,Rattus norvegicus,,CHEMBL627900,Half life was determined,,3747,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9446,Rattus norvegicus,,CHEMBL627901,Half life after 10 mg/kg oral administration in rat,In vivo,17858,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9447,Rattus norvegicus,,CHEMBL627902,Half life after administering orally a dose of 10 mg/kg to a fasting rat,In vivo,16365,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9448,Rattus norvegicus,,CHEMBL627903,Half life after administering orally a dose of 30 mg/kg,In vivo,16365,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9449,Rattus norvegicus,,CHEMBL627904,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,,5031,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9450,Rattus norvegicus,,CHEMBL627905,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,,4722,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9451,Rattus norvegicus,,CHEMBL627906,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,,6078,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9452,Rattus norvegicus,,CHEMBL627907,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,,6078,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9453,Rattus norvegicus,,CHEMBL876783,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,,6078,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9454,Rattus norvegicus,,CHEMBL627908,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,,6078,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9455,Rattus norvegicus,,CHEMBL627909,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,,17065,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9456,Rattus norvegicus,,CHEMBL627910,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,,1353,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9457,Rattus norvegicus,,CHEMBL627911,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),,1353,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9458,Rattus norvegicus,,CHEMBL627912,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),,1353,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9459,Rattus norvegicus,,CHEMBL627913,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),,1353,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9460,Rattus norvegicus,,CHEMBL627914,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),,1353,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9461,Rattus norvegicus,,CHEMBL627915,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,,16423,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9462,Rattus norvegicus,,CHEMBL627916,Area under the curve was evaluated after 20 uM/kg of peroral administration,,16423,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9463,Rattus norvegicus,,CHEMBL627917,Area under the curve was measured in rat after an iv dose of 1 mg/kg,,6062,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9464,Rattus norvegicus,,CHEMBL627918,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,,6056,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9465,Rattus norvegicus,,CHEMBL627919,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,,5182,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9466,Rattus norvegicus,,CHEMBL627920,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,,6410,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9467,Rattus norvegicus,,CHEMBL627921,Area under the curve was evaluated at an oral dose of 30 mg/kg,,6410,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9468,Rattus norvegicus,,CHEMBL627922,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,4723,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9469,Rattus norvegicus,,CHEMBL876784,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,4723,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9470,Rattus norvegicus,,CHEMBL627923,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,4723,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9471,Rattus norvegicus,,CHEMBL626208,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,4723,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9472,Rattus norvegicus,,CHEMBL626209,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,4723,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9473,Rattus norvegicus,,CHEMBL626210,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,4723,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9474,Rattus norvegicus,1969.0,CHEMBL627994,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,2463,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9475,Rattus norvegicus,,CHEMBL627995,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,,4709,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9476,Rattus norvegicus,,CHEMBL627996,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,,4075,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9477,Rattus norvegicus,,CHEMBL627997,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,,5394,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9478,Rattus norvegicus,,CHEMBL627998,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,,2661,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9479,Rattus norvegicus,,CHEMBL628640,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,,2661,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9480,Rattus norvegicus,,CHEMBL628641,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,,2661,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9481,Rattus norvegicus,,CHEMBL628642,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,,2661,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9482,Rattus norvegicus,,CHEMBL628643,Compound was evaluated for area under the curve expressed as (h*ug/ml),,17791,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9483,Rattus norvegicus,,CHEMBL628644,Compound was tested for area under curve in rat,,2591,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9484,Rattus norvegicus,,CHEMBL628645,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,,6567,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9485,Rattus norvegicus,,CHEMBL628646,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,6211,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9486,Rattus norvegicus,,CHEMBL628647,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),,5529,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9487,Rattus norvegicus,,CHEMBL628648,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,5408,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9488,Rattus norvegicus,,CHEMBL625358,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,5408,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9489,Rattus norvegicus,,CHEMBL625359,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,5408,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9490,Rattus norvegicus,,CHEMBL625360,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,5408,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9491,Rattus norvegicus,,CHEMBL625361,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),,429,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9492,Rattus norvegicus,,CHEMBL625362,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),,429,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9493,Rattus norvegicus,,CHEMBL625363,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),,429,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9494,Rattus norvegicus,,CHEMBL625364,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,4796,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9495,Rattus norvegicus,,CHEMBL625365,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,5974,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9496,Rattus norvegicus,,CHEMBL625366,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,5974,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9497,Rattus norvegicus,,CHEMBL625367,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,5974,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9498,Rattus norvegicus,2113.0,CHEMBL625368,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",,11450,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9499,Rattus norvegicus,2113.0,CHEMBL625369,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",,11450,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9500,Rattus norvegicus,2113.0,CHEMBL625370,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",,11450,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9501,Rattus norvegicus,2113.0,CHEMBL625371,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",,11450,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9502,Rattus norvegicus,2113.0,CHEMBL625372,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",,11450,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9503,Rattus norvegicus,2113.0,CHEMBL625373,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",,11450,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9504,Rattus norvegicus,2107.0,CHEMBL625374,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",,11450,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9505,Rattus norvegicus,2107.0,CHEMBL877593,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",,11450,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9506,Rattus norvegicus,2107.0,CHEMBL625375,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",,11450,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9507,Rattus norvegicus,2107.0,CHEMBL625376,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",,11450,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9508,Rattus norvegicus,2107.0,CHEMBL621973,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",,11450,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9509,Rattus norvegicus,2107.0,CHEMBL621974,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",,11450,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9510,Rattus norvegicus,2048.0,CHEMBL621975,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",,11450,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9511,Rattus norvegicus,2048.0,CHEMBL622166,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",,11450,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9512,Rattus norvegicus,2048.0,CHEMBL622167,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",,11450,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9513,Rattus norvegicus,2048.0,CHEMBL622168,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",,11450,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9514,Rattus norvegicus,2048.0,CHEMBL622169,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",,11450,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9515,Rattus norvegicus,2048.0,CHEMBL622170,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",,11450,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9516,Rattus norvegicus,2046.0,CHEMBL622171,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",,11450,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9517,Rattus norvegicus,2046.0,CHEMBL622172,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",,11450,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9518,Rattus norvegicus,2046.0,CHEMBL622173,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",,11450,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9519,Rattus norvegicus,2046.0,CHEMBL622174,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",,11450,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9520,Rattus norvegicus,2046.0,CHEMBL622175,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",,11450,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9521,Rattus norvegicus,2046.0,CHEMBL622176,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",,11450,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9522,Rattus norvegicus,2046.0,CHEMBL622177,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",,11450,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9523,Rattus norvegicus,2046.0,CHEMBL622178,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",,11450,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9524,Rattus norvegicus,2046.0,CHEMBL622179,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",,11450,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9525,Rattus norvegicus,2046.0,CHEMBL622180,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",,11450,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9526,Rattus norvegicus,,CHEMBL622181,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9527,Rattus norvegicus,,CHEMBL622182,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9528,Rattus norvegicus,,CHEMBL622183,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9529,Rattus norvegicus,,CHEMBL622184,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9530,Rattus norvegicus,,CHEMBL622185,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9531,Rattus norvegicus,,CHEMBL622186,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9532,Rattus norvegicus,,CHEMBL622187,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9533,Rattus norvegicus,,CHEMBL625002,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9534,Rattus norvegicus,,CHEMBL622090,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9535,Rattus norvegicus,,CHEMBL622091,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9536,Rattus norvegicus,,CHEMBL622092,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9537,Rattus norvegicus,,CHEMBL622093,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9538,Rattus norvegicus,,CHEMBL622094,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9539,Rattus norvegicus,,CHEMBL622095,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9540,Rattus norvegicus,,CHEMBL622264,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9541,Rattus norvegicus,2106.0,CHEMBL622265,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,16434,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9542,Rattus norvegicus,2106.0,CHEMBL622266,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,16434,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9543,Rattus norvegicus,2106.0,CHEMBL622267,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,16434,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9544,Rattus norvegicus,2106.0,CHEMBL622268,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,16434,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9545,Rattus norvegicus,2106.0,CHEMBL622269,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,16434,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9546,Rattus norvegicus,2106.0,CHEMBL625071,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,16434,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9547,Rattus norvegicus,2106.0,CHEMBL621621,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,16434,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9548,Rattus norvegicus,2106.0,CHEMBL621622,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,16434,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9549,Rattus norvegicus,2106.0,CHEMBL621623,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,16435,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9550,Rattus norvegicus,2106.0,CHEMBL621624,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,16435,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9551,Rattus norvegicus,2106.0,CHEMBL621625,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,16435,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9552,Rattus norvegicus,2106.0,CHEMBL621626,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,16435,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9553,Rattus norvegicus,2106.0,CHEMBL621627,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,16435,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9554,Rattus norvegicus,2106.0,CHEMBL621628,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,16435,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9555,Rattus norvegicus,2106.0,CHEMBL875328,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,16435,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9556,Rattus norvegicus,2106.0,CHEMBL621629,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,16435,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9557,Rattus norvegicus,2106.0,CHEMBL621630,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,16434,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9558,Rattus norvegicus,2106.0,CHEMBL621631,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,16434,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9559,Rattus norvegicus,2106.0,CHEMBL621632,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,16434,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9560,Rattus norvegicus,2106.0,CHEMBL621633,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,16435,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9561,Rattus norvegicus,2106.0,CHEMBL621634,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,16435,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9562,Rattus norvegicus,2106.0,CHEMBL621635,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,16435,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9563,Rattus norvegicus,2106.0,CHEMBL621636,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,16435,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9564,Rattus norvegicus,2106.0,CHEMBL621637,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,16435,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9565,Rattus norvegicus,2106.0,CHEMBL621638,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,16435,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9566,Rattus norvegicus,,CHEMBL618883,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9567,Rattus norvegicus,,CHEMBL618884,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9568,Rattus norvegicus,,CHEMBL628627,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9569,Rattus norvegicus,,CHEMBL628628,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9570,Rattus norvegicus,,CHEMBL628629,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9571,Rattus norvegicus,,CHEMBL628630,Half life after administering orally a dose of 3 mg/kg,In vivo,16365,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9572,Rattus norvegicus,,CHEMBL628631,Half life after administering orally a dose of 3 mg/kg to a fasting rat,In vivo,16365,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9573,Rattus norvegicus,,CHEMBL628632,Half life after administering intravenously a dose of 1 mg/kg,In vivo,16365,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9574,Rattus norvegicus,,CHEMBL628633,Half life after oral dosing in rats,In vivo,526,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9575,Rattus norvegicus,,CHEMBL628634,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,In vivo,16365,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9576,Rattus norvegicus,,CHEMBL627789,Half life by intravenous administration of 3.4 mg/kg in rat,In vivo,4368,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9577,Rattus norvegicus,,CHEMBL627790,Half life in rat,,3371,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9578,Rattus norvegicus,,CHEMBL627791,Half life in rat,,6448,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9579,Rattus norvegicus,,CHEMBL627792,Half life in rat,,6453,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9580,Rattus norvegicus,,CHEMBL627793,Half life in rat after intravenous administration of the compound,In vivo,4353,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9581,Rattus norvegicus,1969.0,CHEMBL627794,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,In vivo,4353,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9582,Rattus norvegicus,,CHEMBL627795,Half life in rat after po administration of the compound,In vivo,4353,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9583,Rattus norvegicus,,CHEMBL627796,Half life in rat after po administration of the compound; ND means Not determined,In vivo,4353,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9584,Rattus norvegicus,1969.0,CHEMBL875335,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,In vivo,4353,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9585,Rattus norvegicus,1969.0,CHEMBL627797,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,In vivo,4353,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9586,Rattus norvegicus,,CHEMBL627798,Half life in rat i.v.,In vivo,5789,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9587,Rattus norvegicus,,CHEMBL627799,Half life in rat i.v. at 2 mg/kg concentration,In vivo,17686,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9588,Rattus norvegicus,,CHEMBL627800,Half life in rats,,6495,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9589,Rattus norvegicus,,CHEMBL627801,Half life in rats after intravenous administration,In vivo,484,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9590,Rattus norvegicus,,CHEMBL627802,Half life in rats at the dose of 1.0 mpk by i.v. administration,In vivo,6467,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9591,Rattus norvegicus,,CHEMBL627803,Half life in rat,,6642,,50597,,,BAO_0000218,,Expert,,10116.0,N,1,1,
9592,Rattus norvegicus,,CHEMBL873820,Half life was evaluated after intravenous administration to rats,In vivo,16367,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9593,Rattus norvegicus,,CHEMBL627804,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),,1369,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9594,Rattus norvegicus,,CHEMBL627805,Half life was evaluated in rat,,5472,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9595,Rattus norvegicus,,CHEMBL627806,Half life was evaluated in rat,,6049,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9596,Rattus norvegicus,,CHEMBL627107,Half life was evaluated in rat; Not tested,,5472,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9597,Rattus norvegicus,,CHEMBL627108,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,In vivo,16366,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9598,Rattus norvegicus,,CHEMBL627109,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,In vivo,11149,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9599,Rattus norvegicus,178.0,CHEMBL627110,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,In vivo,11149,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9600,Primates,,CHEMBL627111,Half life was measured in monkey at dose of 10 mg/kg by po administration,In vivo,2891,,22224,,,BAO_0000218,,Intermediate,,9443.0,U,0,1,
9601,Primates,,CHEMBL627112,Half life was measured in monkey at dose of 10 mg/kg by po administration,In vivo,2891,,22224,,,BAO_0000218,,Intermediate,,9443.0,U,0,1,
9602,Rattus norvegicus,,CHEMBL627113,Half life was measured in rat at dose of 30 mg/kg by iv administration,In vivo,2891,,22224,,,BAO_0000218,,Intermediate,,10116.0,U,0,1,
9603,Rattus norvegicus,,CHEMBL627114,Half life was measured in rat at dose of 30 mg/kg by po administration,In vivo,2891,,22224,,,BAO_0000218,,Intermediate,,10116.0,U,0,1,
9604,Rattus norvegicus,,CHEMBL627115,Half life (t1/2) was determined,,4026,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9605,Rattus norvegicus,,CHEMBL627116,Half life period at a dose of 10 uM/kg in rat was determined,,4527,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9606,Rattus norvegicus,,CHEMBL627117,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,In vivo,4527,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9607,Rattus norvegicus,,CHEMBL627118,Half life period was determined,,5503,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9608,Rattus norvegicus,,CHEMBL627119,Half life period after intravenous administration at 20 mpk in rats,In vivo,4426,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9609,Rattus norvegicus,,CHEMBL627120,Half life period after intravenous administration at 20 mpk in rats; Not performed.,In vivo,4426,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9610,Rattus norvegicus,,CHEMBL626922,Half life period after intravenous administration in rat,In vivo,6109,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9611,Rattus norvegicus,,CHEMBL626923,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,In vivo,5654,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9612,Rattus norvegicus,,CHEMBL626924,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,In vivo,5654,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9613,Rattus norvegicus,1969.0,CHEMBL626925,Half life period in 80% rat plasma at 37 degree Centigrade,,4755,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9614,Rattus norvegicus,,CHEMBL626926,Half life period in SD rats,,5862,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9615,Rattus norvegicus,1969.0,CHEMBL626927,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),,1515,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9616,Rattus norvegicus,1969.0,CHEMBL626928,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),,1515,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9617,Rattus norvegicus,1969.0,CHEMBL626929,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,1515,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9618,Rattus norvegicus,1969.0,CHEMBL626930,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,1515,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9619,Rattus norvegicus,,CHEMBL626931,Half life period in rat,,5960,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9620,Rattus norvegicus,,CHEMBL626932,Half life period in rat,,6103,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9621,Rattus norvegicus,,CHEMBL626933,Half life period in rat,,6317,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9622,Rattus norvegicus,,CHEMBL873826,Half life period in rat after oral administration at 10.5 mg/kg dose,In vivo,6644,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9623,Rattus norvegicus,,CHEMBL626934,Half life period in rat after oral administration at 11.2 mg/kg dose,In vivo,6644,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9624,Rattus norvegicus,,CHEMBL626935,Half life period in rat after oral administration at 13 mg/kg dose,In vivo,6644,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9625,Rattus norvegicus,,CHEMBL626936,Half life period in rat after oral administration at 9.7 mg/kg dose,In vivo,6644,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9626,Rattus norvegicus,,CHEMBL626937,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,5974,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9627,Rattus norvegicus,,CHEMBL625906,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,6295,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9628,Rattus norvegicus,,CHEMBL625907,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,6296,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9629,Rattus norvegicus,,CHEMBL625908,PK study was carried to determine AUC (area under curve) value in rat,,16427,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9630,Rattus norvegicus,,CHEMBL625909,Pharmacokinetic parameter AUC after intravenous administration to rats,,16367,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9631,Rattus norvegicus,,CHEMBL625910,Pharmacokinetic parameter AUC after oral administration to rats,,16367,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9632,Rattus norvegicus,,CHEMBL625911,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,,16365,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9633,Rattus norvegicus,,CHEMBL625912,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,,16365,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9634,Rattus norvegicus,,CHEMBL626538,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,,16365,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9635,Rattus norvegicus,,CHEMBL876794,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,,16365,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9636,Rattus norvegicus,,CHEMBL626539,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,,16365,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9637,Rattus norvegicus,,CHEMBL626540,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,,16365,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9638,Rattus norvegicus,,CHEMBL626541,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,,5394,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9639,Rattus norvegicus,,CHEMBL626542,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,,5394,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9640,Rattus norvegicus,,CHEMBL626543,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,,2792,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9641,Rattus norvegicus,,CHEMBL626544,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,,2792,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9642,Rattus norvegicus,,CHEMBL626545,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,,2792,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9643,Rattus norvegicus,,CHEMBL626546,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,,2792,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9644,Rattus norvegicus,,CHEMBL626547,Pharmacokinetic parameter area under curve was reported,,5334,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9645,Rattus norvegicus,,CHEMBL626548,Pharmacokinetic property (AUC) in rat,,4408,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9646,Rattus norvegicus,,CHEMBL626549,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,,5983,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9647,Rattus norvegicus,,CHEMBL626550,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,,4397,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9648,Rattus norvegicus,,CHEMBL626551,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,,4397,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9649,Rattus norvegicus,,CHEMBL623777,Pharmacokinetic property was determined,,5491,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9650,Rattus norvegicus,,CHEMBL623778,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,,5491,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9651,Rattus norvegicus,,CHEMBL623779,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,,5491,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9652,Rattus norvegicus,1969.0,CHEMBL623780,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,4199,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9653,Rattus norvegicus,1969.0,CHEMBL622015,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,,4199,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9654,Rattus norvegicus,1969.0,CHEMBL622016,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,,4199,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9655,Rattus norvegicus,,CHEMBL622017,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",,5173,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9656,Rattus norvegicus,,CHEMBL622018,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",,5173,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9657,Rattus norvegicus,,CHEMBL622019,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",,5173,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9658,Rattus norvegicus,,CHEMBL622020,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",,5173,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9659,Rattus norvegicus,,CHEMBL622021,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,,16366,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9660,Rattus norvegicus,,CHEMBL622022,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,,16366,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9661,Rattus norvegicus,,CHEMBL622023,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,,5327,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9662,Rattus norvegicus,,CHEMBL622024,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,,6681,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9663,Rattus norvegicus,,CHEMBL622693,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),,12873,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9664,Rattus norvegicus,,CHEMBL622694,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),,12873,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9665,Rattus norvegicus,,CHEMBL622695,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,6685,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9666,Rattus norvegicus,,CHEMBL622696,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,6685,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9667,Rattus norvegicus,,CHEMBL622697,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",,6685,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9668,Rattus norvegicus,,CHEMBL622874,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",,6619,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9669,Rattus norvegicus,,CHEMBL622875,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",,6619,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9670,Rattus norvegicus,,CHEMBL622876,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,10363,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9671,Rattus norvegicus,,CHEMBL622877,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,4796,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9672,Rattus norvegicus,,CHEMBL622878,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,4910,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9673,Rattus norvegicus,1969.0,CHEMBL622879,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,,4910,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9674,Rattus norvegicus,,CHEMBL877602,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,,4839,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9675,Rattus norvegicus,,CHEMBL622880,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,15078,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9676,Rattus norvegicus,,CHEMBL622881,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",,15078,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9677,Rattus norvegicus,,CHEMBL622882,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,15078,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9678,Rattus norvegicus,,CHEMBL622883,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",,15078,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9679,Rattus norvegicus,2046.0,CHEMBL622884,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",,11450,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9680,Rattus norvegicus,2046.0,CHEMBL622885,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",,11450,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9681,Rattus norvegicus,,CHEMBL622886,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,8151,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9682,Rattus norvegicus,,CHEMBL622887,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,8151,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9683,Rattus norvegicus,1088.0,CHEMBL622888,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,8151,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9684,Rattus norvegicus,178.0,CHEMBL622889,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,8677,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9685,Rattus norvegicus,178.0,CHEMBL622890,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,8677,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9686,Rattus norvegicus,178.0,CHEMBL622891,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,8677,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9687,Rattus norvegicus,178.0,CHEMBL877603,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,8677,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9688,Rattus norvegicus,955.0,CHEMBL622892,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,8677,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9689,Rattus norvegicus,955.0,CHEMBL622893,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,8677,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9690,Rattus norvegicus,955.0,CHEMBL622894,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,8677,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9691,Rattus norvegicus,955.0,CHEMBL622895,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,8677,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9692,Rattus norvegicus,955.0,CHEMBL622896,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,In vivo,8677,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9693,Rattus norvegicus,948.0,CHEMBL622897,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,8677,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9694,Rattus norvegicus,948.0,CHEMBL622898,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,8677,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9695,Rattus norvegicus,948.0,CHEMBL622899,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,8677,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9696,Rattus norvegicus,2113.0,CHEMBL622900,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,8677,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9697,Rattus norvegicus,2113.0,CHEMBL624114,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,8677,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9698,Rattus norvegicus,2113.0,CHEMBL624115,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,8677,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9699,Rattus norvegicus,2113.0,CHEMBL624116,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,8677,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9700,Rattus norvegicus,2107.0,CHEMBL624117,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,8677,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9701,Rattus norvegicus,2107.0,CHEMBL624118,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,8677,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9702,Rattus norvegicus,2107.0,CHEMBL624119,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,8677,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9703,Rattus norvegicus,2107.0,CHEMBL624120,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,8677,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9704,Rattus norvegicus,2048.0,CHEMBL624121,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,8677,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9705,Rattus norvegicus,2048.0,CHEMBL624122,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,8677,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9706,Rattus norvegicus,2048.0,CHEMBL624123,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,8677,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9707,Rattus norvegicus,2048.0,CHEMBL624124,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,8677,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9708,Rattus norvegicus,2385.0,CHEMBL624125,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,8677,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9709,Rattus norvegicus,2385.0,CHEMBL624126,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,8677,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9710,Rattus norvegicus,2385.0,CHEMBL624127,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,8677,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9711,Rattus norvegicus,2385.0,CHEMBL624128,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,8677,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9712,Rattus norvegicus,14.0,CHEMBL624129,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,8677,Zone of skin,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9713,Rattus norvegicus,14.0,CHEMBL624130,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,8677,Zone of skin,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9714,Rattus norvegicus,14.0,CHEMBL622340,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,8677,Zone of skin,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9715,Rattus norvegicus,14.0,CHEMBL622341,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,8677,Zone of skin,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9716,Rattus norvegicus,160.0,CHEMBL622342,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,8677,Intestine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9717,Rattus norvegicus,160.0,CHEMBL622343,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,8677,Intestine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9718,Rattus norvegicus,160.0,CHEMBL622344,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,8677,Intestine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9719,Rattus norvegicus,160.0,CHEMBL622345,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,8677,Intestine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9720,Rattus norvegicus,2106.0,CHEMBL622346,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,8677,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9721,Rattus norvegicus,2106.0,CHEMBL622347,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,8677,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9722,Rattus norvegicus,2106.0,CHEMBL622348,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,8677,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9723,Rattus norvegicus,2106.0,CHEMBL622349,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,8677,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9724,Rattus norvegicus,,CHEMBL622350,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9725,Rattus norvegicus,,CHEMBL622351,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9726,Rattus norvegicus,,CHEMBL622352,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9727,Rattus norvegicus,,CHEMBL622353,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9728,Rattus norvegicus,,CHEMBL622354,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9729,Rattus norvegicus,,CHEMBL622355,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9730,Rattus norvegicus,,CHEMBL622356,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9731,Rattus norvegicus,,CHEMBL622357,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9732,Rattus norvegicus,,CHEMBL622358,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9733,Rattus norvegicus,,CHEMBL622359,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9734,Rattus norvegicus,,CHEMBL874393,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9735,Rattus norvegicus,,CHEMBL622872,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9736,Rattus norvegicus,,CHEMBL622873,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9737,Rattus norvegicus,,CHEMBL623047,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9738,Rattus norvegicus,,CHEMBL623048,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9739,Rattus norvegicus,,CHEMBL623049,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9740,Rattus norvegicus,,CHEMBL623050,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9741,Rattus norvegicus,,CHEMBL623051,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9742,Rattus norvegicus,,CHEMBL623052,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9743,Rattus norvegicus,,CHEMBL626343,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9744,Rattus norvegicus,,CHEMBL626344,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9745,Rattus norvegicus,,CHEMBL626345,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9746,Rattus norvegicus,,CHEMBL626346,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9747,Rattus norvegicus,,CHEMBL626347,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9748,Rattus norvegicus,,CHEMBL626348,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9749,Rattus norvegicus,,CHEMBL626349,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,16434,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9750,Rattus norvegicus,,CHEMBL626350,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9751,Rattus norvegicus,,CHEMBL626351,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9752,Rattus norvegicus,,CHEMBL627650,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9753,Rattus norvegicus,,CHEMBL627651,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9754,Rattus norvegicus,,CHEMBL627652,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9755,Rattus norvegicus,,CHEMBL627653,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,16435,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9756,Rattus norvegicus,,CHEMBL627654,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,,13091,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9757,Rattus norvegicus,,CHEMBL627835,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,,13091,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9758,Rattus norvegicus,,CHEMBL627836,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,,13091,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9759,Rattus norvegicus,,CHEMBL627837,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,,13091,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9760,Rattus norvegicus,,CHEMBL627838,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,,13091,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9761,Rattus norvegicus,,CHEMBL875338,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,,13091,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9762,Rattus norvegicus,,CHEMBL627839,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,,13091,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9763,Rattus norvegicus,,CHEMBL627840,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,,13091,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9764,Rattus norvegicus,,CHEMBL627841,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,,13091,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9765,Rattus norvegicus,,CHEMBL627842,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,,13091,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9766,Rattus norvegicus,,CHEMBL627843,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,,13091,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9767,Rattus norvegicus,,CHEMBL627844,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,,13091,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9768,Rattus norvegicus,,CHEMBL627845,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,,13091,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9769,Rattus norvegicus,,CHEMBL627846,Half life period in rat by iv administration at a dose of 3 mg/kg,In vivo,5874,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9770,Rattus norvegicus,1969.0,CHEMBL627847,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),,1515,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9771,Rattus norvegicus,1969.0,CHEMBL873821,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),,1515,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9772,Rattus norvegicus,1969.0,CHEMBL626079,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,1515,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9773,Rattus norvegicus,1969.0,CHEMBL626080,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,1515,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9774,Rattus norvegicus,1969.0,CHEMBL626081,Half life period was evaluated in rat plasma,,5491,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9775,Rattus norvegicus,1969.0,CHEMBL875344,Half life period was evaluated in rat plasma; Not tested,,5491,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9776,Rattus norvegicus,,CHEMBL626082,Half life period was evaluated in rats,,1918,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9777,Rattus norvegicus,,CHEMBL626250,"Half life period was evaluated in rats, iv",In vivo,1918,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9778,Rattus norvegicus,,CHEMBL626251,Half life period after intravenous administration at 5 mg/kg in rat,In vivo,6113,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9779,Rattus norvegicus,,CHEMBL626252,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,In vivo,5546,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9780,Rattus norvegicus,,CHEMBL626253,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,In vivo,5553,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9781,Rattus norvegicus,1969.0,CHEMBL626254,Half life stability of compound was evaluated in rat plasma,,4188,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9782,Rattus norvegicus,,CHEMBL626255,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,In vivo,6215,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9783,Rattus norvegicus,,CHEMBL626256,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,In vivo,6141,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9784,Rattus norvegicus,,CHEMBL626257,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,In vivo,5182,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9785,Rattus norvegicus,,CHEMBL626258,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,In vivo,5182,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9786,Rattus norvegicus,,CHEMBL626259,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,In vivo,5710,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9787,Rattus norvegicus,,CHEMBL626260,Half in rat i.v.,In vivo,5789,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9788,Rattus norvegicus,,CHEMBL875345,Half period in rat after intravenous administration,In vivo,6011,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9789,Rattus norvegicus,,CHEMBL626261,Half-life after repeated oral dose of compound at 1 mg/kg in rats,In vivo,17594,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9790,Rattus norvegicus,2107.0,CHEMBL626262,Half-life measured in in vitro Cathepsin B assay in rat liver,In vitro,12357,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9791,Rattus norvegicus,,CHEMBL626263,Half-life of compound was determined in rats,,5210,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9792,Rattus norvegicus,,CHEMBL625270,Half-life at 10 mg/kg in rat upon intravenous administration,In vivo,17596,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9793,Rattus norvegicus,,CHEMBL625271,Half-life determined in rat,,6672,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9794,Rattus norvegicus,,CHEMBL625272,Half-life determined in rat,,6673,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9795,Rattus norvegicus,955.0,CHEMBL625273,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,In vivo,4910,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9796,Rattus norvegicus,1969.0,CHEMBL625274,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",,3741,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9797,Rattus norvegicus,,CHEMBL625275,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,In vivo,17671,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9798,Rattus norvegicus,1969.0,CHEMBL625276,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,In vivo,4910,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9799,Rattus norvegicus,1969.0,CHEMBL625277,Half-life in rat plasma,,17537,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9800,Rattus norvegicus,1969.0,CHEMBL625278,Half-life in rat plasma was determined,,4965,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9801,Rattus norvegicus,1969.0,CHEMBL625279,Half-life in rat plasma; Not tested,,17537,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9802,Rattus norvegicus,1977.0,CHEMBL625280,Half-life in rat serum,,6124,Serum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9803,Rattus norvegicus,1977.0,CHEMBL876797,Half-life in rat serum; na is not available,,6124,Serum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9804,Rattus norvegicus,,CHEMBL625281,Half-life was calculated in rat,,6078,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9805,Rattus norvegicus,1969.0,CHEMBL873827,Half-life was calculated in rat plasma,,17668,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9806,Rattus norvegicus,,CHEMBL625282,Half-life was determined,,3185,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9807,Rattus norvegicus,,CHEMBL625283,Half-life was determined,,4883,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9808,Rattus norvegicus,,CHEMBL625284,Half-life after administration of 20 mg/Kg oral dose in rat,In vivo,2959,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9809,Rattus norvegicus,,CHEMBL625285,Half-life after administration of 3.2 mg/kg intravenously in male rat,In vivo,4029,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9810,Rattus norvegicus,,CHEMBL625286,Half-life after intravenous administration in female rat,In vivo,4029,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9811,Rattus norvegicus,,CHEMBL625287,Half-life after intravenous administration in male rat,In vivo,4029,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9812,Rattus norvegicus,,CHEMBL625288,Half-life after intravenous dose in rat,In vivo,6180,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9813,Rattus norvegicus,2107.0,CHEMBL625289,Half-life in a rat liver homogenate preparation,,1557,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9814,Rattus norvegicus,1969.0,CHEMBL625290,Half-life in plasma of rat,,12500,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9815,Rattus norvegicus,1969.0,CHEMBL876798,Half-life in plasma of rat at dose of 3-10 mgkg,,12500,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9816,Rattus norvegicus,,CHEMBL625291,Half-life in rat,,5064,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9817,Rattus norvegicus,,CHEMBL625292,Half-life in rat,,5145,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9818,Rattus norvegicus,,CHEMBL625293,Half-life in rat,,5147,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9819,Rattus norvegicus,,CHEMBL622832,Half-life in rat,,5833,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9820,Rattus norvegicus,,CHEMBL622833,Half-life in rat,,6596,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9821,Rattus norvegicus,,CHEMBL622834,Half-life in rat,,17655,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9822,Rattus norvegicus,,CHEMBL622835,Half-life in rat after oral administration at 10 mg/kg,In vivo,6495,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9823,Rattus norvegicus,,CHEMBL622836,Half-life in rat after po administration at a dose of 10 mg/kg,In vivo,17538,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9824,Rattus norvegicus,,CHEMBL622837,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,In vivo,17538,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9825,Rattus norvegicus,,CHEMBL622838,Half-life in rat at 3 mg/kg dose administered intravenously,In vivo,10,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9826,Rattus norvegicus,955.0,CHEMBL622839,Half-life in rat brain homogenate,,17669,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9827,Rattus norvegicus,1969.0,CHEMBL622840,Half-life in rat plasma,,17065,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9828,Rattus norvegicus,,CHEMBL622841,Half-life in rats,,4333,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9829,Rattus norvegicus,,CHEMBL622842,Half-life in Dawley rats,,6827,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9830,Rattus norvegicus,1969.0,CHEMBL622843,Half-life in vitro in rat plasma,In vitro,889,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9831,Rattus norvegicus,1969.0,CHEMBL622844,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,In vitro,889,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9832,Rattus norvegicus,,CHEMBL622845,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",,3747,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9833,Rattus norvegicus,,CHEMBL622846,The area under the curve of compound was measured at the dose of 100 umol/kg,,15022,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9834,Rattus norvegicus,,CHEMBL622847,The area under the curve of compound was measured at the dose of 300 umol/kg,,15022,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9835,Rattus norvegicus,,CHEMBL622848,The area under the curve of compound was measured at the dose of 30 umol/kg,,15022,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9836,Rattus norvegicus,,CHEMBL622849,Bioavailability as oral AUC in rats,In vivo,3360,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9837,Rattus norvegicus,1969.0,CHEMBL622850,The plasma concentration versus time curve (AUC) was determined,,5334,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9838,Rattus norvegicus,,CHEMBL876807,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,17411,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9839,Rattus norvegicus,,CHEMBL622851,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,17411,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9840,Rattus norvegicus,,CHEMBL622852,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,17411,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9841,Rattus norvegicus,,CHEMBL622853,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,,6570,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9842,Rattus norvegicus,,CHEMBL622854,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,,6570,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9843,Rattus norvegicus,,CHEMBL622855,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,17411,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9844,Rattus norvegicus,1969.0,CHEMBL622856,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",,14941,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9845,Rattus norvegicus,1969.0,CHEMBL622857,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",,14941,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9846,Rattus norvegicus,1969.0,CHEMBL622858,AUC in rat after po administration at a dose of 10 mg/kg,,17538,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9847,Rattus norvegicus,1969.0,CHEMBL622859,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,,17752,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9848,Rattus norvegicus,,CHEMBL622860,Area under curve value 24 hr after 10 mg/kg iv administration in rats,,17509,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9849,Rattus norvegicus,,CHEMBL622861,Area under curve value 24 hr after 10 mg/kg oral administration in rats,,17509,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9850,Rattus norvegicus,,CHEMBL622862,Area under curve value 24 hr after 2 mg/kg iv administration in rats,,17509,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9851,Rattus norvegicus,,CHEMBL622863,Area under curve value 24 hr after 2 mg/kg oral administration in rats,,17509,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9852,Rattus norvegicus,,CHEMBL623817,Area under curve value 6 hr after po administration in rat,,17509,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9853,Rattus norvegicus,,CHEMBL623818,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,17717,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9854,Rattus norvegicus,,CHEMBL623819,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",,17717,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9855,Rattus norvegicus,,CHEMBL623820,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,17717,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9856,Rattus norvegicus,,CHEMBL623821,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,,17717,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9857,Rattus norvegicus,1969.0,CHEMBL623822,AUC normalized for dose (AUCN) in rat,,6642,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9858,Rattus norvegicus,,CHEMBL623823,Area under curve in rat after p.o. administration,,6640,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9859,Rattus norvegicus,,CHEMBL623824,Area under curve in rat after p.o. administration,,6641,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9860,Rattus norvegicus,,CHEMBL623825,Area under curve in rat after p.o. administration; Not determined,,6641,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9861,Rattus norvegicus,,CHEMBL622070,Area under curve in rat after peroral administration,,6641,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9862,Rattus norvegicus,,CHEMBL622071,Area under curve (carotid artery) value of the compound,,3603,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9863,Rattus norvegicus,,CHEMBL622072,Bioavailability expressed as the area under curve of rat carotid artery,,3550,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9864,Rattus norvegicus,,CHEMBL622073,Area under curve in male SD rats was observed after intravenous administration in rat,,15662,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9865,Rattus norvegicus,,CHEMBL622074,Area under curve of the compound was determined,,17720,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9866,Rattus norvegicus,,CHEMBL622075,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,,5407,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9867,Rattus norvegicus,1969.0,CHEMBL622076,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,,17752,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9868,Rattus norvegicus,1969.0,CHEMBL622077,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,,17752,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9869,Rattus norvegicus,,CHEMBL622078,Area under curve (portal vein) value of the compound,,3603,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9870,Rattus norvegicus,,CHEMBL622079,Bioavailability expressed as the area under curve of rat portal vein,,3550,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9871,Rattus norvegicus,1969.0,CHEMBL622080,Area Under plasma concentration time curve in rat upon peroral administration,,17655,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9872,Rattus norvegicus,,CHEMBL877612,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,,17582,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9873,Rattus norvegicus,,CHEMBL622081,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,,17582,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9874,Rattus norvegicus,,CHEMBL622082,Compound was evaluated for oral bioavailability in rats,,17791,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9875,Rattus norvegicus,,CHEMBL622083,Compound was evaluated for oral bioavailability in rats after iv administration,,17791,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9876,Rattus norvegicus,,CHEMBL622084,Compound was evaluated for oral bioavailability in rats; 30-80,,17791,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9877,Rattus norvegicus,,CHEMBL622085,Compound was evaluated for oral bioavailability in rats; 50-60,,17791,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9878,Rattus norvegicus,,CHEMBL622086,Compound was evaluated for oral bioavailability in rats; no data,,17791,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9879,Rattus norvegicus,,CHEMBL622087,Compound was evaluated for oral bioavailability in rats; peptide,,17791,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9880,Rattus norvegicus,178.0,CHEMBL622088,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",,7768,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9881,Rattus norvegicus,178.0,CHEMBL622089,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",,7768,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9882,Rattus norvegicus,178.0,CHEMBL623685,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",,7768,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9883,Rattus norvegicus,178.0,CHEMBL623686,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",,7768,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9884,Rattus norvegicus,945.0,CHEMBL623687,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,8677,Stomach,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9885,Rattus norvegicus,945.0,CHEMBL623688,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,8677,Stomach,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9886,Rattus norvegicus,945.0,CHEMBL623689,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,8677,Stomach,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9887,Rattus norvegicus,945.0,CHEMBL622485,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,8677,Stomach,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9888,Rattus norvegicus,2046.0,CHEMBL622486,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,8677,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9889,Rattus norvegicus,2046.0,CHEMBL877613,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,8677,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9890,Rattus norvegicus,2046.0,CHEMBL622487,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",In vivo,8677,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9891,Rattus norvegicus,2046.0,CHEMBL622488,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,8677,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9892,Rattus norvegicus,948.0,CHEMBL622489,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",In vivo,8677,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9893,Rattus norvegicus,1088.0,CHEMBL622490,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,6899,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9894,Rattus norvegicus,1088.0,CHEMBL622491,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,6899,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9895,Rattus norvegicus,2107.0,CHEMBL622492,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,,6899,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9896,Rattus norvegicus,1088.0,CHEMBL622493,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,6899,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9897,Rattus norvegicus,1088.0,CHEMBL622494,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,6899,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9898,Rattus norvegicus,2385.0,CHEMBL622495,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,8677,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9899,Rattus norvegicus,,CHEMBL622496,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,,6899,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9900,Rattus norvegicus,1088.0,CHEMBL622497,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,6899,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9901,Rattus norvegicus,,CHEMBL622498,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,,2189,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9902,Rattus norvegicus,1088.0,CHEMBL624918,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,,2189,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9903,Rattus norvegicus,1088.0,CHEMBL624919,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,,2189,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9904,Rattus norvegicus,178.0,CHEMBL624920,Biodistribution of compound in rat blood after 5 min of administration,In vivo,10839,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9905,Rattus norvegicus,178.0,CHEMBL624921,Biodistribution of compound in rat blood after 5 min of administration.,In vivo,10839,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9906,Rattus norvegicus,955.0,CHEMBL624922,Biodistribution of compound in rat brain after 5 min of administration,In vivo,10839,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9907,Rattus norvegicus,948.0,CHEMBL624923,Biodistribution of compound in rat heart after 5 min of administration,In vivo,10839,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9908,Rattus norvegicus,948.0,CHEMBL624924,Biodistribution of compound in rat heart after 5 min of administration.,In vivo,10839,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9909,Rattus norvegicus,2113.0,CHEMBL624925,Biodistribution of compound in rat kidney after 5 min of administration,In vivo,10839,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9910,Rattus norvegicus,2113.0,CHEMBL624926,Biodistribution of compound in rat kidney after 5 min of administration.,In vivo,10839,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9911,Rattus norvegicus,2107.0,CHEMBL624927,Biodistribution of compound in rat liver after 5 min of administration,In vivo,10839,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9912,Rattus norvegicus,2107.0,CHEMBL874402,Biodistribution of compound in rat liver after 5 min of administration.,In vivo,10839,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9913,Rattus norvegicus,2048.0,CHEMBL624928,Biodistribution of compound in rat lung after 5 min of administration,In vivo,10839,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9914,Rattus norvegicus,2048.0,CHEMBL624929,Biodistribution of compound in rat lung after 5 min of administration.,In vivo,10839,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9915,Rattus norvegicus,2385.0,CHEMBL624930,Biodistribution of compound in rat muscle after 5 min of administration,In vivo,10839,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9916,Rattus norvegicus,2385.0,CHEMBL624931,Biodistribution of compound in rat muscle after 5 min of administration.,In vivo,10839,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9917,Rattus norvegicus,948.0,CHEMBL624932,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,4043,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9918,Rattus norvegicus,948.0,CHEMBL624933,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,4043,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9919,Rattus norvegicus,2107.0,CHEMBL624934,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,4043,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9920,Rattus norvegicus,2107.0,CHEMBL624935,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,4043,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9921,Rattus norvegicus,,CHEMBL624936,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,4043,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9922,Rattus norvegicus,,CHEMBL624937,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,4043,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9923,Rattus norvegicus,2106.0,CHEMBL624938,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,4043,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9924,Rattus norvegicus,2106.0,CHEMBL624939,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,4043,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9925,Rattus norvegicus,,CHEMBL624940,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,4043,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9926,Rattus norvegicus,,CHEMBL874403,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,4043,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9927,Rattus norvegicus,,CHEMBL624941,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,,1446,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9928,Rattus norvegicus,1088.0,CHEMBL624942,Dose required to lower urine osmolality to 300 mOsm/kg in rat,,9971,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9929,Rattus norvegicus,1088.0,CHEMBL624943,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,,9971,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9930,Rattus norvegicus,,CHEMBL624944,% Bioavailability after 1 day of the drug administration in rats,In vivo,5765,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9931,Rattus norvegicus,,CHEMBL624945,% Bioavailability after 4 day of the drug administration in rats,In vivo,5765,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9932,Rattus norvegicus,,CHEMBL624946,Absolute bioavailability was evaluated in rat,In vivo,4257,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9933,Rattus norvegicus,,CHEMBL624947,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,,13091,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9934,Rattus norvegicus,,CHEMBL624948,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,,13091,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9935,Rattus norvegicus,,CHEMBL624949,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,,13091,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9936,Rattus norvegicus,2113.0,CHEMBL622025,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,,13091,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9937,Rattus norvegicus,2113.0,CHEMBL622026,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,,13091,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9938,Rattus norvegicus,2113.0,CHEMBL622027,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,,13091,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9939,Rattus norvegicus,2113.0,CHEMBL622028,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,,13091,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9940,Rattus norvegicus,2107.0,CHEMBL622029,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,,13091,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9941,Rattus norvegicus,2107.0,CHEMBL622208,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,,13091,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9942,Rattus norvegicus,2107.0,CHEMBL622209,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,,13091,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9943,Rattus norvegicus,2107.0,CHEMBL622210,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,,13091,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9944,Rattus norvegicus,,CHEMBL622211,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,,13091,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9945,Rattus norvegicus,,CHEMBL622212,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,,13091,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9946,Rattus norvegicus,,CHEMBL622213,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,,13091,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9947,Rattus norvegicus,,CHEMBL874404,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,,13091,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9948,Rattus norvegicus,2385.0,CHEMBL620452,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,,13091,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9949,Rattus norvegicus,2385.0,CHEMBL620453,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,,13091,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9950,Rattus norvegicus,2385.0,CHEMBL620454,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,,13091,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9951,Rattus norvegicus,2385.0,CHEMBL624067,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,,13091,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9952,Rattus norvegicus,,CHEMBL624068,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,,13091,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9953,Rattus norvegicus,992.0,CHEMBL624069,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,,13091,Female gonad,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9954,Rattus norvegicus,992.0,CHEMBL624070,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,,13091,Female gonad,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9955,Rattus norvegicus,992.0,CHEMBL624071,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,,13091,Female gonad,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9956,Rattus norvegicus,995.0,CHEMBL624072,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,,13091,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9957,Rattus norvegicus,995.0,CHEMBL624073,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,,13091,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9958,Rattus norvegicus,995.0,CHEMBL624788,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,,13091,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9959,Rattus norvegicus,995.0,CHEMBL624789,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,,13091,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9960,Rattus norvegicus,,CHEMBL624790,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,,13091,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9961,Rattus norvegicus,,CHEMBL624791,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,,13091,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9962,Rattus norvegicus,,CHEMBL624792,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,,13091,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9963,Rattus norvegicus,,CHEMBL624793,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,,13091,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9964,Rattus norvegicus,2385.0,CHEMBL877491,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,,13091,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9965,Rattus norvegicus,2385.0,CHEMBL624957,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,,13091,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9966,Rattus norvegicus,2385.0,CHEMBL624958,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,,13091,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9967,Rattus norvegicus,2385.0,CHEMBL624959,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,,13091,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9968,Rattus norvegicus,,CHEMBL624960,Dissociation constant was determined,,11977,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9969,Rattus norvegicus,,CHEMBL624961,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",,14941,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9970,Rattus norvegicus,,CHEMBL624962,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,15078,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9971,Rattus norvegicus,,CHEMBL624963,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",,15078,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9972,Rattus norvegicus,,CHEMBL624964,Observed rate constant in 80% rat plasma at 37 degree Centigrade,,4755,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9973,Rattus norvegicus,,CHEMBL624965,LogP value was evaluated in the in situ rat gut perfusion assay,,589,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9974,Rattus norvegicus,,CHEMBL624966,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,In vivo,17582,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9975,Rattus norvegicus,,CHEMBL624967,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,In vivo,5031,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9976,Rattus norvegicus,,CHEMBL624968,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,In vivo,17764,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9977,Rattus norvegicus,,CHEMBL624969,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,,17720,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9978,Rattus norvegicus,,CHEMBL624970,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,,2862,,50597,,,BAO_0000218,,Expert,,10116.0,N,1,1,
9979,Rattus norvegicus,,CHEMBL624971,Half-life was evaluated after 10 uM/kg of intra arterial administration,,16423,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9980,Rattus norvegicus,,CHEMBL624972,Half-life was evaluated after 20 uM/kg of peroral administration,In vivo,16423,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9981,Rattus norvegicus,,CHEMBL624973,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,In vivo,6005,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9982,Rattus norvegicus,1969.0,CHEMBL624974,Half-life was evaluated in plasma of rat,,2938,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9983,Rattus norvegicus,,CHEMBL624975,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,In vivo,6410,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9984,Rattus norvegicus,,CHEMBL877492,Half-life was evaluated in rats at an oral dose of 30 mg/kg,In vivo,6410,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9985,Rattus norvegicus,,CHEMBL624976,Half-life was measured in rat after an iv dose of 1 mg/kg,In vivo,6062,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9986,Rattus norvegicus,,CHEMBL624977,Half-life period of compound in rats after peroral administration,In vivo,6571,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9987,Rattus norvegicus,1969.0,CHEMBL626848,Half-life period of compound was measured in rat plasma.,,3136,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9988,Rattus norvegicus,1969.0,CHEMBL626849,Half-life period of compound was measured in rat plasma; ND is not determined,,3136,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9989,Rattus norvegicus,1969.0,CHEMBL626850,Half-life period of compound was measured in rat plasma; not determined,,3136,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9990,Rattus norvegicus,,CHEMBL626851,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,In vivo,4521,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9991,Rattus norvegicus,,CHEMBL626852,Half-life period in rat by iv administration,In vivo,5871,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9992,Rattus norvegicus,,CHEMBL626853,Half-life period in rats following intravenous administration at 2 mg/kg,In vivo,6077,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9993,Rattus norvegicus,,CHEMBL626854,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,In vivo,6679,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9994,Rattus norvegicus,,CHEMBL627486,Half-life period was determined for the compound in rat,,5144,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9995,Rattus norvegicus,,CHEMBL627487,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",In vivo,4498,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9996,Rattus norvegicus,,CHEMBL627488,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",In vivo,4498,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9997,Rattus norvegicus,,CHEMBL627489,Half-life value after IV dose at a dose of 5 mg/kg in rats.,In vivo,1908,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9998,Rattus norvegicus,,CHEMBL627490,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,In vivo,6211,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
9999,Rattus norvegicus,,CHEMBL873829,Half-life was determined in rat after intravenous administration (0.5 mg/kg),In vivo,5529,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10000,Rattus norvegicus,,CHEMBL627655,Half-life was determined in rat at a dose of 1 mpk i.v.,In vivo,6444,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10001,Rattus norvegicus,,CHEMBL625994,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,In vivo,6444,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10002,Rattus norvegicus,,CHEMBL625995,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,In vivo,6444,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10003,Rattus norvegicus,,CHEMBL625996,Half-life in rat,,5207,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10004,Rattus norvegicus,1969.0,CHEMBL625850,In vitro half life in rat plasma,In vitro,530,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10005,Rattus norvegicus,1969.0,CHEMBL625851,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",In vitro,1116,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10006,Rattus norvegicus,,CHEMBL625852,In vitro half life in rat,In vitro,3219,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10007,Rattus norvegicus,,CHEMBL625853,In vivo half life period after intravenous administration in rat,In vivo,6109,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10008,Rattus norvegicus,,CHEMBL625854,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,In vivo,17582,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10009,Rattus norvegicus,,CHEMBL874450,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,In vivo,17582,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10010,Rattus norvegicus,,CHEMBL625855,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,In vivo,5974,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10011,Rattus norvegicus,,CHEMBL625856,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,In vivo,5974,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10012,Rattus norvegicus,,CHEMBL625857,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,In vivo,5974,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10013,Rattus norvegicus,,CHEMBL873831,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,In vivo,5974,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10014,Rattus norvegicus,,CHEMBL625858,Longer half-life in rat (i.v.) at 0.5 mpk,In vivo,17853,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10015,Rattus norvegicus,,CHEMBL625859,Longer half-life in rat (p.o.) at 2.0 mpk,In vivo,17853,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10016,Rattus norvegicus,,CHEMBL625860,Pharmacokinetic property (half life) in rat,,3457,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10017,Rattus norvegicus,,CHEMBL625861,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,In vivo,2792,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10018,Rattus norvegicus,,CHEMBL625862,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,In vivo,2792,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10019,Rattus norvegicus,,CHEMBL625863,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,In vivo,2792,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10020,Rattus norvegicus,,CHEMBL625864,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,In vivo,2792,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10021,Rattus norvegicus,,CHEMBL625865,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,In vivo,5739,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10022,Rattus norvegicus,,CHEMBL625866,Pharmacokinetic half time was determined intravenously in rats.,In vivo,15765,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10023,Rattus norvegicus,1969.0,CHEMBL625867,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,In vivo,6567,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10024,Rattus norvegicus,1969.0,CHEMBL625868,Plasma half life of hydrolysis of the compound,,2448,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10025,Rattus norvegicus,1969.0,CHEMBL625869,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,In vivo,5423,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10026,Rattus norvegicus,1969.0,CHEMBL874451,Plasma half life period was calculated in rat,,4853,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10027,Rattus norvegicus,1969.0,CHEMBL625870,Plasma half-life in Sprague-Dawley rats,,4514,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10028,Rattus norvegicus,1969.0,CHEMBL625871,Plasma half-life in Sprague-Dawley rats; Not determined,,4514,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10029,Rattus norvegicus,1969.0,CHEMBL625872,Plasma half-life in rats,,1500,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10030,Rattus norvegicus,1969.0,CHEMBL625873,Plasma half-life in rats; <MQL,,1500,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10031,Rattus norvegicus,1969.0,CHEMBL625874,Plasma half-life period (0-8 h) was determined,,5334,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10032,Rattus norvegicus,1969.0,CHEMBL625875,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,,5334,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10033,Rattus norvegicus,1969.0,CHEMBL625876,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,In vivo,5334,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10034,Rattus norvegicus,1969.0,CHEMBL631258,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,In vivo,5334,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10035,Rattus norvegicus,1969.0,CHEMBL631259,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,,4956,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10036,Rattus norvegicus,1969.0,CHEMBL631260,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,,4956,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10037,Rattus norvegicus,178.0,CHEMBL631261,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",,7768,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10038,Rattus norvegicus,178.0,CHEMBL631262,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",,7768,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10039,Rattus norvegicus,178.0,CHEMBL631263,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",,7768,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10040,Rattus norvegicus,,CHEMBL631264,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",,7768,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10041,Rattus norvegicus,,CHEMBL631265,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",,7768,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10042,Rattus norvegicus,,CHEMBL631266,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",,7768,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10043,Rattus norvegicus,,CHEMBL631267,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",,7768,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10044,Rattus norvegicus,,CHEMBL631268,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",,7768,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10045,Rattus norvegicus,,CHEMBL631269,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",,7768,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10046,Rattus norvegicus,,CHEMBL631270,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",,7768,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10047,Rattus norvegicus,948.0,CHEMBL631271,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,7768,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10048,Rattus norvegicus,948.0,CHEMBL631272,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",,7768,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10049,Rattus norvegicus,948.0,CHEMBL631273,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",,7768,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10050,Rattus norvegicus,948.0,CHEMBL631274,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",,7768,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10051,Rattus norvegicus,948.0,CHEMBL631275,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",,7768,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10052,Rattus norvegicus,948.0,CHEMBL626984,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",,7768,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10053,Rattus norvegicus,948.0,CHEMBL626985,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",,7768,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10054,Rattus norvegicus,2107.0,CHEMBL626986,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,7768,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10055,Rattus norvegicus,2107.0,CHEMBL626987,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",,7768,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10056,Rattus norvegicus,2107.0,CHEMBL626988,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",,7768,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10057,Rattus norvegicus,2107.0,CHEMBL626989,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",,7768,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10058,Rattus norvegicus,2107.0,CHEMBL626990,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",,7768,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10059,Rattus norvegicus,2107.0,CHEMBL626991,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",,7768,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10060,Rattus norvegicus,2107.0,CHEMBL626992,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",,7768,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10061,Rattus norvegicus,2048.0,CHEMBL626993,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",,7768,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10062,Rattus norvegicus,2048.0,CHEMBL874593,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",,7768,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10063,Rattus norvegicus,2048.0,CHEMBL626994,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",,7768,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10064,Rattus norvegicus,2048.0,CHEMBL626995,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",,7768,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10065,Rattus norvegicus,2048.0,CHEMBL626190,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",,7768,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10066,Rattus norvegicus,2048.0,CHEMBL626191,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",,7768,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10067,Rattus norvegicus,2048.0,CHEMBL626364,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",,7768,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10068,Rattus norvegicus,2046.0,CHEMBL626365,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",,7768,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10069,Rattus norvegicus,2046.0,CHEMBL626366,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",,7768,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10070,Rattus norvegicus,2046.0,CHEMBL626367,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",,7768,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10071,Rattus norvegicus,2046.0,CHEMBL626368,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",,7768,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10072,Rattus norvegicus,2046.0,CHEMBL626369,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",,7768,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10073,Rattus norvegicus,2046.0,CHEMBL626370,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",,7768,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10074,Rattus norvegicus,,CHEMBL626371,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",In vivo,4498,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10075,Rattus norvegicus,,CHEMBL626372,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",In vivo,4498,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10076,Rattus norvegicus,,CHEMBL626373,Bioavailability after a dose of 10 mg/kg p.o.,In vivo,3603,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10077,Rattus norvegicus,,CHEMBL626374,Bioavailability after peroral administration (10 mg/kg) was determined in rat,In vivo,6215,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10078,Rattus norvegicus,,CHEMBL626375,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,In vivo,5710,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10079,Rattus norvegicus,,CHEMBL626376,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),In vivo,5710,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10080,Rattus norvegicus,,CHEMBL626377,Bioavailability in rat po was determined,In vivo,5676,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10081,Rattus norvegicus,,CHEMBL626378,Bioavailability of compound at 10 mg/kg in rat after oral administration,In vivo,17667,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10082,Rattus norvegicus,,CHEMBL626379,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,In vivo,17667,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10083,Rattus norvegicus,,CHEMBL626380,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),In vivo,6848,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10084,Rattus norvegicus,,CHEMBL626381,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),In vivo,6848,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10085,Rattus norvegicus,,CHEMBL626382,Bioavailability in rat,In vivo,17267,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10086,Rattus norvegicus,,CHEMBL626383,Bioavailability in rat (Sprague-Dawley) (female),In vivo,6362,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10087,Rattus norvegicus,,CHEMBL874652,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,In vivo,17671,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10088,Rattus norvegicus,,CHEMBL626384,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),In vivo,17671,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10089,Rattus norvegicus,,CHEMBL626385,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,In vivo,4333,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10090,Rattus norvegicus,,CHEMBL626386,Bioavailability in rat at an oral dose of 2 mg/kg,In vivo,6077,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10091,Rattus norvegicus,,CHEMBL626387,Bioavailability in rat,In vivo,3278,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10092,Rattus norvegicus,,CHEMBL626388,Bioavailability in rat,In vivo,5964,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10093,Rattus norvegicus,,CHEMBL626389,Bioavailability in rat,In vivo,4884,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10094,Rattus norvegicus,,CHEMBL626390,Bioavailability in rat,In vivo,4905,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10095,Rattus norvegicus,,CHEMBL626391,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,In vivo,4884,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10096,Rattus norvegicus,,CHEMBL626392,Bioavailability in rat,In vivo,6850,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10097,Rattus norvegicus,,CHEMBL626393,Oral bioavailability in rat,In vivo,2864,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10098,Rattus norvegicus,,CHEMBL623026,Bioavailability was determined in rat,In vivo,5780,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10099,Rattus norvegicus,,CHEMBL623027,Bioavailability,In vivo,1465,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10100,Rattus norvegicus,,CHEMBL623028,Bioavailability,In vivo,5199,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10101,Rattus norvegicus,,CHEMBL623029,Bioavailability in rat after 1 day dosing,In vivo,5765,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10102,Rattus norvegicus,,CHEMBL623030,Bioavailability in rat after 4 day dosing,In vivo,5765,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10103,Rattus norvegicus,,CHEMBL623031,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,In vivo,6518,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10104,Rattus norvegicus,,CHEMBL623032,Bioavailability after IV dosing at 1 mg/kg in rat; no data,In vivo,6518,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10105,Rattus norvegicus,,CHEMBL623033,Bioavailability after oral administration at a dose of 2 mg/kg in rat,In vivo,6518,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10106,Rattus norvegicus,,CHEMBL623034,Bioavailability after oral administration at a dose of 4 mg/kg in rat,In vivo,6518,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10107,Rattus norvegicus,,CHEMBL623035,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,In vivo,2083,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10108,Rattus norvegicus,,CHEMBL623036,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,In vivo,17260,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10109,Rattus norvegicus,,CHEMBL623037,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),In vivo,4956,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10110,Rattus norvegicus,,CHEMBL623038,Bioavailability by intravenous administration of 3.4 mg/kg in rat,In vivo,4368,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10111,Rattus norvegicus,1969.0,CHEMBL874385,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,In vivo,17752,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10112,Rattus norvegicus,,CHEMBL623039,Bioavailability in rat (Fisher) (fasted),In vivo,1446,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10113,Primates,,CHEMBL623040,Bioavailability in monkey after po administration of 10 mg/kg dose,In vivo,2891,,22224,,,BAO_0000218,,Intermediate,,9443.0,U,0,1,
10114,Primates,,CHEMBL623041,Oral bioavailability in monkey (dose 10 mg/kg),In vivo,2891,,22224,,,BAO_0000218,,Intermediate,,9443.0,U,0,1,
10115,Rattus norvegicus,,CHEMBL623741,Bioavailability in rat,In vivo,6672,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10116,Rattus norvegicus,,CHEMBL623742,Bioavailability in rat,In vivo,6673,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10117,Rattus norvegicus,,CHEMBL623743,Bioavailability in rat,In vivo,17655,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10118,Rattus norvegicus,,CHEMBL623744,Bioavailability in rat,In vivo,17796,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10119,Rattus norvegicus,,CHEMBL623745,Bioavailability in rat (dose 2.0 mg/kg p.o.),In vivo,17853,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10120,Rattus norvegicus,,CHEMBL623746,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),In vivo,4521,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10121,Rattus norvegicus,,CHEMBL623747,Oral bioavailability in rat (dose 5 mg/kg p.o.),In vivo,4940,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10122,Rattus norvegicus,,CHEMBL623748,Bioavailability in rat after po administration of 30 mg/kg dose,In vivo,2891,,22224,,,BAO_0000218,,Intermediate,,10116.0,U,0,1,
10123,Rattus norvegicus,,CHEMBL623916,Bioavailability in rat after po administration of 30 mg/kg dose,In vivo,2891,,22224,,,BAO_0000218,,Intermediate,,10116.0,U,0,1,
10124,Rattus norvegicus,,CHEMBL623917,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,In vivo,4521,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10125,Rattus norvegicus,,CHEMBL623918,Bioavailability in rat (dose 2 mg/kg i.v.),In vivo,17686,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10126,Rattus norvegicus,,CHEMBL874386,Bioavailability in rat,In vivo,17796,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10127,Rattus norvegicus,1969.0,CHEMBL623919,Bioavailability in rat; Only traces detected in rat plasma,In vivo,17796,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10128,Rattus norvegicus,,CHEMBL623920,Bioavailability in rat,In vivo,5064,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10129,Rattus norvegicus,,CHEMBL623148,Bioavailability upon oral administration of compound,In vivo,5147,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10130,Rattus norvegicus,,CHEMBL623149,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),In vivo,1916,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10131,Rattus norvegicus,,CHEMBL623150,Bioavailability in rat,In vivo,6049,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10132,Rattus norvegicus,,CHEMBL623151,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",In vivo,1445,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10133,Rattus norvegicus,,CHEMBL623152,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",In vivo,1445,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10134,Rattus norvegicus,,CHEMBL623153,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,,2862,,50597,,,BAO_0000218,,Expert,,10116.0,N,1,1,
10135,Rattus norvegicus,,CHEMBL623154,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,,2862,,50597,,,BAO_0000218,,Expert,,10116.0,N,1,1,
10136,Rattus norvegicus,,CHEMBL623155,In vitro and metabolic stability was determined,,4194,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10137,Rattus norvegicus,,CHEMBL623156,In vitro metabolic stability in rat hepatocytes,,4194,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10138,Rattus norvegicus,,CHEMBL623157,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,,5486,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10139,Rattus norvegicus,2107.0,CHEMBL623158,Metabolic rate for compound was observed in rat hepatocytes,In vitro,17582,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,401.0
10140,Rattus norvegicus,,CHEMBL623159,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,,5600,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10141,Rattus norvegicus,,CHEMBL874390,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),,14294,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10142,Rattus norvegicus,,CHEMBL623160,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),,14294,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10143,Rattus norvegicus,,CHEMBL623161,Metabolism of compound in rat S9 microsomes; Trace,,14294,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10144,Rattus norvegicus,,CHEMBL623162,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,,17847,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10145,Rattus norvegicus,,CHEMBL623163,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10146,Rattus norvegicus,,CHEMBL623164,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10147,Rattus norvegicus,,CHEMBL623165,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10148,Rattus norvegicus,,CHEMBL623166,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10149,Rattus norvegicus,,CHEMBL624983,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10150,Rattus norvegicus,,CHEMBL624984,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10151,Rattus norvegicus,,CHEMBL624985,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10152,Rattus norvegicus,,CHEMBL622970,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10153,Rattus norvegicus,,CHEMBL622971,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10154,Rattus norvegicus,,CHEMBL622972,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10155,Rattus norvegicus,,CHEMBL622973,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10156,Rattus norvegicus,,CHEMBL622974,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10157,Rattus norvegicus,,CHEMBL622975,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10158,Rattus norvegicus,,CHEMBL622976,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10159,Rattus norvegicus,,CHEMBL622977,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10160,Rattus norvegicus,,CHEMBL624351,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10161,Rattus norvegicus,,CHEMBL624352,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10162,Rattus norvegicus,,CHEMBL624353,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10163,Rattus norvegicus,,CHEMBL622397,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10164,Rattus norvegicus,,CHEMBL622398,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10165,Rattus norvegicus,,CHEMBL622399,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10166,Rattus norvegicus,,CHEMBL622400,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10167,Rattus norvegicus,,CHEMBL628428,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10168,Rattus norvegicus,,CHEMBL628590,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10169,Rattus norvegicus,,CHEMBL628591,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10170,Rattus norvegicus,,CHEMBL628592,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10171,Rattus norvegicus,,CHEMBL628593,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10172,Rattus norvegicus,,CHEMBL875333,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10173,Rattus norvegicus,,CHEMBL628594,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10174,Rattus norvegicus,1969.0,CHEMBL628595,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,,4969,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10175,Rattus norvegicus,1969.0,CHEMBL628596,Stability in rat plasma was determined,,6737,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10176,Rattus norvegicus,1969.0,CHEMBL628597,Stability in rat plasma was determined; ND= no data,,6737,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10177,Rattus norvegicus,1969.0,CHEMBL628598,Tested for plasma half life period in rat (0-8 hr),,5089,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10178,Rattus norvegicus,1969.0,CHEMBL628599,Tested for plasma half life period in rat (0-8 hr); Not determined,,5089,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10179,Rattus norvegicus,,CHEMBL628600,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,In vivo,1466,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10180,Rattus norvegicus,,CHEMBL628601,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,In vivo,1466,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10181,Rattus norvegicus,,CHEMBL628602,Tested for the half life in rat,,4950,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10182,Rattus norvegicus,,CHEMBL628603,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,In vitro,2412,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10183,Rattus norvegicus,,CHEMBL628604,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,In vitro,2412,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10184,Rattus norvegicus,,CHEMBL628605,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,In vitro,2412,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10185,Rattus norvegicus,,CHEMBL628606,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,In vitro,2412,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10186,Rattus norvegicus,,CHEMBL628607,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,In vitro,2412,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10187,Rattus norvegicus,,CHEMBL628608,The biological half life the compound was measured at the dose of 100 umol/kg,,15022,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10188,Rattus norvegicus,,CHEMBL628609,The biological half life the compound was measured at the dose of 30 umol/kg,,15022,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10189,Rattus norvegicus,1969.0,CHEMBL628610,The compound was evaluated for plasma half life period in rat,,406,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10190,Rattus norvegicus,,CHEMBL873819,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",In vivo,15078,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10191,Rattus norvegicus,,CHEMBL628611,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",In vivo,15078,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10192,Rattus norvegicus,,CHEMBL628612,The pharmacokinetic parameter half-life period in vivo in rats,In vivo,5247,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10193,Rattus norvegicus,,CHEMBL628613,"The pharmacokinetic property, Half-life was determined",In vivo,5041,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10194,Rattus norvegicus,,CHEMBL628614,"The pharmacokinetic property, Half-life in rat in vivo",In vivo,5041,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10195,Rattus norvegicus,,CHEMBL628615,"The pharmacokinetic property, Half-life was determined; ND denotes no data",In vivo,5041,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10196,Rattus norvegicus,,CHEMBL628616,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",In vivo,5041,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10197,Rattus norvegicus,1969.0,CHEMBL627924,The plasma half life period in rats,,3918,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10198,Rattus norvegicus,2107.0,CHEMBL627925,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,,2906,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10199,Rattus norvegicus,,CHEMBL627926,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,In vivo,6467,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10200,Rattus norvegicus,,CHEMBL627927,t1/2 (apparent elimination)of the compound was determined,,5510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10201,Rattus norvegicus,,CHEMBL627928,t1/2 value in rat,,3788,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10202,Rattus norvegicus,,CHEMBL627539,Half life in rat,,17796,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10203,Rattus norvegicus,1969.0,CHEMBL876790,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",In vivo,12873,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10204,Rattus norvegicus,,CHEMBL858186,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,In vivo,5983,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10205,Rattus norvegicus,,CHEMBL627540,Half-life period in fasted rats,,15765,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10206,Rattus norvegicus,,CHEMBL627541,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,In vivo,2661,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10207,Rattus norvegicus,,CHEMBL627715,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,In vivo,2661,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10208,Rattus norvegicus,,CHEMBL627716,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,In vivo,429,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10209,Rattus norvegicus,,CHEMBL627717,Maximum time required to achieve Cmax was determined in rat,,17655,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10210,Rattus norvegicus,,CHEMBL627718,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,In vivo,17717,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10211,Rattus norvegicus,,CHEMBL627719,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,In vivo,17717,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10212,Rattus norvegicus,,CHEMBL627720,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,In vivo,17717,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10213,Rattus norvegicus,,CHEMBL627721,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,In vivo,6570,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10214,Rattus norvegicus,,CHEMBL627722,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,In vivo,6570,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10215,Rattus norvegicus,,CHEMBL627723,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,5978,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10216,Rattus norvegicus,,CHEMBL626058,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,5978,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10217,Rattus norvegicus,,CHEMBL626059,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,5978,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10218,Rattus norvegicus,,CHEMBL626060,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,5978,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10219,Rattus norvegicus,1969.0,CHEMBL626061,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,In vivo,17720,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10220,Rattus norvegicus,,CHEMBL876791,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,In vivo,4723,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10221,Rattus norvegicus,,CHEMBL626062,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,In vivo,4723,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10222,Rattus norvegicus,,CHEMBL626063,Tmax at the dose of 2 mg/Kg administered perorally in rats,In vivo,4756,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10223,Rattus norvegicus,,CHEMBL626064,Tmax at the dose of 5 mg/Kg administered perorally in rats,In vivo,4756,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10224,Rattus norvegicus,1969.0,CHEMBL626065,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,In vivo,17720,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10225,Rattus norvegicus,1969.0,CHEMBL626066,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,In vivo,17720,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10226,Rattus norvegicus,,CHEMBL626067,tmax upon peroral administration of 10.0 mg/Kg dose in rat,In vivo,1466,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10227,Rattus norvegicus,,CHEMBL626068,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,,7449,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10228,Rattus norvegicus,,CHEMBL626069,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,,7449,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10229,Rattus norvegicus,,CHEMBL626070,Percent total excretion of 3-methoxyacetaminophen glucuronide,,7449,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10230,Rattus norvegicus,,CHEMBL626071,Percent total excretion of N-methoxyacetaminophen glucuronide,,7449,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10231,Rattus norvegicus,,CHEMBL626072,Percent total excretion of N-methoxyacetaminophen sulfate,,7449,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10232,Rattus norvegicus,,CHEMBL626073,Percent total excretion of acetaminophen,,7449,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10233,Rattus norvegicus,2046.0,CHEMBL626741,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",,7768,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10234,Rattus norvegicus,,CHEMBL626742,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",,17655,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10235,Rattus norvegicus,,CHEMBL626743,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,,17735,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10236,Rattus norvegicus,,CHEMBL876792,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,,5960,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10237,Rattus norvegicus,,CHEMBL626744,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,17735,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10238,Rattus norvegicus,,CHEMBL626745,Compound was tested for antidiuretic activity in rats,,7116,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10239,Rattus norvegicus,1969.0,CHEMBL626746,AUC in rat after 3mg/kg oral dose,In vivo,4878,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10240,Rattus norvegicus,,CHEMBL626747,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,,5939,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10241,Rattus norvegicus,,CHEMBL626748,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,,5939,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10242,Rattus norvegicus,,CHEMBL626749,Bioavailability administered orally at a dose of 10 mg/kg to rats,,16367,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10243,Rattus norvegicus,,CHEMBL626750,Oral Bioavailability was determined,,16366,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10244,Rattus norvegicus,,CHEMBL626751,Oral bioavailability in rat,,4426,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10245,Rattus norvegicus,,CHEMBL626913,Oral bioavailability in rat; Not performed.,,4426,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10246,Rattus norvegicus,,CHEMBL626914,Bioavailability,,5041,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10247,Rattus norvegicus,,CHEMBL626915,Bioavailability was determined; ND denotes no data,,5041,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10248,Rattus norvegicus,,CHEMBL626916,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,,1500,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10249,Rattus norvegicus,,CHEMBL626917,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,,1500,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10250,Rattus norvegicus,,CHEMBL626918,Binding towards rat plasma protein at 10 uM,,17409,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10251,Rattus norvegicus,,CHEMBL626919,Binding towards rat plasma protein at 100 uM,,17409,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10252,Rattus norvegicus,,CHEMBL626920,Bioavailability in rat (dose 20 mg/kg p.o.),In vivo,2959,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10253,Rattus norvegicus,,CHEMBL621976,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,In vivo,13501,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10254,Rattus norvegicus,,CHEMBL877599,Bioavailability in rat after 5 mg/kg oral gavage,In vivo,6567,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10255,Rattus norvegicus,,CHEMBL621977,Bioavailability in rat,In vivo,6571,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10256,Rattus norvegicus,,CHEMBL621978,Bioavailability in rat (dose 1 mg/kg i.v.),In vivo,6715,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10257,Rattus norvegicus,,CHEMBL621979,Bioavailability in rat (dose 3 mg/kg p.o.),In vivo,6715,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10258,Rattus norvegicus,,CHEMBL621980,Oral bioavailability in rat,In vivo,2932,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10259,Rattus norvegicus,,CHEMBL621981,Bioavailability of the compound in rats after administration of 30 mg/kg,In vivo,4171,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10260,Rattus norvegicus,,CHEMBL621982,Bioavailability after administration of 10 mg/kg in rats,In vivo,17509,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10261,Rattus norvegicus,,CHEMBL882953,Bioavailability after administration of 2 mg/kg in rats,In vivo,17509,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10262,Rattus norvegicus,,CHEMBL621983,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,In vivo,4527,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10263,Rattus norvegicus,,CHEMBL621984,Bioavailability in dogs was determined; high,In vivo,4026,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10264,Rattus norvegicus,,CHEMBL621985,Bioavailability in monkey after intravenous administration at 1 mpk,In vivo,6659,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10265,Rattus norvegicus,,CHEMBL621986,Bioavailability in monkey after peroral administration at 10 mpk,In vivo,6659,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10266,Rattus norvegicus,,CHEMBL621987,Bioavailability in rat after intravenous administration at 1 mpk,In vivo,6659,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10267,Rattus norvegicus,,CHEMBL877600,Bioavailability in rat after intravenous administration at 2 mpk,In vivo,6659,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10268,Rattus norvegicus,,CHEMBL621988,Bioavailability in rat after peroral administration at 30 mpk,In vivo,6659,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10269,Rattus norvegicus,,CHEMBL621989,Bioavailability in rat after peroral administration at at 100 mpk,In vivo,6659,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10270,Rattus norvegicus,,CHEMBL621990,Bioavailability in rats was evaluated,In vivo,6597,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10271,Rattus norvegicus,,CHEMBL621991,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,In vivo,1202,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10272,Rattus norvegicus,,CHEMBL621992,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,In vivo,1202,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10273,Rattus norvegicus,,CHEMBL621993,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,In vivo,1202,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10274,Rattus norvegicus,,CHEMBL621994,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,In vivo,1202,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10275,Rattus norvegicus,,CHEMBL621995,Bioavailability in rat,In vivo,5207,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10276,Rattus norvegicus,,CHEMBL621996,Bioavailability in rat,In vivo,5970,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10277,Rattus norvegicus,,CHEMBL621997,Oral bioavailability in rat (dose 10 mg/kg),In vivo,17538,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10278,Rattus norvegicus,,CHEMBL621998,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,In vivo,17538,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10279,Rattus norvegicus,,CHEMBL621999,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,In vivo,1466,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10280,Rattus norvegicus,,CHEMBL622000,Oral bioavailability in rat,In vivo,2879,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10281,Rattus norvegicus,,CHEMBL622001,Bioavailability was measured in rat after oral administration; 2-4,In vivo,2879,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10282,Rattus norvegicus,,CHEMBL622002,Bioavailability was measured in rat after oral administration; 3-7,In vivo,2879,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10283,Rattus norvegicus,,CHEMBL622003,Bioavailability in rat (intraduodenal administration),In vivo,3777,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10284,Rattus norvegicus,,CHEMBL877601,Bioavailability in rat (intraduodenal administration),In vivo,3777,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10285,Rattus norvegicus,,CHEMBL624871,Oral bioavailability in rat,In vivo,3777,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10286,Rattus norvegicus,,CHEMBL622004,Oral bioavailability in rat,In vivo,3777,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10287,Rattus norvegicus,,CHEMBL882954,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),In vivo,5423,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10288,Rattus norvegicus,,CHEMBL622005,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,In vivo,16365,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10289,Rattus norvegicus,,CHEMBL622006,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,In vivo,16365,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10290,Rattus norvegicus,,CHEMBL622007,Bioavailability was measured in rat,In vivo,4239,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10291,Rattus norvegicus,,CHEMBL622008,Bioavailability was reported,In vivo,5438,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10292,Rattus norvegicus,,CHEMBL622009,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),In vivo,5334,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10293,Rattus norvegicus,,CHEMBL622010,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),In vivo,5334,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10294,Rattus norvegicus,,CHEMBL622011,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,In vivo,4199,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10295,Rattus norvegicus,,CHEMBL622012,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),In vivo,4199,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10296,Rattus norvegicus,,CHEMBL622013,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),In vivo,4199,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10297,Rattus norvegicus,,CHEMBL622014,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,In vivo,4890,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10298,Rattus norvegicus,,CHEMBL624749,Bioavailability was determined at 3 mg/kg po dose in rats,In vivo,2792,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10299,Rattus norvegicus,,CHEMBL624750,Oral bioavailability in rat (dose 2 mg/kg),In vivo,5529,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10300,Rattus norvegicus,,CHEMBL624751,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",In vivo,6685,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10301,Rattus norvegicus,,CHEMBL624752,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",In vivo,6685,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10302,Rattus norvegicus,,CHEMBL624753,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",In vivo,6685,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10303,Rattus norvegicus,,CHEMBL624754,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,In vivo,6005,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10304,Rattus norvegicus,,CHEMBL624755,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,In vivo,6410,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10305,Rattus norvegicus,,CHEMBL624756,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,In vivo,6410,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10306,Rattus norvegicus,,CHEMBL624757,Bioavailability in rat,In vivo,6103,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10307,Rattus norvegicus,,CHEMBL624758,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,In vivo,6410,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10308,Rattus norvegicus,,CHEMBL622270,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,In vivo,6410,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10309,Rattus norvegicus,,CHEMBL622271,Bioavailability in rat (Sprague-Dawley),In vivo,5353,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10310,Rattus norvegicus,,CHEMBL622272,Bioavailability in rat at the dose of 2 mg/kg,In vivo,4727,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10311,Rattus norvegicus,,CHEMBL622273,Oral bioavailability in rat,In vivo,17804,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10312,Rattus norvegicus,,CHEMBL622274,Bioavailability in rat (cannulated) (dose 2 mg/kg),In vivo,5809,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10313,Rattus norvegicus,,CHEMBL622275,Bioavailability value of compound in rats was determined after peroral administration,In vivo,17804,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10314,Rattus norvegicus,,CHEMBL622276,Oral bioavailability in rat (dose 20 mg/kg),In vivo,3634,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10315,Rattus norvegicus,,CHEMBL622277,Oral bioavailability in rat,In vivo,3341,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10316,Rattus norvegicus,,CHEMBL622278,Oral bioavailability in rat (dose 5 mg/kg),In vivo,2690,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10317,Rattus norvegicus,,CHEMBL622279,Oral bioavailability in rat,In vivo,3184,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10318,Rattus norvegicus,,CHEMBL622280,Oral bioavailability in rat,In vivo,740,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10319,Rattus norvegicus,,CHEMBL624083,Compound was evaluated for oral bioavailability in rats; 15-27 %,In vivo,1806,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10320,Rattus norvegicus,,CHEMBL624084,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,In vivo,4891,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10321,Rattus norvegicus,,CHEMBL624085,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),In vivo,3634,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10322,Rattus norvegicus,,CHEMBL624086,Compound was tested for bioavailability in rats,In vivo,64,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10323,Rattus norvegicus,,CHEMBL624087,Bioavailability in rat,In vivo,4839,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10324,Rattus norvegicus,,CHEMBL624088,Oral bioavailability in rat,In vivo,1094,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10325,Macaca mulatta,,CHEMBL624089,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,In vivo,5005,,22224,,,BAO_0000218,,Intermediate,,9544.0,U,0,1,
10326,Rattus norvegicus,,CHEMBL624090,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),In vivo,5005,,22224,,,BAO_0000218,,Intermediate,,10116.0,U,0,1,
10327,Rattus norvegicus,,CHEMBL624091,Evaluated for the bioavailability in rat (in vivo),In vivo,4687,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10328,Rattus norvegicus,,CHEMBL624092,F value of compound in rats was determined after peroral administration,In vivo,17804,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10329,Rattus norvegicus,,CHEMBL624093,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,In vivo,5974,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10330,Rattus norvegicus,,CHEMBL624094,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,In vivo,5974,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10331,Rattus norvegicus,,CHEMBL624095,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,In vivo,5974,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10332,Rattus norvegicus,,CHEMBL624096,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,In vivo,5974,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10333,Rattus norvegicus,,CHEMBL624097,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",In vivo,1088,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10334,Rattus norvegicus,,CHEMBL624098,Maximum fall in carotid flow in rat,In vivo,1742,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10335,Rattus norvegicus,,CHEMBL874392,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,In vivo,4689,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10336,Rattus norvegicus,,CHEMBL624099,Oral bioavailability in rat (dose 5 mg/kg),In vivo,2463,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10337,Rattus norvegicus,,CHEMBL624100,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,In vivo,5654,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10338,Rattus norvegicus,,CHEMBL624101,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,In vivo,5654,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10339,Rattus norvegicus,,CHEMBL624102,Oral bioavailability in rat (male Wistar),In vivo,6874,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10340,Rattus norvegicus,,CHEMBL624103,Oral bioavailability after administration (30 mg/kg) in rat; good,In vivo,5633,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10341,Rattus norvegicus,,CHEMBL624104,Oral bioavailability at the dose of 2 mg/kg in rat,In vivo,5496,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10342,Rattus norvegicus,,CHEMBL624105,Oral bioavailability determined in rats,In vivo,2358,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10343,Rattus norvegicus,,CHEMBL624106,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),In vivo,16456,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10344,Rattus norvegicus,,CHEMBL624107,Oral bioavailability in rat (dose single 10 mg/kg),In vivo,5302,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10345,Rattus norvegicus,,CHEMBL623943,Oral bioavailability in rat (dose single 10 mg/kg),In vivo,5302,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10346,Rattus norvegicus,,CHEMBL623944,Oral bioavailability in rat (dose 5 mg/kg,In vivo,5302,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10347,Rattus norvegicus,,CHEMBL623945,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10348,Rattus norvegicus,,CHEMBL623946,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10349,Rattus norvegicus,,CHEMBL623947,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10350,Rattus norvegicus,,CHEMBL623948,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10351,Rattus norvegicus,,CHEMBL623949,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10352,Rattus norvegicus,,CHEMBL623950,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10353,Rattus norvegicus,,CHEMBL874398,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10354,Rattus norvegicus,,CHEMBL623951,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10355,Rattus norvegicus,,CHEMBL623952,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10356,Rattus norvegicus,,CHEMBL623953,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10357,Rattus norvegicus,,CHEMBL623954,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10358,Rattus norvegicus,,CHEMBL623955,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10359,Rattus norvegicus,,CHEMBL623956,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10360,Rattus norvegicus,,CHEMBL627807,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10361,Rattus norvegicus,,CHEMBL627808,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10362,Rattus norvegicus,,CHEMBL627809,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10363,Rattus norvegicus,,CHEMBL627810,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10364,Rattus norvegicus,,CHEMBL627811,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10365,Rattus norvegicus,,CHEMBL627812,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10366,Rattus norvegicus,,CHEMBL627813,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10367,Rattus norvegicus,,CHEMBL627814,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10368,Rattus norvegicus,,CHEMBL875336,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10369,Rattus norvegicus,,CHEMBL627815,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10370,Rattus norvegicus,,CHEMBL627816,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10371,Rattus norvegicus,,CHEMBL627817,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10372,Rattus norvegicus,,CHEMBL627818,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10373,Rattus norvegicus,,CHEMBL627819,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10374,Rattus norvegicus,,CHEMBL627820,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10375,Rattus norvegicus,,CHEMBL627821,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10376,Rattus norvegicus,,CHEMBL628464,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10377,Rattus norvegicus,,CHEMBL626239,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10378,Rattus norvegicus,,CHEMBL626240,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10379,Rattus norvegicus,,CHEMBL626241,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10380,Rattus norvegicus,,CHEMBL626242,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10381,Rattus norvegicus,,CHEMBL626243,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10382,Rattus norvegicus,,CHEMBL626244,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10383,Rattus norvegicus,,CHEMBL626907,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10384,Rattus norvegicus,,CHEMBL626908,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10385,Rattus norvegicus,,CHEMBL626909,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10386,Rattus norvegicus,,CHEMBL626910,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10387,Rattus norvegicus,,CHEMBL875342,Percent total excretion of acetaminophen cysteine conjugate,,7449,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10388,Rattus norvegicus,,CHEMBL626911,Percent total excretion of acetaminophen glucuronide,,7449,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10389,Rattus norvegicus,,CHEMBL626912,Percent total excretion of acetaminophen sulfate,,7449,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10390,Rattus norvegicus,,CHEMBL627065,Percent total excretion of acetaminophen-mercapturic acid,,7449,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10391,Rattus norvegicus,1088.0,CHEMBL627066,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,,3172,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10392,Rattus norvegicus,,CHEMBL627067,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,In vivo,16456,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10393,ratrat,2385.0,CHEMBL627068,Biodistribution of compound in rat muscle after 5 min of administration,In vivo,10839,Muscle tissue,22224,,,BAO_0000218,,Autocuration,,8656.0,U,0,1,
10394,ratrat,2385.0,CHEMBL627069,Biodistribution of compound in rat muscle after 5 min of administration.,In vivo,10839,Muscle tissue,22224,,,BAO_0000218,,Autocuration,,8656.0,U,0,1,
10395,Ovis aries,,CHEMBL627070,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),In vivo,5334,,22224,,,BAO_0000218,,Autocuration,,9940.0,U,0,1,
10396,Ovis aries,,CHEMBL627071,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),In vivo,5334,,22224,,,BAO_0000218,,Autocuration,,9940.0,U,0,1,
10397,Ovis aries,,CHEMBL627072,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),In vivo,5334,,22224,,,BAO_0000218,,Autocuration,,9940.0,U,0,1,
10398,Ovis aries,,CHEMBL627073,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),In vivo,5334,,22224,,,BAO_0000218,,Autocuration,,9940.0,U,0,1,
10399,Ovis aries,,CHEMBL625387,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),In vivo,5334,,22224,,,BAO_0000218,,Autocuration,,9940.0,U,0,1,
10400,Ovis aries,,CHEMBL625388,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),In vivo,5334,,22224,,,BAO_0000218,,Autocuration,,9940.0,U,0,1,
10401,Ovis aries,1969.0,CHEMBL625389,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),In vivo,5334,Plasma,22224,,,BAO_0000218,,Autocuration,,9940.0,U,0,1,
10402,Ovis aries,1969.0,CHEMBL875343,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),In vivo,5334,Plasma,22224,,,BAO_0000218,,Autocuration,,9940.0,U,0,1,
10403,Serpentes,,CHEMBL876795,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),,1735,,50497,,,BAO_0000218,,Intermediate,,8570.0,N,1,1,
10404,Serpentes,,CHEMBL626552,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,,1469,,50497,,,BAO_0000218,,Intermediate,,8570.0,N,1,1,
10405,Serpentes,,CHEMBL626553,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,,1336,,50497,,,BAO_0000218,,Intermediate,,8570.0,N,1,1,
10406,Homo sapiens,1969.0,CHEMBL626554,The human biological plasma half life of the compound,,12403,Plasma,22224,,,BAO_0000366,,Autocuration,,9606.0,U,0,1,
10407,Rattus norvegicus,1088.0,CHEMBL626555,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,8151,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10408,Rattus norvegicus,,CHEMBL626556,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,,8004,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10409,Rattus norvegicus,,CHEMBL626557,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,,8004,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10410,Rattus norvegicus,,CHEMBL626558,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,,8004,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10411,Rattus norvegicus,,CHEMBL626559,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,,8004,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10412,Rattus norvegicus,,CHEMBL626560,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,,8004,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10413,Rattus norvegicus,,CHEMBL876803,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,,8004,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10414,Rattus norvegicus,,CHEMBL627964,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,,8004,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10415,Rattus norvegicus,,CHEMBL627965,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,,8004,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10416,Rattus norvegicus,,CHEMBL627966,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,,8004,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10417,Rattus norvegicus,,CHEMBL627967,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,,8004,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10418,Rattus norvegicus,,CHEMBL627968,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,,8004,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10419,Rattus norvegicus,,CHEMBL627969,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,,8004,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10420,Rattus norvegicus,,CHEMBL627970,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,,8004,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10421,Rattus norvegicus,178.0,CHEMBL627971,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,,8004,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10422,Rattus norvegicus,178.0,CHEMBL627972,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,,8004,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10423,Homo sapiens,,CHEMBL856029,Dissociation constant against binding to human cyclophilin A,,15917,,180,,,BAO_0000357,,Expert,,9606.0,D,9,1,
10424,Bos taurus,,CHEMBL627973,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,,12396,,11591,,,BAO_0000019,,Expert,,9913.0,H,8,1,
10425,,,CHEMBL627974,-Log C was determined by performing the electroshock minimum test,,7065,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10426,,,CHEMBL627975,-Log C was determined by performing the foot shock test,,7065,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10427,,,CHEMBL627976,-Log C was determined by performing the incl screen test,,7065,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10428,,,CHEMBL627977,-Log C was determined by performing the maximum electroshock test,,7065,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10429,,,CHEMBL627978,-Log C was determined by performing the pentylenetetrazole test,,7065,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10430,,,CHEMBL627979,Tested for experimental arotinoid inhibitory dose,,12415,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10431,,,CHEMBL876804,Negative log transformed activity,,10256,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10432,,,CHEMBL627980,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",,7991,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10433,Cavia porcellus,,CHEMBL627981,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,,14342,,50512,,,BAO_0000218,,Intermediate,,10141.0,N,1,1,
10434,Cavia porcellus,,CHEMBL627982,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,,14342,,50512,,,BAO_0000218,,Intermediate,,10141.0,N,1,1,
10435,Cavia porcellus,,CHEMBL627983,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,,14342,,50512,,,BAO_0000218,,Intermediate,,10141.0,N,1,1,
10436,Cavia porcellus,2116.0,CHEMBL627984,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,,14342,Ileum,50512,,,BAO_0000218,,Intermediate,,10141.0,N,1,1,
10437,,,CHEMBL627985,Solubility in water was determined; values expressed as -log,,6047,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
10438,,,CHEMBL627986,Ratio of Kcat to that of Km was determined,,17269,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10439,,,CHEMBL627987,Observed first order rate constant,,10026,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10440,,,CHEMBL627988,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,,14583,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10441,Rattus norvegicus,,CHEMBL627989,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,In vivo,2661,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10442,Rattus norvegicus,,CHEMBL627990,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,In vivo,2661,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10443,Rattus norvegicus,,CHEMBL876805,Oral Bioavailability after administration of 10 mg/kg in male rat,In vivo,4029,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10444,Rattus norvegicus,,CHEMBL627991,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),In vivo,17735,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10445,Rattus norvegicus,,CHEMBL627992,Oral bioavailability in rat,In vivo,4576,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10446,Rattus norvegicus,,CHEMBL627993,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,In vivo,17582,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10447,Rattus norvegicus,,CHEMBL622817,Oral bioavailability at 1 mg/kg was determined in rat,In vivo,17651,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10448,Rattus norvegicus,,CHEMBL622818,Oral bioavailability at 10 mg/kg was determined in rat,In vivo,17651,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10449,Rattus norvegicus,,CHEMBL622819,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",In vivo,17670,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10450,Rattus norvegicus,,CHEMBL872267,Oral bioavailability in rat,In vivo,5045,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10451,Rattus norvegicus,,CHEMBL622820,Oral bioavailability in rat,In vivo,1696,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10452,Rattus norvegicus,,CHEMBL622821,Oral bioavailability after intravenous administration in rats at 24 uM/kg,In vivo,17764,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10453,Rattus norvegicus,,CHEMBL622822,Oral bioavailability in rat,In vivo,6448,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10454,Rattus norvegicus,,CHEMBL622823,Oral bioavailability in rat,In vivo,6596,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10455,Rattus norvegicus,,CHEMBL622824,Oral bioavailability in rat,In vivo,17547,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10456,Rattus norvegicus,,CHEMBL622825,Oral bioavailability in rat at a dose of 3 mg/kg,In vivo,17771,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10457,Rattus norvegicus,,CHEMBL622901,Oral bioavailability in rat after oral administration at 10 mg/kg,In vivo,6495,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10458,Rattus norvegicus,,CHEMBL622902,Oral bioavailability in rat,In vivo,4558,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10459,Rattus norvegicus,,CHEMBL621844,Oral bioavailability in rat,In vivo,17596,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10460,Rattus norvegicus,,CHEMBL621845,Oral bioavailability in Dawley rats,In vivo,6827,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10461,Rattus norvegicus,,CHEMBL621846,Oral bioavailability,In vivo,4026,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10462,Rattus norvegicus,,CHEMBL621847,Oral bioavailability in rat (dose 30 mg/kg),In vivo,10,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10463,Rattus norvegicus,,CHEMBL877609,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,In vivo,17717,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10464,Rattus norvegicus,,CHEMBL621848,Bioavailability in rat (dose 3 mg/kg i.v.),In vivo,17717,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10465,Rattus norvegicus,,CHEMBL621849,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,In vivo,17717,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10466,Rattus norvegicus,,CHEMBL622030,Oral bioavailability in rat (dose 60 mg/kg p.o.),In vivo,17717,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10467,Rattus norvegicus,,CHEMBL622031,Percent oral bioavailability determined in rats,In vivo,4796,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10468,Rattus norvegicus,,CHEMBL622032,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,In vivo,4883,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10469,Rattus norvegicus,,CHEMBL622033,The compound was evaluated for bioavailability in rats; 32-51,In vivo,2137,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10470,Rattus norvegicus,,CHEMBL622034,Bioavailability in rat (dose 20 mg/kg p.o.),In vivo,2959,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10471,Rattus norvegicus,,CHEMBL622035,Oral bioavailability in rat,In vivo,1361,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10472,Rattus norvegicus,,CHEMBL882966,Bioavailability percent in rat at the dose of 2 mg/kg,In vivo,4727,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10473,Rattus norvegicus,,CHEMBL622036,Bioavailability was evaluated after 20 uM/kg of peroral administration,In vivo,16423,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10474,Rattus norvegicus,,CHEMBL622037,Oral bioavailability in rat,In vivo,5206,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10475,Rattus norvegicus,,CHEMBL622038,Oral bioavailability in rat,In vivo,6448,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10476,Rattus norvegicus,,CHEMBL622039,Bioavailability in rats,In vivo,17723,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10477,Rattus norvegicus,178.0,CHEMBL622040,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,In vivo,17738,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10478,Rattus norvegicus,178.0,CHEMBL622041,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,In vivo,17738,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10479,Rattus norvegicus,178.0,CHEMBL622042,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,In vivo,17738,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10480,Rattus norvegicus,178.0,CHEMBL622043,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,In vivo,17738,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10481,Rattus norvegicus,178.0,CHEMBL622044,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,In vivo,17738,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10482,Rattus norvegicus,10000001.0,CHEMBL622045,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,In vivo,17738,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10483,Rattus norvegicus,10000001.0,CHEMBL622046,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,In vivo,17738,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10484,Rattus norvegicus,10000001.0,CHEMBL622047,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,In vivo,17738,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10485,Rattus norvegicus,10000001.0,CHEMBL877610,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,In vivo,17738,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10486,Rattus norvegicus,955.0,CHEMBL622048,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,In vivo,17738,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10487,Rattus norvegicus,955.0,CHEMBL622049,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,In vivo,17738,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10488,Rattus norvegicus,955.0,CHEMBL622050,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,In vivo,17738,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10489,Rattus norvegicus,955.0,CHEMBL622051,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,In vivo,17738,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10490,Rattus norvegicus,,CHEMBL622052,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,In vivo,17738,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10491,Rattus norvegicus,,CHEMBL622053,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,In vivo,17738,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10492,Rattus norvegicus,,CHEMBL622054,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,In vivo,17738,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10493,Rattus norvegicus,,CHEMBL622055,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,In vivo,17738,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10494,Rattus norvegicus,,CHEMBL622056,Oral bioavailability in rats was determined; High,In vivo,5237,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10495,Rattus norvegicus,,CHEMBL622057,Oral bioavailability in the rat was determined,In vivo,5503,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10496,Rattus norvegicus,,CHEMBL628008,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,In vivo,15765,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10497,Rattus norvegicus,,CHEMBL622058,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),In vivo,15660,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10498,Rattus norvegicus,,CHEMBL622059,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,5978,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10499,Rattus norvegicus,,CHEMBL622060,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,5978,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10500,Rattus norvegicus,,CHEMBL622061,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,5978,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10501,Rattus norvegicus,,CHEMBL622062,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,In vivo,5978,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10502,Rattus norvegicus,,CHEMBL622063,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,In vivo,5656,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10503,Rattus norvegicus,,CHEMBL877611,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,In vivo,3598,,50597,,,BAO_0000218,,Expert,,10116.0,N,1,1,
10504,Rattus norvegicus,,CHEMBL622064,Oral bioavailability of compound in Sprague Dawley rats,In vivo,4216,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10505,Rattus norvegicus,,CHEMBL622065,Oral bioavailability of compound in rat,In vivo,17839,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10506,Rattus norvegicus,,CHEMBL622066,Oral bioavailability in rat (dose 2 mg/kg),In vivo,6570,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10507,Rattus norvegicus,,CHEMBL622067,Oral bioavailability of compound in rat was determined,In vivo,5334,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10508,Rattus norvegicus,,CHEMBL622068,Oral bioavailability of compound in rats,In vivo,6886,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10509,Rattus norvegicus,,CHEMBL622069,Oral bioavailability of compound was determined in rats,In vivo,5210,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10510,Rattus norvegicus,,CHEMBL624796,Oral bioavailability at a dose of 30 mg/kg in rats,In vivo,4170,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10511,Rattus norvegicus,,CHEMBL624797,Oral bioavailability in rat (dose 10 mg/kg),In vivo,6028,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10512,Rattus norvegicus,,CHEMBL623053,Oral bioavailability in rat (dose 10 mg/kg),In vivo,6028,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10513,Rattus norvegicus,,CHEMBL623054,Oral bioavailability evaluated in rat,In vivo,6078,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10514,Rattus norvegicus,,CHEMBL623055,Oral bioavailability in fasted rat,In vivo,6168,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10515,Rattus norvegicus,,CHEMBL623056,Oral bioavailability in fed rat,In vivo,6168,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10516,Rattus norvegicus,,CHEMBL623057,Oral bioavailability in rat (mature male) (dose 30 mg/kg),In vivo,5160,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10517,Rattus norvegicus,,CHEMBL623058,Oral bioavailability in rat,In vivo,6057,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10518,Rattus norvegicus,,CHEMBL623059,Oral bioavailability in rat (dose 10 mg/kg p.o.),In vivo,6535,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10519,Rattus norvegicus,,CHEMBL623060,Oral bioavailability in rat after administration of 10 mg/kg po,In vivo,6535,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10520,Rattus norvegicus,,CHEMBL623061,Oral bioavailability in rat,In vivo,4194,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10521,Rattus norvegicus,,CHEMBL623062,Oral bioavailability in rat,In vivo,6230,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10522,Rattus norvegicus,,CHEMBL623063,Oral bioavailability in rat,In vivo,6619,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10523,Rattus norvegicus,,CHEMBL623064,Oral bioavailability in rat,In vivo,17607,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10524,Rattus norvegicus,,CHEMBL623065,Oral bioavailability in ratrs,In vivo,4942,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10525,Rattus norvegicus,,CHEMBL623066,Oral bioavailability in rat,In vivo,4942,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10526,Rattus norvegicus,,CHEMBL623067,Oral bioavailability in rat,In vivo,6646,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10527,Rattus norvegicus,,CHEMBL623068,Oral bioavailability in rats was determined; High,In vivo,5237,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10528,Rattus norvegicus,,CHEMBL623069,Oral bioavailability in rat,In vivo,6646,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10529,Rattus norvegicus,,CHEMBL623070,Oral bioavailability in rat,In vivo,4449,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10530,Rattus norvegicus,,CHEMBL623071,Oral bioavailability was calculated in rat,In vivo,6057,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10531,Rattus norvegicus,,CHEMBL623072,Oral bioavailability,In vivo,2552,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10532,Rattus norvegicus,,CHEMBL623073,Oral bioavailability,In vivo,5496,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10533,Rattus norvegicus,,CHEMBL623074,Oral bioavailability,In vivo,6484,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10534,Rattus norvegicus,,CHEMBL623075,Oral bioavailability,In vivo,6485,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10535,Rattus norvegicus,,CHEMBL623076,Oral bioavailability after i.v. administration,In vivo,6616,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10536,Rattus norvegicus,,CHEMBL623077,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),In vivo,4969,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10537,Rattus norvegicus,,CHEMBL623078,Oral bioavailability in rat (Sprague-Dawley),In vivo,5862,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10538,Rattus norvegicus,,CHEMBL623079,Oral bioavailability in Sprague-Dawley rats,In vivo,4514,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10539,Rattus norvegicus,,CHEMBL623080,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),In vivo,4514,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10540,Rattus norvegicus,,CHEMBL623081,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),In vivo,4514,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10541,Rattus norvegicus,,CHEMBL623082,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,In vivo,5546,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10542,Rattus norvegicus,,CHEMBL874400,Oral bioavailability in fasted rat,In vivo,6168,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10543,Rattus norvegicus,,CHEMBL623083,Oral bioavailability in fed rat,In vivo,6168,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10544,Rattus norvegicus,,CHEMBL623084,Oral bioavailability in rat,In vivo,3624,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10545,Rattus norvegicus,,CHEMBL623085,Oral bioavailability in rat,In vivo,5213,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10546,Rattus norvegicus,,CHEMBL623086,Oral bioavailability in rat,In vivo,5496,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10547,Rattus norvegicus,,CHEMBL623087,Oral bioavailability in rat,In vivo,5553,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10548,Rattus norvegicus,,CHEMBL623088,Oral bioavailability in rat,In vivo,5833,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10549,Rattus norvegicus,,CHEMBL623089,Oral bioavailability in rat,In vivo,5836,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10550,Rattus norvegicus,,CHEMBL623090,Oral bioavailability in rat,In vivo,5865,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10551,Rattus norvegicus,,CHEMBL623091,Oral bioavailability in rat,In vivo,5960,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10552,Rattus norvegicus,,CHEMBL623092,Oral bioavailability in rat,In vivo,6249,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10553,Rattus norvegicus,,CHEMBL623093,Oral bioavailability in rat,In vivo,6448,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10554,Rattus norvegicus,,CHEMBL874401,Oral bioavailability in rat,In vivo,6453,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10555,Rattus norvegicus,,CHEMBL623094,Oral bioavailability in rat,In vivo,6640,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10556,Rattus norvegicus,,CHEMBL623095,Oral bioavailability in rat,In vivo,17607,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10557,Rattus norvegicus,,CHEMBL623096,Oral bioavailability in rat after peroral administration at 10 mg/kg,In vivo,5939,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10558,Rattus norvegicus,,CHEMBL624913,Oral bioavailability in rat after peroral administration at 5 mg/kg,In vivo,5939,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10559,Rattus norvegicus,,CHEMBL624914,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),In vivo,6281,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10560,Rattus norvegicus,,CHEMBL624915,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,In vivo,5874,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10561,Rattus norvegicus,,CHEMBL624916,Oral bioavailability in rat; Not measured,In vivo,5213,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10562,Rattus norvegicus,,CHEMBL624917,Oral bioavailability in rat,In vivo,4964,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10563,Rattus norvegicus,,CHEMBL625157,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,,11020,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10564,Rattus norvegicus,2107.0,CHEMBL625158,In vitro metabolic potential in rat liver microsomes,,6251,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10565,Rattus norvegicus,,CHEMBL625159,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",In vivo,1568,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10566,Rattus norvegicus,,CHEMBL625160,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",In vivo,3032,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10567,Rattus norvegicus,,CHEMBL625161,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,In vivo,3748,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10568,Rattus norvegicus,,CHEMBL625162,Oral bioavailability in rat,In vivo,401,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10569,Rattus norvegicus,,CHEMBL625163,Oral bioavailability in rat,In vivo,6512,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10570,Rattus norvegicus,,CHEMBL625164,Oral bioavailability in rats at 10 mg/kg,In vivo,17617,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10571,Rattus norvegicus,,CHEMBL625165,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,In vivo,6679,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10572,Rattus norvegicus,,CHEMBL625166,Oral bioavailability in rat,In vivo,6742,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10573,Rattus norvegicus,,CHEMBL625167,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,,589,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10574,Rattus norvegicus,,CHEMBL625168,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,,589,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10575,Rattus norvegicus,,CHEMBL625169,Plasma clearance of the compound,In vivo,3185,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10576,Rattus norvegicus,,CHEMBL626264,Plasma clearance at 10 mg/kg in rat upon intravenous administration,In vivo,17596,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10577,Rattus norvegicus,,CHEMBL626265,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,In vivo,2713,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10578,Rattus norvegicus,1969.0,CHEMBL626266,The compound was tested for plasma clearance in rat,In vivo,12500,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10579,Rattus norvegicus,1969.0,CHEMBL626267,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,In vivo,12500,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10580,Rattus norvegicus,,CHEMBL626268,Plasma concentration upon oral administration of 1 mg/Kg in rats,,2713,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10581,Rattus norvegicus,,CHEMBL626269,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,,1446,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10582,Rattus norvegicus,,CHEMBL626270,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,,6227,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10583,Rattus norvegicus,,CHEMBL626271,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,,4709,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10584,Rattus norvegicus,,CHEMBL626272,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",,5510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10585,Rattus norvegicus,,CHEMBL626273,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,5510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10586,Rattus norvegicus,,CHEMBL875346,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,5510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10587,Rattus norvegicus,,CHEMBL626274,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",,5510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10588,Rattus norvegicus,,CHEMBL626275,Compound was tested for protein binding in rat plasma,,4514,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10589,Rattus norvegicus,,CHEMBL624646,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,,2713,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10590,Rattus norvegicus,,CHEMBL624647,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,,2713,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10591,Rattus norvegicus,2107.0,CHEMBL624648,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,,5340,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10592,Rattus norvegicus,,CHEMBL624649,Area under curve ratio was determined (po/iv) in rat,,12058,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10593,Rattus norvegicus,,CHEMBL624650,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,,11195,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10594,Rattus norvegicus,,CHEMBL624651,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,,11195,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10595,Rattus norvegicus,,CHEMBL624652,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,,11195,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10596,Rattus norvegicus,,CHEMBL624653,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,,6495,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10597,Rattus norvegicus,,CHEMBL624654,Ratio of AUCbrain to AUCplasma,,6078,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10598,Rattus norvegicus,,CHEMBL624655,Ratio of brain to plasma,,5656,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10599,Rattus norvegicus,,CHEMBL624656,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,,4910,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10600,Rattus norvegicus,,CHEMBL624657,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,4910,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10601,Rattus norvegicus,,CHEMBL624658,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,4910,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10602,Rattus norvegicus,,CHEMBL624659,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,,10130,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10603,Rattus norvegicus,,CHEMBL624660,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,,10130,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10604,Rattus norvegicus,,CHEMBL624661,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,,10130,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10605,Rattus norvegicus,,CHEMBL624662,Steady state brain :blood ratio was determined,,5213,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10606,Rattus norvegicus,,CHEMBL625199,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,4910,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10607,Rattus norvegicus,,CHEMBL625200,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,4910,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10608,Rattus norvegicus,,CHEMBL625201,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,,4910,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10609,Rattus norvegicus,,CHEMBL625202,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,4910,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10610,Rattus norvegicus,,CHEMBL625203,Percentage recovery after 3h incubation with rat hapatocytes was determined,,2083,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10611,Rattus norvegicus,,CHEMBL625204,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,,2082,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10612,Rattus norvegicus,,CHEMBL625205,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,,2082,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10613,Rattus norvegicus,,CHEMBL625206,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,,6351,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10614,,,CHEMBL625207,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",,14583,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10615,,,CHEMBL625208,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,,14583,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10616,Homo sapiens,,CHEMBL625209,In vivo absorption in Caco-2 cell line monolayers was determined,,4608,,50587,,,BAO_0000218,,Intermediate,,9606.0,N,1,1,495.0
10617,,,CHEMBL625210,Calculated partition coefficient (clogP),,13668,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
10618,Rattus norvegicus,,CHEMBL625211,Area under curve was determine after peroral administration at 10 mpk in Rat,,5669,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10619,Macaca mulatta,,CHEMBL625212,Area under curve was determine after peroral administration at 10 mpk in Rhesus,,5669,,50797,,,BAO_0000218,,Intermediate,,9544.0,N,1,1,
10620,Rattus norvegicus,,CHEMBL625213,Area under curve was determine after peroral administration at 160 mpk in Rat,,5669,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10621,Rattus norvegicus,,CHEMBL625214,Area under curve was determine after peroral administration at 20 mpk in Rat,,5669,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10622,Rattus norvegicus,,CHEMBL874542,Area under curve was determine after peroral administration at 50 mpk in Rat,,5669,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10623,,,CHEMBL625215,Calculated partition coefficient (clogP) (AlogP),,6472,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
10624,,,CHEMBL625216,Activated partial thromboplastin time measured,,15106,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10625,,,CHEMBL625217,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),,15207,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
10626,,,CHEMBL625218,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),,15207,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
10627,Canis lupus familiaris,1969.0,CHEMBL622864,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,,13941,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10628,Rattus norvegicus,1969.0,CHEMBL622865,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,,13941,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10629,Rattus norvegicus,1969.0,CHEMBL622866,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,,13941,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10630,Canis lupus familiaris,1969.0,CHEMBL622867,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,,13941,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10631,Cavia porcellus,1969.0,CHEMBL876808,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,,15240,Plasma,50512,,,BAO_0000218,,Intermediate,,10141.0,N,1,1,
10632,,955.0,CHEMBL627725,AUC in brain,,10655,Brain,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10633,,1977.0,CHEMBL627726,AUC in serum,,10655,Serum,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10634,,1969.0,CHEMBL627727,AUC was determined,,6504,Plasma,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10635,,1969.0,CHEMBL627728,AUC of the compound.,,10615,Plasma,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10636,,1969.0,CHEMBL627729,AUC value (0-4 hr),,10353,Plasma,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10637,,1969.0,CHEMBL627730,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",,14907,Plasma,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10638,,1969.0,CHEMBL627731,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,,14907,Plasma,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10639,,1969.0,CHEMBL627732,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",,14907,Plasma,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10640,,1969.0,CHEMBL627733,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",,14907,Plasma,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10641,Rattus norvegicus,1969.0,CHEMBL627734,AUC(area under curve) was determined after intravenous administration in rats,,16359,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10642,Rattus norvegicus,1969.0,CHEMBL627735,AUC(area under curve) was determined after oral administration in rats,,16359,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10643,Cavia porcellus,1969.0,CHEMBL627736,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,,15240,Plasma,50512,,,BAO_0000218,,Intermediate,,10141.0,N,1,1,
10644,Rattus norvegicus,1969.0,CHEMBL876809,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,,15240,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10645,,,CHEMBL627737,Area Under Curve after oral dosing of 100 uM/Kg,,15469,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10646,,,CHEMBL627738,Area Under Curve after oral dosing of 30 uM/Kg,,15469,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10647,,,CHEMBL627739,Area Under Curve was measured by ploting the graph between concentration verses time,,13520,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10648,Canis lupus familiaris,,CHEMBL626143,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,,17025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10649,Simiiformes,,CHEMBL626144,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,,17025,,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
10650,Oryctolagus cuniculus,,CHEMBL626145,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,,17025,,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
10651,Rattus norvegicus,,CHEMBL626146,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,,17025,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10652,Rattus norvegicus,178.0,CHEMBL626147,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,,12032,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10653,,,CHEMBL626148,Area under curve (AUC) was determined,,10291,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10654,,,CHEMBL626149,Area under curve (AUC) following ip administration at 1 mg/kg,,5767,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
10655,,,CHEMBL626150,Area under curve (AUC) was determined; ND is Not determined,,1434,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10656,Canis lupus familiaris,,CHEMBL626151,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,,14925,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10657,Canis lupus familiaris,,CHEMBL626152,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,,14925,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10658,Canis lupus familiaris,,CHEMBL626153,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,,14925,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10659,,,CHEMBL626154,Area under curve (AUR) was determined,,1434,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10660,,,CHEMBL626155,Area under curve at 1 uM/dg administered intravenously,,11883,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10661,,,CHEMBL626156,Area under curve at 10 uM/dg administered perorally,,11883,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10662,,,CHEMBL626157,Area under curve at 2 uM/dg administered intravenously,,11883,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10663,,,CHEMBL626158,Area under curve at 20 uM/dg administered perorally,,11883,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10664,Canis lupus familiaris,,CHEMBL626159,Area under curve at a peroral dose of 3 mg/kg in dog,,15233,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10665,Rattus norvegicus,,CHEMBL626160,Area under curve at a peroral dose of 3 mg/kg in rat,,15233,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10666,Canis lupus familiaris,,CHEMBL626161,Area under curve at an iv dose of 1 mg/kg in dog,,15233,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10667,Rattus norvegicus,,CHEMBL626162,Area under curve at an iv dose of 1 mg/kg in rat,,15233,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10668,,,CHEMBL626163,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,,12978,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10669,,,CHEMBL626164,Area under curve gives the effective duration for the angiotensin II antagonist effect.,,12978,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
10670,Mus musculus,,CHEMBL626165,Area under curve measured as conc vs time after intravenous administration to mice.,,11355,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
10671,Mus musculus,,CHEMBL626166,Area under curve measured as conc vs time after peroral administration to mice.,,11355,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
10672,Canis lupus familiaris,,CHEMBL626167,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,12923,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10673,Canis lupus familiaris,,CHEMBL626168,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,,12923,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10674,Canis lupus familiaris,,CHEMBL877463,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,,12923,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10675,Canis lupus familiaris,,CHEMBL626169,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,,12923,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10676,Rattus norvegicus,948.0,CHEMBL626170,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,In vivo,17738,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10677,Rattus norvegicus,948.0,CHEMBL626171,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,In vivo,17738,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10678,Rattus norvegicus,948.0,CHEMBL626172,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,In vivo,17738,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10679,Rattus norvegicus,948.0,CHEMBL626173,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,In vivo,17738,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10680,Rattus norvegicus,2113.0,CHEMBL626174,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,In vivo,17738,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10681,Rattus norvegicus,2113.0,CHEMBL626175,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,In vivo,17738,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10682,Rattus norvegicus,2113.0,CHEMBL626176,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,In vivo,17738,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10683,Rattus norvegicus,2113.0,CHEMBL626177,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,In vivo,17738,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10684,Rattus norvegicus,2113.0,CHEMBL622499,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,In vivo,17738,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10685,Rattus norvegicus,2107.0,CHEMBL622500,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,In vivo,17738,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10686,Rattus norvegicus,2107.0,CHEMBL622501,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,In vivo,17738,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10687,Rattus norvegicus,2107.0,CHEMBL622502,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,In vivo,17738,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10688,Rattus norvegicus,2107.0,CHEMBL622503,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,In vivo,17738,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10689,Rattus norvegicus,2107.0,CHEMBL877614,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,In vivo,17738,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10690,Rattus norvegicus,2048.0,CHEMBL624839,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,In vivo,17738,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10691,Rattus norvegicus,2048.0,CHEMBL624840,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,In vivo,17738,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10692,Rattus norvegicus,2048.0,CHEMBL624841,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,In vivo,17738,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10693,Rattus norvegicus,2048.0,CHEMBL624842,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,In vivo,17738,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10694,Rattus norvegicus,2385.0,CHEMBL624843,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,In vivo,17738,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10695,Rattus norvegicus,2385.0,CHEMBL624844,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,In vivo,17738,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10696,Rattus norvegicus,2385.0,CHEMBL624845,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,In vivo,17738,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10697,Rattus norvegicus,2385.0,CHEMBL621904,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,In vivo,17738,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10698,Rattus norvegicus,178.0,CHEMBL621905,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,In vivo,11195,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10699,Rattus norvegicus,178.0,CHEMBL874382,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,In vivo,11195,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10700,Rattus norvegicus,178.0,CHEMBL621906,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,In vivo,11195,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10701,Rattus norvegicus,955.0,CHEMBL621907,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,In vivo,11195,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10702,Rattus norvegicus,955.0,CHEMBL622096,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,In vivo,11195,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10703,Rattus norvegicus,955.0,CHEMBL622097,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,In vivo,11195,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10704,Rattus norvegicus,948.0,CHEMBL622098,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,In vivo,11195,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10705,Rattus norvegicus,948.0,CHEMBL622099,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,In vivo,11195,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10706,Rattus norvegicus,948.0,CHEMBL622100,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,In vivo,11195,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10707,Rattus norvegicus,2113.0,CHEMBL622101,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,In vivo,11195,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10708,Rattus norvegicus,2113.0,CHEMBL622102,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,In vivo,11195,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10709,Rattus norvegicus,2113.0,CHEMBL622103,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,In vivo,11195,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10710,Rattus norvegicus,2107.0,CHEMBL622104,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,In vivo,11195,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10711,Rattus norvegicus,2107.0,CHEMBL622105,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,In vivo,11195,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10712,Rattus norvegicus,2107.0,CHEMBL622106,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,In vivo,11195,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10713,Rattus norvegicus,2048.0,CHEMBL622107,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,In vivo,11195,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10714,Rattus norvegicus,2048.0,CHEMBL622108,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,In vivo,11195,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10715,Rattus norvegicus,2048.0,CHEMBL622109,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,In vivo,11195,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10716,Rattus norvegicus,2385.0,CHEMBL622110,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,In vivo,11195,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10717,Rattus norvegicus,2385.0,CHEMBL622111,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,In vivo,11195,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10718,Rattus norvegicus,2385.0,CHEMBL874383,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,In vivo,11195,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10719,Rattus norvegicus,14.0,CHEMBL622112,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,In vivo,11195,Zone of skin,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10720,Rattus norvegicus,14.0,CHEMBL622113,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,In vivo,11195,Zone of skin,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10721,Rattus norvegicus,14.0,CHEMBL622114,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,In vivo,11195,Zone of skin,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10722,Rattus norvegicus,2106.0,CHEMBL622115,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,In vivo,11195,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10723,Rattus norvegicus,2106.0,CHEMBL622116,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,In vivo,11195,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10724,Rattus norvegicus,,CHEMBL622117,Oral bioavailability in rat,In vivo,6193,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10725,Rattus norvegicus,,CHEMBL622118,Oral bioavailability in rat,In vivo,6803,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10726,Rattus norvegicus,,CHEMBL622119,Oral bioavailability in rats at 6 mg/kg,In vivo,6647,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10727,Rattus norvegicus,,CHEMBL622120,Oral bioavailability in rat (dose 6 mg/kg),In vivo,6647,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10728,Rattus norvegicus,,CHEMBL622121,Oral bioavailability in rats at 6 mg/kg dose; Not tested,In vivo,6647,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10729,Rattus norvegicus,,CHEMBL622122,Oral bioavailability in rat,In vivo,6640,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10730,Rattus norvegicus,,CHEMBL622123,Oral bioavailability in rat,In vivo,6641,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10731,Rattus norvegicus,,CHEMBL622124,Oral bioavailability in rat,In vivo,6641,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10732,Rattus norvegicus,,CHEMBL622125,Bioavailability in rat,In vivo,6642,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10733,Rattus norvegicus,,CHEMBL622126,Oral bioavailability,In vivo,5472,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10734,Rattus norvegicus,,CHEMBL620455,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),In vivo,6141,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10735,Rattus norvegicus,,CHEMBL620456,Oral bioavailability in rat,In vivo,4390,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10736,Rattus norvegicus,,CHEMBL620457,Oral bioavailability in rat,In vivo,5472,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10737,Rattus norvegicus,,CHEMBL620458,Oral bioavailability was evaluated; Not tested,In vivo,5472,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10738,Rattus norvegicus,,CHEMBL620459,Oral bioavailability,In vivo,5438,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10739,Rattus norvegicus,,CHEMBL620460,Oral bioavailability in rat by oral dosing,In vivo,4883,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10740,Rattus norvegicus,,CHEMBL620461,Oral bioavailability in rat (dose 10 mg/kg p.o.),In vivo,1908,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10741,Rattus norvegicus,,CHEMBL620462,Oral bioavailability in rat (Sprague-Dawley),In vivo,4853,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10742,Rattus norvegicus,,CHEMBL620463,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),In vivo,4853,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10743,Rattus norvegicus,,CHEMBL620464,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),In vivo,4853,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10744,Rattus norvegicus,,CHEMBL620465,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),In vivo,4853,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10745,Rattus norvegicus,,CHEMBL620466,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),In vivo,4853,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10746,Rattus norvegicus,,CHEMBL620467,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,In vivo,4853,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10747,Rattus norvegicus,,CHEMBL620468,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,In vivo,4853,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10748,Rattus norvegicus,,CHEMBL620469,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,In vivo,12873,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10749,Rattus norvegicus,,CHEMBL620470,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,In vivo,12873,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10750,Rattus norvegicus,,CHEMBL620471,Oral bioavailability in rat,In vivo,3169,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10751,Rattus norvegicus,,CHEMBL620472,Oral bioavailability in rat,In vivo,6305,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10752,Rattus norvegicus,,CHEMBL620473,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,In vivo,4762,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10753,Rattus norvegicus,,CHEMBL620474,Oral bioavailability in rat,In vivo,17847,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10754,Rattus norvegicus,,CHEMBL620475,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),In vivo,6211,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10755,Rattus norvegicus,,CHEMBL620476,Oral bioavailability in rat,In vivo,6011,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10756,Rattus norvegicus,,CHEMBL620477,Oral bioavailability in rat,In vivo,6317,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10757,Rattus norvegicus,,CHEMBL620478,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,In vivo,6644,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10758,Rattus norvegicus,,CHEMBL618768,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,In vivo,6644,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10759,Rattus norvegicus,,CHEMBL618769,Oral bioavailability in rat after oral administration at 13 mg/kg dose,In vivo,6644,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10760,Rattus norvegicus,,CHEMBL618770,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,In vivo,6644,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10761,Rattus norvegicus,,CHEMBL618771,Oral bioavailability (dose 20 mg/kg p.o.),In vivo,6113,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10762,Rattus norvegicus,,CHEMBL618772,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,In vivo,5937,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10763,Rattus norvegicus,,CHEMBL618773,Oral bioavailability in rat at 10 mg/kg of the compound,In vivo,5711,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10764,Rattus norvegicus,,CHEMBL875842,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,In vivo,17717,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10765,Rattus norvegicus,,CHEMBL618774,Bioavailability in rat (dose 3 mg/kg i.v.),In vivo,17717,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10766,Rattus norvegicus,,CHEMBL618775,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,In vivo,17717,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10767,Rattus norvegicus,,CHEMBL618776,Oral bioavailability in rat (dose 60 mg/kg p.o.),In vivo,17717,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10768,Rattus norvegicus,,CHEMBL618777,Percent bioavailability (F) in rats after iv administration,In vivo,4722,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10769,Rattus norvegicus,,CHEMBL618778,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,In vivo,4722,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10770,Rattus norvegicus,,CHEMBL618779,Bioavailability in rat (dose 5 uM/kg p.o.),In vivo,4353,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10771,Rattus norvegicus,,CHEMBL618780,Oral bioavailability,In vivo,15662,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10772,Rattus norvegicus,,CHEMBL618781,Bioavailability in rat (dose 2 mg/kg p.o.),In vivo,4756,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10773,Rattus norvegicus,,CHEMBL618782,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,In vivo,4756,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10774,Rattus norvegicus,,CHEMBL618783,Oral bioavailability in rat (dose 20 mg/kg),In vivo,3436,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10775,Rattus norvegicus,,CHEMBL618784,Oral bioavailability in rat,In vivo,17800,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10776,Rattus norvegicus,,CHEMBL618785,Percent oral bioavailability evaluated in rat,In vivo,15762,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10777,Rattus norvegicus,,CHEMBL618786,Oral bioavailability in rat,In vivo,5089,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10778,Rattus norvegicus,,CHEMBL618787,Percent oral bioavailability in rat; Not determined,In vivo,5089,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10779,Rattus norvegicus,,CHEMBL618788,Oral bioavailability in rat,In vivo,3185,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10780,Rattus norvegicus,,CHEMBL618789,Bioavailability in rat,In vivo,5145,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10781,Rattus norvegicus,,CHEMBL618790,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),In vivo,3457,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10782,Rattus norvegicus,,CHEMBL618791,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),In vivo,3457,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10783,Rattus norvegicus,,CHEMBL875843,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,In vivo,5983,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10784,Rattus norvegicus,,CHEMBL618792,Oral bioavailability in rat (dose 20 mg/kg p.o.),In vivo,5739,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10785,Rattus norvegicus,,CHEMBL623395,Cmax at a dose of 30 mg/kg in rat,In vivo,3579,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10786,Simiiformes,,CHEMBL623396,Cmax in monkeys at a dose of 1 mg/kg,In vivo,17788,,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
10787,Rattus norvegicus,,CHEMBL623397,Cmax in rat,In vivo,14956,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10788,Rattus norvegicus,,CHEMBL623398,Cmax in rats at a dose of 1 mg/kg,In vivo,17788,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10789,Mus musculus,,CHEMBL623399,Cmax was measured in mice after an oral dose of 50 mg/kg.,In vivo,9750,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
10790,,,CHEMBL623400,"Cmax value at a dose of 12.7 uM/kg, po",In vivo,12767,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
10791,,,CHEMBL623401,"Cmax value at a dose of 6.3 uM/kg, iv",In vivo,12767,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
10792,,,CHEMBL623402,"Cmax value at a dose of 7.1 uM/kg, iv",In vivo,12767,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
10793,,,CHEMBL623403,Cmax value of compound was determined after 1 hr,In vivo,12703,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
10794,,,CHEMBL623404,Cmax value of the compound,In vivo,15778,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
10795,Rattus norvegicus,,CHEMBL625997,Cmax value administered intraintestinal in rats.,In vivo,12818,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10796,Rattus norvegicus,,CHEMBL625998,Cmax value administered perorally was determined in rat; Not determined,In vivo,14964,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10797,,,CHEMBL625999,Cmax value at the dose of 2.3 mg/kg,In vivo,15808,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
10798,,,CHEMBL626000,Cmax value at the dose of 5 mg/kg,In vivo,15808,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
10799,,,CHEMBL626001,Cmax value in the period of 8 hr after dosing. ,In vivo,15778,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
10800,,,CHEMBL626002,Cmax value at a oral dose of 20 mg/kg; Not tested,In vivo,3715,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
10801,,,CHEMBL626003,Cmax value at a oral dose of 20 mg/kg,In vivo,3715,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
10802,Rattus norvegicus,,CHEMBL626004,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,In vivo,1446,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10803,Cavia porcellus,,CHEMBL626005,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,In vivo,15240,,50512,,,BAO_0000218,,Intermediate,,10141.0,N,1,1,
10804,Rattus norvegicus,,CHEMBL626006,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,In vivo,15240,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10805,Rattus norvegicus,1969.0,CHEMBL626007,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,In vivo,14810,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10806,Mus musculus,1969.0,CHEMBL626008,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,In vivo,14239,Plasma,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
10807,Canis lupus familiaris,2107.0,CHEMBL626009,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,In vivo,12555,Liver,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10808,Canis lupus familiaris,,CHEMBL626010,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,In vivo,10754,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10809,Mus musculus,178.0,CHEMBL626011,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,In vivo,10754,Blood,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
10810,Mus musculus,178.0,CHEMBL626012,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,In vivo,10754,Blood,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
10811,Mus musculus,178.0,CHEMBL626013,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,In vivo,10754,Blood,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
10812,Mus musculus,178.0,CHEMBL626014,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,In vivo,10754,Blood,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
10813,Mus musculus,178.0,CHEMBL877496,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,In vivo,10754,Blood,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
10814,Canis lupus familiaris,,CHEMBL626015,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,In vivo,14600,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10815,Canis lupus familiaris,,CHEMBL626016,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,In vivo,14600,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10816,Canis lupus familiaris,,CHEMBL626017,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,In vivo,14600,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10817,Canis lupus familiaris,1969.0,CHEMBL626018,Bioavailability as maximal plasma concentration in dogs,In vivo,13543,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10818,Canis lupus familiaris,1969.0,CHEMBL626692,Bioavailability as maximal plasma concentration in dogs,In vivo,13543,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10819,Rattus norvegicus,1969.0,CHEMBL626693,Bioavailability as maximal plasma concentration in rats,In vivo,13543,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10820,Rattus norvegicus,1969.0,CHEMBL626694,Bioavailability as maximal plasma concentration in rats,In vivo,13543,Plasma,22224,,,BAO_0000218,,Autocuration,,10116.0,U,0,1,
10821,Canis lupus familiaris,178.0,CHEMBL626695,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,In vivo,14600,Blood,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10822,Canis lupus familiaris,178.0,CHEMBL626696,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,In vivo,14600,Blood,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10823,Canis lupus familiaris,178.0,CHEMBL626697,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,In vivo,14600,Blood,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10824,Canis lupus familiaris,178.0,CHEMBL626859,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,In vivo,14600,Blood,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10825,Canis lupus familiaris,178.0,CHEMBL626860,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,In vivo,14600,Blood,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10826,Canis lupus familiaris,178.0,CHEMBL626861,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,In vivo,14600,Blood,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10827,Rattus norvegicus,,CHEMBL626296,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,In vivo,14681,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10828,,,CHEMBL626297,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,In vivo,15905,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
10829,,1969.0,CHEMBL626298,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,In vivo,15905,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
10830,Rattus norvegicus,1969.0,CHEMBL626299,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",In vivo,13304,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10831,Rattus norvegicus,1969.0,CHEMBL626300,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,In vivo,15137,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10832,Rattus norvegicus,1969.0,CHEMBL626301,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,In vivo,15137,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10833,Rattus norvegicus,1969.0,CHEMBL626962,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,In vivo,15137,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10834,Rattus norvegicus,1969.0,CHEMBL626963,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,In vivo,15137,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10835,Rattus norvegicus,1969.0,CHEMBL626964,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,In vivo,15137,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10836,Macaca fascicularis,1969.0,CHEMBL626965,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,In vivo,14839,Plasma,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
10837,Mus musculus,1969.0,CHEMBL626966,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,In vivo,14839,Plasma,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
10838,Mus musculus,1969.0,CHEMBL626967,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,In vivo,14839,Plasma,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
10839,Macaca fascicularis,1969.0,CHEMBL626968,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,In vivo,14839,Plasma,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
10840,Rattus norvegicus,948.0,CHEMBL626969,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,,8418,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10841,Rattus norvegicus,948.0,CHEMBL627126,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,,8418,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10842,Rattus norvegicus,948.0,CHEMBL631276,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,,8418,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10843,Rattus norvegicus,948.0,CHEMBL631277,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,,8418,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10844,Rattus norvegicus,948.0,CHEMBL631278,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,,8418,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10845,Rattus norvegicus,948.0,CHEMBL874457,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,,8418,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10846,Rattus norvegicus,948.0,CHEMBL631279,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,,8418,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10847,Rattus norvegicus,948.0,CHEMBL631280,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,,8418,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10848,Rattus norvegicus,948.0,CHEMBL631281,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,,8418,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10849,Rattus norvegicus,948.0,CHEMBL631968,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,,8418,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10850,Rattus norvegicus,948.0,CHEMBL631969,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,,8418,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10851,Rattus norvegicus,948.0,CHEMBL631970,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,,8418,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10852,Rattus norvegicus,948.0,CHEMBL631971,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,,8418,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10853,Rattus norvegicus,948.0,CHEMBL631972,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,,8418,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10854,Rattus norvegicus,948.0,CHEMBL630435,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,,8418,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10855,Rattus norvegicus,948.0,CHEMBL630436,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,,8418,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10856,Rattus norvegicus,948.0,CHEMBL630437,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,,8418,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10857,Rattus norvegicus,948.0,CHEMBL630438,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,,8418,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10858,Rattus norvegicus,948.0,CHEMBL630439,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,,8418,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10859,Rattus norvegicus,2113.0,CHEMBL630440,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,,8418,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10860,Rattus norvegicus,2113.0,CHEMBL630441,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,,8418,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10861,Rattus norvegicus,2113.0,CHEMBL630442,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,,8418,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10862,Rattus norvegicus,2113.0,CHEMBL625234,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,,8418,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10863,Rattus norvegicus,2113.0,CHEMBL625235,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,,8418,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10864,Rattus norvegicus,2113.0,CHEMBL625236,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,,8418,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10865,Rattus norvegicus,2113.0,CHEMBL625237,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,,8418,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10866,Rattus norvegicus,2113.0,CHEMBL626125,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,,8418,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10867,Rattus norvegicus,2113.0,CHEMBL626126,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,,8418,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10868,Rattus norvegicus,2113.0,CHEMBL626127,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,,8418,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10869,Rattus norvegicus,2113.0,CHEMBL626128,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,,8418,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10870,Rattus norvegicus,2113.0,CHEMBL626129,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,,8418,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10871,Rattus norvegicus,2113.0,CHEMBL626130,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,,8418,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10872,Rattus norvegicus,2113.0,CHEMBL626131,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,,8418,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10873,Rattus norvegicus,2113.0,CHEMBL626132,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,,8418,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10874,Rattus norvegicus,2113.0,CHEMBL626752,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,,8418,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10875,Rattus norvegicus,2113.0,CHEMBL626753,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,,8418,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10876,Rattus norvegicus,2113.0,CHEMBL626754,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,,8418,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10877,Rattus norvegicus,2113.0,CHEMBL626755,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,,8418,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10878,Rattus norvegicus,2107.0,CHEMBL626756,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,,8418,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10879,Rattus norvegicus,2107.0,CHEMBL626757,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,,8418,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10880,Rattus norvegicus,2107.0,CHEMBL626758,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,,8418,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10881,Rattus norvegicus,2107.0,CHEMBL626759,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,,8418,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10882,Rattus norvegicus,2107.0,CHEMBL626760,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,,8418,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10883,Canis lupus familiaris,,CHEMBL626394,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10884,Canis lupus familiaris,,CHEMBL626395,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10885,Canis lupus familiaris,,CHEMBL626396,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10886,Canis lupus familiaris,,CHEMBL626397,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10887,Canis lupus familiaris,,CHEMBL626398,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10888,Canis lupus familiaris,,CHEMBL626399,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10889,Rattus norvegicus,,CHEMBL874653,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10890,Rattus norvegicus,,CHEMBL626400,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10891,Rattus norvegicus,,CHEMBL626401,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10892,Rattus norvegicus,,CHEMBL626402,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10893,Rattus norvegicus,,CHEMBL626403,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10894,Rattus norvegicus,,CHEMBL626404,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10895,Rattus norvegicus,,CHEMBL626405,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10896,Rattus norvegicus,,CHEMBL625529,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10897,Rattus norvegicus,,CHEMBL625530,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10898,Rattus norvegicus,,CHEMBL625531,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10899,Rattus norvegicus,,CHEMBL625532,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10900,Rattus norvegicus,,CHEMBL625533,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10901,Rattus norvegicus,,CHEMBL875474,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10902,Rattus norvegicus,,CHEMBL625534,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10903,Rattus norvegicus,,CHEMBL625535,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10904,Rattus norvegicus,,CHEMBL625536,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10905,Rattus norvegicus,,CHEMBL625537,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10906,Rattus norvegicus,,CHEMBL625538,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10907,Rattus norvegicus,,CHEMBL625539,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10908,Rattus norvegicus,,CHEMBL625540,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10909,Rattus norvegicus,,CHEMBL625541,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10910,Rattus norvegicus,,CHEMBL625542,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10911,Rattus norvegicus,,CHEMBL625543,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10912,Rattus norvegicus,,CHEMBL625544,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10913,Canis lupus familiaris,,CHEMBL625545,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10914,Canis lupus familiaris,,CHEMBL625546,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10915,Canis lupus familiaris,,CHEMBL625547,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10916,Canis lupus familiaris,,CHEMBL625548,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10917,Canis lupus familiaris,,CHEMBL625549,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10918,Canis lupus familiaris,,CHEMBL625550,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10919,Canis lupus familiaris,,CHEMBL625551,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10920,Canis lupus familiaris,,CHEMBL875475,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10921,Canis lupus familiaris,,CHEMBL625552,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10922,Canis lupus familiaris,,CHEMBL625553,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10923,Canis lupus familiaris,,CHEMBL625554,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10924,Canis lupus familiaris,,CHEMBL625555,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10925,Canis lupus familiaris,,CHEMBL625556,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10926,Canis lupus familiaris,,CHEMBL624986,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10927,Canis lupus familiaris,,CHEMBL624987,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10928,Canis lupus familiaris,,CHEMBL624988,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10929,Canis lupus familiaris,1637.0,CHEMBL624989,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,In vivo,9025,Artery,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10930,Canis lupus familiaris,1637.0,CHEMBL624990,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,In vivo,9025,Artery,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10931,Canis lupus familiaris,1637.0,CHEMBL874391,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,In vivo,9025,Artery,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10932,Canis lupus familiaris,1637.0,CHEMBL624991,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,In vivo,9025,Artery,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10933,Canis lupus familiaris,1637.0,CHEMBL624992,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,In vivo,9025,Artery,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10934,Canis lupus familiaris,1637.0,CHEMBL624993,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,In vivo,9025,Artery,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10935,Canis lupus familiaris,1637.0,CHEMBL624994,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,In vivo,9025,Artery,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10936,Canis lupus familiaris,1637.0,CHEMBL624995,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,In vivo,9025,Artery,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10937,Canis lupus familiaris,1637.0,CHEMBL624996,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,In vivo,9025,Artery,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10938,Canis lupus familiaris,1637.0,CHEMBL624997,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,In vivo,9025,Artery,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10939,Canis lupus familiaris,1637.0,CHEMBL624998,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,In vivo,9025,Artery,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10940,Canis lupus familiaris,1637.0,CHEMBL624999,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,In vivo,9025,Artery,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10941,Canis lupus familiaris,1637.0,CHEMBL882955,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,In vivo,9025,Artery,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10942,Canis lupus familiaris,1637.0,CHEMBL625000,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,In vivo,9025,Artery,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10943,Canis lupus familiaris,1637.0,CHEMBL625001,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,In vivo,9025,Artery,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10944,Canis lupus familiaris,1637.0,CHEMBL625089,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,In vivo,9025,Artery,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10945,Canis lupus familiaris,1637.0,CHEMBL625090,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,In vivo,9025,Artery,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10946,Canis lupus familiaris,1637.0,CHEMBL625091,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,In vivo,9025,Artery,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10947,Canis lupus familiaris,1637.0,CHEMBL625092,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,In vivo,9025,Artery,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10948,Canis lupus familiaris,1637.0,CHEMBL625093,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,In vivo,9025,Artery,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10949,Canis lupus familiaris,1637.0,CHEMBL625094,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,In vivo,9025,Artery,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10950,Canis lupus familiaris,1637.0,CHEMBL625095,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,In vivo,9025,Artery,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10951,Canis lupus familiaris,,CHEMBL625096,Compound was evaluated for its bioavailability in the dogs,In vivo,2249,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10952,Rattus norvegicus,,CHEMBL625097,Compound was evaluated for its bioavailability in the rats,In vivo,2249,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10953,,,CHEMBL882956,Compound was evaluated for oral bioavailability,In vivo,17515,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
10954,Rattus norvegicus,,CHEMBL625098,Compound was evaluated for percentage of Oral bioavailability in rats,In vivo,14541,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10955,Cavia porcellus,,CHEMBL625099,Bioavailability in guinea pig,In vivo,12797,,22224,,,BAO_0000218,,Autocuration,,10141.0,U,0,1,
10956,Rattus norvegicus,,CHEMBL625100,Compound was evaluated for the oral bioavailability in rat,In vivo,12797,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10957,Canis lupus familiaris,,CHEMBL625101,Compound was evaluated for the oral bioavailability in dog,In vivo,12797,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10958,Rattus norvegicus,,CHEMBL874396,Compound was evaluated for the oral bioavailability in rat,In vivo,12797,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10959,Canis lupus familiaris,,CHEMBL625102,Bioavailability in dog (dosed i.v.),In vivo,11727,,22224,,,BAO_0000218,,Autocuration,,9615.0,U,0,1,
10960,Canis lupus familiaris,,CHEMBL625103,Compound was tested for in vivo bioavailability in dog,In vivo,13249,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
10961,Cricetinae,,CHEMBL625104,Compound was tested for in vivo bioavailability in hamsters,In vivo,13249,,100712,,,BAO_0000218,,Intermediate,,10026.0,N,1,1,
10962,Simiiformes,,CHEMBL625105,Compound was tested for in vivo bioavailability in monkey,In vivo,13249,,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
10963,Rattus norvegicus,,CHEMBL625106,Compound was tested for in vivo bioavailability in rat,In vivo,13249,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10964,Mus musculus,,CHEMBL625107,Oral bioavailability in mouse,In vivo,9552,,22224,,,BAO_0000218,,Autocuration,,10090.0,U,0,1,
10965,Mus musculus,,CHEMBL625108,Compound was tested for percent of oral bioavailability in mice; 56-74,In vivo,9552,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
10966,Mus musculus,,CHEMBL625109,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),In vivo,14839,,22224,,,BAO_0000218,,Autocuration,,10090.0,U,0,1,
10967,Macaca fascicularis,,CHEMBL625110,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),In vivo,14839,,22224,,,BAO_0000218,,Autocuration,,9541.0,U,0,1,
10968,Macaca fascicularis,,CHEMBL625111,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),In vivo,14839,,22224,,,BAO_0000218,,Autocuration,,9541.0,U,0,1,
10969,Mus musculus,,CHEMBL625112,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),In vivo,14839,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
10970,Mus musculus,,CHEMBL875334,Oral bioavailability in nude mice,In vivo,14839,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
10971,Primates,,CHEMBL628617,Bioavailability in monkey (i.d. dosing),In vivo,11219,,22224,,,BAO_0000218,,Autocuration,,9443.0,U,0,1,
10972,Rattus norvegicus,,CHEMBL628618,Bioavailability in rat,In vivo,9552,,22224,,,BAO_0000218,,Autocuration,,10116.0,U,0,1,
10973,,,CHEMBL628619,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,In vivo,11732,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
10974,,,CHEMBL628620,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,In vivo,11732,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
10975,Macaca fascicularis,,CHEMBL628621,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",In vivo,14839,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
10976,Macaca fascicularis,,CHEMBL628622,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",In vivo,14839,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
10977,Macaca fascicularis,,CHEMBL628623,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",In vivo,14839,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
10978,Macaca fascicularis,1969.0,CHEMBL628624,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,In vivo,14839,Plasma,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
10979,Mus musculus,1969.0,CHEMBL628625,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,In vivo,14839,Plasma,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
10980,Macaca fascicularis,1969.0,CHEMBL628626,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,In vivo,14839,Plasma,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
10981,Mus musculus,1969.0,CHEMBL627041,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,In vivo,14839,Plasma,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
10982,Mus musculus,1969.0,CHEMBL627042,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,In vivo,14839,Plasma,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
10983,Mus musculus,1969.0,CHEMBL627043,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,In vivo,14839,Plasma,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
10984,,1969.0,CHEMBL627044,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,In vivo,13932,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
10985,Mus musculus,1969.0,CHEMBL627045,Cmax in mouse plasma,In vivo,11637,Plasma,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
10986,,1969.0,CHEMBL627046,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,In vivo,11637,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
10987,Rattus norvegicus,1969.0,CHEMBL627047,Maximal plasma concentration in rat,In vivo,13960,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10988,Rattus norvegicus,1969.0,CHEMBL627048,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,In vivo,15905,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10989,Rattus norvegicus,,CHEMBL627049,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,In vivo,14062,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10990,Rattus norvegicus,,CHEMBL627050,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,In vivo,14062,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10991,Rattus norvegicus,,CHEMBL627051,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,In vivo,14062,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10992,Rattus norvegicus,,CHEMBL627052,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,In vivo,14062,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10993,Rattus norvegicus,,CHEMBL627053,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,In vivo,14062,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10994,Rattus norvegicus,,CHEMBL627054,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,In vivo,14062,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
10995,Mus musculus,,CHEMBL627055,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,In vivo,15011,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
10996,Mus musculus,,CHEMBL627056,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,In vivo,15011,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
10997,Mus musculus,,CHEMBL627057,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),In vivo,15011,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
10998,Mus musculus,,CHEMBL627058,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,In vivo,15011,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
10999,Mus musculus,,CHEMBL626211,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,In vivo,15011,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11000,,,CHEMBL626212,Maximum Concentration of the compound.,In vivo,10291,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11001,Canis lupus familiaris,,CHEMBL626213,Maximum Concentration was measured after iv administration into Beagle dog,In vivo,14599,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11002,Canis lupus familiaris,,CHEMBL626214,Maximum Concentration was measured after iv administration into Beagle dog.,In vivo,14599,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11003,Canis lupus familiaris,,CHEMBL626215,Maximum Concentration was measured after po administration into Beagle dog,In vivo,14599,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11004,Canis lupus familiaris,,CHEMBL626216,Maximum Concentration was measured after po administration into Beagle dog.,In vivo,14599,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11005,,178.0,CHEMBL626217,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,In vivo,12767,Blood,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11006,,178.0,CHEMBL626218,Maximum blood level reached after an iv dose of 12.2 uM/kg,In vivo,12767,Blood,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11007,,178.0,CHEMBL626219,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,In vivo,12767,Blood,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11008,,178.0,CHEMBL626220,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,In vivo,12767,Blood,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11009,,178.0,CHEMBL626221,Maximum blood level reached after an oral dose of 5.0 mg/kg,In vivo,12767,Blood,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11010,,178.0,CHEMBL626222,Maximum blood level reached at dose of 10.6 uM/kg orally,In vivo,12767,Blood,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11011,Cavia porcellus,,CHEMBL626223,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,In vivo,14706,,50512,,,BAO_0000218,,Intermediate,,10141.0,N,1,1,
11012,Cavia porcellus,,CHEMBL626224,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,In vivo,14706,,50512,,,BAO_0000218,,Intermediate,,10141.0,N,1,1,
11013,Rattus norvegicus,955.0,CHEMBL626225,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,In vivo,14793,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11014,Rattus norvegicus,955.0,CHEMBL626226,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,In vivo,14793,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11015,Rattus norvegicus,955.0,CHEMBL626227,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,In vivo,14793,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11016,Rattus norvegicus,955.0,CHEMBL626228,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,In vivo,14793,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11017,Rattus norvegicus,,CHEMBL626229,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,In vivo,14793,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11018,Rattus norvegicus,,CHEMBL626921,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,In vivo,14793,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11019,Rattus norvegicus,,CHEMBL876793,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,In vivo,14793,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11020,Rattus norvegicus,,CHEMBL625309,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,In vivo,14793,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11021,Bacillus subtilis,,CHEMBL625310,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),In vivo,10524,,50278,,,BAO_0000218,,Intermediate,,1423.0,N,1,1,
11022,Simiiformes,,CHEMBL625311,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,In vivo,11871,,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
11023,Rattus norvegicus,,CHEMBL625312,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,In vivo,11871,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11024,,,CHEMBL625313,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,In vivo,3437,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11025,Mus musculus,,CHEMBL625314,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,In vivo,12038,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11026,Rattus norvegicus,,CHEMBL625315,Maximum concentration in male rats after iv administration of 20 mg/kg,In vivo,12038,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11027,Rattus norvegicus,2107.0,CHEMBL625316,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,,8418,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11028,Rattus norvegicus,2107.0,CHEMBL625317,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,,8418,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11029,Rattus norvegicus,2107.0,CHEMBL625318,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,,8418,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11030,Rattus norvegicus,2107.0,CHEMBL625319,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,,8418,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11031,Rattus norvegicus,2107.0,CHEMBL625320,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,,8418,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11032,Rattus norvegicus,2107.0,CHEMBL625321,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,,8418,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11033,Rattus norvegicus,2107.0,CHEMBL625322,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,,8418,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11034,Rattus norvegicus,2107.0,CHEMBL876801,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,,8418,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11035,Rattus norvegicus,2107.0,CHEMBL625323,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,,8418,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11036,Rattus norvegicus,2107.0,CHEMBL625324,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,,8418,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11037,Rattus norvegicus,2107.0,CHEMBL625325,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,,8418,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11038,Rattus norvegicus,2107.0,CHEMBL625326,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,,8418,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11039,Rattus norvegicus,2107.0,CHEMBL625327,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,,8418,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11040,Rattus norvegicus,2107.0,CHEMBL625328,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,,8418,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11041,Rattus norvegicus,2048.0,CHEMBL625329,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,,8418,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11042,Rattus norvegicus,2048.0,CHEMBL625330,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,,8418,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11043,Rattus norvegicus,2048.0,CHEMBL627774,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,,8418,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11044,Rattus norvegicus,2048.0,CHEMBL627775,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,,8418,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11045,Rattus norvegicus,2048.0,CHEMBL627949,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,,8418,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11046,Rattus norvegicus,2048.0,CHEMBL627950,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,,8418,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11047,Rattus norvegicus,2048.0,CHEMBL627951,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,,8418,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11048,Rattus norvegicus,2048.0,CHEMBL627952,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,,8418,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11049,Rattus norvegicus,2048.0,CHEMBL627953,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,,8418,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11050,Rattus norvegicus,2048.0,CHEMBL627954,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,,8418,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11051,Rattus norvegicus,2048.0,CHEMBL627955,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,,8418,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11052,Rattus norvegicus,2048.0,CHEMBL627956,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,,8418,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11053,Rattus norvegicus,2048.0,CHEMBL876802,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,,8418,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11054,Rattus norvegicus,2048.0,CHEMBL627957,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,,8418,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11055,Rattus norvegicus,2048.0,CHEMBL627958,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,,8418,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11056,Rattus norvegicus,2048.0,CHEMBL627959,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,,8418,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11057,Rattus norvegicus,2048.0,CHEMBL627960,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,,8418,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11058,Rattus norvegicus,2048.0,CHEMBL627961,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,,8418,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11059,Rattus norvegicus,2048.0,CHEMBL627962,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,,8418,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11060,Rattus norvegicus,,CHEMBL627963,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,9796,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11061,Rattus norvegicus,,CHEMBL624759,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,9796,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11062,Rattus norvegicus,,CHEMBL624760,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,9796,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11063,Rattus norvegicus,,CHEMBL624761,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,9796,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11064,Rattus norvegicus,,CHEMBL877607,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,9796,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11065,Rattus norvegicus,2107.0,CHEMBL624762,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,9796,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11066,Rattus norvegicus,2107.0,CHEMBL624763,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,9796,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11067,Rattus norvegicus,2107.0,CHEMBL624764,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,9796,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11068,Rattus norvegicus,2107.0,CHEMBL624765,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,9796,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11069,Rattus norvegicus,2107.0,CHEMBL624766,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,9796,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11070,Canis lupus familiaris,,CHEMBL624767,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11071,Canis lupus familiaris,,CHEMBL624768,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11072,Canis lupus familiaris,,CHEMBL624769,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11073,Canis lupus familiaris,,CHEMBL624770,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11074,Canis lupus familiaris,,CHEMBL624771,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11075,Canis lupus familiaris,,CHEMBL624772,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11076,Rattus norvegicus,,CHEMBL624773,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11077,Rattus norvegicus,,CHEMBL624774,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11078,Rattus norvegicus,,CHEMBL624775,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11079,Rattus norvegicus,,CHEMBL624776,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11080,Rattus norvegicus,,CHEMBL624777,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11081,Rattus norvegicus,,CHEMBL624778,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11082,Rattus norvegicus,,CHEMBL624779,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11083,Rattus norvegicus,,CHEMBL624780,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11084,Rattus norvegicus,,CHEMBL624781,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11085,Rattus norvegicus,,CHEMBL877608,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11086,Rattus norvegicus,,CHEMBL624782,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11087,Rattus norvegicus,,CHEMBL624783,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11088,Rattus norvegicus,,CHEMBL624784,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11089,Rattus norvegicus,,CHEMBL624785,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11090,Rattus norvegicus,,CHEMBL624786,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11091,Rattus norvegicus,,CHEMBL624787,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11092,Rattus norvegicus,,CHEMBL628676,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11093,Rattus norvegicus,,CHEMBL621842,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11094,Rattus norvegicus,,CHEMBL621843,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11095,Rattus norvegicus,,CHEMBL623873,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11096,Rattus norvegicus,,CHEMBL623874,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11097,Rattus norvegicus,,CHEMBL623875,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11098,Rattus norvegicus,,CHEMBL623876,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11099,Canis lupus familiaris,,CHEMBL623877,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11100,Canis lupus familiaris,,CHEMBL623878,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11101,Canis lupus familiaris,,CHEMBL623879,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11102,Canis lupus familiaris,,CHEMBL623880,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11103,Canis lupus familiaris,,CHEMBL623881,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11104,Canis lupus familiaris,,CHEMBL623957,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11105,Canis lupus familiaris,,CHEMBL623958,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11106,Canis lupus familiaris,,CHEMBL623959,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11107,Canis lupus familiaris,,CHEMBL623960,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11108,Canis lupus familiaris,,CHEMBL623961,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11109,Canis lupus familiaris,,CHEMBL623962,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11110,Canis lupus familiaris,,CHEMBL624676,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11111,Canis lupus familiaris,,CHEMBL624677,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11112,Canis lupus familiaris,,CHEMBL624678,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11113,Canis lupus familiaris,,CHEMBL624679,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11114,Canis lupus familiaris,,CHEMBL624680,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11115,,,CHEMBL624849,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,In vivo,11732,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11116,,,CHEMBL624850,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,In vivo,11732,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11117,,,CHEMBL874399,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,In vivo,11732,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11118,,,CHEMBL624851,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,In vivo,11732,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11119,,,CHEMBL624852,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,In vivo,11732,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11120,Rattus norvegicus,,CHEMBL624853,Oral bioavailability in rat (dose 10 mg/kg),In vivo,13359,,22224,,,BAO_0000218,,Autocuration,,10116.0,U,0,1,
11121,Rattus norvegicus,,CHEMBL624854,Oral bioavailability in rat (Sprague-Dawley),In vivo,16618,,22224,,,BAO_0000218,,Autocuration,,10116.0,U,0,1,
11122,Rattus norvegicus,,CHEMBL624855,Oral bioavailability in rat,In vivo,13960,,22224,,,BAO_0000218,,Autocuration,,10116.0,U,0,1,
11123,Rattus norvegicus,,CHEMBL624856,Oral bioavailability in rats was determined in vivo,In vivo,13917,,22224,,,BAO_0000218,,Autocuration,,10116.0,U,0,1,
11124,Canis lupus familiaris,,CHEMBL882957,Oral bioavailability in dog,In vivo,14266,,22224,,,BAO_0000218,,Autocuration,,9615.0,U,0,1,
11125,Simiiformes,,CHEMBL624857,Oral bioavailability of compound in monkey,In vivo,12359,,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
11126,Rattus norvegicus,,CHEMBL622202,Oral bioavailability of compound in rat,In vivo,12359,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11127,Rattus norvegicus,,CHEMBL622203,Bioavailability in rat of PMEA prodrug,In vivo,12359,,22224,,,BAO_0000218,,Autocuration,,10116.0,U,0,1,
11128,Rattus norvegicus,,CHEMBL625522,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,In vivo,12359,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11129,Macaca mulatta,,CHEMBL622868,Serum conc at 3 hours following 25 mg/kg dose,In vivo,10791,,22224,,,BAO_0000218,,Autocuration,,9544.0,U,0,1,
11130,Macaca mulatta,1088.0,CHEMBL622869,Urine conc 0-5 hours following 25 mg/kg dose,In vivo,10791,Urine,22224,,,BAO_0000218,,Autocuration,,9544.0,U,0,1,
11131,Macaca mulatta,1088.0,CHEMBL622870,Urine conc 0-24 hours following 25 mg/kg dose,In vivo,10791,Urine,22224,,,BAO_0000218,,Autocuration,,9544.0,U,0,1,
11132,Chlorocebus aethiops,,CHEMBL622871,Oral bioavailability in African green monkeys; 20-25,In vivo,138,,22224,,,BAO_0000218,,Autocuration,,9534.0,U,0,1,
11133,Macaca fascicularis,,CHEMBL620560,Oral bioavailability in cynomolgus monkey.,In vivo,14521,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
11134,Canis lupus familiaris,,CHEMBL620561,Oral bioavailability in dog,In vivo,13953,,22224,,,BAO_0000218,,Autocuration,,9615.0,U,0,1,
11135,Canis lupus familiaris,,CHEMBL620562,Oral bioavailability in dog at 10 mg/kg oral dose,In vivo,12836,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11136,Cricetinae,,CHEMBL620563,Oral bioavailability in hamster at 10 mg/kg oral dose,In vivo,12836,,100712,,,BAO_0000218,,Intermediate,,10026.0,N,1,1,
11137,Rattus norvegicus,,CHEMBL620564,Oral bioavailability in rat at 10 mg/kg oral dose,In vivo,12836,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11138,Rattus norvegicus,,CHEMBL872265,Oral bioavailability in rat,In vivo,14521,,22224,,,BAO_0000218,,Autocuration,,10116.0,U,0,1,
11139,Rattus norvegicus,,CHEMBL620565,Oral bioavailability in rat,In vivo,13953,,22224,,,BAO_0000218,,Autocuration,,10116.0,U,0,1,
11140,Eutheria,,CHEMBL620566,Oral bioavailability,In vivo,6799,,22224,,,BAO_0000218,,Autocuration,,9347.0,U,0,1,
11141,,,CHEMBL620567,Oral bioavailability was determined; range 49-102%,In vivo,11311,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11142,Canis lupus familiaris,,CHEMBL620568,Oral bioavailability was determined in dogs,In vivo,4013,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11143,Rattus norvegicus,,CHEMBL620569,Oral bioavailability in rat,In vivo,4013,,22224,,,BAO_0000218,,Autocuration,,10116.0,U,0,1,
11144,Eutheria,,CHEMBL620570,Oral bioavailability,In vivo,17591,,22224,,,BAO_0000218,,Autocuration,,9347.0,U,0,1,
11145,,,CHEMBL620571,Oral bioavailability was determined; Not orally available,In vivo,17591,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11146,Mus musculus,,CHEMBL620572,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),In vivo,15011,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11147,Mus musculus,,CHEMBL620573,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),In vivo,15011,,22224,,,BAO_0000218,,Autocuration,,10090.0,U,0,1,
11148,Mus musculus,,CHEMBL620574,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,In vivo,15011,,22224,,,BAO_0000218,,Autocuration,,10090.0,U,0,1,
11149,Macaca mulatta,,CHEMBL620575,Oral bioavailability in Rhesus monkey,In vivo,9552,,22224,,,BAO_0000218,,Autocuration,,9544.0,U,0,1,
11150,Canis lupus familiaris,,CHEMBL620576,Oral bioavailability in dog (female mongrel),In vivo,9552,,22224,,,BAO_0000218,,Autocuration,,9615.0,U,0,1,
11151,,,CHEMBL875846,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,In vivo,3639,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11152,Canis lupus familiaris,,CHEMBL620577,Oral bioavailability in dog,In vivo,13397,,22224,,,BAO_0000218,,Autocuration,,9615.0,U,0,1,
11153,,,CHEMBL620578,Percentage Bioavailability was evaluated.,In vivo,3031,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11154,Rattus norvegicus,,CHEMBL620579,Bioavailability in rat administered i.d.,In vivo,12818,,22224,,,BAO_0000218,,Autocuration,,10116.0,U,0,1,
11155,Eutheria,,CHEMBL621248,Bioavailability,In vivo,4847,,22224,,,BAO_0000218,,Autocuration,,9347.0,U,0,1,
11156,Canis lupus familiaris,,CHEMBL625390,Bioavailability in dog (male Beagle) i.v. administration,In vivo,12421,,22224,,,BAO_0000218,,Autocuration,,9615.0,U,0,1,
11157,Rattus norvegicus,,CHEMBL625391,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",In vivo,11966,,22224,,,BAO_0000218,,Autocuration,,10116.0,U,0,1,
11158,Primates,,CHEMBL872266,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),In vivo,11218,,22224,,,BAO_0000218,,Autocuration,,9443.0,U,0,1,
11159,Rattus norvegicus,,CHEMBL625392,Oral bioavailability in rat (Sprague-Dawley) (male),In vivo,13129,,22224,,,BAO_0000218,,Autocuration,,10116.0,U,0,1,
11160,Rattus norvegicus,,CHEMBL625393,The oral bioavailability was measured on rats after oral administration,In vivo,12350,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11161,Rattus norvegicus,,CHEMBL625394,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,In vivo,2231,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11162,Macaca mulatta,,CHEMBL625395,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,In vivo,2231,,50797,,,BAO_0000218,,Intermediate,,9544.0,N,1,1,
11163,Rattus norvegicus,,CHEMBL625396,Bioavailability in rat (dose 10 mg/kg i.d.),In vivo,12187,,22224,,,BAO_0000218,,Autocuration,,10116.0,U,0,1,
11164,Canis lupus familiaris,,CHEMBL625397,Bioavailability in dog (male Beagle) i.v. administration,In vivo,12421,,22224,,,BAO_0000218,,Autocuration,,9615.0,U,0,1,
11165,Mus musculus,,CHEMBL625398,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,13256,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11166,Mus musculus,178.0,CHEMBL625399,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,13256,Blood,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11167,Mus musculus,2037.0,CHEMBL626074,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,13256,Cerebellum,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11168,Mus musculus,,CHEMBL626075,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,13256,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11169,Rattus norvegicus,1969.0,CHEMBL626076,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,In vivo,2231,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11170,Macaca mulatta,1969.0,CHEMBL626077,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,In vivo,2231,Plasma,50797,,,BAO_0000218,,Intermediate,,9544.0,N,1,1,
11171,Rattus norvegicus,178.0,CHEMBL626078,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),In vivo,12178,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11172,,178.0,CHEMBL625846,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),In vivo,12178,Blood,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11173,,178.0,CHEMBL625847,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),In vivo,12178,Blood,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11174,Rattus norvegicus,,CHEMBL625848,Maximum concentration observed in rats at an oral dose of 50 mg/kg,In vivo,15633,,50597,,,BAO_0000218,,Expert,,10116.0,N,1,1,
11175,Rattus norvegicus,1969.0,CHEMBL625849,Maximum concentration of compound in plasma administered orally to rats,In vivo,14258,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11176,Canis lupus familiaris,1969.0,CHEMBL626023,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",In vivo,14224,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11177,Canis lupus familiaris,1969.0,CHEMBL626024,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",In vivo,14224,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11178,Canis lupus familiaris,1969.0,CHEMBL626025,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",In vivo,14224,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11179,,,CHEMBL626026,Maximum concentration after 10 mg/kg by oral administration,In vivo,5566,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11180,,,CHEMBL626027,Maximum concentration at a dose of 1.5 mg/kg,In vivo,16935,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11181,,,CHEMBL626028,Maximum concentration at a dose of 2.0 mg/kg,In vivo,16935,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11182,Canis lupus familiaris,1969.0,CHEMBL626029,Maximum concentration in dog plasma,In vivo,14224,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11183,,1969.0,CHEMBL626030,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,In vivo,12536,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11184,,1969.0,CHEMBL626031,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,In vivo,12536,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11185,,1969.0,CHEMBL626032,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,In vivo,12536,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11186,,1969.0,CHEMBL626033,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,In vivo,12536,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11187,,1969.0,CHEMBL626034,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,In vivo,12536,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11188,Canis lupus familiaris,1969.0,CHEMBL626035,Maximum concentration in plasma after oral administration in dog (25 mg/kg),In vivo,9994,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11189,,1969.0,CHEMBL626036,Maximum concentration in plasma at Tmax,In vivo,1434,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11190,Canis lupus familiaris,1969.0,CHEMBL626037,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,In vivo,12836,Plasma,50588,,,BAO_0000218,,Expert,,9615.0,N,1,1,
11191,Cricetinae,1969.0,CHEMBL626038,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,In vivo,12836,Plasma,100712,,,BAO_0000218,,Intermediate,,10026.0,N,1,1,
11192,Rattus norvegicus,1969.0,CHEMBL626039,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,In vivo,12836,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11193,Rattus norvegicus,1969.0,CHEMBL626040,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,In vivo,12545,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11194,Oryctolagus cuniculus,1969.0,CHEMBL626041,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,In vivo,13856,Plasma,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
11195,,,CHEMBL626042,Maximum concentration was calculated,In vivo,3550,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11196,,,CHEMBL626043,Maximum concentration was calculated.,In vivo,2632,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11197,,,CHEMBL626044,Maximum concentration at a peroral dose of 10 mg/kg,In vivo,5566,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11198,,,CHEMBL626045,Maximum concentration of the drug at 10 uM/dg administered perorally,In vivo,11883,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11199,,,CHEMBL626046,Maximum concentration of the drug at 2 uM/dg administered intravenously,In vivo,11883,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11200,Canis lupus familiaris,1969.0,CHEMBL626047,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",In vivo,14122,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11201,Cricetinae,1969.0,CHEMBL626048,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",In vivo,14122,Plasma,100712,,,BAO_0000218,,Intermediate,,10026.0,N,1,1,
11202,Rattus norvegicus,1969.0,CHEMBL626049,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",In vivo,14122,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11203,Rattus norvegicus,1969.0,CHEMBL626050,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,In vivo,12542,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11204,Canis lupus familiaris,1969.0,CHEMBL874541,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,In vivo,12542,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11205,Cricetinae,1969.0,CHEMBL622826,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,In vivo,12542,Plasma,100712,,,BAO_0000218,,Intermediate,,10026.0,N,1,1,
11206,Cricetinae,1969.0,CHEMBL622827,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,In vivo,12542,Plasma,100712,,,BAO_0000218,,Intermediate,,10026.0,N,1,1,
11207,Rattus norvegicus,1969.0,CHEMBL622828,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,In vivo,12542,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11208,Rattus norvegicus,1969.0,CHEMBL622829,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,In vivo,14080,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11209,Rattus norvegicus,,CHEMBL876806,Maximum concentration reached following intravenous administration in male rat,In vivo,11911,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11210,Canis lupus familiaris,,CHEMBL622830,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,In vivo,13204,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11211,Rattus norvegicus,,CHEMBL622831,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,In vivo,13204,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11212,Canis lupus familiaris,,CHEMBL626794,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,In vivo,14346,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11213,Rattus norvegicus,,CHEMBL626795,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,In vivo,14346,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11214,Rattus norvegicus,,CHEMBL626796,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,In vivo,14346,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11215,Rattus norvegicus,,CHEMBL626797,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,In vivo,14346,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11216,Rattus norvegicus,,CHEMBL626798,Maximum drug concentration is determined after oral dosing in rats.,In vivo,14127,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11217,Canis lupus familiaris,,CHEMBL626799,Maximum observed concentration in oral (5 mg/kg) fasted dogs,In vivo,14339,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11218,Canis lupus familiaris,,CHEMBL626800,Maximum observed concentration in oral (5 mg/kg) fed dogs,In vivo,14339,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11219,,1969.0,CHEMBL626801,Maximum plasma concentration,In vivo,13494,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11220,Rattus norvegicus,1969.0,CHEMBL876816,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,In vivo,14925,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11221,Rattus norvegicus,1969.0,CHEMBL626802,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,In vivo,14474,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11222,Canis lupus familiaris,1969.0,CHEMBL626803,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,In vivo,14474,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11223,,1969.0,CHEMBL626804,Maximum plasma concentration following oral administration of 30 umol/kg,In vivo,13917,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11224,Rattus norvegicus,1969.0,CHEMBL626805,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,,9796,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11225,Rattus norvegicus,1969.0,CHEMBL626309,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,9796,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11226,Rattus norvegicus,1969.0,CHEMBL626310,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,9796,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11227,Rattus norvegicus,1969.0,CHEMBL626311,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,9796,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11228,Rattus norvegicus,1969.0,CHEMBL626312,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,9796,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11229,Rattus norvegicus,995.0,CHEMBL626313,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,9796,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11230,Rattus norvegicus,995.0,CHEMBL626314,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,9796,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11231,Rattus norvegicus,995.0,CHEMBL626315,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,9796,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11232,Rattus norvegicus,995.0,CHEMBL626316,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,9796,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11233,Rattus norvegicus,995.0,CHEMBL626317,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,9796,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11234,Rattus norvegicus,,CHEMBL626318,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),,8363,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11235,Rattus norvegicus,,CHEMBL626319,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),,8363,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11236,Rattus norvegicus,,CHEMBL626320,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),,8363,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11237,Rattus norvegicus,,CHEMBL875053,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),,8363,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11238,Rattus norvegicus,,CHEMBL626321,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),,8363,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11239,Rattus norvegicus,,CHEMBL626322,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),,8363,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11240,Rattus norvegicus,,CHEMBL626323,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),,8363,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11241,Rattus norvegicus,,CHEMBL626324,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),,8363,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11242,Rattus norvegicus,,CHEMBL626325,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),,8363,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11243,Rattus norvegicus,,CHEMBL626326,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),,8363,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11244,Rattus norvegicus,,CHEMBL626327,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),,8363,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11245,Rattus norvegicus,,CHEMBL626328,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),,8363,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11246,Rattus norvegicus,178.0,CHEMBL626329,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",,8684,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11247,Rattus norvegicus,178.0,CHEMBL626330,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",,8684,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11248,Rattus norvegicus,178.0,CHEMBL626331,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",,8684,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11249,Rattus norvegicus,178.0,CHEMBL626332,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",,8684,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11250,Rattus norvegicus,178.0,CHEMBL626333,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",,8684,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11251,Rattus norvegicus,178.0,CHEMBL626334,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",,8684,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11252,Rattus norvegicus,178.0,CHEMBL626335,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",,8684,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11253,Rattus norvegicus,178.0,CHEMBL624798,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",,8684,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11254,Rattus norvegicus,955.0,CHEMBL624799,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",,8684,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11255,Rattus norvegicus,955.0,CHEMBL624800,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",,8684,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11256,Rattus norvegicus,955.0,CHEMBL624801,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",,8684,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11257,Rattus norvegicus,955.0,CHEMBL624802,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",,8684,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11258,Rattus norvegicus,955.0,CHEMBL624803,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",,8684,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11259,Rattus norvegicus,955.0,CHEMBL624804,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",,8684,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11260,Rattus norvegicus,955.0,CHEMBL624805,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",,8684,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11261,Rattus norvegicus,955.0,CHEMBL624806,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",,8684,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11262,Rattus norvegicus,,CHEMBL624807,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11263,Rattus norvegicus,,CHEMBL624808,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11264,Rattus norvegicus,,CHEMBL624809,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11265,Rattus norvegicus,,CHEMBL624810,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11266,Rattus norvegicus,,CHEMBL877618,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11267,Rattus norvegicus,,CHEMBL624811,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11268,Rattus norvegicus,,CHEMBL624812,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11269,Rattus norvegicus,,CHEMBL624813,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11270,Rattus norvegicus,,CHEMBL624814,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11271,Rattus norvegicus,,CHEMBL624815,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11272,Rattus norvegicus,,CHEMBL624816,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11273,Rattus norvegicus,,CHEMBL624817,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11274,Canis lupus familiaris,,CHEMBL624818,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11275,Canis lupus familiaris,,CHEMBL624819,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11276,Canis lupus familiaris,,CHEMBL624820,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11277,Canis lupus familiaris,,CHEMBL624821,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11278,Canis lupus familiaris,,CHEMBL624822,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11279,Canis lupus familiaris,,CHEMBL624823,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11280,Escherichia coli,,CHEMBL624824,Observed diffusion coefficient in organic solvent for Escherichia coli,,15599,,50212,,,BAO_0000218,,Intermediate,,562.0,N,1,1,
11281,Rattus norvegicus,178.0,CHEMBL624825,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,9614,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11282,Rattus norvegicus,178.0,CHEMBL624826,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,9614,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11283,Rattus norvegicus,2081.0,CHEMBL876817,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,9614,Cardiac atrium,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11284,Rattus norvegicus,2081.0,CHEMBL624827,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,9614,Cardiac atrium,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11285,Rattus norvegicus,,CHEMBL624828,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,9614,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11286,Rattus norvegicus,,CHEMBL624829,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,9614,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11287,Rattus norvegicus,2107.0,CHEMBL624830,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,9614,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11288,Rattus norvegicus,2107.0,CHEMBL624831,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,9614,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11289,Rattus norvegicus,2081.0,CHEMBL624832,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,9614,Cardiac atrium,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11290,Rattus norvegicus,2081.0,CHEMBL624833,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,9614,Cardiac atrium,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11291,Rattus norvegicus,,CHEMBL624834,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,9614,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11292,Rattus norvegicus,,CHEMBL624835,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,9614,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11293,Rattus norvegicus,2106.0,CHEMBL624836,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,9614,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11294,Rattus norvegicus,2106.0,CHEMBL624837,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,9614,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11295,Rattus norvegicus,178.0,CHEMBL624838,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,,9071,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11296,Rattus norvegicus,178.0,CHEMBL622188,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,,9071,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11297,Rattus norvegicus,948.0,CHEMBL622189,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,,9071,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11298,Rattus norvegicus,948.0,CHEMBL622190,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,,9071,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11299,Rattus norvegicus,948.0,CHEMBL625170,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,,9071,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11300,Rattus norvegicus,2113.0,CHEMBL625171,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,9071,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11301,Rattus norvegicus,2113.0,CHEMBL625172,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,9071,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11302,Rattus norvegicus,2113.0,CHEMBL625173,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,,9071,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11303,Rattus norvegicus,2107.0,CHEMBL625174,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,,9071,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11304,Rattus norvegicus,2107.0,CHEMBL625175,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,,9071,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11305,Rattus norvegicus,2107.0,CHEMBL625176,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,,9071,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11306,Rattus norvegicus,2048.0,CHEMBL625177,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,9071,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11307,Rattus norvegicus,2048.0,CHEMBL625178,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,,9071,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11308,Rattus norvegicus,2048.0,CHEMBL625179,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,,9071,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11309,Rattus norvegicus,2048.0,CHEMBL625180,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,9071,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11310,,,CHEMBL625181,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",,10677,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11311,Mus musculus,1088.0,CHEMBL625182,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,,9750,Urine,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11312,Rattus norvegicus,,CHEMBL625183,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,8319,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11313,Rattus norvegicus,,CHEMBL875848,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,8319,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11314,Rattus norvegicus,,CHEMBL622260,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,8319,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11315,Rattus norvegicus,,CHEMBL622261,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,8319,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11316,Rattus norvegicus,,CHEMBL622262,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,8319,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11317,Rattus norvegicus,2113.0,CHEMBL622263,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,8319,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11318,Rattus norvegicus,2113.0,CHEMBL622418,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,8319,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11319,Rattus norvegicus,2107.0,CHEMBL622419,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,8319,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11320,Mus musculus,,CHEMBL623388,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,13256,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11321,Mus musculus,2107.0,CHEMBL623389,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,13256,Liver,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11322,Mus musculus,,CHEMBL623390,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,13256,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11323,Mus musculus,,CHEMBL623391,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,13256,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11324,Mus musculus,178.0,CHEMBL623392,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,13256,Blood,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11325,Mus musculus,2037.0,CHEMBL623393,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,13256,Cerebellum,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11326,Mus musculus,,CHEMBL623394,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,13256,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11327,Mus musculus,,CHEMBL618885,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,13256,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11328,Mus musculus,2107.0,CHEMBL618886,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,13256,Liver,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11329,Mus musculus,,CHEMBL618887,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,13256,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11330,Mus musculus,,CHEMBL619535,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,13256,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11331,Mus musculus,178.0,CHEMBL619536,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,13256,Blood,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11332,Mus musculus,2037.0,CHEMBL619537,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,13256,Cerebellum,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11333,Mus musculus,,CHEMBL619705,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,13256,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11334,Mus musculus,,CHEMBL619706,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,13256,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11335,Mus musculus,2107.0,CHEMBL619707,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,13256,Liver,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11336,Mus musculus,,CHEMBL619708,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,13256,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11337,Mus musculus,,CHEMBL625219,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,13256,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11338,Mus musculus,178.0,CHEMBL625220,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,13256,Blood,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11339,Mus musculus,2037.0,CHEMBL625221,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,13256,Cerebellum,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11340,Mus musculus,,CHEMBL625222,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,13256,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11341,Mus musculus,,CHEMBL625223,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,13256,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11342,Mus musculus,2107.0,CHEMBL625224,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,13256,Liver,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11343,Mus musculus,,CHEMBL625225,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),In vivo,13256,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11344,Rattus norvegicus,178.0,CHEMBL625226,Biodistribution in Rat blood after 24 hours of iv administration,In vivo,8829,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11345,Rattus norvegicus,178.0,CHEMBL625227,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,In vivo,8829,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11346,Rattus norvegicus,178.0,CHEMBL625228,Biodistribution in Rat blood after 30 minutes of iv administration,In vivo,8829,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11347,Rattus norvegicus,178.0,CHEMBL875354,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,In vivo,8829,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11348,Rattus norvegicus,178.0,CHEMBL625229,Biodistribution in Rat blood after 5 minutes of iv administration,In vivo,8829,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11349,Rattus norvegicus,178.0,CHEMBL625230,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,In vivo,8829,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11350,Rattus norvegicus,948.0,CHEMBL625231,Biodistribution in Rat heart after 24 hours of iv administration,In vivo,8829,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11351,Rattus norvegicus,948.0,CHEMBL625900,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,In vivo,8829,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11352,Rattus norvegicus,948.0,CHEMBL625901,Biodistribution in Rat heart after 30 minutes of iv administration,In vivo,8829,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11353,Rattus norvegicus,948.0,CHEMBL625902,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,In vivo,8829,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11354,Rattus norvegicus,948.0,CHEMBL625903,Biodistribution in Rat heart after 5 minutes of iv administration,In vivo,8829,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11355,Rattus norvegicus,948.0,CHEMBL625904,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,In vivo,8829,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11356,Rattus norvegicus,2107.0,CHEMBL625905,Biodistribution in Rat liver after 24 hours of iv administration,In vivo,8829,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11357,Rattus norvegicus,2107.0,CHEMBL627861,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,In vivo,8829,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11358,Rattus norvegicus,2107.0,CHEMBL627862,Biodistribution in Rat liver after 30 minutes of iv administration,In vivo,8829,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11359,Rattus norvegicus,2107.0,CHEMBL627863,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,In vivo,8829,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11360,Rattus norvegicus,2107.0,CHEMBL627769,Biodistribution in Rat liver after 30 minutes of iv administration,In vivo,8829,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11361,Canis lupus familiaris,1969.0,CHEMBL627770,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,In vivo,13249,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11362,Macaca fascicularis,,CHEMBL627771,Cmax in cynomolgus monkey (PO dose),In vivo,13622,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
11363,Rattus norvegicus,,CHEMBL627772,Cmax in rat (PO dose),In vivo,13622,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11364,Rattus norvegicus,,CHEMBL627773,Cmax in rat (PO dose),In vivo,13622,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11365,Rattus norvegicus,1969.0,CHEMBL621922,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,In vivo,13494,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11366,Rattus norvegicus,1969.0,CHEMBL621923,Cmax in rat plasma after oral dose (10 mg/kg),In vivo,12170,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11367,,1969.0,CHEMBL621924,Cmax in plasma after oral dose (10 mg/kg),In vivo,12170,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11368,Canis lupus familiaris,1969.0,CHEMBL621925,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,In vivo,17025,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11369,Simiiformes,1969.0,CHEMBL621926,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,In vivo,17025,Plasma,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
11370,Oryctolagus cuniculus,1969.0,CHEMBL621927,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,In vivo,17025,Plasma,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
11371,Rattus norvegicus,1969.0,CHEMBL621928,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,In vivo,17025,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11372,Rattus norvegicus,1969.0,CHEMBL621929,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,In vivo,14187,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11373,Mus musculus,1969.0,CHEMBL621930,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,In vivo,14816,Plasma,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11374,Rattus norvegicus,1969.0,CHEMBL621931,Maximum plasma concentration after oral dosing in rat,In vivo,17820,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11375,,1969.0,CHEMBL621932,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,In vivo,14380,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11376,,1969.0,CHEMBL621933,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,In vivo,14380,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11377,Canis lupus familiaris,1969.0,CHEMBL621934,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,In vivo,14691,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11378,Canis lupus familiaris,1969.0,CHEMBL621935,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,In vivo,14691,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11379,Rattus norvegicus,1969.0,CHEMBL621936,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,In vivo,13375,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11380,,1969.0,CHEMBL621937,Maximum plasma concentration was determined,In vivo,6236,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11381,,1969.0,CHEMBL621938,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,In vivo,14380,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11382,,1969.0,CHEMBL621939,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,In vivo,14380,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11383,,1969.0,CHEMBL621940,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,In vivo,14380,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11384,,1969.0,CHEMBL621941,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,In vivo,14380,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11385,,1969.0,CHEMBL621942,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,In vivo,14380,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11386,,1969.0,CHEMBL626178,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,In vivo,14380,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11387,,1969.0,CHEMBL626179,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,In vivo,14380,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11388,,1969.0,CHEMBL626180,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,In vivo,14380,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11389,Rattus norvegicus,1969.0,CHEMBL626181,Plasma Cmax in rat (PO dose),In vivo,13622,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11390,Rattus norvegicus,,CHEMBL626182,Maximum serum concentration after po dose of 5.22 mg/kg in rats,In vivo,15372,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11391,Rattus norvegicus,,CHEMBL626183,Maximum serum concentration after po dose of 5.46 mg/kg in rats,In vivo,15372,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11392,Rattus norvegicus,,CHEMBL626184,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,In vivo,15372,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11393,Rattus norvegicus,,CHEMBL626185,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,In vivo,15372,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11394,Canis lupus familiaris,1969.0,CHEMBL626186,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,In vivo,14925,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11395,Canis lupus familiaris,1969.0,CHEMBL877589,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,In vivo,14925,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11396,,,CHEMBL626187,Maximum concentration of the drug at 1 uM/dg administered intravenously,In vivo,11883,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11397,,,CHEMBL626188,Maximum concentration of the drug at 20 uM/dg administered perorally,In vivo,11883,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11398,,,CHEMBL626189,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,In vivo,13391,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11399,,178.0,CHEMBL626855,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,In vivo,13391,Blood,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11400,,178.0,CHEMBL623781,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,In vivo,13391,Blood,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11401,,178.0,CHEMBL623782,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,In vivo,13391,Blood,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11402,Rattus norvegicus,1969.0,CHEMBL623783,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,In vivo,16360,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11403,Canis lupus familiaris,1969.0,CHEMBL623784,Cmax in dog plasma after 1mg/kg oral dose,In vivo,3673,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11404,Canis lupus familiaris,1969.0,CHEMBL623785,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,In vivo,14431,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11405,Rattus norvegicus,1969.0,CHEMBL623786,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,In vivo,14431,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11406,Rattus norvegicus,,CHEMBL623787,Oral maximum concentration in rat,In vivo,14964,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11407,Rattus norvegicus,,CHEMBL623788,Oral maximum concentration in rat,In vivo,14964,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11408,Mus musculus,1969.0,CHEMBL623789,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,In vivo,14209,Plasma,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11409,Mus musculus,178.0,CHEMBL623790,Peak concentration in blood after intravenous administration to mice,In vivo,11355,Blood,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11410,Mus musculus,178.0,CHEMBL623791,Peak concentration in blood after peroral administration to mice,In vivo,11355,Blood,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11411,Rattus norvegicus,1969.0,CHEMBL623792,Peak concentration in rat plasma was determined,In vivo,11966,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11412,Simiiformes,1969.0,CHEMBL623793,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,In vivo,8918,Plasma,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
11413,Mus musculus,1969.0,CHEMBL623794,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,In vivo,8918,Plasma,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11414,Rattus norvegicus,1969.0,CHEMBL623795,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,In vivo,8918,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11415,Rattus norvegicus,,CHEMBL623796,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11416,Rattus norvegicus,,CHEMBL623797,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11417,Rattus norvegicus,,CHEMBL623798,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11418,Rattus norvegicus,,CHEMBL623799,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11419,Rattus norvegicus,160.0,CHEMBL624490,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",,8684,Intestine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11420,Rattus norvegicus,160.0,CHEMBL624491,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",,8684,Intestine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11421,Rattus norvegicus,160.0,CHEMBL624492,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",,8684,Intestine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11422,Rattus norvegicus,160.0,CHEMBL624493,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",,8684,Intestine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11423,Rattus norvegicus,160.0,CHEMBL877595,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",,8684,Intestine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11424,Rattus norvegicus,160.0,CHEMBL624494,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",,8684,Intestine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11425,Rattus norvegicus,160.0,CHEMBL624495,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",,8684,Intestine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11426,Rattus norvegicus,160.0,CHEMBL624681,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",,8684,Intestine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11427,Rattus norvegicus,,CHEMBL624682,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11428,Rattus norvegicus,,CHEMBL624683,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11429,Rattus norvegicus,,CHEMBL624684,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11430,Rattus norvegicus,,CHEMBL624685,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11431,Rattus norvegicus,,CHEMBL624686,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11432,Rattus norvegicus,,CHEMBL624687,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11433,Rattus norvegicus,,CHEMBL624688,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11434,Rattus norvegicus,,CHEMBL627161,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11435,Rattus norvegicus,,CHEMBL622127,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11436,Rattus norvegicus,,CHEMBL622128,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11437,Rattus norvegicus,,CHEMBL874384,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11438,Rattus norvegicus,,CHEMBL624898,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11439,Rattus norvegicus,,CHEMBL624899,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11440,Rattus norvegicus,,CHEMBL624900,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11441,Rattus norvegicus,,CHEMBL624901,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11442,Rattus norvegicus,,CHEMBL624902,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11443,Rattus norvegicus,,CHEMBL624903,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11444,Rattus norvegicus,,CHEMBL624904,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11445,Rattus norvegicus,,CHEMBL624905,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11446,Rattus norvegicus,,CHEMBL624906,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11447,Rattus norvegicus,,CHEMBL624907,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11448,Rattus norvegicus,,CHEMBL624908,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11449,Rattus norvegicus,,CHEMBL624909,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11450,Rattus norvegicus,,CHEMBL624910,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11451,Rattus norvegicus,2385.0,CHEMBL624911,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",,8684,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11452,Rattus norvegicus,2385.0,CHEMBL874388,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",,8684,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11453,Rattus norvegicus,2385.0,CHEMBL624912,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",,8684,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11454,Rattus norvegicus,2385.0,CHEMBL622930,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",,8684,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11455,Rattus norvegicus,2385.0,CHEMBL623121,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",,8684,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11456,Rattus norvegicus,2385.0,CHEMBL623122,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",,8684,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11457,Rattus norvegicus,2385.0,CHEMBL623123,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",,8684,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11458,Rattus norvegicus,2385.0,CHEMBL623124,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",,8684,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11459,Rattus norvegicus,,CHEMBL623125,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11460,Rattus norvegicus,,CHEMBL623126,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11461,Rattus norvegicus,,CHEMBL623127,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11462,Rattus norvegicus,,CHEMBL623128,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11463,Rattus norvegicus,,CHEMBL623129,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11464,Rattus norvegicus,,CHEMBL623130,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11465,Rattus norvegicus,,CHEMBL623131,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11466,Rattus norvegicus,,CHEMBL623132,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11467,Rattus norvegicus,2107.0,CHEMBL623133,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,8319,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11468,Rattus norvegicus,,CHEMBL623134,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,8319,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11469,Rattus norvegicus,,CHEMBL874389,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,8319,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11470,Rattus norvegicus,,CHEMBL623135,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,8319,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11471,Rattus norvegicus,,CHEMBL623136,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,8319,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11472,Rattus norvegicus,,CHEMBL623137,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,8319,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11473,Rattus norvegicus,,CHEMBL623138,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,8319,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11474,Rattus norvegicus,2113.0,CHEMBL623139,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,8319,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11475,Rattus norvegicus,2113.0,CHEMBL623140,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,8319,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11476,Rattus norvegicus,2107.0,CHEMBL623141,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,8319,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11477,Rattus norvegicus,2107.0,CHEMBL623142,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,8319,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11478,Rattus norvegicus,,CHEMBL623143,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,8319,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11479,Mus musculus,1088.0,CHEMBL623144,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,,14571,Urine,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11480,Rattus norvegicus,1088.0,CHEMBL623405,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,,14571,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11481,Rattus norvegicus,,CHEMBL624074,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,8319,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11482,Rattus norvegicus,,CHEMBL624075,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,8319,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11483,Rattus norvegicus,,CHEMBL624076,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,8319,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11484,Rattus norvegicus,,CHEMBL624077,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,8319,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11485,Rattus norvegicus,,CHEMBL624078,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,8319,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11486,Rattus norvegicus,2113.0,CHEMBL624079,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,8319,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11487,Rattus norvegicus,2113.0,CHEMBL624261,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,8319,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11488,Rattus norvegicus,,CHEMBL624262,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,8319,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11489,Rattus norvegicus,,CHEMBL624263,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,8319,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11490,Rattus norvegicus,,CHEMBL624264,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,8319,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11491,Rattus norvegicus,,CHEMBL624265,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,8319,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11492,Rattus norvegicus,,CHEMBL624266,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,8319,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11493,Rattus norvegicus,,CHEMBL624267,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,8319,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11494,Rattus norvegicus,,CHEMBL624268,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,8319,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11495,Rattus norvegicus,,CHEMBL875227,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,8319,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11496,Rattus norvegicus,2113.0,CHEMBL624269,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,8319,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11497,Rattus norvegicus,2113.0,CHEMBL624270,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,8319,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11498,Rattus norvegicus,,CHEMBL624271,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,8319,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11499,Rattus norvegicus,,CHEMBL624272,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,8319,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11500,Rattus norvegicus,,CHEMBL624273,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,8319,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11501,Rattus norvegicus,1088.0,CHEMBL624274,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,,12064,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11502,Rattus norvegicus,1088.0,CHEMBL624275,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,,12064,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11503,Rattus norvegicus,1088.0,CHEMBL624276,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,,12064,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11504,Rattus norvegicus,1088.0,CHEMBL624277,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,,12038,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11505,,,CHEMBL624278,% dose converted to 2-amino-5-chlorophenyl sulfate,,14314,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11506,,,CHEMBL624279,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),,14314,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11507,Rattus norvegicus,1988.0,CHEMBL624280,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,11488,Feces,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11508,Rattus norvegicus,1988.0,CHEMBL624281,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,11488,Feces,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11509,Rattus norvegicus,1988.0,CHEMBL622933,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,11488,Feces,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11510,Rattus norvegicus,1988.0,CHEMBL622934,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,11488,Feces,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11511,Rattus norvegicus,2107.0,CHEMBL622935,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,In vivo,8829,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11512,Rattus norvegicus,2107.0,CHEMBL622936,Biodistribution in Rat liver after 5 minutes of iv administration,In vivo,8829,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11513,Rattus norvegicus,2107.0,CHEMBL875228,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,In vivo,8829,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11514,Rattus norvegicus,2048.0,CHEMBL622937,Biodistribution in Rat lung after 24 hours of iv administration,In vivo,8829,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11515,Rattus norvegicus,2048.0,CHEMBL622938,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,In vivo,8829,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11516,Rattus norvegicus,2048.0,CHEMBL619736,Biodistribution in Rat lung after 30 minutes of iv administration,In vivo,8829,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11517,Rattus norvegicus,2048.0,CHEMBL625117,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,In vivo,8829,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11518,Rattus norvegicus,2048.0,CHEMBL625118,Biodistribution in Rat lung after 5 minutes of iv administration,In vivo,8829,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11519,Rattus norvegicus,2048.0,CHEMBL625119,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,In vivo,8829,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11520,Rattus norvegicus,2037.0,CHEMBL625120,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",In vivo,14972,Cerebellum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11521,Rattus norvegicus,,CHEMBL625121,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",In vivo,14972,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11522,Rattus norvegicus,10000006.0,CHEMBL625122,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",In vivo,14972,Thalamus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11523,Rattus norvegicus,178.0,CHEMBL622204,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,14608,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11524,Rattus norvegicus,178.0,CHEMBL877503,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,14608,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11525,Rattus norvegicus,178.0,CHEMBL627127,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,14608,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11526,,10000000.0,CHEMBL627128,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,14608,Hippocampus,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11527,,10000000.0,CHEMBL627129,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,14608,Hippocampus,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11528,,10000000.0,CHEMBL627130,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,14608,Hippocampus,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11529,Rattus norvegicus,955.0,CHEMBL627131,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,14608,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11530,Rattus norvegicus,955.0,CHEMBL627132,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,14608,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11531,Rattus norvegicus,955.0,CHEMBL627133,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,14608,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11532,Rattus norvegicus,2037.0,CHEMBL627134,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,14608,Cerebellum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11533,Rattus norvegicus,2037.0,CHEMBL627135,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,14608,Cerebellum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11534,Rattus norvegicus,2037.0,CHEMBL627136,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,14608,Cerebellum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11535,Rattus norvegicus,,CHEMBL628435,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,14608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11536,Rattus norvegicus,,CHEMBL628436,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,14608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11537,Rattus norvegicus,,CHEMBL628437,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,14608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11538,Rattus norvegicus,948.0,CHEMBL628438,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,14608,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11539,Rattus norvegicus,948.0,CHEMBL628439,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,14608,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11540,Rattus norvegicus,948.0,CHEMBL628440,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,14608,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11541,Rattus norvegicus,10000000.0,CHEMBL628441,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,14608,Hippocampus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11542,Rattus norvegicus,10000000.0,CHEMBL628442,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,14608,Hippocampus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11543,Rattus norvegicus,10000000.0,CHEMBL628443,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,14608,Hippocampus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11544,Rattus norvegicus,2113.0,CHEMBL628444,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,14608,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11545,Rattus norvegicus,2113.0,CHEMBL628445,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,14608,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11546,Rattus norvegicus,2113.0,CHEMBL877504,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,14608,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11547,Rattus norvegicus,2107.0,CHEMBL628446,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,14608,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11548,Rattus norvegicus,2107.0,CHEMBL626874,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,14608,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11549,Rattus norvegicus,2107.0,CHEMBL626875,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,14608,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11550,Rattus norvegicus,2048.0,CHEMBL626876,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,14608,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11551,Rattus norvegicus,2048.0,CHEMBL626877,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,14608,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11552,Rattus norvegicus,2048.0,CHEMBL626878,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,14608,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11553,Rattus norvegicus,2385.0,CHEMBL626879,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,14608,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11554,Simiiformes,1969.0,CHEMBL626880,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,In vivo,8918,Plasma,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
11555,Mus musculus,1969.0,CHEMBL626881,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,In vivo,8918,Plasma,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11556,Rattus norvegicus,1969.0,CHEMBL626882,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,In vivo,8918,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11557,Canis lupus familiaris,1969.0,CHEMBL626883,Peak plasma concentration was measured in dogs,In vivo,14470,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11558,Rattus norvegicus,,CHEMBL626884,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,In vivo,14393,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11559,Rattus norvegicus,,CHEMBL626885,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,In vivo,14886,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11560,Rattus norvegicus,,CHEMBL626886,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,In vivo,14886,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11561,Rattus norvegicus,,CHEMBL626887,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,In vivo,14886,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11562,Rattus norvegicus,,CHEMBL626888,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,In vivo,14393,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11563,Canis lupus familiaris,,CHEMBL626889,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,In vivo,13465,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11564,Simiiformes,,CHEMBL626761,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,In vivo,13465,,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
11565,Canis lupus familiaris,,CHEMBL626762,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,In vivo,13465,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11566,Canis lupus familiaris,,CHEMBL626763,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,In vivo,13465,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11567,Rattus norvegicus,,CHEMBL626764,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,In vivo,13465,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11568,Rattus norvegicus,,CHEMBL626765,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,In vivo,13465,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11569,Canis lupus familiaris,,CHEMBL626766,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,In vivo,13465,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11570,Rattus norvegicus,,CHEMBL626767,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,In vivo,13465,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11571,Rattus norvegicus,,CHEMBL626768,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,In vivo,13465,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11572,Canis lupus familiaris,,CHEMBL626769,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,In vivo,13465,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11573,Canis lupus familiaris,,CHEMBL874463,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,In vivo,13465,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11574,Simiiformes,,CHEMBL626770,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,In vivo,13465,,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
11575,Simiiformes,,CHEMBL626771,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,In vivo,13465,,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
11576,Rattus norvegicus,,CHEMBL626772,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,In vivo,13465,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11577,Macaca fascicularis,,CHEMBL626773,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,In vivo,14731,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
11578,Mus musculus,,CHEMBL626774,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,In vivo,14731,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11579,Canis lupus familiaris,,CHEMBL626775,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,In vivo,13376,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11580,Canis lupus familiaris,,CHEMBL626776,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,In vivo,13376,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11581,Rattus norvegicus,,CHEMBL626777,Maximum concentration (Cmax) in rat when administered orally,In vivo,14443,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11582,Simiiformes,1969.0,CHEMBL626778,Maximal concentration in monkey plasma after 25 mg/kg oral dose,In vivo,13465,Plasma,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
11583,Rattus norvegicus,,CHEMBL626779,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",In vivo,16359,,22224,,,BAO_0000218,,Autocuration,,10116.0,U,0,1,
11584,Rattus norvegicus,,CHEMBL626780,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",In vivo,16359,,22224,,,BAO_0000218,,Autocuration,,10116.0,U,0,1,
11585,,1969.0,CHEMBL626781,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,In vivo,15618,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11586,Rattus norvegicus,,CHEMBL632164,Pharmacokinetic profile Cmax was evaluated in rats,In vivo,14554,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11587,Canis lupus familiaris,,CHEMBL632165,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),In vivo,11537,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11588,Mus musculus,,CHEMBL632166,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),In vivo,11537,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11589,Canis lupus familiaris,,CHEMBL632167,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),In vivo,11537,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11590,Mus musculus,,CHEMBL632168,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),In vivo,11537,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11591,Rattus norvegicus,1969.0,CHEMBL632169,Cmax in rat plasma,In vivo,2021,Plasma,22224,,,BAO_0000218,,Autocuration,,10116.0,U,0,1,
11592,Canis lupus familiaris,1969.0,CHEMBL632170,Cmax in dog plasma after 30mg/kg oral dose,In vivo,5932,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11593,Rattus norvegicus,1969.0,CHEMBL632171,Cmax in rat plasma after 30mg/kg oral dose,In vivo,5932,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11594,Rattus norvegicus,1969.0,CHEMBL632172,Plasma level in rats at 30 mg/kg,In vivo,17320,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11595,Mus musculus,1969.0,CHEMBL632173,Tested for maximum plasma concentration in mice,In vivo,15831,Plasma,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11596,Rattus norvegicus,,CHEMBL632174,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",In vivo,15078,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11597,Rattus norvegicus,,CHEMBL632175,The Cmax values in female wistar rats.,In vivo,14941,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11598,Canis lupus familiaris,1969.0,CHEMBL632176,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,In vivo,15343,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11599,Rattus norvegicus,1969.0,CHEMBL632177,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,In vivo,15343,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11600,Rattus norvegicus,1969.0,CHEMBL632178,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,In vivo,14856,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11601,Rattus norvegicus,,CHEMBL632179,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,In vivo,13129,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11602,Rattus norvegicus,178.0,CHEMBL632180,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,In vivo,13098,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11603,Rattus norvegicus,178.0,CHEMBL632181,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,In vivo,13098,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11604,Rattus norvegicus,178.0,CHEMBL632182,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,In vivo,13098,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11605,Mus musculus,178.0,CHEMBL632183,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,In vivo,15478,Blood,22224,,,BAO_0000218,,Autocuration,,10090.0,U,0,1,
11606,Canis lupus familiaris,,CHEMBL632184,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,In vivo,15341,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11607,Rattus norvegicus,,CHEMBL874470,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,In vivo,15341,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11608,Rattus norvegicus,,CHEMBL631302,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11609,Rattus norvegicus,,CHEMBL631303,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11610,Rattus norvegicus,,CHEMBL631304,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11611,Rattus norvegicus,,CHEMBL631305,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11612,Rattus norvegicus,,CHEMBL631306,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11613,Rattus norvegicus,,CHEMBL631307,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11614,Rattus norvegicus,,CHEMBL631308,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11615,Rattus norvegicus,,CHEMBL625557,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",,8684,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11616,Rattus norvegicus,2106.0,CHEMBL625558,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",,8684,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11617,Rattus norvegicus,2106.0,CHEMBL625559,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",,8684,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11618,Rattus norvegicus,2106.0,CHEMBL625560,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",,8684,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11619,Rattus norvegicus,2106.0,CHEMBL625561,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",,8684,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11620,Rattus norvegicus,2106.0,CHEMBL625562,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",,8684,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11621,Rattus norvegicus,2106.0,CHEMBL875320,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",,8684,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11622,Rattus norvegicus,2106.0,CHEMBL625563,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",,8684,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11623,Rattus norvegicus,2106.0,CHEMBL625564,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",,8684,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11624,Rattus norvegicus,995.0,CHEMBL625565,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",,8684,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11625,Rattus norvegicus,995.0,CHEMBL625566,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",,8684,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11626,Rattus norvegicus,995.0,CHEMBL625567,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",,8684,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11627,Rattus norvegicus,995.0,CHEMBL625568,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",,8684,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11628,Rattus norvegicus,995.0,CHEMBL628217,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",,8684,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11629,Rattus norvegicus,995.0,CHEMBL628218,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",,8684,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11630,Rattus norvegicus,995.0,CHEMBL628219,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",,8684,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11631,Rattus norvegicus,995.0,CHEMBL628220,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",,8684,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11632,,,CHEMBL628221,Distribution in the blood after 120 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11633,,,CHEMBL628222,Distribution in the blood after 15 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11634,,,CHEMBL628223,Distribution in the blood after 30 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11635,,,CHEMBL628224,Distribution in the blood after 5 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11636,,,CHEMBL628225,Distribution in the blood after 60 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11637,,,CHEMBL628226,Distribution in the blood after 90 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11638,,,CHEMBL628227,Distribution in the bone after 120 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11639,,,CHEMBL875481,Distribution in the bone after 15 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11640,,,CHEMBL628228,Distribution in the bone after 30 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11641,,,CHEMBL628229,Distribution in the bone after 5 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11642,,,CHEMBL628230,Distribution in the bone after 60 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11643,,,CHEMBL628231,Distribution in the bone after 90 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11644,,,CHEMBL628232,Distribution in the heart after 120 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11645,,,CHEMBL628233,Distribution in the heart after 15 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11646,,,CHEMBL628234,Distribution in the heart after 30 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11647,,,CHEMBL628235,Distribution in the heart after 5 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11648,,,CHEMBL628236,Distribution in the heart after 60 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11649,,,CHEMBL628237,Distribution in the heart after 90 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11650,,,CHEMBL628238,Distribution in the kidneys after 120 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11651,,,CHEMBL628239,Distribution in the kidneys after 15 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11652,,,CHEMBL628240,Distribution in the kidneys after 30 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11653,,,CHEMBL628241,Distribution in the kidneys after 5 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11654,,,CHEMBL628242,Distribution in the kidneys after 60 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11655,,,CHEMBL875482,Distribution in the kidneys after 90 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11656,,,CHEMBL628243,Distribution in the liver after 120 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11657,,,CHEMBL628244,Distribution in the liver after 15 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11658,,,CHEMBL628245,Distribution in the liver after 30 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11659,,,CHEMBL628246,Distribution in the liver after 5 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11660,,,CHEMBL628247,Distribution in the liver after 60 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11661,,,CHEMBL628248,Distribution in the liver after 90 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11662,,,CHEMBL628249,Distribution in the lung after 120 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11663,Mus musculus,,CHEMBL625452,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",,14839,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11664,Mus musculus,,CHEMBL625453,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",,14839,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11665,Mus musculus,,CHEMBL625454,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",,14839,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11666,Mus musculus,,CHEMBL623844,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",,14839,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11667,Rattus norvegicus,,CHEMBL623845,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,,12178,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11668,Rattus norvegicus,,CHEMBL623846,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,,12178,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11669,,,CHEMBL623847,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,,12178,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11670,Macaca fascicularis,,CHEMBL623848,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,12186,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
11671,Macaca fascicularis,,CHEMBL623849,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,12186,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
11672,Macaca fascicularis,,CHEMBL623850,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,12186,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
11673,Macaca fascicularis,,CHEMBL623851,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,12186,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
11674,Simiiformes,,CHEMBL623852,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,12187,,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
11675,Mustela putorius furo,,CHEMBL624551,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,12187,,50506,,,BAO_0000218,,Intermediate,,9669.0,N,1,1,
11676,Mustela putorius furo,,CHEMBL624552,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,12187,,50506,,,BAO_0000218,,Intermediate,,9669.0,N,1,1,
11677,Simiiformes,,CHEMBL624553,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,12187,,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
11678,Simiiformes,,CHEMBL624554,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,,12187,,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
11679,Rattus norvegicus,,CHEMBL624555,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,12187,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11680,Rattus norvegicus,,CHEMBL624741,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,12187,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11681,Canis lupus familiaris,,CHEMBL624742,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",,14122,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11682,Cricetinae,,CHEMBL624743,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",,14122,,100712,,,BAO_0000218,,Intermediate,,10026.0,N,1,1,
11683,Rattus norvegicus,,CHEMBL877606,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",,14122,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11684,,,CHEMBL624744,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,,13391,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11685,,178.0,CHEMBL624745,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,13391,Blood,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11686,,178.0,CHEMBL624746,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,13391,Blood,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11687,,178.0,CHEMBL624747,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,13391,Blood,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11688,,,CHEMBL624748,Oral absorption expressed as Area under curve was determined,,16360,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11689,Canis lupus familiaris,,CHEMBL622504,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,,3673,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11690,Canis lupus familiaris,,CHEMBL622505,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",,14122,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11691,Cricetinae,,CHEMBL622506,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,14122,,100712,,,BAO_0000218,,Intermediate,,10026.0,N,1,1,
11692,Cricetinae,,CHEMBL622507,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,14122,,100712,,,BAO_0000218,,Intermediate,,10026.0,N,1,1,
11693,Rattus norvegicus,,CHEMBL622508,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",,14122,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11694,,,CHEMBL622509,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,,13889,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11695,Rattus norvegicus,,CHEMBL622510,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,14393,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11696,Rattus norvegicus,,CHEMBL622511,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),,17279,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11697,Macaca fascicularis,,CHEMBL622512,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,14548,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
11698,Macaca fascicularis,,CHEMBL622513,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,14548,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
11699,Macaca fascicularis,,CHEMBL622514,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,,14548,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
11700,Canis lupus familiaris,,CHEMBL622515,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,14548,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11701,Canis lupus familiaris,,CHEMBL622516,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,,14548,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11702,Rattus norvegicus,,CHEMBL622517,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,14548,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11703,Rattus norvegicus,,CHEMBL622518,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,,14548,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11704,Rattus norvegicus,,CHEMBL622519,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,,14548,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11705,Rattus norvegicus,2385.0,CHEMBL622520,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,14608,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11706,Rattus norvegicus,2385.0,CHEMBL622521,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,14608,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11707,Mus musculus,14.0,CHEMBL625113,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,14608,Zone of skin,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11708,Rattus norvegicus,14.0,CHEMBL625114,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,14608,Zone of skin,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11709,Rattus norvegicus,14.0,CHEMBL874397,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,14608,Zone of skin,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11710,Rattus norvegicus,2106.0,CHEMBL625115,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,14608,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11711,Rattus norvegicus,2106.0,CHEMBL625116,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,14608,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11712,Rattus norvegicus,2106.0,CHEMBL623932,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,14608,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11713,Rattus norvegicus,2435.0,CHEMBL623933,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,14608,Striatum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11714,Rattus norvegicus,2435.0,CHEMBL623934,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,14608,Striatum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11715,Rattus norvegicus,2435.0,CHEMBL623935,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,14608,Striatum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11716,Rattus norvegicus,2046.0,CHEMBL623936,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,In vivo,14608,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11717,Rattus norvegicus,2046.0,CHEMBL623937,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,In vivo,14608,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11718,Rattus norvegicus,2046.0,CHEMBL623938,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,In vivo,14608,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11719,Mus musculus,,CHEMBL623939,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,15383,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11720,Mus musculus,,CHEMBL623940,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,15383,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11721,Mus musculus,,CHEMBL623941,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,15383,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11722,Mus musculus,,CHEMBL627216,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,15383,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11723,Mus musculus,,CHEMBL623942,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,15383,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11724,Mus musculus,955.0,CHEMBL618793,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,15383,Brain,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11725,Mus musculus,955.0,CHEMBL618794,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,15383,Brain,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11726,Mus musculus,955.0,CHEMBL618795,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,15383,Brain,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11727,Mus musculus,,CHEMBL618796,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,15383,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11728,Mus musculus,,CHEMBL618797,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,15383,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11729,Mus musculus,2113.0,CHEMBL618798,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,15383,Kidney,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11730,Mus musculus,2113.0,CHEMBL618799,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,15383,Kidney,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11731,Mus musculus,2113.0,CHEMBL618800,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,15383,Kidney,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11732,Mus musculus,2113.0,CHEMBL618801,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,15383,Kidney,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11733,Mus musculus,2113.0,CHEMBL618802,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,15383,Kidney,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11734,Mus musculus,2113.0,CHEMBL618803,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,15383,Kidney,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11735,Mus musculus,2107.0,CHEMBL618804,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,15383,Liver,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11736,Mus musculus,2107.0,CHEMBL618805,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,15383,Liver,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11737,Mus musculus,2107.0,CHEMBL618806,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,15383,Liver,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11738,Mus musculus,2107.0,CHEMBL618807,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,15383,Liver,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11739,Mus musculus,2107.0,CHEMBL618808,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,15383,Liver,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11740,Mus musculus,2107.0,CHEMBL618809,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,15383,Liver,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11741,Mus musculus,2385.0,CHEMBL618810,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,15383,Muscle tissue,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11742,Mus musculus,2385.0,CHEMBL618811,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,15383,Muscle tissue,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11743,Mus musculus,2385.0,CHEMBL875844,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,15383,Muscle tissue,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11744,Mus musculus,2385.0,CHEMBL618812,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,15383,Muscle tissue,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11745,Mus musculus,2385.0,CHEMBL618813,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,15383,Muscle tissue,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11746,Mus musculus,,CHEMBL618814,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,15383,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11747,Mus musculus,,CHEMBL618815,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,15383,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11748,Mus musculus,,CHEMBL618816,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,15383,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11749,Mus musculus,,CHEMBL618817,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,15383,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11750,Mus musculus,,CHEMBL620544,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,15383,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11751,Rattus norvegicus,,CHEMBL626230,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,In vivo,15341,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11752,Rattus norvegicus,,CHEMBL626231,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,In vivo,15341,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11753,Rattus norvegicus,,CHEMBL626232,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,In vivo,15341,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11754,Canis lupus familiaris,1969.0,CHEMBL626233,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,In vivo,14906,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11755,Rattus norvegicus,1969.0,CHEMBL626234,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,In vivo,14906,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11756,Rattus norvegicus,1969.0,CHEMBL875341,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,In vivo,14906,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11757,Homo sapiens,1969.0,CHEMBL626235,The maximum plasma concentration (100 mg/kg) administered orally in human,In vivo,14215,Plasma,50587,,,BAO_0000218,,Intermediate,,9606.0,N,1,1,
11758,Callithrix,1969.0,CHEMBL626236,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,In vivo,14215,Plasma,22224,,,BAO_0000218,,Autocuration,,9481.0,U,0,1,
11759,Simiiformes,1969.0,CHEMBL626237,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,In vivo,14215,Plasma,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
11760,Canis lupus familiaris,1969.0,CHEMBL626238,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,In vivo,14215,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11761,Homo sapiens,1969.0,CHEMBL622412,The maximum plasma concentration (200 mg/kg) administered orally in human,In vivo,14215,Plasma,50587,,,BAO_0000218,,Intermediate,,9606.0,N,1,1,
11762,Rattus norvegicus,1969.0,CHEMBL623114,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,In vivo,14215,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11763,Callithrix,1969.0,CHEMBL623115,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,In vivo,14215,Plasma,22224,,,BAO_0000218,,Autocuration,,9481.0,U,0,1,
11764,Simiiformes,1969.0,CHEMBL623116,The maximum plasma concentration (25 mg/kg) administered orally in monkey,In vivo,14215,Plasma,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
11765,Canis lupus familiaris,1969.0,CHEMBL623117,The maximum plasma concentration (30 mg/kg) administered orally in dog,In vivo,14215,Plasma,22224,,,BAO_0000218,,Autocuration,,9615.0,U,0,1,
11766,Homo sapiens,1969.0,CHEMBL623118,The maximum plasma concentration (400 mg/kg) administered orally in human,In vivo,14215,Plasma,50587,,,BAO_0000218,,Intermediate,,9606.0,N,1,1,
11767,Rattus norvegicus,1969.0,CHEMBL623119,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,In vivo,14215,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11768,Rattus norvegicus,1969.0,CHEMBL623120,The maximum plasma concentration (50 mg/kg) administered orally in rat,In vivo,14215,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11769,Homo sapiens,1969.0,CHEMBL623286,The maximum plasma concentration (800 mg/kg) administered orally in human,In vivo,14215,Plasma,50587,,,BAO_0000218,,Intermediate,,9606.0,N,1,1,
11770,Rattus norvegicus,1969.0,CHEMBL623287,The maximum plasma concentration was measured on rats,In vivo,14067,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11771,Rattus norvegicus,1969.0,CHEMBL623288,The maximum plasma concentration was measured on rats after oral administration,In vivo,12350,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11772,Rattus norvegicus,1969.0,CHEMBL623289,Plasma drug Cmax in rat (PO dose),In vivo,14813,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11773,,,CHEMBL623290,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,In vivo,12536,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11774,Canis lupus familiaris,1969.0,CHEMBL623291,maximum Plasma concentration in Dog was determined after Peroral administration,In vivo,14169,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11775,Rattus norvegicus,1969.0,CHEMBL623292,maximum Plasma concentration in Rats was determined after Peroral administration,In vivo,14169,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11776,Canis lupus familiaris,1969.0,CHEMBL623293,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,In vivo,15604,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11777,Simiiformes,1969.0,CHEMBL623294,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,In vivo,15604,Plasma,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
11778,Rattus norvegicus,1969.0,CHEMBL623295,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,In vivo,15604,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11779,Mus musculus,,CHEMBL623296,maximum concentration was measured when administered through oral route in mice,In vivo,14387,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11780,Mus musculus,,CHEMBL875349,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,,15115,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11781,Simiiformes,,CHEMBL623297,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,,15115,,22224,,,BAO_0000019,,Autocuration,,314293.0,U,0,1,
11782,Simiiformes,,CHEMBL623298,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,,15115,,22224,,,BAO_0000019,,Autocuration,,314293.0,U,0,1,
11783,Simiiformes,,CHEMBL623299,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,,15115,,22224,,,BAO_0000019,,Autocuration,,314293.0,U,0,1,
11784,Rattus norvegicus,,CHEMBL623300,Pharmacokinetic parameter was evaluated in rats,,16359,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11785,Mus musculus,,CHEMBL623301,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,12829,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11786,Mus musculus,,CHEMBL623302,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,,12829,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11787,Mus musculus,,CHEMBL623303,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,12829,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11788,Mus musculus,,CHEMBL623304,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,,12829,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11789,Mus musculus,,CHEMBL623305,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,,12829,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11790,Rattus norvegicus,1969.0,CHEMBL623306,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,,15137,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11791,Rattus norvegicus,1969.0,CHEMBL623307,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,,15137,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11792,Rattus norvegicus,1969.0,CHEMBL623308,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,,15137,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11793,Mus musculus,1969.0,CHEMBL623309,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,,15137,Plasma,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11794,Mus musculus,,CHEMBL623310,Plasma Concentration after 120 min of oral administration to mice,,13509,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11795,Mus musculus,,CHEMBL623311,Plasma Concentration after 30 min of oral administration to mice,,13509,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11796,Macaca fascicularis,,CHEMBL623312,Plasma Concentration after 60 min of oral administration to mice,,13509,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
11797,Mus musculus,,CHEMBL875350,Plasma Concentration after 60 min of oral administration to mice; Not determined,,13509,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11798,Mus musculus,,CHEMBL628635,Plasma Concentration after 90 min of oral administration to mice,,13509,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11799,Rattus norvegicus,,CHEMBL628636,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,,12064,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11800,Rattus norvegicus,,CHEMBL628637,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,,12064,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11801,Rattus norvegicus,,CHEMBL628058,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,,12064,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11802,Rattus norvegicus,,CHEMBL628059,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,,10677,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11803,Rattus norvegicus,,CHEMBL628060,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,,10677,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11804,,,CHEMBL628061,Distribution in the lung after 15 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11805,,,CHEMBL628062,Distribution in the lung after 30 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11806,,,CHEMBL628063,Distribution in the lung after 5 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11807,,,CHEMBL628064,Distribution in the lung after 60 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11808,,,CHEMBL628065,Distribution in the lung after 90 min of intravenous administration,,8926,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11809,,2385.0,CHEMBL628066,Distribution in the muscle after 120 min of intravenous administration,,8926,Muscle tissue,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11810,,2385.0,CHEMBL628067,Distribution in the muscle after 15 min of intravenous administration,,8926,Muscle tissue,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11811,Mus musculus,2385.0,CHEMBL874646,Distribution in the muscle after 30 min of intravenous administration,,8926,Muscle tissue,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11812,,2385.0,CHEMBL628068,Distribution in the muscle after 5 min of intravenous administration,,8926,Muscle tissue,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11813,,2385.0,CHEMBL628069,Distribution in the muscle after 60 min of intravenous administration,,8926,Muscle tissue,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11814,,2385.0,CHEMBL628070,Distribution in the muscle after 90 min of intravenous administration,,8926,Muscle tissue,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11815,,2106.0,CHEMBL628071,Distribution in the spleen after 120 min of intravenous administration,,8926,Spleen,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11816,,2106.0,CHEMBL628072,Distribution in the spleen after 15 min of intravenous administration,,8926,Spleen,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11817,,2106.0,CHEMBL628073,Distribution in the spleen after 30 min of intravenous administration,,8926,Spleen,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11818,,2106.0,CHEMBL628074,Distribution in the spleen after 5 min of intravenous administration,,8926,Spleen,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11819,,2106.0,CHEMBL628075,Distribution in the spleen after 60 min of intravenous administration,,8926,Spleen,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11820,,2106.0,CHEMBL628076,Distribution in the spleen after 90 min of intravenous administration,,8926,Spleen,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11821,Rattus norvegicus,1235.0,CHEMBL628077,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,,7570,Adrenal cortex,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11822,Rattus norvegicus,178.0,CHEMBL628078,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,,7570,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11823,Rattus norvegicus,2107.0,CHEMBL628079,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,,7570,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11824,Rattus norvegicus,992.0,CHEMBL628080,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,,7570,Female gonad,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11825,Rattus norvegicus,2046.0,CHEMBL628081,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,,7570,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11826,Rattus norvegicus,1235.0,CHEMBL628082,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,,7570,Adrenal cortex,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11827,Rattus norvegicus,178.0,CHEMBL874647,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,,7570,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11828,Rattus norvegicus,2107.0,CHEMBL626406,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,,7570,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11829,Rattus norvegicus,992.0,CHEMBL626407,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,,7570,Female gonad,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11830,Rattus norvegicus,2046.0,CHEMBL626408,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,,7570,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11831,Rattus norvegicus,178.0,CHEMBL626409,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",,8608,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11832,Rattus norvegicus,178.0,CHEMBL626410,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",,8608,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11833,Rattus norvegicus,178.0,CHEMBL626411,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",,8608,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11834,Rattus norvegicus,178.0,CHEMBL626412,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",,8608,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11835,Rattus norvegicus,178.0,CHEMBL626413,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",,8608,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11836,Rattus norvegicus,178.0,CHEMBL626414,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",,8608,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11837,Rattus norvegicus,178.0,CHEMBL626415,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",,8608,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11838,Rattus norvegicus,178.0,CHEMBL626416,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",,8608,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11839,Rattus norvegicus,178.0,CHEMBL627062,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",,8608,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11840,Rattus norvegicus,178.0,CHEMBL627063,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",,8608,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11841,Rattus norvegicus,178.0,CHEMBL627064,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",,8608,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11842,Rattus norvegicus,178.0,CHEMBL627227,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",,8608,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11843,Rattus norvegicus,178.0,CHEMBL627228,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",,8608,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11844,Rattus norvegicus,178.0,CHEMBL627229,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",,8608,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11845,Rattus norvegicus,178.0,CHEMBL625792,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",,8608,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11846,Rattus norvegicus,178.0,CHEMBL625793,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",,8608,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11847,Rattus norvegicus,178.0,CHEMBL625794,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",,8608,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11848,Rattus norvegicus,178.0,CHEMBL625795,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",,8608,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11849,Mus musculus,,CHEMBL625796,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,,13792,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11850,Canis lupus familiaris,,CHEMBL625797,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,,13376,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11851,Canis lupus familiaris,,CHEMBL625798,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,,13376,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
11852,,,CHEMBL875613,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,14380,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11853,,,CHEMBL625799,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,14380,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11854,,,CHEMBL625800,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,,14380,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11855,,,CHEMBL625801,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,14380,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11856,,,CHEMBL625802,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,14380,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11857,,,CHEMBL625803,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,14380,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11858,,,CHEMBL625804,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,,14380,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11859,,,CHEMBL622530,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,,14380,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11860,Mus musculus,,CHEMBL622531,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,,13701,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11861,Mus musculus,,CHEMBL622532,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,13701,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11862,Mus musculus,,CHEMBL623176,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,13701,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11863,Mus musculus,,CHEMBL623177,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,13701,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11864,Mus musculus,,CHEMBL623178,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,13701,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11865,Mus musculus,,CHEMBL623179,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,,13701,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11866,Mus musculus,,CHEMBL623180,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,13701,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11867,Mus musculus,,CHEMBL623181,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,13701,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11868,Mus musculus,,CHEMBL624131,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,13701,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11869,Mus musculus,,CHEMBL624132,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),,13701,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11870,Mus musculus,,CHEMBL624133,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,13701,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11871,Mus musculus,,CHEMBL624846,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,,13701,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11872,Mus musculus,,CHEMBL624847,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,13701,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11873,Mus musculus,,CHEMBL624848,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,13701,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11874,Mus musculus,,CHEMBL625012,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,13701,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11875,Mus musculus,,CHEMBL625013,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,13701,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11876,Mus musculus,,CHEMBL625014,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,,13701,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11877,Mus musculus,,CHEMBL625015,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),,13701,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11878,Mus musculus,,CHEMBL625016,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,13701,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11879,Mus musculus,,CHEMBL625017,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,,13701,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11880,Mus musculus,,CHEMBL625018,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,13701,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11881,Mus musculus,,CHEMBL625019,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),,13701,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11882,Mus musculus,,CHEMBL625020,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),,13701,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11883,Mus musculus,,CHEMBL625021,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,,13701,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11884,Rattus norvegicus,,CHEMBL625022,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,14393,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11885,Mus musculus,,CHEMBL625023,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,,14731,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11886,Macaca fascicularis,,CHEMBL625024,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,,14731,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
11887,Macaca fascicularis,,CHEMBL627626,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,14731,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
11888,,955.0,CHEMBL627627,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,13758,Brain,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11889,,1977.0,CHEMBL627628,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,,13758,Serum,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11890,,955.0,CHEMBL627629,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,13758,Brain,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11891,,1977.0,CHEMBL627630,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,,13758,Serum,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11892,,,CHEMBL627631,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),,16359,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
11893,,,CHEMBL629515,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),,16359,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
11894,Mus musculus,2106.0,CHEMBL629516,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,15383,Spleen,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11895,Mus musculus,2106.0,CHEMBL629517,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,15383,Spleen,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11896,Mus musculus,2106.0,CHEMBL629518,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,15383,Spleen,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11897,Mus musculus,,CHEMBL877499,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,15383,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11898,Mus musculus,,CHEMBL629519,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,15383,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11899,Mus musculus,,CHEMBL629520,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,15383,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11900,Mus musculus,,CHEMBL629521,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,15383,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11901,Mus musculus,,CHEMBL629522,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),,14439,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11902,Mus musculus,,CHEMBL629523,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),,14439,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11903,Mus musculus,,CHEMBL629524,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),,14439,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11904,Mus musculus,,CHEMBL629525,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),,14439,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11905,Mus musculus,,CHEMBL629526,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),,14439,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11906,Mus musculus,,CHEMBL629527,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),,14439,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11907,Mus musculus,,CHEMBL629528,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),,14439,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11908,Mus musculus,,CHEMBL629529,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),,14439,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11909,Mus musculus,,CHEMBL629530,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),,14439,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11910,Mus musculus,,CHEMBL629531,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),,14439,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11911,Mus musculus,,CHEMBL628656,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),,14439,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11912,Mus musculus,,CHEMBL628657,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),,14439,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
11913,Rattus norvegicus,,CHEMBL628658,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",In vivo,13751,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11914,Rattus norvegicus,,CHEMBL628659,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,13751,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11915,Rattus norvegicus,,CHEMBL877500,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,13751,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11916,Rattus norvegicus,,CHEMBL628660,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,13751,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11917,Rattus norvegicus,,CHEMBL628661,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,13751,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11918,Rattus norvegicus,,CHEMBL628662,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,13751,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11919,Rattus norvegicus,,CHEMBL628663,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,13751,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11920,Rattus norvegicus,,CHEMBL628664,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,13751,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11921,Rattus norvegicus,178.0,CHEMBL628665,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,13751,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11922,Rattus norvegicus,178.0,CHEMBL628666,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,13751,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11923,Rattus norvegicus,178.0,CHEMBL628667,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,13751,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11924,Rattus norvegicus,178.0,CHEMBL628668,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,13751,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11925,Rattus norvegicus,178.0,CHEMBL628669,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,13751,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11926,Rattus norvegicus,178.0,CHEMBL628670,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,13751,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11927,Rattus norvegicus,178.0,CHEMBL628671,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,13751,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11928,Rattus norvegicus,10000001.0,CHEMBL628672,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,13751,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11929,Rattus norvegicus,10000001.0,CHEMBL630300,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,13751,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11930,Rattus norvegicus,10000001.0,CHEMBL629787,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,13751,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11931,Rattus norvegicus,10000001.0,CHEMBL629788,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,13751,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11932,Rattus norvegicus,955.0,CHEMBL629789,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,13751,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11933,Rattus norvegicus,955.0,CHEMBL629790,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,13751,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11934,Rattus norvegicus,955.0,CHEMBL629791,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,13751,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11935,Rattus norvegicus,955.0,CHEMBL629792,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,13751,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11936,Rattus norvegicus,955.0,CHEMBL629793,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,13751,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11937,Rattus norvegicus,955.0,CHEMBL629794,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,13751,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11938,Rattus norvegicus,,CHEMBL874459,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,,10677,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11939,Rattus norvegicus,,CHEMBL629795,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,,10677,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11940,Rattus norvegicus,,CHEMBL629796,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,,10677,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11941,Rattus norvegicus,,CHEMBL629797,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,,10677,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11942,Rattus norvegicus,,CHEMBL629798,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,,10677,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11943,Rattus norvegicus,2369.0,CHEMBL629799,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,10911,Adrenal gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11944,Rattus norvegicus,2369.0,CHEMBL629800,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,10911,Adrenal gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11945,Rattus norvegicus,2369.0,CHEMBL629801,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,10911,Adrenal gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11946,Rattus norvegicus,2369.0,CHEMBL629802,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,In vivo,10911,Adrenal gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11947,Rattus norvegicus,2369.0,CHEMBL629803,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,10911,Adrenal gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11948,Rattus norvegicus,178.0,CHEMBL629804,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,10911,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11949,Rattus norvegicus,178.0,CHEMBL629805,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,10911,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11950,Rattus norvegicus,178.0,CHEMBL629806,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,In vivo,10911,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11951,Rattus norvegicus,178.0,CHEMBL629807,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,10911,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11952,Rattus norvegicus,178.0,CHEMBL629808,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,10911,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11953,Rattus norvegicus,955.0,CHEMBL629809,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,10911,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11954,Rattus norvegicus,955.0,CHEMBL629810,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,10911,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11955,Rattus norvegicus,955.0,CHEMBL629811,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,In vivo,10911,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11956,Rattus norvegicus,955.0,CHEMBL629812,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,10911,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11957,Rattus norvegicus,955.0,CHEMBL629813,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,In vivo,10911,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11958,Rattus norvegicus,955.0,CHEMBL874460,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,10911,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11959,Rattus norvegicus,,CHEMBL629814,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,10911,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11960,Rattus norvegicus,,CHEMBL629815,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,10911,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11961,Rattus norvegicus,,CHEMBL629816,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,10911,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11962,Rattus norvegicus,,CHEMBL629817,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,10911,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11963,Rattus norvegicus,2113.0,CHEMBL626643,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,10911,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11964,Rattus norvegicus,2113.0,CHEMBL626644,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,10911,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11965,Rattus norvegicus,2113.0,CHEMBL626806,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,10911,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11966,Rattus norvegicus,2113.0,CHEMBL626807,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,10911,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11967,Rattus norvegicus,2107.0,CHEMBL627261,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,10911,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11968,Rattus norvegicus,2107.0,CHEMBL627262,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,10911,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11969,Rattus norvegicus,2107.0,CHEMBL627263,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,10911,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11970,Rattus norvegicus,2107.0,CHEMBL627264,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,10911,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11971,Rattus norvegicus,2048.0,CHEMBL627265,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,10911,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11972,Rattus norvegicus,2048.0,CHEMBL627266,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,10911,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11973,Rattus norvegicus,2048.0,CHEMBL627267,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,10911,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11974,Rattus norvegicus,2048.0,CHEMBL627268,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,10911,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11975,Rattus norvegicus,2385.0,CHEMBL627269,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,10911,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11976,Rattus norvegicus,2385.0,CHEMBL627270,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,10911,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11977,Rattus norvegicus,,CHEMBL627271,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11978,Rattus norvegicus,,CHEMBL627946,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11979,Rattus norvegicus,,CHEMBL875472,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11980,Rattus norvegicus,,CHEMBL627947,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11981,Rattus norvegicus,,CHEMBL627948,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11982,Rattus norvegicus,,CHEMBL628113,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11983,Rattus norvegicus,,CHEMBL628114,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11984,Rattus norvegicus,,CHEMBL628115,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11985,Rattus norvegicus,,CHEMBL628116,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11986,Rattus norvegicus,,CHEMBL628117,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11987,Rattus norvegicus,,CHEMBL628118,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11988,Rattus norvegicus,,CHEMBL628119,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11989,Rattus norvegicus,,CHEMBL628120,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11990,Rattus norvegicus,,CHEMBL628121,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11991,Rattus norvegicus,,CHEMBL628122,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11992,Rattus norvegicus,,CHEMBL627297,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11993,Rattus norvegicus,,CHEMBL627298,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11994,Rattus norvegicus,,CHEMBL627299,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11995,Rattus norvegicus,,CHEMBL627300,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11996,Rattus norvegicus,,CHEMBL627301,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11997,Rattus norvegicus,,CHEMBL627302,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11998,Rattus norvegicus,,CHEMBL627303,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
11999,Rattus norvegicus,,CHEMBL627304,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12000,Rattus norvegicus,,CHEMBL627305,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12001,Rattus norvegicus,,CHEMBL627306,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12002,Rattus norvegicus,,CHEMBL623982,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12003,Rattus norvegicus,,CHEMBL623983,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12004,Rattus norvegicus,,CHEMBL623984,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12005,Rattus norvegicus,,CHEMBL623985,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12006,Rattus norvegicus,,CHEMBL623986,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12007,Rattus norvegicus,,CHEMBL623987,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12008,Rattus norvegicus,,CHEMBL623988,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12009,Rattus norvegicus,,CHEMBL623989,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12010,Rattus norvegicus,,CHEMBL622215,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12011,Rattus norvegicus,,CHEMBL622216,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12012,Rattus norvegicus,,CHEMBL877481,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",,8608,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12013,,,CHEMBL622217,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),,16359,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12014,Mus musculus,,CHEMBL622218,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,13701,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
12015,Rattus norvegicus,,CHEMBL622219,Pharmacokinetic profile AUC was evaluated in rats,,14554,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12016,,,CHEMBL622220,Pharmacokinetic property (Area under curve),,6241,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12017,Canis lupus familiaris,,CHEMBL622221,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",,11537,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12018,Mus musculus,,CHEMBL622222,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",,11537,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
12019,Canis lupus familiaris,,CHEMBL622223,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",,11537,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12020,Mus musculus,,CHEMBL622224,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",,11537,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
12021,,,CHEMBL622225,Plasma concentration (AUC) was determined,,13118,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12022,,,CHEMBL622226,Plasma concentration (AUC) was determined; Not detectable,,13118,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12023,Cavia porcellus,,CHEMBL624154,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),,9562,,50512,,,BAO_0000218,,Intermediate,,10141.0,N,1,1,
12024,Rattus norvegicus,,CHEMBL624155,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,,10363,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12025,Rattus norvegicus,,CHEMBL624156,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,10363,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12026,Rattus norvegicus,,CHEMBL624157,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,,10363,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12027,Rattus norvegicus,,CHEMBL624158,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,,10363,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12028,Rattus norvegicus,,CHEMBL624159,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,,12504,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12029,Rattus norvegicus,,CHEMBL624160,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,,12504,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12030,Rattus norvegicus,,CHEMBL624161,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,,12504,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12031,Rattus norvegicus,,CHEMBL624162,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,,12504,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12032,Canis lupus familiaris,,CHEMBL624163,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,,13317,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12033,Rattus norvegicus,,CHEMBL624164,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,15078,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12034,Rattus norvegicus,,CHEMBL624165,The AUC(0-infinity) values in female wistar rats.,,14941,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12035,Rattus norvegicus,,CHEMBL624166,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,15078,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12036,Rattus norvegicus,,CHEMBL624167,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",,15078,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12037,Rattus norvegicus,,CHEMBL624168,The AUC(0-t)values in female wistar rats.,,14941,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12038,Rattus norvegicus,,CHEMBL624169,The Area under the concentration time curve of compound was measured on rats,,14067,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12039,Homo sapiens,,CHEMBL624170,The area under curve (100 mg/kg) administered orally in humans,,14215,,50587,,,BAO_0000218,,Intermediate,,9606.0,N,1,1,
12040,Callithrix,,CHEMBL624171,The area under curve (12.5 mg/kg) administered intravenously in marmoset,,14215,,22224,,,BAO_0000218,,Autocuration,,9481.0,U,0,1,
12041,Simiiformes,,CHEMBL624172,The area under curve (12.5 mg/kg) administered intravenously in monkey,,14215,,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
12042,Canis lupus familiaris,,CHEMBL624173,The area under curve (15 mg/kg) administered intravenously in dog,,14215,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12043,Homo sapiens,,CHEMBL877488,The area under curve (200 mg/kg) administered orally in humans,,14215,,50587,,,BAO_0000218,,Intermediate,,9606.0,N,1,1,
12044,Rattus norvegicus,,CHEMBL624174,The area under curve (25 mg/kg) administered intravenously in rat,,14215,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12045,Callithrix,,CHEMBL624175,The area under curve (25 mg/kg) administered orally in marmoset,,14215,,22224,,,BAO_0000218,,Autocuration,,9481.0,U,0,1,
12046,Simiiformes,,CHEMBL624176,The area under curve (25 mg/kg) administered orally in monkey,,14215,,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
12047,Canis lupus familiaris,,CHEMBL624177,The area under curve (30 mg/kg) administered orally in dog,,14215,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12048,Homo sapiens,,CHEMBL624178,The area under curve (400 mg/kg) administered orally in humans,,14215,,50587,,,BAO_0000218,,Intermediate,,9606.0,N,1,1,
12049,Rattus norvegicus,,CHEMBL624179,The area under curve (50 mg/kg) administered orally in fasted rat,,14215,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12050,Rattus norvegicus,,CHEMBL627689,The area under curve (50 mg/kg) administered orally in rat,,14215,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12051,Homo sapiens,,CHEMBL627690,The area under curve (800 mg/kg) administered orally in humans,,14215,,50587,,,BAO_0000218,,Intermediate,,9606.0,N,1,1,
12052,,,CHEMBL627691,The compound was evaluated for area under the curve,,11324,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12053,Callithrix,,CHEMBL627692,The compound was evaluated for area under the curve in marmosets,,11324,,22224,,,BAO_0000019,,Autocuration,,9481.0,U,0,1,
12054,Callithrix,,CHEMBL627693,The compound was evaluated for area under the curve in marmosets,,11324,,22224,,,BAO_0000019,,Autocuration,,9481.0,U,0,1,
12055,Rattus norvegicus,,CHEMBL627694,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,13875,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12056,Rattus norvegicus,,CHEMBL627695,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,,13875,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12057,,,CHEMBL627696,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),,13875,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12058,Rattus norvegicus,,CHEMBL627697,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,13875,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12059,Rattus norvegicus,,CHEMBL627698,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,13875,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12060,Rattus norvegicus,,CHEMBL627699,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,,13875,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12061,Rattus norvegicus,,CHEMBL627700,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,,13807,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12062,Rattus norvegicus,,CHEMBL627701,Total drug exposure is determined after oral dosing in rats.,,14127,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12063,,,CHEMBL627702,Total drug exposure (5 mg/kg) when administered intravenously,,15116,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12064,,,CHEMBL627703,Total drug exposure (5 mg/kg) when administered orally,,15116,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12065,Simiiformes,,CHEMBL626873,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,15604,,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
12066,Rattus norvegicus,,CHEMBL629583,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,15604,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12067,Canis lupus familiaris,,CHEMBL629584,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,15604,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12068,Canis lupus familiaris,,CHEMBL629585,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,15604,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12069,Rattus norvegicus,955.0,CHEMBL629586,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,13751,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12070,Rattus norvegicus,955.0,CHEMBL629587,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,13751,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12071,Rattus norvegicus,,CHEMBL629588,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,13751,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12072,Rattus norvegicus,,CHEMBL629589,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,13751,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12073,Rattus norvegicus,,CHEMBL629590,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,13751,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12074,Rattus norvegicus,,CHEMBL629591,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,13751,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12075,Rattus norvegicus,,CHEMBL629592,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,13751,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12076,Rattus norvegicus,,CHEMBL629593,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,13751,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12077,Rattus norvegicus,,CHEMBL629594,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,13751,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12078,Rattus norvegicus,948.0,CHEMBL629595,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,13751,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12079,Rattus norvegicus,948.0,CHEMBL630290,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,13751,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12080,Rattus norvegicus,948.0,CHEMBL627137,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,13751,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12081,Rattus norvegicus,948.0,CHEMBL627138,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,13751,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12082,Rattus norvegicus,948.0,CHEMBL627139,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,13751,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12083,Rattus norvegicus,948.0,CHEMBL627140,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,13751,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12084,Rattus norvegicus,948.0,CHEMBL627141,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,13751,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12085,Rattus norvegicus,2113.0,CHEMBL627142,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,13751,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12086,Rattus norvegicus,2113.0,CHEMBL627143,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,13751,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12087,Rattus norvegicus,2113.0,CHEMBL874449,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,13751,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12088,Rattus norvegicus,2113.0,CHEMBL627144,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,13751,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12089,Rattus norvegicus,2113.0,CHEMBL627145,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,13751,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12090,Rattus norvegicus,2113.0,CHEMBL627146,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,13751,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12091,Rattus norvegicus,2113.0,CHEMBL627147,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,13751,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12092,Rattus norvegicus,2107.0,CHEMBL627148,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,13751,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12093,Rattus norvegicus,2048.0,CHEMBL627149,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,13751,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12094,Rattus norvegicus,2048.0,CHEMBL632160,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,13751,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12095,Rattus norvegicus,2048.0,CHEMBL632161,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,13751,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12096,Rattus norvegicus,2048.0,CHEMBL632162,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,13751,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12097,Rattus norvegicus,2048.0,CHEMBL632163,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,13751,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12098,Rattus norvegicus,2048.0,CHEMBL874469,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,13751,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12099,Rattus norvegicus,2048.0,CHEMBL627182,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,13751,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12100,Rattus norvegicus,2385.0,CHEMBL627183,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",In vivo,13751,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12101,Rattus norvegicus,2385.0,CHEMBL627184,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,13751,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12102,Rattus norvegicus,2385.0,CHEMBL627185,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,13751,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12103,Rattus norvegicus,2385.0,CHEMBL627186,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,13751,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12104,Rattus norvegicus,2385.0,CHEMBL627187,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,13751,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12105,Rattus norvegicus,2385.0,CHEMBL627188,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,13751,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12106,Rattus norvegicus,2385.0,CHEMBL627189,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,13751,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12107,Rattus norvegicus,,CHEMBL627190,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,13751,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12108,Rattus norvegicus,2107.0,CHEMBL627191,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",In vivo,13751,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12109,Rattus norvegicus,2107.0,CHEMBL627192,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",In vivo,13751,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12110,Rattus norvegicus,2107.0,CHEMBL627193,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",In vivo,13751,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12111,Rattus norvegicus,2385.0,CHEMBL874590,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,In vivo,10911,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12112,Rattus norvegicus,2385.0,CHEMBL627194,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,10911,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12113,Rattus norvegicus,2385.0,CHEMBL627195,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,10911,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12114,Rattus norvegicus,992.0,CHEMBL627196,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,10911,Female gonad,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12115,Rattus norvegicus,992.0,CHEMBL627197,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,10911,Female gonad,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12116,Rattus norvegicus,992.0,CHEMBL627198,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,10911,Female gonad,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12117,Rattus norvegicus,992.0,CHEMBL627199,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,In vivo,10911,Female gonad,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12118,Rattus norvegicus,992.0,CHEMBL627200,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,10911,Female gonad,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12119,Rattus norvegicus,1969.0,CHEMBL627201,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,10911,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12120,Rattus norvegicus,1969.0,CHEMBL627202,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,10911,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12121,Rattus norvegicus,1969.0,CHEMBL627203,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,10911,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12122,Rattus norvegicus,1969.0,CHEMBL627204,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,10911,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12123,Rattus norvegicus,2106.0,CHEMBL627205,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,10911,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12124,Rattus norvegicus,2106.0,CHEMBL627206,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,10911,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12125,Rattus norvegicus,2106.0,CHEMBL627207,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,10911,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12126,Rattus norvegicus,2106.0,CHEMBL627208,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,10911,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12127,Rattus norvegicus,2046.0,CHEMBL627209,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,10911,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12128,Rattus norvegicus,2046.0,CHEMBL627210,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,10911,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12129,Rattus norvegicus,2046.0,CHEMBL627211,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,10911,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12130,Rattus norvegicus,2046.0,CHEMBL627212,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,10911,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12131,Rattus norvegicus,995.0,CHEMBL627213,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,In vivo,10911,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12132,Rattus norvegicus,995.0,CHEMBL626599,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,In vivo,10911,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12133,Rattus norvegicus,995.0,CHEMBL626600,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,In vivo,10911,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12134,Rattus norvegicus,995.0,CHEMBL626601,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,In vivo,10911,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12135,,,CHEMBL627484,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,,8081,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12136,Macaca fascicularis,1969.0,CHEMBL627485,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),,17248,Plasma,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
12137,Macaca fascicularis,1969.0,CHEMBL628147,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,,17248,Plasma,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
12138,Macaca fascicularis,1969.0,CHEMBL628148,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,,17248,Plasma,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
12139,Canis lupus familiaris,1969.0,CHEMBL628149,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),,17248,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12140,Canis lupus familiaris,1969.0,CHEMBL628150,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,,17248,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12141,Canis lupus familiaris,1969.0,CHEMBL628318,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,,17248,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12142,Canis lupus familiaris,1969.0,CHEMBL628319,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,,17248,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12143,Canis lupus familiaris,,CHEMBL875609,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,15592,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12144,,,CHEMBL628320,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,,7040,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12145,,,CHEMBL628321,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,,7040,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12146,,,CHEMBL628322,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,,7040,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12147,,,CHEMBL628323,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,,7040,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12148,,,CHEMBL628324,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,,7040,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12149,,,CHEMBL628325,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,,7040,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12150,,,CHEMBL628326,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,,7040,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12151,Canis lupus familiaris,1236.0,CHEMBL628327,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",,9614,Adrenal medulla,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12152,Canis lupus familiaris,1236.0,CHEMBL628328,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",,9614,Adrenal medulla,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12153,Canis lupus familiaris,178.0,CHEMBL628329,"Concentration of compound in blood of dog 1, after administering intravenously",,9614,Blood,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12154,Rattus norvegicus,2107.0,CHEMBL628330,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",,8608,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12155,Rattus norvegicus,2107.0,CHEMBL628331,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",,8608,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12156,Rattus norvegicus,2107.0,CHEMBL628332,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",,8608,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12157,Rattus norvegicus,2107.0,CHEMBL628333,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",,8608,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12158,Rattus norvegicus,2107.0,CHEMBL628334,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",,8608,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12159,Rattus norvegicus,2107.0,CHEMBL628335,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",,8608,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12160,Rattus norvegicus,2107.0,CHEMBL628336,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",,8608,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12161,Rattus norvegicus,2107.0,CHEMBL628337,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,8608,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12162,Rattus norvegicus,2107.0,CHEMBL628338,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",,8608,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12163,Rattus norvegicus,2107.0,CHEMBL875610,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",,8608,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12164,Rattus norvegicus,2107.0,CHEMBL628339,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",,8608,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12165,Rattus norvegicus,2107.0,CHEMBL628340,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",,8608,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12166,Rattus norvegicus,2107.0,CHEMBL628341,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",,8608,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12167,Rattus norvegicus,2107.0,CHEMBL622214,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",,8608,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12168,Rattus norvegicus,2107.0,CHEMBL623167,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",,8608,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12169,Rattus norvegicus,2107.0,CHEMBL623168,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",,8608,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12170,Rattus norvegicus,2107.0,CHEMBL623169,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",,8608,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12171,Rattus norvegicus,2107.0,CHEMBL623170,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",,8608,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12172,Rattus norvegicus,2048.0,CHEMBL627224,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",,8608,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12173,Rattus norvegicus,2048.0,CHEMBL875634,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",,8608,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12174,Rattus norvegicus,2048.0,CHEMBL627225,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",,8608,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12175,Rattus norvegicus,2048.0,CHEMBL627226,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",,8608,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12176,Rattus norvegicus,2048.0,CHEMBL626083,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",,8608,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12177,Rattus norvegicus,2048.0,CHEMBL626084,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",,8608,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12178,Rattus norvegicus,2048.0,CHEMBL626085,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",,8608,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12179,Rattus norvegicus,2048.0,CHEMBL626086,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",,8608,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12180,Rattus norvegicus,2048.0,CHEMBL626087,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",,8608,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12181,Rattus norvegicus,2048.0,CHEMBL626088,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",,8608,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12182,Rattus norvegicus,2048.0,CHEMBL626089,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",,8608,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12183,Rattus norvegicus,2048.0,CHEMBL626090,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",,8608,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12184,Rattus norvegicus,2048.0,CHEMBL626091,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",,8608,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12185,Rattus norvegicus,2048.0,CHEMBL626092,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",,8608,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12186,Rattus norvegicus,2048.0,CHEMBL626093,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",,8608,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12187,Rattus norvegicus,2048.0,CHEMBL626094,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",,8608,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12188,Rattus norvegicus,2048.0,CHEMBL626095,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",,8608,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12189,Rattus norvegicus,2048.0,CHEMBL626096,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",,8608,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12190,Simiiformes,,CHEMBL626097,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,15604,,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
12191,Rattus norvegicus,,CHEMBL626098,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,15604,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12192,,1969.0,CHEMBL626099,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,,1806,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12193,,1969.0,CHEMBL626100,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,,1806,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12194,Canis lupus familiaris,1969.0,CHEMBL626101,AUC 0-inf in dog,,17237,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12195,Cavia porcellus,1969.0,CHEMBL626102,AUC 0-inf in guinea pig,,17237,Plasma,50512,,,BAO_0000218,,Intermediate,,10141.0,N,1,1,
12196,Canis lupus familiaris,1969.0,CHEMBL626103,AUC 0-t in dog,,17237,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12197,Cavia porcellus,1969.0,CHEMBL628391,AUC 0-t in guinea pig,,17237,Plasma,50512,,,BAO_0000218,,Intermediate,,10141.0,N,1,1,
12198,Rattus norvegicus,,CHEMBL628392,The compound was tested for brain to plasma partition in rat,,15194,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12199,Rattus norvegicus,,CHEMBL628393,The compound was tested for brain to plasma partition in rat.,,15194,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12200,,178.0,CHEMBL628394,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,,8787,Blood,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12201,Canis lupus familiaris,,CHEMBL628395,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,,17025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12202,Simiiformes,,CHEMBL628396,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,,17025,,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
12203,Oryctolagus cuniculus,,CHEMBL628397,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,,17025,,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12204,Rattus norvegicus,,CHEMBL628398,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,,17025,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12205,Macaca mulatta,,CHEMBL628399,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,,4236,,50797,,,BAO_0000218,,Intermediate,,9544.0,N,1,1,
12206,Canis lupus familiaris,,CHEMBL628400,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,,15343,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12207,Rattus norvegicus,,CHEMBL874907,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,,15343,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12208,,,CHEMBL628401,Area under curve of the compound was determined,,17720,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12209,Simiiformes,1969.0,CHEMBL628402,AUC in monkeys at a dose of 1 mg/kg,,17788,Plasma,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
12210,Rattus norvegicus,1969.0,CHEMBL628403,AUC in rats at a dose of 1 mg/kg,,17788,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12211,,,CHEMBL628404,Compound was evaluated for the overall absorbance loss at pH of 2,,8778,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12212,,,CHEMBL628405,Compound was evaluated for the overall absorbance loss at pH of 4,,8778,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12213,,,CHEMBL628406,Compound was evaluated for the overall absorbance loss at pH of 7,,8778,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12214,Rattus norvegicus,,CHEMBL628407,Compound was evaluated for its absorption in the rats,,2249,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12215,Rattus norvegicus,1088.0,CHEMBL628408,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,8881,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12216,Rattus norvegicus,1088.0,CHEMBL629171,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,,8881,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12217,Rattus norvegicus,1088.0,CHEMBL629172,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,8881,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12218,Rattus norvegicus,1088.0,CHEMBL629173,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,,8881,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12219,Rattus norvegicus,,CHEMBL629174,In vitro percent permeability into rat ileum,,15286,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12220,Rattus norvegicus,,CHEMBL629175,In vitro percent permeability into rat ileum; Range is 10-17,,15286,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12221,Rattus norvegicus,,CHEMBL629176,In vitro percent permeability into rat ileum; Range is 10-18,,15286,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12222,Rattus norvegicus,,CHEMBL629177,In vitro percent permeability into rat ileum; Range is 10-19,,15286,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12223,Rattus norvegicus,,CHEMBL629178,In vitro percent permeability into rat ileum; Range is 12-15,,15286,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12224,Rattus norvegicus,,CHEMBL631869,In vitro percent permeability into rat ileum; Range is 13-19,,15286,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12225,Rattus norvegicus,,CHEMBL631870,In vitro percent permeability into rat ileum; Range is 14-17,,15286,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12226,Rattus norvegicus,,CHEMBL631871,In vitro percent permeability into rat ileum; Range is 15-18,,15286,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12227,Rattus norvegicus,,CHEMBL631872,In vitro percent permeability into rat ileum; Range is 2-5,,15286,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12228,,2116.0,CHEMBL875775,In vitro percent permeability into rat ileum; Range is 23-42,,15286,Ileum,22224,,,BAO_0000221,,Autocuration,,,U,0,1,
12229,Rattus norvegicus,,CHEMBL631873,In vitro percent permeability into rat ileum; Range is 28-36,,15286,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12230,Rattus norvegicus,,CHEMBL631874,In vitro percent permeability into rat ileum; Range is 29-35,,15286,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12231,Rattus norvegicus,,CHEMBL631875,In vitro percent permeability into rat ileum; Range is 46-66,,15286,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12232,Rattus norvegicus,,CHEMBL631876,In vitro percent permeability into rat ileum; Range is 50-68,,15286,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12233,Rattus norvegicus,,CHEMBL631877,In vitro percent permeability into rat ileum; Range is 78-81,,15286,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12234,Rattus norvegicus,,CHEMBL631878,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,,15286,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12235,Rattus norvegicus,,CHEMBL631879,In vitro percent permeability into rat ileum; nd indicates not detected,,15286,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12236,Rattus norvegicus,,CHEMBL631880,In vitro percent permeability into rat ileum; nt indicates not detected,,15286,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12237,Rattus norvegicus,,CHEMBL631881,In vitro percent permeability into rat ileum; nt indicates not tested,,15286,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12238,Rattus norvegicus,,CHEMBL631882,Compound was tested for oral absorption in bile-duct cannulated rats,,13770,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12239,Rattus norvegicus,,CHEMBL630749,Compound was tested for oral absorption in bile-duct cannulated rats.,,13770,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12240,Homo sapiens,,CHEMBL630750,Oral absorption using Caco-2 cell monolayers.,,5202,,50587,,,BAO_0000218,,Intermediate,,9606.0,N,1,1,
12241,Homo sapiens,,CHEMBL630253,Percent of the drug absorbed after administration to humans was determined,,14920,,50587,,,BAO_0000218,,Intermediate,,9606.0,N,1,1,
12242,Rattus norvegicus,1969.0,CHEMBL630254,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,14103,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12243,Rattus norvegicus,1969.0,CHEMBL630255,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,14103,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12244,Rattus norvegicus,1969.0,CHEMBL630256,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,14103,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12245,Rattus norvegicus,2107.0,CHEMBL875781,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",In vivo,13751,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12246,Rattus norvegicus,2107.0,CHEMBL630257,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",In vivo,13751,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12247,Rattus norvegicus,2107.0,CHEMBL630258,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",In vivo,13751,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12248,Rattus norvegicus,,CHEMBL630259,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",,15807,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12249,Rattus norvegicus,2435.0,CHEMBL630260,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",,15807,Striatum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12250,Rattus norvegicus,2435.0,CHEMBL630261,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",,15807,Striatum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12251,Rattus norvegicus,,CHEMBL630262,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,,14950,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12252,Rattus norvegicus,,CHEMBL630263,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,,14950,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12253,Rattus norvegicus,,CHEMBL630264,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,,14950,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12254,Rattus norvegicus,,CHEMBL630265,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,,14950,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12255,Rattus norvegicus,,CHEMBL630266,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,,14950,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12256,Rattus norvegicus,2113.0,CHEMBL630267,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,,14950,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12257,Rattus norvegicus,2113.0,CHEMBL630268,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,,14950,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12258,Rattus norvegicus,,CHEMBL630269,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,,14950,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12259,Rattus norvegicus,,CHEMBL630270,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,,14950,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12260,Rattus norvegicus,2048.0,CHEMBL630141,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,,14950,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12261,Rattus norvegicus,2048.0,CHEMBL630142,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,,14950,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12262,Rattus norvegicus,2385.0,CHEMBL630143,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,,14950,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12263,Rattus norvegicus,2385.0,CHEMBL630144,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,,14950,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12264,Rattus norvegicus,2367.0,CHEMBL630145,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,,14950,Prostate gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12265,Rattus norvegicus,2367.0,CHEMBL630146,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,,14950,Prostate gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12266,Rattus norvegicus,,CHEMBL630147,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,,14950,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12267,Rattus norvegicus,,CHEMBL630148,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,,14950,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12268,Rattus norvegicus,,CHEMBL630149,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,,14950,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12269,Rattus norvegicus,2106.0,CHEMBL630150,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,,14950,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12270,Rattus norvegicus,2106.0,CHEMBL630151,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,,14950,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12271,Rattus norvegicus,2046.0,CHEMBL632031,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,,14950,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12272,Rattus norvegicus,2046.0,CHEMBL632032,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,,14950,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12273,Rattus norvegicus,,CHEMBL632033,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,,14950,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12274,Rattus norvegicus,,CHEMBL632034,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,,14950,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12275,Rattus norvegicus,2385.0,CHEMBL632035,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,,14950,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12276,Rattus norvegicus,,CHEMBL632036,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,,14950,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12277,Rattus norvegicus,2046.0,CHEMBL632037,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,,14950,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12278,Rattus norvegicus,178.0,CHEMBL632038,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,8631,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12279,Rattus norvegicus,178.0,CHEMBL632039,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,8631,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12280,Rattus norvegicus,178.0,CHEMBL632040,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,8631,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12281,Rattus norvegicus,178.0,CHEMBL632041,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,8631,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12282,Canis lupus familiaris,178.0,CHEMBL632042,"Concentration of compound in blood of dog 2, after administering intravenously",,9614,Blood,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12283,Canis lupus familiaris,,CHEMBL632043,"Concentration of compound in left ventricle of dog 1, after administering intravenously",,9614,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12284,Canis lupus familiaris,,CHEMBL632044,"Concentration of compound in left ventricle of dog 2, after administering intravenously",,9614,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12285,Canis lupus familiaris,2107.0,CHEMBL632045,"Concentration of compound in liver of dog 1, after administering intravenously",,9614,Liver,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12286,Canis lupus familiaris,2107.0,CHEMBL632046,"Concentration of compound in liver of dog 2, after administering intravenously",,9614,Liver,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12287,Canis lupus familiaris,2048.0,CHEMBL632047,"Concentration of compound in lung of dog 1, after administering intravenously",,9614,Lung,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12288,Canis lupus familiaris,2048.0,CHEMBL632048,"Concentration of compound in lung of dog 2, after administering intravenously",,9614,Lung,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12289,Canis lupus familiaris,2385.0,CHEMBL632049,"Concentration of compound in muscle of dog 1, after administering intravenously",,9614,Muscle tissue,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12290,Canis lupus familiaris,2385.0,CHEMBL876418,"Concentration of compound in muscle of dog 2, after administering intravenously",,9614,Muscle tissue,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12291,Canis lupus familiaris,2106.0,CHEMBL632050,"Concentration of compound in spleen of dog 1,after administering intravenously",,9614,Spleen,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12292,Canis lupus familiaris,2106.0,CHEMBL632051,"Concentration of compound in spleen of dog 2, after administering intravenously",,9614,Spleen,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12293,,,CHEMBL632052,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,,10353,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12294,,,CHEMBL632053,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,,10353,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12295,,,CHEMBL632054,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,10353,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12296,,,CHEMBL632055,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,10353,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12297,,,CHEMBL631181,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,,10353,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12298,,,CHEMBL631182,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12299,,,CHEMBL631183,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12300,,,CHEMBL631184,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12301,,,CHEMBL629774,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12302,,,CHEMBL629775,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12303,,,CHEMBL876549,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12304,,,CHEMBL628172,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12305,,,CHEMBL628173,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12306,,,CHEMBL628174,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12307,,,CHEMBL628175,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12308,,,CHEMBL628176,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12309,,,CHEMBL628177,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12310,,,CHEMBL628178,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12311,,,CHEMBL628179,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12312,,,CHEMBL628180,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12313,,,CHEMBL628181,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12314,,,CHEMBL628182,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12315,,,CHEMBL628183,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12316,,,CHEMBL628184,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12317,,,CHEMBL628185,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12318,,,CHEMBL875617,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12319,,,CHEMBL628186,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12320,,,CHEMBL628187,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12321,,,CHEMBL628188,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12322,,,CHEMBL628189,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12323,,,CHEMBL628190,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12324,,,CHEMBL628191,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12325,,,CHEMBL626513,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12326,Rattus norvegicus,2046.0,CHEMBL626514,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",,8608,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12327,Rattus norvegicus,2046.0,CHEMBL626515,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",,8608,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12328,Rattus norvegicus,2046.0,CHEMBL626516,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",,8608,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12329,Rattus norvegicus,2046.0,CHEMBL626517,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",,8608,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12330,Rattus norvegicus,2046.0,CHEMBL626518,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",,8608,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12331,Rattus norvegicus,2046.0,CHEMBL626519,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",,8608,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12332,Rattus norvegicus,2046.0,CHEMBL626520,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",,8608,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12333,Rattus norvegicus,2046.0,CHEMBL626521,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",,8608,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12334,Rattus norvegicus,2046.0,CHEMBL626522,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",,8608,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12335,Rattus norvegicus,2046.0,CHEMBL626523,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",,8608,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12336,Rattus norvegicus,2046.0,CHEMBL626524,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",,8608,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12337,Rattus norvegicus,2046.0,CHEMBL626688,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",,8608,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12338,Rattus norvegicus,2046.0,CHEMBL626689,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",,8608,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12339,Rattus norvegicus,2046.0,CHEMBL626690,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",,8608,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12340,Rattus norvegicus,2046.0,CHEMBL626691,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",,8608,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12341,Rattus norvegicus,2046.0,CHEMBL627319,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",,8608,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12342,Rattus norvegicus,2046.0,CHEMBL624052,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",,8608,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12343,Rattus norvegicus,2046.0,CHEMBL624053,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",,8608,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12344,Rattus norvegicus,,CHEMBL624054,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,8085,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12345,Rattus norvegicus,,CHEMBL624055,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,8085,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12346,Rattus norvegicus,,CHEMBL624056,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,8085,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12347,Rattus norvegicus,995.0,CHEMBL624057,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,8085,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12348,Rattus norvegicus,995.0,CHEMBL622281,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,8085,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12349,Rattus norvegicus,995.0,CHEMBL622282,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,8085,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12350,Rattus norvegicus,995.0,CHEMBL622283,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,8085,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12351,Rattus norvegicus,995.0,CHEMBL622284,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,8085,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12352,Rattus norvegicus,995.0,CHEMBL622285,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,8085,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12353,Rattus norvegicus,995.0,CHEMBL622286,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,8085,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12354,,,CHEMBL622287,Distribution coefficient (D %) between octanol and buffer of pH 7.4,,7657,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
12355,Mus musculus,,CHEMBL622288,Partition coefficient (logD7.4),,8935,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
12356,Mus musculus,,CHEMBL622289,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,13792,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
12357,Mus musculus,955.0,CHEMBL622290,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,13792,Brain,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
12358,Mus musculus,,CHEMBL622291,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,13792,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
12359,Mus musculus,955.0,CHEMBL622292,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,13792,Brain,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
12360,Mus musculus,,CHEMBL622293,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,13792,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
12361,Mus musculus,955.0,CHEMBL622294,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,13792,Brain,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
12362,Mus musculus,,CHEMBL622295,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,13792,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
12363,Rattus norvegicus,955.0,CHEMBL622296,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,13792,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12364,Rattus norvegicus,1969.0,CHEMBL874409,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,,14103,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12365,Rattus norvegicus,1969.0,CHEMBL622297,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,14103,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12366,Rattus norvegicus,1969.0,CHEMBL622298,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,14103,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12367,Rattus norvegicus,1969.0,CHEMBL622299,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,14103,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12368,Rattus norvegicus,1969.0,CHEMBL622300,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,14103,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12369,Rattus norvegicus,1969.0,CHEMBL622301,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,14103,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12370,Rattus norvegicus,1969.0,CHEMBL622302,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,14103,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12371,Rattus norvegicus,1969.0,CHEMBL622303,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,14103,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12372,Rattus norvegicus,1969.0,CHEMBL622304,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,14103,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12373,Rattus norvegicus,1969.0,CHEMBL622305,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,,14103,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12374,Rattus norvegicus,1969.0,CHEMBL622306,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,14103,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12375,Rattus norvegicus,1969.0,CHEMBL626864,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,,14103,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12376,Rattus norvegicus,1969.0,CHEMBL626865,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,14103,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12377,Rattus norvegicus,1969.0,CHEMBL626866,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,,14103,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12378,Rattus norvegicus,1969.0,CHEMBL626867,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,14103,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12379,Rattus norvegicus,1969.0,CHEMBL626868,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,14103,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12380,Rattus norvegicus,1969.0,CHEMBL626869,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,,14103,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12381,Rattus norvegicus,1969.0,CHEMBL626870,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,14103,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12382,Rattus norvegicus,1969.0,CHEMBL626871,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,,14103,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12383,Rattus norvegicus,1969.0,CHEMBL626872,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,14103,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12384,Rattus norvegicus,1969.0,CHEMBL632185,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,14103,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12385,Rattus norvegicus,1969.0,CHEMBL632186,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,,14103,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12386,,,CHEMBL629310,Amount of acetic acid produced by the compound,,12904,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12387,,,CHEMBL629311,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,,12904,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12388,Rattus norvegicus,,CHEMBL629312,Log of (Cbrain/Cblood) in rats,,9663,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12389,,,CHEMBL629313,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),,7652,,22224,,,BAO_0000221,,Autocuration,,,U,0,1,
12390,,,CHEMBL629314,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,7652,,22224,,,BAO_0000221,,Autocuration,,,U,0,1,
12391,,,CHEMBL629315,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),,7652,,22224,,,BAO_0000221,,Autocuration,,,U,0,1,
12392,,,CHEMBL629316,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),,7652,,22224,,,BAO_0000219,,Autocuration,,,U,0,1,
12393,,,CHEMBL629317,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,7652,,22224,,,BAO_0000221,,Autocuration,,,U,0,1,
12394,,,CHEMBL629318,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),,7652,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12395,,,CHEMBL877497,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),,7652,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12396,,,CHEMBL629319,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),,7652,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12397,,,CHEMBL629320,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,7652,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12398,,,CHEMBL629496,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),,7652,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12399,,,CHEMBL629497,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),,7652,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12400,,,CHEMBL629498,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),,7652,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12401,,,CHEMBL629499,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),,7652,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12402,,,CHEMBL629500,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),,7652,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12403,,,CHEMBL629501,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),,7652,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12404,,,CHEMBL629502,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),,7652,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12405,,,CHEMBL629503,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,In vivo,8267,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12406,Canis lupus familiaris,,CHEMBL629504,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,,8267,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12407,,,CHEMBL629505,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,,14479,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12408,,,CHEMBL629506,Compound was evaluated for total body clearance,,17515,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12409,,,CHEMBL629507,Compound was evaluated for volume of distribution at steady state,,17515,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12410,,,CHEMBL877498,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,,8142,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12411,,,CHEMBL629508,Percentage of the diamine which is monoprotonated at pH 7.4,,14849,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12412,,,CHEMBL629509,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,,7653,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12413,Rattus norvegicus,178.0,CHEMBL629510,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,8631,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12414,Rattus norvegicus,178.0,CHEMBL629511,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,8631,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12415,Rattus norvegicus,178.0,CHEMBL629512,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,8631,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12416,Rattus norvegicus,178.0,CHEMBL629513,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,8631,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12417,Rattus norvegicus,178.0,CHEMBL629514,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,8631,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12418,Rattus norvegicus,178.0,CHEMBL628447,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,8631,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12419,Rattus norvegicus,178.0,CHEMBL628448,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,8631,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12420,Rattus norvegicus,178.0,CHEMBL628449,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,8631,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12421,Rattus norvegicus,178.0,CHEMBL631119,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,8631,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12422,Rattus norvegicus,178.0,CHEMBL631120,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,8631,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12423,Rattus norvegicus,178.0,CHEMBL631121,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,8631,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12424,Rattus norvegicus,178.0,CHEMBL874458,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,,8631,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12425,Rattus norvegicus,178.0,CHEMBL631122,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,8631,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12426,Rattus norvegicus,178.0,CHEMBL631123,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,8631,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12427,Rattus norvegicus,178.0,CHEMBL631124,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,8631,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12428,Rattus norvegicus,178.0,CHEMBL631125,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,8631,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12429,Rattus norvegicus,178.0,CHEMBL631290,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,8631,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12430,Rattus norvegicus,178.0,CHEMBL631291,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,8631,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12431,Rattus norvegicus,178.0,CHEMBL631292,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,8631,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12432,Rattus norvegicus,178.0,CHEMBL631293,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,8631,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12433,Rattus norvegicus,178.0,CHEMBL631294,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,8631,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12434,Rattus norvegicus,178.0,CHEMBL631295,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,8631,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12435,Rattus norvegicus,178.0,CHEMBL631296,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,8631,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12436,Rattus norvegicus,178.0,CHEMBL631297,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,8631,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12437,,,CHEMBL631298,Maximum biodistribution (Bmax) was determined.,,10263,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12438,Mus musculus,,CHEMBL631299,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,,12364,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
12439,Mus musculus,,CHEMBL631300,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,,12364,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
12440,Mus musculus,,CHEMBL631301,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,,12364,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
12441,Mus musculus,,CHEMBL630291,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,,12364,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
12442,,,CHEMBL630292,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,,14793,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12443,,,CHEMBL630293,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,,14793,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12444,,,CHEMBL630294,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,,14793,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12445,,,CHEMBL630295,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,,14793,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12446,,,CHEMBL630296,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,,14793,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12447,,,CHEMBL626782,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,,14793,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12448,,,CHEMBL626783,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,,14793,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12449,,,CHEMBL626784,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,,14793,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12450,,,CHEMBL626785,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,,14793,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12451,,,CHEMBL626786,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,,14793,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12452,,,CHEMBL626787,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12453,,,CHEMBL626788,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12454,,,CHEMBL625927,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12455,Rattus norvegicus,178.0,CHEMBL625928,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12456,Rattus norvegicus,178.0,CHEMBL625929,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12457,Rattus norvegicus,178.0,CHEMBL625930,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12458,Rattus norvegicus,178.0,CHEMBL625931,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12459,Rattus norvegicus,178.0,CHEMBL627230,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12460,Rattus norvegicus,178.0,CHEMBL627231,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12461,Rattus norvegicus,178.0,CHEMBL627232,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12462,Rattus norvegicus,178.0,CHEMBL627233,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12463,Rattus norvegicus,178.0,CHEMBL875470,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12464,Rattus norvegicus,178.0,CHEMBL627234,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12465,Rattus norvegicus,178.0,CHEMBL627235,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12466,Rattus norvegicus,178.0,CHEMBL627236,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12467,Rattus norvegicus,178.0,CHEMBL627237,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12468,Rattus norvegicus,178.0,CHEMBL627238,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12469,Rattus norvegicus,178.0,CHEMBL627239,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12470,Rattus norvegicus,178.0,CHEMBL627240,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12471,Rattus norvegicus,178.0,CHEMBL627241,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12472,Rattus norvegicus,178.0,CHEMBL627242,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12473,Rattus norvegicus,178.0,CHEMBL627243,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12474,Rattus norvegicus,178.0,CHEMBL627244,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12475,Rattus norvegicus,178.0,CHEMBL627245,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12476,Rattus norvegicus,178.0,CHEMBL627246,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12477,Rattus norvegicus,178.0,CHEMBL627247,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12478,Rattus norvegicus,178.0,CHEMBL627248,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12479,Rattus norvegicus,178.0,CHEMBL627249,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12480,Rattus norvegicus,178.0,CHEMBL625569,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12481,Rattus norvegicus,178.0,CHEMBL625570,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12482,Rattus norvegicus,178.0,CHEMBL625571,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12483,Rattus norvegicus,178.0,CHEMBL625572,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12484,Rattus norvegicus,178.0,CHEMBL625573,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12485,Rattus norvegicus,178.0,CHEMBL625574,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12486,Rattus norvegicus,178.0,CHEMBL626245,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12487,Rattus norvegicus,178.0,CHEMBL626246,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12488,,,CHEMBL626247,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12489,,,CHEMBL626248,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12490,,,CHEMBL626249,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12491,,,CHEMBL626420,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12492,,,CHEMBL626421,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12493,,,CHEMBL626422,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12494,,,CHEMBL626423,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12495,,,CHEMBL626424,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12496,Canis lupus familiaris,,CHEMBL626425,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,,12023,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12497,Rattus norvegicus,,CHEMBL875476,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,,12023,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12498,Macaca fascicularis,,CHEMBL626426,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,,12023,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
12499,,,CHEMBL626427,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,,10580,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
12500,,,CHEMBL626428,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,,10580,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
12501,,,CHEMBL626429,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,,16032,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12502,,1088.0,CHEMBL625025,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,,16032,Urine,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12503,Rattus norvegicus,178.0,CHEMBL625026,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,8594,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12504,Rattus norvegicus,178.0,CHEMBL625027,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,8594,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12505,Rattus norvegicus,178.0,CHEMBL874410,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,8594,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12506,Rattus norvegicus,178.0,CHEMBL625028,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,8594,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12507,Rattus norvegicus,178.0,CHEMBL625029,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,8594,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12508,Rattus norvegicus,178.0,CHEMBL625030,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,8594,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12509,Rattus norvegicus,178.0,CHEMBL625031,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,8594,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12510,Rattus norvegicus,178.0,CHEMBL625032,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,8594,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12511,Rattus norvegicus,178.0,CHEMBL625033,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,8594,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12512,Rattus norvegicus,178.0,CHEMBL625034,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,8594,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12513,Rattus norvegicus,948.0,CHEMBL624872,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,8594,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12514,Rattus norvegicus,948.0,CHEMBL624873,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,8594,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12515,Rattus norvegicus,948.0,CHEMBL624874,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,8594,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12516,Rattus norvegicus,948.0,CHEMBL624875,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,8594,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12517,Rattus norvegicus,948.0,CHEMBL624876,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,8594,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12518,Rattus norvegicus,948.0,CHEMBL624877,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,8594,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12519,Rattus norvegicus,948.0,CHEMBL624878,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,8594,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12520,Rattus norvegicus,948.0,CHEMBL624879,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,8594,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12521,Rattus norvegicus,948.0,CHEMBL624880,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,8594,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12522,Rattus norvegicus,948.0,CHEMBL624881,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,,8594,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12523,Rattus norvegicus,948.0,CHEMBL624882,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",,8594,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12524,Rattus norvegicus,2113.0,CHEMBL624883,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,8594,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12525,Rattus norvegicus,2113.0,CHEMBL624884,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,8594,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12526,Rattus norvegicus,2113.0,CHEMBL624885,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,8594,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12527,Rattus norvegicus,2113.0,CHEMBL624886,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,8594,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12528,Rattus norvegicus,2113.0,CHEMBL624887,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,8594,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12529,Rattus norvegicus,2113.0,CHEMBL624888,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,8594,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12530,Rattus norvegicus,2113.0,CHEMBL624889,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,8594,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12531,Rattus norvegicus,2113.0,CHEMBL624890,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,8594,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12532,Rattus norvegicus,2113.0,CHEMBL621964,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,8594,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12533,Rattus norvegicus,2113.0,CHEMBL621965,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,8594,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12534,Rattus norvegicus,2107.0,CHEMBL621966,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,8594,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12535,Rattus norvegicus,2107.0,CHEMBL621967,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,8594,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12536,Rattus norvegicus,2107.0,CHEMBL622164,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,8594,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12537,,,CHEMBL623097,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),,7653,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12538,,,CHEMBL623098,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),,7653,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12539,,,CHEMBL623099,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,,7653,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12540,,,CHEMBL623100,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,,7653,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12541,Rattus norvegicus,,CHEMBL628673,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",,9104,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12542,Rattus norvegicus,,CHEMBL628674,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",,9104,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12543,Rattus norvegicus,,CHEMBL628675,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",,9104,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12544,Rattus norvegicus,,CHEMBL627644,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",,9104,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12545,Rattus norvegicus,,CHEMBL627645,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",,9104,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12546,Rattus norvegicus,,CHEMBL627646,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",,9104,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12547,Rattus norvegicus,,CHEMBL627647,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",,9104,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12548,Rattus norvegicus,,CHEMBL627648,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",,9104,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12549,Rattus norvegicus,,CHEMBL627649,Free level in rat plasma,,12902,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12550,,,CHEMBL628313,Level reaching in blood plasma of rat or human was determined,,6614,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12551,Rattus norvegicus,,CHEMBL628314,Log (Cbrain/Cblood) in rats,,9663,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12552,,,CHEMBL628315,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,,17658,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12553,,,CHEMBL628316,Mean percentage of compound transport through membrane; expressed as membrane transport,,17658,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12554,,,CHEMBL628317,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,,14314,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12555,,,CHEMBL628473,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,,7385,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12556,,,CHEMBL628474,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",,7385,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12557,,,CHEMBL628475,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,,7385,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12558,,,CHEMBL628476,Net water uptake by a carrier mediated transport (%cm) mechanism,,1329,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12559,Simiiformes,,CHEMBL628477,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,12187,,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
12560,Mustela putorius furo,,CHEMBL628478,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,12187,,50506,,,BAO_0000218,,Intermediate,,9669.0,N,1,1,
12561,Mustela putorius furo,,CHEMBL628479,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,12187,,50506,,,BAO_0000218,,Intermediate,,9669.0,N,1,1,
12562,Simiiformes,,CHEMBL628480,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,12187,,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
12563,Simiiformes,,CHEMBL628481,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",,12187,,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
12564,Rattus norvegicus,,CHEMBL628482,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,12187,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12565,Rattus norvegicus,,CHEMBL628483,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,12187,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12566,Rattus norvegicus,1969.0,CHEMBL628484,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,9278,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12567,Rattus norvegicus,1969.0,CHEMBL628485,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,9278,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12568,Macaca fascicularis,1969.0,CHEMBL628486,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",,9278,Plasma,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
12569,Homo sapiens,1969.0,CHEMBL628487,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",,9278,Plasma,50587,,,BAO_0000218,,Intermediate,,9606.0,N,1,1,
12570,Rattus norvegicus,1969.0,CHEMBL628488,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,9278,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12571,Rattus norvegicus,1969.0,CHEMBL628489,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,9278,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12572,Rattus norvegicus,1969.0,CHEMBL628490,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,9278,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12573,Macaca fascicularis,,CHEMBL628491,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,12186,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
12574,Macaca fascicularis,,CHEMBL877507,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,12186,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
12575,,,CHEMBL628492,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,12186,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12576,Simiiformes,,CHEMBL628493,% metabolized in monkey S-9 after 2 hours (10 ug/mL),,12041,,22224,,,BAO_0000019,,Autocuration,,314293.0,U,0,1,
12577,Simiiformes,,CHEMBL628494,% metabolized in monkey S-9 after 2 hours (1 ug/ml),,12041,,22224,,,BAO_0000019,,Autocuration,,314293.0,U,0,1,
12578,Simiiformes,,CHEMBL628495,% metabolized in monkey S-9 after 2 hours (10 ug/ml),,12041,,22224,,,BAO_0000019,,Autocuration,,314293.0,U,0,1,
12579,Homo sapiens,,CHEMBL628496,Permeability in Caco-2 assay at 10E-6,,6737,,50587,,,BAO_0000218,,Intermediate,,9606.0,N,1,1,
12580,,955.0,CHEMBL628497,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,13758,Brain,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12581,,955.0,CHEMBL628498,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,13758,Brain,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12582,,,CHEMBL628499,Plasma protein binding was determined,,5676,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12583,,,CHEMBL627656,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,,14793,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12584,,,CHEMBL627657,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,,14793,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12585,,,CHEMBL626808,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,,14793,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12586,,,CHEMBL626809,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,,14793,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12587,,,CHEMBL626810,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,,14793,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12588,,,CHEMBL626811,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,,14793,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12589,,,CHEMBL874465,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,,14793,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12590,,,CHEMBL626812,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,,14793,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12591,,,CHEMBL626813,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,,14793,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12592,,,CHEMBL626814,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,,14793,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12593,,,CHEMBL626815,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,,14000,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12594,,,CHEMBL628566,Partition coefficient (logP),,5948,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12595,,,CHEMBL628567,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,13824,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12596,,,CHEMBL628568,Calculated partition coefficient (clogP),,10778,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12597,Canis lupus familiaris,,CHEMBL628569,C max in dog,In vivo,17237,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12598,Cavia porcellus,,CHEMBL628570,C max in guinea pig,In vivo,17237,,50512,,,BAO_0000218,,Intermediate,,10141.0,N,1,1,
12599,,,CHEMBL628571,C max value was evaluated,In vivo,2809,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12600,,,CHEMBL628572,Cmax value after oral dose of 0.1 mg//kg,In vivo,11954,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12601,,,CHEMBL628573,Cmax value after oral dose of 0.3 mg/kg,In vivo,11954,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12602,,,CHEMBL628574,Cmax value after oral dose of 1 mg/kg,In vivo,11954,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12603,,,CHEMBL628575,Cmax value after oral dose of 10 mg/kg,In vivo,11954,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12604,,,CHEMBL628576,Cmax value after oral dose of 23.4 mg/kg,In vivo,11954,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12605,,,CHEMBL628577,Cmax value after oral dose of 3 mg/kg,In vivo,11954,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12606,,,CHEMBL628578,Cmax value after oral dose of 3.87 mg/kg,In vivo,11954,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12607,Canis lupus familiaris,,CHEMBL874466,Cmax value in female Beagle dogs,In vivo,12768,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12608,Rattus norvegicus,,CHEMBL628579,Cmax value in male rats,In vivo,12768,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12609,Rattus norvegicus,1969.0,CHEMBL628580,Cmax value in rat plasma when administered 20 mg/kg perorally,In vivo,12780,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12610,Canis lupus familiaris,1969.0,CHEMBL628581,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,In vivo,15592,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12611,Canis lupus familiaris,1969.0,CHEMBL628582,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,In vivo,15592,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12612,Canis lupus familiaris,,CHEMBL628583,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,,17025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12613,Simiiformes,,CHEMBL625782,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,,17025,,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
12614,Oryctolagus cuniculus,,CHEMBL625783,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,,17025,,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12615,Rattus norvegicus,,CHEMBL625784,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,,17025,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12616,Macaca mulatta,1969.0,CHEMBL625785,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,,4236,Plasma,50797,,,BAO_0000218,,Intermediate,,9544.0,N,1,1,
12617,Rattus norvegicus,,CHEMBL625786,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,,15791,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12618,,,CHEMBL874467,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,,11149,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12619,Canis lupus familiaris,,CHEMBL625787,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,15592,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12620,Human immunodeficiency virus,,CHEMBL625964,cytotoxicity against HIV protease enzyme.,,15778,,50677,,,BAO_0000218,,Intermediate,,12721.0,N,1,1,
12621,Mus musculus,,CHEMBL625965,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,,12745,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
12622,Mus musculus,,CHEMBL625966,Apparent clearance in mice after oral administration of 100 mg/kg of dose,,12745,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
12623,Canis lupus familiaris,1969.0,CHEMBL625967,The plasma clearance in dog.,In vivo,13941,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12624,Rattus norvegicus,1969.0,CHEMBL625968,The plasma clearance in rat.,In vivo,13941,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12625,Rattus norvegicus,1969.0,CHEMBL625969,Clearance from plasma in male Sprague-Dawley rats,In vivo,16449,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12626,Macaca fascicularis,1969.0,CHEMBL625970,Clearance from plasma in male cynomolgus monkeys,In vivo,16449,Plasma,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
12627,Canis lupus familiaris,1969.0,CHEMBL625971,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",In vivo,14224,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12628,Canis lupus familiaris,1969.0,CHEMBL625972,Clearance of compound in dog plasma,In vivo,14224,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12629,Homo sapiens,1969.0,CHEMBL625973,Clearance of compound in human plasma,In vivo,14224,Plasma,50587,,,BAO_0000218,,Intermediate,,9606.0,N,1,1,
12630,Canis lupus familiaris,,CHEMBL625974,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,In vivo,14317,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12631,Canis lupus familiaris,,CHEMBL625975,Clearance of compound when administered intravenously as an individual dose to a single dog.,In vivo,14317,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12632,Canis lupus familiaris,1969.0,CHEMBL625976,"Clearance (10 mg/kg, intravenously) in dog plasma",In vivo,14224,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12633,Canis lupus familiaris,,CHEMBL625977,Clearance value in dog,In vivo,17237,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12634,Cavia porcellus,,CHEMBL625978,Clearance value in guinea pig,In vivo,17237,,50512,,,BAO_0000218,,Intermediate,,10141.0,N,1,1,
12635,Rattus norvegicus,,CHEMBL874468,Clearance values in rats after iv administration.,In vivo,14187,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12636,,1969.0,CHEMBL625421,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,In vivo,4806,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12637,Oryctolagus cuniculus,,CHEMBL625422,In vivo clearance (5 mg/kg) was determined in rabbits,In vivo,15025,,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12638,Rattus norvegicus,,CHEMBL625423,Plasma Clearance rate was determined for the compound in rats,In vivo,13197,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12639,Saimiri,,CHEMBL625424,Plasma Clearance rate was determined for the compound in squirrel monkeys,In vivo,13197,,22224,,,BAO_0000218,,Autocuration,,9520.0,U,0,1,
12640,Rattus norvegicus,,CHEMBL625425,Plasma clearance in rat,In vivo,13960,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12641,,,CHEMBL625426,Plasma clearance of the compound,In vivo,17820,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12642,Cavia porcellus,,CHEMBL625427,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,In vivo,14706,,50512,,,BAO_0000218,,Intermediate,,10141.0,N,1,1,
12643,Cavia porcellus,,CHEMBL625428,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,In vivo,14706,,50512,,,BAO_0000218,,Intermediate,,10141.0,N,1,1,
12644,,,CHEMBL625429,Plasma clearance was determined,In vivo,6504,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12645,Canis lupus familiaris,,CHEMBL625430,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,In vivo,14925,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12646,Rattus norvegicus,,CHEMBL625431,Plasma clearance rate was determined for the compound in rats,In vivo,13197,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12647,Saimiri,,CHEMBL627307,Plasma clearance rate was determined for the compound in squirrel monkeys,In vivo,13197,,22224,,,BAO_0000218,,Autocuration,,9520.0,U,0,1,
12648,,,CHEMBL627308,Slow clearance (CL) was determined,In vivo,3437,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12649,,,CHEMBL627309,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12650,,,CHEMBL627310,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12651,,,CHEMBL627311,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12652,,,CHEMBL627312,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12653,,,CHEMBL627313,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12654,,,CHEMBL627314,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12655,,,CHEMBL627315,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12656,,,CHEMBL627316,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12657,,,CHEMBL627317,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12658,,,CHEMBL627318,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12659,,,CHEMBL627999,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12660,,,CHEMBL628000,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12661,,,CHEMBL628001,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12662,,,CHEMBL628002,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12663,,,CHEMBL625610,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12664,,,CHEMBL625611,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12665,,,CHEMBL625612,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12666,,,CHEMBL625613,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12667,,,CHEMBL875479,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12668,,,CHEMBL625614,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12669,,,CHEMBL625615,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12670,,,CHEMBL626302,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,9196,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12671,Rattus norvegicus,178.0,CHEMBL626303,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12672,Rattus norvegicus,178.0,CHEMBL627420,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,8374,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12673,Rattus norvegicus,,CHEMBL627421,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,,13477,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12674,Rattus norvegicus,,CHEMBL625695,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,,13477,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12675,Rattus norvegicus,,CHEMBL625696,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,,13477,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12676,Mus musculus,955.0,CHEMBL875606,Distribution of compound in mice brain was measured after 1 hr,,10009,Brain,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
12677,Mus musculus,955.0,CHEMBL625697,Distribution of compound in mice brain was measured after 24 hr r,,10009,Brain,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
12678,Mus musculus,955.0,CHEMBL625698,Distribution of compound in mice brain was measured after 2 hr,,10009,Brain,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
12679,Mus musculus,955.0,CHEMBL625699,Distribution of compound in mice brain was measured after 3 hr,,10009,Brain,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
12680,Mus musculus,955.0,CHEMBL625700,Distribution of compound in mice brain was measured after 6 hr,,10009,Brain,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
12681,Mus musculus,,CHEMBL625701,Distribution of compound in mice liver was measured after 1 hr,,10009,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
12682,Mus musculus,,CHEMBL625702,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,,10009,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
12683,Mus musculus,,CHEMBL625703,Distribution of compound in mice liver was measured after 2 hr,,10009,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
12684,Mus musculus,,CHEMBL625704,Distribution of compound in mice liver was measured after 3 hr,,10009,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
12685,Mus musculus,,CHEMBL625705,Distribution of compound in mice liver was measured after 6 hr,,10009,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
12686,Canis lupus familiaris,1236.0,CHEMBL625706,Distribution in dog adrenal medulla 30 min after administration.,,8170,Adrenal medulla,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12687,Canis lupus familiaris,1236.0,CHEMBL625707,Distribution in dog adrenal medulla 72 hours after administration.,,8170,Adrenal medulla,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12688,Canis lupus familiaris,,CHEMBL625708,Distribution in female dog Ovary 24 hours after administration.,,8170,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12689,Canis lupus familiaris,,CHEMBL625709,Distribution in female dog Ovary 72 hours after administration.,,8170,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12690,Canis lupus familiaris,,CHEMBL624180,Distribution in female dog adipose 24 hours after administration.,,8170,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12691,Canis lupus familiaris,,CHEMBL624181,Distribution in female dog adipose 72 hours after administration.,,8170,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12692,Canis lupus familiaris,1235.0,CHEMBL624182,Distribution in female dog adrenal cortex 72 hours after administration.,,8170,Adrenal cortex,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12693,Canis lupus familiaris,1235.0,CHEMBL624183,Distribution in female dog adrenal cortex 72 hours after administration.,,8170,Adrenal cortex,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12694,Rattus norvegicus,2107.0,CHEMBL624184,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,8594,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12695,Rattus norvegicus,2107.0,CHEMBL877489,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,8594,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12696,Rattus norvegicus,2107.0,CHEMBL624185,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,8594,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12697,Rattus norvegicus,2107.0,CHEMBL624186,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,8594,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12698,Rattus norvegicus,2107.0,CHEMBL624187,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,8594,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12699,Rattus norvegicus,2107.0,CHEMBL624188,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,8594,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12700,Rattus norvegicus,2048.0,CHEMBL624189,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,8594,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12701,Rattus norvegicus,2048.0,CHEMBL624190,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,8594,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12702,Rattus norvegicus,2048.0,CHEMBL624191,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,8594,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12703,Rattus norvegicus,2048.0,CHEMBL624192,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,8594,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12704,Rattus norvegicus,2048.0,CHEMBL624193,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,8594,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12705,Rattus norvegicus,2048.0,CHEMBL624194,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,8594,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12706,Rattus norvegicus,2048.0,CHEMBL624891,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,8594,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12707,Rattus norvegicus,2048.0,CHEMBL624892,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,8594,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12708,Rattus norvegicus,2048.0,CHEMBL624893,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,8594,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12709,Rattus norvegicus,2048.0,CHEMBL627632,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,8594,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12710,Rattus norvegicus,,CHEMBL627633,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,8594,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12711,Rattus norvegicus,,CHEMBL627634,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,8594,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12712,Rattus norvegicus,,CHEMBL627635,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,8594,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12713,Rattus norvegicus,,CHEMBL627636,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,8594,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12714,Rattus norvegicus,,CHEMBL626816,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,8594,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12715,Rattus norvegicus,,CHEMBL626817,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,8594,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12716,Rattus norvegicus,,CHEMBL626818,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,8594,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12717,Rattus norvegicus,,CHEMBL626819,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,8594,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12718,Rattus norvegicus,,CHEMBL626820,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,8594,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12719,Rattus norvegicus,,CHEMBL626821,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,8594,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12720,Rattus norvegicus,2046.0,CHEMBL626822,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,8594,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12721,Rattus norvegicus,2046.0,CHEMBL626823,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,8594,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12722,Rattus norvegicus,2046.0,CHEMBL626824,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,8594,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12723,Rattus norvegicus,2046.0,CHEMBL626825,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,8594,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12724,Rattus norvegicus,2046.0,CHEMBL626826,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,8594,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12725,Rattus norvegicus,2046.0,CHEMBL626827,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,8594,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12726,Rattus norvegicus,2046.0,CHEMBL626828,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,8594,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12727,Rattus norvegicus,2046.0,CHEMBL626829,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,8594,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12728,Rattus norvegicus,2046.0,CHEMBL626830,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,8594,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12729,Rattus norvegicus,,CHEMBL627150,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,8594,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12730,Rattus norvegicus,,CHEMBL627151,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,8594,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12731,Rattus norvegicus,,CHEMBL627152,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,8594,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12732,Rattus norvegicus,,CHEMBL627153,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,8594,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12733,,,CHEMBL627154,Rate of acetate production by the compound was determined,,12904,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12734,,,CHEMBL627155,Rate of acetate production by the compound was determined; Not determined,,12904,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12735,,,CHEMBL627156,Rate of hydrolysis of nitrocefin by compound was evaluated in water,,3730,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12736,,,CHEMBL627157,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,,3627,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12737,Oryctolagus cuniculus,,CHEMBL627158,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,13799,,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12738,Oryctolagus cuniculus,1969.0,CHEMBL627159,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,13799,Plasma,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12739,Mus musculus,,CHEMBL627160,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,13799,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
12740,Rattus norvegicus,,CHEMBL628540,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,13799,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12741,Rattus norvegicus,1969.0,CHEMBL628541,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,13799,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12742,Rattus norvegicus,1969.0,CHEMBL628542,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,13799,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12743,,,CHEMBL628543,Solubility after at a pH 1.2,,6629,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12744,,,CHEMBL628544,Solubility after at pH 1.2,,6629,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12745,,,CHEMBL628545,Solubility after injection of water,,6629,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12746,,,CHEMBL628546,Statistical significance of IC 50 values; Expressed as R value,,14000,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12747,,,CHEMBL874455,Systemic availability with respect to methyldopa was determined,,8267,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12748,Rattus norvegicus,,CHEMBL628547,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,,13799,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12749,Rattus norvegicus,1969.0,CHEMBL628548,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,,13799,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12750,Oryctolagus cuniculus,1988.0,CHEMBL628549,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",,7132,Feces,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12751,Oryctolagus cuniculus,1988.0,CHEMBL628550,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",,7132,Feces,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12752,Oryctolagus cuniculus,1988.0,CHEMBL628551,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",,7132,Feces,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12753,Oryctolagus cuniculus,1088.0,CHEMBL628552,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",,7132,Urine,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12754,Oryctolagus cuniculus,1088.0,CHEMBL628553,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",,7132,Urine,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12755,Oryctolagus cuniculus,1088.0,CHEMBL628554,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",,7132,Urine,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12756,Oryctolagus cuniculus,1088.0,CHEMBL628555,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",,7132,Urine,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12757,Oryctolagus cuniculus,1088.0,CHEMBL628556,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",,7132,Urine,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12758,Oryctolagus cuniculus,2113.0,CHEMBL628557,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",,7132,Kidney,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12759,Oryctolagus cuniculus,1988.0,CHEMBL628558,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",,7132,Feces,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12760,Oryctolagus cuniculus,1988.0,CHEMBL628559,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",,7132,Feces,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12761,Oryctolagus cuniculus,1988.0,CHEMBL628560,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",,7132,Feces,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12762,Oryctolagus cuniculus,1088.0,CHEMBL874456,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",,7132,Urine,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12763,Oryctolagus cuniculus,1988.0,CHEMBL628561,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",,7132,Feces,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12764,Oryctolagus cuniculus,1988.0,CHEMBL628562,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",,7132,Feces,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12765,Oryctolagus cuniculus,1088.0,CHEMBL628563,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",,7132,Urine,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12766,Oryctolagus cuniculus,1088.0,CHEMBL628564,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",,7132,Urine,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12767,Oryctolagus cuniculus,1088.0,CHEMBL628565,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",,7132,Urine,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12768,Oryctolagus cuniculus,1088.0,CHEMBL631248,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",,7132,Urine,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12769,Oryctolagus cuniculus,1088.0,CHEMBL631249,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",,7132,Urine,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12770,Oryctolagus cuniculus,2113.0,CHEMBL627214,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",,7132,Kidney,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12771,Oryctolagus cuniculus,1988.0,CHEMBL874591,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",,7132,Feces,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12772,Oryctolagus cuniculus,1988.0,CHEMBL627215,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",,7132,Feces,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12773,Oryctolagus cuniculus,1988.0,CHEMBL625471,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,,7132,Feces,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12774,Oryctolagus cuniculus,,CHEMBL625472,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,,7132,,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12775,Oryctolagus cuniculus,,CHEMBL625473,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,,7132,,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12776,Canis lupus familiaris,,CHEMBL625474,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,In vivo,13317,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12777,Canis lupus familiaris,,CHEMBL625475,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,In vivo,15341,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12778,Rattus norvegicus,,CHEMBL625476,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,In vivo,15341,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12779,Rattus norvegicus,,CHEMBL625477,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,In vivo,15341,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12780,Rattus norvegicus,,CHEMBL625478,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,In vivo,15341,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12781,Rattus norvegicus,,CHEMBL625479,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,In vitro,12801,esophageal tunica muscularis mucosae,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12782,Rattus norvegicus,,CHEMBL625480,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,In vitro,12801,esophageal tunica muscularis mucosae,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12783,Rattus norvegicus,1969.0,CHEMBL625481,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,In vivo,14856,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12784,Rattus norvegicus,,CHEMBL625482,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,In vivo,14062,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12785,Rattus norvegicus,,CHEMBL625483,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,In vivo,14062,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12786,Rattus norvegicus,,CHEMBL625484,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,In vivo,14062,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12787,Rattus norvegicus,,CHEMBL625485,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,In vivo,14062,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12788,Canis lupus familiaris,1969.0,CHEMBL625486,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,In vivo,14346,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12789,Rattus norvegicus,1969.0,CHEMBL625487,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,In vivo,14346,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12790,Rattus norvegicus,1969.0,CHEMBL625488,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,In vivo,14346,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12791,Rattus norvegicus,1969.0,CHEMBL625489,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,In vivo,14346,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12792,Rattus norvegicus,1969.0,CHEMBL625490,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,In vivo,14346,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12793,Canis lupus familiaris,1969.0,CHEMBL625491,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,In vivo,14346,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12794,Rattus norvegicus,1969.0,CHEMBL625492,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,In vivo,14346,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12795,Homo sapiens,1969.0,CHEMBL625493,plasma clearance in human,In vivo,15711,Plasma,50587,,,BAO_0000218,,Intermediate,,9606.0,N,1,1,
12796,Rattus norvegicus,,CHEMBL625494,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,In vivo,14886,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12797,Rattus norvegicus,,CHEMBL625495,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,In vivo,14886,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12798,Rattus norvegicus,,CHEMBL625496,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,In vivo,14886,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12799,,,CHEMBL625497,1-Octanol/water partition coefficient measured at 7.4,,4115,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12800,,,CHEMBL625498,Calculated partition coefficient (clogP),,13733,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12801,,,CHEMBL625499,Partition coefficient (logP),,12102,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12802,,,CHEMBL625500,Calculated partition coefficient (clogP),,12676,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12803,,,CHEMBL625501,Calculated partition coefficient (clogP),,13733,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12804,,,CHEMBL625502,Calculated partition coefficient (clogP),,13740,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12805,,,CHEMBL625503,Calculated partition coefficient (clogP) (relative to BAY K 8644),,12766,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12806,,,CHEMBL625504,Calculated partition coefficient (clogP),,2764,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12807,,,CHEMBL625505,Calculated partition coefficient (clogP),,12355,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12808,,,CHEMBL625506,Calculated partition coefficient of the compound,,11314,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12809,,,CHEMBL625507,Partition coefficient (logP),,12706,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12810,,,CHEMBL625508,Calculated partition coefficient (clogP),,12645,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12811,,,CHEMBL625509,Calculated partition coefficient (clogP),,13668,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12812,,,CHEMBL625510,Calculated partition coefficient (clogP),,12819,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12813,,,CHEMBL883125,Calculated partition coefficient (clogP),,13668,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12814,,,CHEMBL625511,Calculated partition coefficient (clogP),,13017,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12815,,,CHEMBL874650,Partition coefficient of the compound,,2448,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12816,,,CHEMBL625512,Partition coefficient of the compound,,11526,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12817,,,CHEMBL625513,Partition coefficient of compound was determined,,12426,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12818,,,CHEMBL625514,Partition coefficient was determined,,2448,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12819,,,CHEMBL625515,Calculated partition coefficient (clogP),,12001,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12820,,,CHEMBL625516,partition coefficient of compound was determined,,12426,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12821,Canis lupus familiaris,,CHEMBL625517,The total body administered intravenously in dog,In vivo,13204,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12822,Rattus norvegicus,,CHEMBL625518,The total body administered intravenously in rats,In vivo,13204,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12823,Mus musculus,,CHEMBL625519,Time taken for the administration to female NIH mice weighing 25-30 g.,,13889,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
12824,,,CHEMBL625520,Time taken for the administration,,13889,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12825,Canis lupus familiaris,,CHEMBL874651,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,In vivo,17025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12826,Simiiformes,,CHEMBL625521,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,In vivo,17025,,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
12827,Oryctolagus cuniculus,,CHEMBL623171,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,In vivo,17025,,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12828,Rattus norvegicus,,CHEMBL623853,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,In vivo,17025,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12829,,,CHEMBL623854,Plasma clearance for the compound was determined.,,15067,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12830,,,CHEMBL874405,CLog P value of the compound,,3091,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
12831,,,CHEMBL623855,Calculated partition coefficient (clogP),,15592,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12832,,,CHEMBL623856,Calculated partition coefficient (clogP),,14738,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12833,,,CHEMBL623857,ClogP value of the compound; nd ='no data',,14738,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
12834,,,CHEMBL623858,ClogP value of the compound; nd ='not determined',,14738,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
12835,,,CHEMBL623859,CLog P was determined,,6076,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
12836,,,CHEMBL839829,Calculated partition coefficient (clogP),,17840,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12837,,,CHEMBL623860,CLogP was calculated,,13589,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12838,,,CHEMBL623861,CLogP value was determined,,17655,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12839,,,CHEMBL623862,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,,5867,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12840,,,CHEMBL874406,Calculated partition coefficient (clogP),,5867,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12841,,,CHEMBL623863,Calculated partition coefficient (clogP),,10783,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12842,,,CHEMBL624021,Calculated partition coefficient (clogP),,14849,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12843,Canis lupus familiaris,1236.0,CHEMBL624022,Distribution in female dog adrenal medulla 24 hours after administration.,,8170,Adrenal medulla,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12844,Canis lupus familiaris,1236.0,CHEMBL624023,Distribution in female dog adrenal medulla 72 hours after administration.,,8170,Adrenal medulla,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12845,Canis lupus familiaris,,CHEMBL624024,Distribution in female dog bile 24 hours after administration.,,8170,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12846,Canis lupus familiaris,,CHEMBL624025,Distribution in female dog bile 72 hr after administration.,,8170,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12847,Canis lupus familiaris,,CHEMBL624026,Distribution in female dog blood 24 hours after administration.,,8170,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12848,Canis lupus familiaris,,CHEMBL624027,Distribution in female dog blood 72 hours after administration.,,8170,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12849,Canis lupus familiaris,,CHEMBL624028,Distribution in female dog heart 24 hours after administration.,,8170,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12850,Canis lupus familiaris,,CHEMBL624029,Distribution in female dog heart 72 hours after administration.,,8170,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12851,Canis lupus familiaris,,CHEMBL624030,Distribution in female dog kidney 24 hours after administration.,,8170,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12852,Canis lupus familiaris,,CHEMBL624031,Distribution in female dog kidney 72 hours after administration.,,8170,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12853,Canis lupus familiaris,160.0,CHEMBL624032,Distribution in female dog large intestine 24 hours after administration.,,8170,Intestine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12854,Canis lupus familiaris,160.0,CHEMBL874407,Distribution in female dog large intestine 72 hours after administration.,,8170,Intestine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12855,Canis lupus familiaris,,CHEMBL624033,Distribution in female dog liver 24 hours after administration.,,8170,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12856,Canis lupus familiaris,,CHEMBL624034,Distribution in female dog liver 72 hours after administration.,,8170,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12857,Canis lupus familiaris,,CHEMBL624035,Distribution in female dog lung 24 hours after administration.,,8170,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12858,Canis lupus familiaris,,CHEMBL624036,Distribution in female dog lung 72 hours after administration.,,8170,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12859,Canis lupus familiaris,2385.0,CHEMBL624037,Distribution in female dog muscle 24 hours after administration.,,8170,Muscle tissue,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12860,Canis lupus familiaris,2385.0,CHEMBL624038,Distribution in female dog muscle 72 hours after administration.,,8170,Muscle tissue,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12861,Canis lupus familiaris,,CHEMBL624039,Distribution in female dog pancreas 24 hours after administration.,,8170,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12862,Canis lupus familiaris,,CHEMBL624040,Distribution in female dog pancreas 72 hours after administration.,,8170,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12863,Canis lupus familiaris,160.0,CHEMBL624041,Distribution in female dog small intestine 24 hours after administration.,,8170,Intestine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12864,Canis lupus familiaris,160.0,CHEMBL624042,Distribution in female dog small intestine 72 hours after administration.,,8170,Intestine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12865,Canis lupus familiaris,2106.0,CHEMBL624043,Distribution in female dog spleen 24 hours after administration.,,8170,Spleen,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12866,Canis lupus familiaris,2106.0,CHEMBL624044,Distribution in female dog spleen 72 hours after administration.,,8170,Spleen,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12867,Canis lupus familiaris,945.0,CHEMBL624045,Distribution in female dog stomach 24 hours after administration.,,8170,Stomach,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12868,Canis lupus familiaris,945.0,CHEMBL624046,Distribution in female dog stomach 72 hours after administration.,,8170,Stomach,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12869,Canis lupus familiaris,2046.0,CHEMBL624047,Distribution in female dog thyroid 24 hours after administration.,,8170,Thyroid gland,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12870,Canis lupus familiaris,2046.0,CHEMBL624048,Distribution in female dog thyroid 72 hours after administration.,,8170,Thyroid gland,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12871,Canis lupus familiaris,1088.0,CHEMBL874408,Distribution in female dog urine 24 hours after administration.,,8170,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12872,Canis lupus familiaris,1088.0,CHEMBL624049,Distribution in female dog urine 72 hr after administration.,,8170,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12873,,1969.0,CHEMBL624050,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,,14283,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12874,,,CHEMBL624051,Plasma concentration at 7 hr after intravenous dosing,,5623,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12875,Rattus norvegicus,,CHEMBL623278,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,,13477,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12876,Rattus norvegicus,,CHEMBL623279,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,,13477,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12877,Rattus norvegicus,,CHEMBL623280,Plasma concentration of 3 mg/kg iv after 1 hr in rats,,13477,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12878,Rattus norvegicus,,CHEMBL623963,Plasma concentration of 3 mg/kg iv after 2 hr in rats,,13477,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12879,Rattus norvegicus,,CHEMBL623964,Plasma concentration of 3 mg/kg iv after 4 hr in rats,,13477,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12880,Rattus norvegicus,,CHEMBL623965,Plasma concentration of 3 mg/kg iv after 6 hr in rats,,13477,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12881,Rattus norvegicus,,CHEMBL623966,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,,13477,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12882,Rattus norvegicus,,CHEMBL874415,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,,13477,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12883,Rattus norvegicus,,CHEMBL623967,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,,13477,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12884,Rattus norvegicus,,CHEMBL623968,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,,13477,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12885,Rattus norvegicus,,CHEMBL623969,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,,13477,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12886,Rattus norvegicus,,CHEMBL628409,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,,13477,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12887,Rattus norvegicus,,CHEMBL628410,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,,13477,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12888,Rattus norvegicus,,CHEMBL628411,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,,13477,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12889,Rattus norvegicus,,CHEMBL628412,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,,13477,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12890,,,CHEMBL628413,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,,12553,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12891,,1969.0,CHEMBL628414,The concentration in plasmat; Not determined,,14548,Plasma,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12892,Rattus norvegicus,,CHEMBL628415,Tissue level at 10 mg/kg/po in wistar rats in blood,,14393,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12893,Rattus norvegicus,,CHEMBL628416,Tissue level at 10 mg/kg/po in wistar rats in brown fat,,14393,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12894,Rattus norvegicus,,CHEMBL628417,Tissue level at 10 mg/kg/po in wistar rats in heart,,14393,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12895,Rattus norvegicus,2107.0,CHEMBL874908,Tissue level at 10 mg/kg/po in wistar rats in liver,,14393,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12896,Rattus norvegicus,,CHEMBL628418,Tissue level at 10 mg/kg/po in wistar rats in plasma,,14393,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12897,Rattus norvegicus,2385.0,CHEMBL628419,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,,14393,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12898,Rattus norvegicus,,CHEMBL628420,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,,14393,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12899,,,CHEMBL628421,Water solubility at 37 degree C.,,1629,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12900,,,CHEMBL626726,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,8194,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12901,,,CHEMBL626727,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,8194,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12902,Rattus norvegicus,178.0,CHEMBL626728,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,8594,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12903,Rattus norvegicus,178.0,CHEMBL626729,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,8594,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12904,Rattus norvegicus,178.0,CHEMBL626730,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,8594,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12905,Rattus norvegicus,178.0,CHEMBL626731,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,8594,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12906,Rattus norvegicus,178.0,CHEMBL626732,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,8594,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12907,Rattus norvegicus,948.0,CHEMBL626733,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,8594,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12908,Rattus norvegicus,948.0,CHEMBL626734,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,8594,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12909,Rattus norvegicus,948.0,CHEMBL626735,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,8594,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12910,Rattus norvegicus,948.0,CHEMBL874909,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,8594,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12911,Rattus norvegicus,948.0,CHEMBL626736,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,8594,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12912,Rattus norvegicus,2113.0,CHEMBL626737,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,8594,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12913,Rattus norvegicus,2113.0,CHEMBL630999,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,8594,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12914,Rattus norvegicus,2113.0,CHEMBL631000,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,8594,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12915,Rattus norvegicus,2113.0,CHEMBL631001,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,8594,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12916,Rattus norvegicus,2113.0,CHEMBL631002,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,8594,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12917,Rattus norvegicus,2107.0,CHEMBL631003,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,8594,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12918,Rattus norvegicus,2107.0,CHEMBL631004,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,8594,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12919,Rattus norvegicus,2107.0,CHEMBL631005,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,8594,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12920,Rattus norvegicus,2107.0,CHEMBL631006,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,8594,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12921,Rattus norvegicus,2107.0,CHEMBL631007,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,8594,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12922,Rattus norvegicus,2048.0,CHEMBL631008,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,8594,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12923,Rattus norvegicus,2048.0,CHEMBL631009,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,8594,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12924,Rattus norvegicus,2048.0,CHEMBL631010,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,8594,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12925,Rattus norvegicus,2048.0,CHEMBL631011,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,8594,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12926,Rattus norvegicus,2048.0,CHEMBL631012,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,8594,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12927,Rattus norvegicus,2046.0,CHEMBL630271,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,8594,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12928,Rattus norvegicus,2046.0,CHEMBL630272,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,8594,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12929,Rattus norvegicus,2046.0,CHEMBL630273,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,8594,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12930,Rattus norvegicus,2046.0,CHEMBL630274,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,8594,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12931,Rattus norvegicus,2046.0,CHEMBL630275,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,8594,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12932,Rattus norvegicus,,CHEMBL875782,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,,8594,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12933,Rattus norvegicus,,CHEMBL630276,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,,8594,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12934,Rattus norvegicus,,CHEMBL630277,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,,8594,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12935,Rattus norvegicus,,CHEMBL630278,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,,8594,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12936,Rattus norvegicus,,CHEMBL630279,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,,8594,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12937,,,CHEMBL630280,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,,8151,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12938,,,CHEMBL630281,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,8151,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12939,Oryctolagus cuniculus,,CHEMBL630282,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,,7132,,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12940,Oryctolagus cuniculus,,CHEMBL630283,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,,7132,,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12941,,,CHEMBL630284,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),,5797,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12942,,,CHEMBL630285,Alkylating activity was determined,,7849,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12943,,,CHEMBL630286,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),,14220,,22224,,,BAO_0000251,,Autocuration,Microsomes,,U,0,1,
12944,Oryctolagus cuniculus,,CHEMBL630069,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",,8650,,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12945,Oryctolagus cuniculus,,CHEMBL630070,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",,8650,,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12946,Oryctolagus cuniculus,,CHEMBL630071,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",,8650,,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12947,Oryctolagus cuniculus,,CHEMBL630072,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",,8650,,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12948,Oryctolagus cuniculus,,CHEMBL875110,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",,8650,,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12949,Rattus norvegicus,,CHEMBL630073,Compound was tested for antidiuretic activity in rats,,7116,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12950,,,CHEMBL630074,Compound was tested for inactivation kinetic values,,14131,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12951,,,CHEMBL630075,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,In vivo,7415,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
12952,,,CHEMBL630076,Dissociation rate calculated from the first-order equation using the t1/2 value,,13178,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12953,,,CHEMBL630077,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,,8815,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12954,,,CHEMBL630078,Aqueous solubility was measured,,1450,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12955,,,CHEMBL630079,Aqueous solubility was measured at a pH 4,,1450,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12956,,,CHEMBL630080,Aqueous solubility (pH 7),,1450,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12957,,,CHEMBL630081,Aqueous solubility was measured at a pH 9,,1450,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12958,,,CHEMBL630082,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",,12711,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12959,,,CHEMBL630083,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,12711,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12960,,,CHEMBL630084,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,12711,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12961,,,CHEMBL629198,Aqueous solubility of the compound,,15032,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12962,,,CHEMBL629199,Aqueous solubility at 37 degree Celsius at pH 7.38,,9964,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12963,,,CHEMBL629200,Aqueous solubility in pH 7.4 phosphate buffer,,14962,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12964,Canis lupus familiaris,,CHEMBL629201,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,,12487,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12965,Canis lupus familiaris,,CHEMBL629202,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,,12487,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
12966,Homo sapiens,,CHEMBL875111,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,,10026,,50587,,,BAO_0000218,,Intermediate,,9606.0,N,1,1,
12967,Homo sapiens,,CHEMBL629203,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,,10026,,50587,,,BAO_0000218,,Intermediate,,9606.0,N,1,1,
12968,Homo sapiens,,CHEMBL629204,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,,10026,,50587,,,BAO_0000218,,Intermediate,,9606.0,N,1,1,
12969,Homo sapiens,,CHEMBL629205,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,,10026,,50587,,,BAO_0000218,,Intermediate,,9606.0,N,1,1,
12970,Homo sapiens,,CHEMBL629206,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,,10026,,50587,,,BAO_0000218,,Intermediate,,9606.0,N,1,1,
12971,,,CHEMBL631185,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,,10026,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12972,Rattus norvegicus,,CHEMBL631186,Compound was evaluated for the average bile flow rat in rats,,7415,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
12973,Oryctolagus cuniculus,,CHEMBL631187,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,17025,,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12974,Oryctolagus cuniculus,,CHEMBL631188,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,17025,,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
12975,,,CHEMBL876419,Average half life period was determined,,10184,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12976,,,CHEMBL631189,Average half life period was determined,,10184,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12977,Human herpesvirus 1,,CHEMBL631190,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,8613,,50602,,,BAO_0000218,,Intermediate,,10298.0,N,1,1,
12978,Human herpesvirus 1,,CHEMBL631191,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,8613,,50602,,,BAO_0000218,,Intermediate,,10298.0,N,1,1,
12979,Human herpesvirus 1,,CHEMBL631192,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,,8613,,50602,,,BAO_0000218,,Intermediate,,10298.0,N,1,1,
12980,Human herpesvirus 1,,CHEMBL632400,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,,8613,,50602,,,BAO_0000218,,Intermediate,,10298.0,N,1,1,
12981,Human herpesvirus 1,,CHEMBL630564,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,8613,,50602,,,BAO_0000218,,Intermediate,,10298.0,N,1,1,
12982,Human herpesvirus 1,,CHEMBL630565,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,8613,,50602,,,BAO_0000218,,Intermediate,,10298.0,N,1,1,
12983,Human herpesvirus 1,,CHEMBL630566,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,,8613,,50602,,,BAO_0000218,,Intermediate,,10298.0,N,1,1,
12984,Human herpesvirus 1,,CHEMBL631229,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,,8613,,50602,,,BAO_0000218,,Intermediate,,10298.0,N,1,1,
12985,Human herpesvirus 1,,CHEMBL631230,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,,8613,,50602,,,BAO_0000218,,Intermediate,,10298.0,N,1,1,
12986,,,CHEMBL876428,Calculated partition coefficient (clogP),,6030,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12987,,,CHEMBL631231,Calculated partition coefficient (clogP),,6147,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12988,,,CHEMBL631232,Calculated partition coefficient (clogP) (MacLogP),,14556,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12989,,,CHEMBL631233,Hydrophilicity was determined,,768,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12990,,,CHEMBL631234,Calculated partition coefficient (clogP),,14452,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12991,,,CHEMBL883126,Increased absorption was determined,,5237,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12992,,,CHEMBL631235,Lipophilicity value was evaluated,,14378,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
12993,,,CHEMBL631236,Log P value of the compound.,,14418,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
12994,,,CHEMBL631237,Partition coefficient of compound was determined,,5249,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12995,,,CHEMBL631238,Calculated partition coefficient (clogP),,14621,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12996,,,CHEMBL876429,Calculated partition coefficient (clogP),,12542,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
12997,,,CHEMBL631414,Partition coefficient was measured by medchem software; Not calculated,,12542,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
12998,,,CHEMBL631415,Partition coefficient was measured by octanol-water using standard shake-flask method,,12542,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
12999,,,CHEMBL631416,Calculated partition coefficient (clogP),,15462,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13000,,,CHEMBL631417,Partition coefficient (logP),,14884,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13001,,,CHEMBL631418,Calculated partition coefficient (clogP),,16526,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13002,,,CHEMBL631419,The Octanol/Water partition coefficient CLogP,,13693,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13003,,,CHEMBL631420,The pharmacokinetic parameter C Log p was reported,,13693,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13004,,,CHEMBL631421,Calculated partition coefficient (clogP),,13779,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13005,,,CHEMBL631422,Calculated partition coefficient (clogP),,14772,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13006,,,CHEMBL631423,Calculated partition coefficient (clogP),,14393,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13007,Rattus norvegicus,1969.0,CHEMBL876430,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,In vivo,14793,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13008,Rattus norvegicus,1969.0,CHEMBL631424,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,In vivo,14793,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13009,Canis lupus familiaris,1969.0,CHEMBL631425,Compound was administered intravenously in dog to evaluate plasma clearance values,In vivo,13744,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13010,Simiiformes,1969.0,CHEMBL631426,Compound was administered intravenously in monkey to evaluate plasma clearance values,In vivo,13744,Plasma,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
13011,Mus musculus,1969.0,CHEMBL631427,Compound was administered intravenously in mouse to evaluate plasma clearance values,In vivo,13744,Plasma,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13012,Canis lupus familiaris,1969.0,CHEMBL631428,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,In vivo,13207,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13013,Macaca mulatta,2107.0,CHEMBL631429,Intrinsic clearance in Rhesus liver microsome,In vitro,5669,Liver,50797,,,BAO_0000218,,Intermediate,Microsomes,9544.0,N,1,1,
13014,Canis lupus familiaris,2107.0,CHEMBL631430,Intrinsic clearance in dog liver microsome,In vitro,5669,Liver,50588,,,BAO_0000218,,Intermediate,Microsomes,9615.0,N,1,1,
13015,Rattus norvegicus,2107.0,CHEMBL631431,Intrinsic clearance in rat liver microsome,In vitro,5669,Liver,50597,,,BAO_0000218,,Intermediate,Microsomes,10116.0,N,1,1,
13016,Macaca mulatta,1969.0,CHEMBL631432,Low plasma clearance was calculated in rhesus monkey,In vivo,4853,Plasma,50797,,,BAO_0000218,,Intermediate,,9544.0,N,1,1,
13017,Canis lupus familiaris,,CHEMBL631433,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,In vivo,16452,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13018,,,CHEMBL631434,Plasma clearance after intravenous dose of 0.3 mg/kg,In vivo,11954,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13019,,,CHEMBL631435,Plasma clearance after intravenous dose of 1 mg/kg,In vivo,11954,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13020,,,CHEMBL631436,Plasma clearance after intravenous dose of 3 mg/kg,In vivo,11954,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13021,,,CHEMBL631437,Plasma clearance after intravenous dose of 3.87 mg/kg,In vivo,11954,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13022,Rattus norvegicus,,CHEMBL631438,Plasma clearance after peroral administration at 10 mpk in Rat,In vivo,5669,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13023,Macaca mulatta,,CHEMBL876431,Plasma clearance after peroral administration at 10 mpk in Rhesus,In vivo,5669,,50797,,,BAO_0000218,,Intermediate,,9544.0,N,1,1,
13024,Canis lupus familiaris,,CHEMBL631439,Plasma clearance after peroral administration at 10 mpk in dog,In vivo,5669,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13025,Rattus norvegicus,,CHEMBL631440,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,In vivo,13662,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13026,,,CHEMBL631441,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),,8272,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13027,,,CHEMBL631442,Critical Micellar concentration was determined,,13410,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13028,,,CHEMBL626525,Critical Micellar concentration of the compound. was determined,,13410,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13029,,,CHEMBL627168,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,,12628,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13030,,,CHEMBL875618,Critical micellar concentration was measured in water by the dye solubilization method,,9675,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13031,,,CHEMBL626612,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,,12628,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13032,,,CHEMBL626613,CMR value (relative to BAY K 8644),,12766,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13033,,,CHEMBL626614,Carbamoylating activity was determined,,7849,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13034,Simiiformes,,CHEMBL626615,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,,12187,,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
13035,,,CHEMBL626616,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,,2040,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13036,,,CHEMBL626617,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,,2040,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13037,Canis lupus familiaris,1969.0,CHEMBL626618,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,In vivo,14180,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13038,Rattus norvegicus,1969.0,CHEMBL626619,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,In vivo,14180,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13039,Canis lupus familiaris,,CHEMBL626620,"Clearance rate at 0.46 mg/kg, iv, in dogs",In vivo,14474,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13040,Rattus norvegicus,,CHEMBL626621,"Clearance rate at 5.5 mg/kg, iv, in rat",In vivo,14474,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13041,Macaca fascicularis,,CHEMBL626622,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,In vivo,14548,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
13042,Macaca fascicularis,,CHEMBL626623,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,In vivo,14548,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
13043,Canis lupus familiaris,,CHEMBL626624,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,In vivo,14548,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13044,Rattus norvegicus,,CHEMBL626625,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,In vivo,14548,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13045,Rattus norvegicus,2107.0,CHEMBL626626,Clearance rate constant using isolated perfused rat liver (IPRL) assay,Ex vivo,6125,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13046,,,CHEMBL626627,Tested for the total clearance of the compound,In vivo,6874,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13047,Canis lupus familiaris,,CHEMBL626628,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,In vivo,15343,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13048,,,CHEMBL626629,Total body clearance was determined,In vivo,6236,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13049,Rattus norvegicus,,CHEMBL626630,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13050,Rattus norvegicus,,CHEMBL626631,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13051,,,CHEMBL626632,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,8194,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13052,,,CHEMBL626633,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,8194,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13053,,,CHEMBL626634,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,,8194,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13054,,,CHEMBL626635,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,8194,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13055,,,CHEMBL626636,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,8194,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13056,,,CHEMBL626637,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,8194,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13057,Pneumocystis carinii,,CHEMBL626638,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),,13273,,50339,,,BAO_0000218,,Intermediate,,4754.0,N,1,1,
13058,Pneumocystis carinii,,CHEMBL626639,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,,13273,,50339,,,BAO_0000218,,Intermediate,,4754.0,N,1,1,
13059,Pneumocystis carinii,,CHEMBL626640,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,,13273,,50339,,,BAO_0000218,,Intermediate,,4754.0,N,1,1,
13060,Pneumocystis carinii,,CHEMBL626641,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,,13273,,50339,,,BAO_0000218,,Intermediate,,4754.0,N,1,1,
13061,Pneumocystis carinii,,CHEMBL627272,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,,13273,,50339,,,BAO_0000218,,Intermediate,,4754.0,N,1,1,
13062,Pneumocystis carinii,,CHEMBL627273,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,,13273,,50339,,,BAO_0000218,,Intermediate,,4754.0,N,1,1,
13063,Pneumocystis carinii,,CHEMBL627441,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),,13273,,50339,,,BAO_0000218,,Intermediate,,4754.0,N,1,1,
13064,Pneumocystis carinii,,CHEMBL628355,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),,13273,,50339,,,BAO_0000218,,Intermediate,,4754.0,N,1,1,
13065,Pneumocystis carinii,,CHEMBL628356,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),,13273,,50339,,,BAO_0000218,,Intermediate,,4754.0,N,1,1,
13066,Pneumocystis carinii,,CHEMBL628357,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),,13273,,50339,,,BAO_0000218,,Intermediate,,4754.0,N,1,1,
13067,Pneumocystis carinii,,CHEMBL628358,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),,13273,,50339,,,BAO_0000218,,Intermediate,,4754.0,N,1,1,
13068,Pneumocystis carinii,,CHEMBL622307,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),,13273,,50339,,,BAO_0000218,,Intermediate,,4754.0,N,1,1,
13069,,,CHEMBL622527,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,,13118,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13070,,,CHEMBL622528,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,,13118,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13071,,,CHEMBL622529,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,,13118,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13072,,,CHEMBL622992,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,,13118,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13073,,,CHEMBL622993,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,,13118,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13074,,,CHEMBL622994,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,,13118,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13075,Rattus norvegicus,,CHEMBL622995,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",,10633,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13076,Rattus norvegicus,,CHEMBL622996,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",,10633,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13077,Rattus norvegicus,,CHEMBL622997,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",,10633,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13078,Rattus norvegicus,,CHEMBL622998,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",,10633,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13079,,,CHEMBL622999,Cp max following ip administration at 1 mg/kg,,5767,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13080,,1969.0,CHEMBL623000,Maximum concentration in plasma was reported at 0.5 hour,In vivo,3302,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13081,,1969.0,CHEMBL623001,Maximum concentration in plasma was reported at 2 hour,In vivo,3302,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13082,Mus musculus,,CHEMBL623002,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,,12467,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13083,,,CHEMBL623003,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),,11778,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13084,,,CHEMBL623004,Steady state concentration was evaluated,,4321,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13085,,,CHEMBL623005,Partition coefficient (logP),,14884,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13086,,,CHEMBL623006,Partition coefficient (logD7.4),,15234,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13087,Rattus norvegicus,2107.0,CHEMBL623007,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,In vivo,14198,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13088,Rattus norvegicus,10000001.0,CHEMBL623008,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,In vivo,14198,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13089,Rattus norvegicus,2037.0,CHEMBL876654,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,In vivo,14198,Cerebellum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13090,Rattus norvegicus,,CHEMBL623009,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,In vivo,14198,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13091,Rattus norvegicus,,CHEMBL623010,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,In vivo,14198,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13092,Rattus norvegicus,948.0,CHEMBL623011,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,In vivo,14198,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13093,Rattus norvegicus,160.0,CHEMBL623012,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,In vivo,14198,Intestine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13094,,,CHEMBL623013,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,8151,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13095,,,CHEMBL623014,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,8151,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13096,,1088.0,CHEMBL623015,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,,8151,Urine,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13097,,1088.0,CHEMBL623016,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,8151,Urine,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13098,,1088.0,CHEMBL624858,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,,8151,Urine,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13099,Rattus norvegicus,,CHEMBL624859,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,,8151,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13100,Rattus norvegicus,,CHEMBL624860,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,8151,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13101,Rattus norvegicus,,CHEMBL624861,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,8151,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13102,Rattus norvegicus,,CHEMBL624862,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,8151,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13103,Rattus norvegicus,,CHEMBL624863,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,,8151,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13104,Rattus norvegicus,,CHEMBL876655,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,8151,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13105,Canis lupus familiaris,,CHEMBL624864,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13106,Canis lupus familiaris,,CHEMBL624865,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13107,Canis lupus familiaris,,CHEMBL624866,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13108,Canis lupus familiaris,,CHEMBL624867,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,,6996,,50588,,,BAO_0000218,,Expert,,9615.0,N,1,1,
13109,Canis lupus familiaris,,CHEMBL624868,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13110,Canis lupus familiaris,,CHEMBL628450,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13111,Canis lupus familiaris,,CHEMBL628451,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13112,Canis lupus familiaris,,CHEMBL628452,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13113,Canis lupus familiaris,,CHEMBL628453,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13114,Canis lupus familiaris,,CHEMBL628454,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13115,Canis lupus familiaris,,CHEMBL628455,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13116,Canis lupus familiaris,,CHEMBL628456,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13117,Canis lupus familiaris,,CHEMBL628457,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13118,Canis lupus familiaris,,CHEMBL877505,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13119,Canis lupus familiaris,,CHEMBL628458,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13120,Canis lupus familiaris,,CHEMBL628459,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13121,Canis lupus familiaris,,CHEMBL628460,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13122,Canis lupus familiaris,,CHEMBL628461,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13123,,,CHEMBL628462,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",,6996,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13124,Canis lupus familiaris,,CHEMBL628463,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13125,Rattus norvegicus,,CHEMBL625666,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",,6996,,50597,,,BAO_0000218,,Expert,,10116.0,N,1,1,
13126,,,CHEMBL625667,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,6996,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13127,Rattus norvegicus,,CHEMBL625668,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,6996,,50597,,,BAO_0000218,,Expert,,10116.0,N,1,1,
13128,Rattus norvegicus,,CHEMBL625669,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13129,,,CHEMBL625670,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,,7114,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13130,Rattus norvegicus,,CHEMBL625671,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,,7114,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13131,Human herpesvirus 1,,CHEMBL625672,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,,8613,,50602,,,BAO_0000218,,Intermediate,,10298.0,N,1,1,
13132,Human herpesvirus 1,,CHEMBL625673,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,,8613,,50602,,,BAO_0000218,,Intermediate,,10298.0,N,1,1,
13133,Human herpesvirus 1,,CHEMBL625674,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,,8613,,50602,,,BAO_0000218,,Intermediate,,10298.0,N,1,1,
13134,Human herpesvirus 1,,CHEMBL625675,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,,8613,,50602,,,BAO_0000218,,Intermediate,,10298.0,N,1,1,
13135,Human herpesvirus 1,,CHEMBL627637,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,8613,,50602,,,BAO_0000218,,Intermediate,,10298.0,N,1,1,
13136,Human herpesvirus 1,,CHEMBL627638,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,,8613,,50602,,,BAO_0000218,,Intermediate,,10298.0,N,1,1,
13137,Human herpesvirus 1,,CHEMBL627639,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,,8613,,50602,,,BAO_0000218,,Intermediate,,10298.0,N,1,1,
13138,Human herpesvirus 1,,CHEMBL627640,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,,8613,,50602,,,BAO_0000218,,Intermediate,,10298.0,N,1,1,
13139,Human herpesvirus 1,,CHEMBL627641,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,,8613,,50602,,,BAO_0000218,,Intermediate,,10298.0,N,1,1,
13140,Human herpesvirus 1,,CHEMBL627642,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,8613,,50602,,,BAO_0000218,,Intermediate,,10298.0,N,1,1,
13141,Human herpesvirus 1,,CHEMBL877506,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,8613,,50602,,,BAO_0000218,,Intermediate,,10298.0,N,1,1,
13142,Mus musculus,,CHEMBL627275,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,8613,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13143,Mustela putorius furo,,CHEMBL627643,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",,11219,,50506,,,BAO_0000218,,Intermediate,,9669.0,N,1,1,
13144,Mustela putorius furo,,CHEMBL631246,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,11219,,50506,,,BAO_0000218,,Intermediate,,9669.0,N,1,1,
13145,Mustela putorius furo,,CHEMBL631247,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,11219,,50506,,,BAO_0000218,,Intermediate,,9669.0,N,1,1,
13146,Mustela putorius furo,,CHEMBL629532,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,11219,,50506,,,BAO_0000218,,Intermediate,,9669.0,N,1,1,
13147,Mustela putorius furo,,CHEMBL629533,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,,11219,,50506,,,BAO_0000218,,Intermediate,,9669.0,N,1,1,
13148,Mustela putorius furo,,CHEMBL629534,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,11219,,50506,,,BAO_0000218,,Intermediate,,9669.0,N,1,1,
13149,Mustela putorius furo,,CHEMBL629535,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,,11219,,50506,,,BAO_0000218,,Intermediate,,9669.0,N,1,1,
13150,,,CHEMBL625932,Pharmacokinetic parameter :drug bound to plasma was reported,,14837,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13151,,,CHEMBL625933,compound was evaluated for drug bound in plasma,,14837,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13152,Rattus norvegicus,,CHEMBL625934,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,,15343,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13153,Eutheria,,CHEMBL625935,Bioavailability,,13761,,22224,,,BAO_0000218,,Autocuration,,9347.0,U,0,1,
13154,Rattus norvegicus,,CHEMBL625936,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,,14810,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13155,Rattus norvegicus,,CHEMBL625937,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,,14810,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13156,Canis lupus familiaris,,CHEMBL625938,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,13249,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13157,Rattus norvegicus,1970.0,CHEMBL625939,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,,9267,Bile,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13158,Rattus norvegicus,1970.0,CHEMBL625940,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,,9267,Bile,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13159,Rattus norvegicus,1970.0,CHEMBL874464,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,,9267,Bile,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13160,Rattus norvegicus,1970.0,CHEMBL625941,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,,9267,Bile,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13161,Rattus norvegicus,1970.0,CHEMBL625942,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,,9267,Bile,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13162,Rattus norvegicus,1970.0,CHEMBL625943,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,,9267,Bile,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13163,Homo sapiens,1977.0,CHEMBL625944,In vitro protein binding in human serum at 5 ug/ml,,15549,Serum,50587,,,BAO_0000218,,Intermediate,,9606.0,N,1,1,
13164,,,CHEMBL625945,Serum protein binding ability was measured,,10929,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13165,,,CHEMBL625946,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),,15444,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13166,Canis lupus familiaris,,CHEMBL625947,Oral bioavailability in dog,In vivo,12860,,22224,,,BAO_0000218,,Autocuration,,9615.0,U,0,1,
13167,Rattus norvegicus,,CHEMBL625948,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,In vivo,12170,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13168,,,CHEMBL625949,Absolute oral bioavailability at an iv dose of 14 mg/kg,In vivo,15173,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13169,,,CHEMBL625950,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,In vivo,15173,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13170,Eutheria,,CHEMBL625951,Oral bioavailability (dose 15 mg/kg i.v.),In vivo,15173,,22224,,,BAO_0000218,,Autocuration,,9347.0,U,0,1,
13171,,,CHEMBL625952,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,In vivo,15173,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13172,,,CHEMBL625953,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,In vivo,15173,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13173,,,CHEMBL625954,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,In vivo,15173,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13174,,,CHEMBL882959,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,In vivo,15173,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13175,Canis lupus familiaris,,CHEMBL625955,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,In vivo,11767,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13176,Mustela putorius furo,,CHEMBL625956,Bioavailability in ferret,In vivo,11219,,22224,,,BAO_0000218,,Autocuration,,9669.0,U,0,1,
13177,Macaca fascicularis,,CHEMBL625957,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,In vivo,12186,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
13178,Rattus norvegicus,,CHEMBL625958,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13179,Rattus norvegicus,,CHEMBL625959,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13180,Rattus norvegicus,,CHEMBL626642,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13181,Rattus norvegicus,,CHEMBL631330,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13182,Rattus norvegicus,,CHEMBL631331,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13183,Rattus norvegicus,,CHEMBL631332,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13184,Rattus norvegicus,,CHEMBL631333,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13185,Rattus norvegicus,,CHEMBL632018,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13186,Rattus norvegicus,,CHEMBL632019,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13187,Rattus norvegicus,,CHEMBL632020,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13188,Rattus norvegicus,,CHEMBL632021,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13189,Rattus norvegicus,,CHEMBL632022,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13190,Rattus norvegicus,,CHEMBL632023,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13191,Rattus norvegicus,,CHEMBL632024,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13192,Rattus norvegicus,,CHEMBL874472,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13193,Rattus norvegicus,,CHEMBL632025,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13194,Rattus norvegicus,,CHEMBL632026,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13195,Rattus norvegicus,,CHEMBL632027,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13196,Rattus norvegicus,,CHEMBL632028,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13197,Rattus norvegicus,,CHEMBL626430,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13198,Rattus norvegicus,,CHEMBL626431,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13199,Rattus norvegicus,,CHEMBL626432,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13200,Rattus norvegicus,,CHEMBL626433,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13201,Rattus norvegicus,,CHEMBL626434,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13202,Rattus norvegicus,,CHEMBL627280,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13203,Rattus norvegicus,,CHEMBL627281,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13204,Rattus norvegicus,,CHEMBL627282,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13205,,,CHEMBL627283,Total body clearance was measured at given dose,,7199,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13206,,,CHEMBL627284,Total body clearance was measured at given dose.,,7199,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13207,Rattus norvegicus,,CHEMBL627285,Metabolic clearance from the body in rat,,7095,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13208,,,CHEMBL627286,Renal clearance from the body,In vivo,7095,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13209,Rattus norvegicus,,CHEMBL875477,Renal clearance from the body in rat,In vivo,7095,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13210,Rattus norvegicus,,CHEMBL627287,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,In vivo,12528,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13211,Canis lupus familiaris,,CHEMBL627288,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,In vivo,12528,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13212,Rattus norvegicus,,CHEMBL627289,Total clearance from the body in rat,,7095,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13213,Rattus norvegicus,1969.0,CHEMBL627290,Clearance into cortex from rat plasma or PBS,In vivo,14223,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13214,,,CHEMBL627291,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,In vivo,13569,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13215,,,CHEMBL627292,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,In vivo,13569,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13216,,,CHEMBL627293,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,In vivo,13569,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13217,,,CHEMBL627294,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,In vivo,13569,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13218,,,CHEMBL875478,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,In vivo,13569,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13219,,,CHEMBL627295,Clearance was determined,In vivo,13979,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13220,Mus musculus,,CHEMBL627296,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,In vivo,14315,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13221,Oryctolagus cuniculus,,CHEMBL626119,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,In vivo,14315,,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
13222,Rattus norvegicus,,CHEMBL626120,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,In vivo,14315,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13223,Rattus norvegicus,,CHEMBL626121,Clearance in rat after iv dose (100 ug/kg),In vivo,12174,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13224,Cavia porcellus,,CHEMBL626122,Clearance in guinea pig,In vivo,12797,,22224,,,BAO_0000218,,Autocuration,,10141.0,U,0,1,
13225,Rattus norvegicus,,CHEMBL626123,Compound was evaluated for clearance in rat,In vivo,12797,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13226,Canis lupus familiaris,,CHEMBL623456,Compound was evaluated for the clearance in dog,In vivo,12797,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13227,Rattus norvegicus,,CHEMBL623457,Compound was evaluated for the clearance in rat,In vivo,12797,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13228,Rattus norvegicus,,CHEMBL623458,Compound was tested in vivo for clearance after iv administration in the rat,In vivo,11500,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13229,,,CHEMBL623459,IV clearance determined at an iv dose of 14 mg/kg,In vivo,15173,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13230,,,CHEMBL875484,IV clearance determined at an iv dose of 15.2 mg/kg,In vivo,15173,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13231,,,CHEMBL623460,IV clearance determined at an iv dose of 15 mg/kg,In vivo,15173,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13232,,,CHEMBL623461,IV clearance determined at an peroral dose of 30 mg/kg.,In vivo,15173,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13233,,,CHEMBL623462,IV clearance determined at an peroral dose of 30.2 mg/kg.,In vivo,15173,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13234,,,CHEMBL627386,IV clearance determined at an peroral dose of 30.3 mg/kg.,In vivo,15173,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13235,Rattus norvegicus,2113.0,CHEMBL627387,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,In vivo,14198,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13236,Rattus norvegicus,2107.0,CHEMBL627388,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,In vivo,14198,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13237,Rattus norvegicus,2048.0,CHEMBL627389,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,In vivo,14198,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13238,Rattus norvegicus,2385.0,CHEMBL627390,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,In vivo,14198,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13239,Rattus norvegicus,1969.0,CHEMBL627391,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,In vivo,14198,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13240,Rattus norvegicus,,CHEMBL627392,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,In vivo,14198,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13241,Rattus norvegicus,2106.0,CHEMBL627393,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,In vivo,14198,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13242,Rattus norvegicus,3126.0,CHEMBL627394,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,In vivo,14198,Trachea,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13243,Rattus norvegicus,10000001.0,CHEMBL627395,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,In vivo,14198,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13244,Rattus norvegicus,2037.0,CHEMBL875485,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,In vivo,14198,Cerebellum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13245,Rattus norvegicus,,CHEMBL627396,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,In vivo,14198,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13246,Rattus norvegicus,,CHEMBL627397,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,In vivo,14198,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13247,Rattus norvegicus,948.0,CHEMBL627398,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,In vivo,14198,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13248,Rattus norvegicus,10000001.0,CHEMBL627399,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,In vivo,14198,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13249,Rattus norvegicus,2113.0,CHEMBL627400,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,In vivo,14198,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13250,Rattus norvegicus,2107.0,CHEMBL627401,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,In vivo,14198,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13251,Rattus norvegicus,2048.0,CHEMBL627402,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,In vivo,14198,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13252,Rattus norvegicus,2385.0,CHEMBL627403,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,In vivo,14198,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13253,Rattus norvegicus,1969.0,CHEMBL627404,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,In vivo,14198,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13254,Rattus norvegicus,,CHEMBL623101,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,In vivo,14198,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13255,Rattus norvegicus,2106.0,CHEMBL877480,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,In vivo,14198,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13256,Rattus norvegicus,3126.0,CHEMBL623102,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,In vivo,14198,Trachea,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13257,Rattus norvegicus,10000001.0,CHEMBL623103,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,In vivo,14198,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13258,Rattus norvegicus,2037.0,CHEMBL623104,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,In vivo,14198,Cerebellum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13259,Rattus norvegicus,,CHEMBL623105,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,In vivo,14198,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13260,Rattus norvegicus,,CHEMBL623106,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,In vivo,14198,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13261,Rattus norvegicus,948.0,CHEMBL623107,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,In vivo,14198,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13262,Rattus norvegicus,160.0,CHEMBL623108,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,In vivo,14198,Intestine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13263,Rattus norvegicus,2113.0,CHEMBL623109,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,In vivo,14198,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13264,Rattus norvegicus,2107.0,CHEMBL623110,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,In vivo,14198,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13265,Rattus norvegicus,2048.0,CHEMBL623111,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,In vivo,14198,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13266,Rattus norvegicus,2385.0,CHEMBL625060,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,In vivo,14198,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13267,Rattus norvegicus,1969.0,CHEMBL625061,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,In vivo,14198,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13268,Rattus norvegicus,,CHEMBL625062,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,In vivo,14198,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13269,Rattus norvegicus,2106.0,CHEMBL625063,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,In vivo,14198,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13270,Rattus norvegicus,3126.0,CHEMBL625064,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,In vivo,14198,Trachea,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13271,Rattus norvegicus,10000001.0,CHEMBL625065,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,In vivo,14198,Bone,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13272,Rattus norvegicus,2037.0,CHEMBL625066,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,In vivo,14198,Cerebellum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13273,Rattus norvegicus,,CHEMBL625067,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,In vivo,14198,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13274,Rattus norvegicus,,CHEMBL625068,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,In vivo,14198,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13275,Rattus norvegicus,948.0,CHEMBL622159,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,In vivo,14198,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13276,Rattus norvegicus,160.0,CHEMBL622160,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,In vivo,14198,Intestine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13277,Rattus norvegicus,2113.0,CHEMBL622161,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,In vivo,14198,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13278,Rattus norvegicus,2048.0,CHEMBL622162,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,In vivo,14198,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13279,Rattus norvegicus,2385.0,CHEMBL622163,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,In vivo,14198,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13280,Rattus norvegicus,1969.0,CHEMBL622313,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,In vivo,14198,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13281,Rattus norvegicus,,CHEMBL622314,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,In vivo,14198,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13282,Rattus norvegicus,2106.0,CHEMBL622315,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,In vivo,14198,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13283,Rattus norvegicus,3126.0,CHEMBL622316,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,In vivo,14198,Trachea,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13284,Escherichia coli,,CHEMBL877486,Normal diffusion coefficient in water for Escherichia coli,,15599,,50212,,,BAO_0000218,,Intermediate,,562.0,N,1,1,
13285,,,CHEMBL622317,Average max percent decrease in RVR (renal vascular resistance) was determined,,8204,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13286,,,CHEMBL622318,Average max percent decrease in RVR (renal vascular resistance) was determined.,,8204,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13287,,,CHEMBL622319,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,,6154,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13288,,,CHEMBL622320,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,,6154,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13289,,,CHEMBL622321,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,,6154,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13290,,,CHEMBL622322,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,,6154,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13291,,,CHEMBL622323,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,,7114,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13292,Rattus norvegicus,,CHEMBL622324,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,,7114,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13293,Canis lupus familiaris,1088.0,CHEMBL622325,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,8133,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13294,Canis lupus familiaris,1088.0,CHEMBL622326,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,8133,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13295,Canis lupus familiaris,1088.0,CHEMBL877487,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",,8133,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13296,Canis lupus familiaris,1088.0,CHEMBL622327,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,8133,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13297,Canis lupus familiaris,1088.0,CHEMBL622328,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",,8133,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13298,Canis lupus familiaris,1088.0,CHEMBL622329,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,8133,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13299,Canis lupus familiaris,1088.0,CHEMBL622330,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,8133,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13300,Canis lupus familiaris,1088.0,CHEMBL622331,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,8133,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13301,Canis lupus familiaris,1088.0,CHEMBL622332,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,8133,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13302,Canis lupus familiaris,1088.0,CHEMBL622333,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",,8133,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13303,Simiiformes,1088.0,CHEMBL627658,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,8133,Urine,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
13304,Simiiformes,1088.0,CHEMBL630428,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",,8133,Urine,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
13305,Simiiformes,1088.0,CHEMBL630429,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,8133,Urine,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
13306,Simiiformes,1088.0,CHEMBL630430,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",,8133,Urine,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
13307,Simiiformes,1088.0,CHEMBL630431,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",,8133,Urine,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
13308,Rattus norvegicus,1088.0,CHEMBL630432,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13309,Rattus norvegicus,1088.0,CHEMBL630433,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13310,Rattus norvegicus,1088.0,CHEMBL630434,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13311,Rattus norvegicus,1088.0,CHEMBL629372,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13312,Rattus norvegicus,1088.0,CHEMBL629553,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13313,Rattus norvegicus,1088.0,CHEMBL629554,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13314,Rattus norvegicus,1088.0,CHEMBL874447,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13315,Rattus norvegicus,1088.0,CHEMBL629555,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13316,Rattus norvegicus,1088.0,CHEMBL629556,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13317,Rattus norvegicus,1088.0,CHEMBL629557,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13318,Rattus norvegicus,1088.0,CHEMBL629558,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13319,Rattus norvegicus,1088.0,CHEMBL629559,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13320,Rattus norvegicus,1088.0,CHEMBL629560,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13321,Canis lupus familiaris,1088.0,CHEMBL629561,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,8133,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13322,Canis lupus familiaris,1088.0,CHEMBL629562,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,8133,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13323,Canis lupus familiaris,1088.0,CHEMBL629563,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,8133,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13324,Canis lupus familiaris,1088.0,CHEMBL629564,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,8133,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13325,Canis lupus familiaris,1088.0,CHEMBL629565,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,8133,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13326,Canis lupus familiaris,1088.0,CHEMBL629566,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,8133,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13327,Canis lupus familiaris,1088.0,CHEMBL629567,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",,8133,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13328,Canis lupus familiaris,1088.0,CHEMBL629568,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,8133,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13329,Canis lupus familiaris,1088.0,CHEMBL629569,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",,8133,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13330,Canis lupus familiaris,1088.0,CHEMBL629570,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,8133,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13331,Simiiformes,1088.0,CHEMBL629571,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,8133,Urine,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
13332,Rattus norvegicus,,CHEMBL629572,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,In vivo,12170,,22224,,,BAO_0000218,,Autocuration,,10116.0,U,0,1,
13333,Rattus norvegicus,,CHEMBL629573,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,In vivo,12170,,22224,,,BAO_0000218,,Autocuration,,10116.0,U,0,1,
13334,Eutheria,,CHEMBL629574,Bioavailability (dose 20 mg/kg),In vivo,4985,,22224,,,BAO_0000218,,Autocuration,,9347.0,U,0,1,
13335,Canis lupus familiaris,,CHEMBL629575,Bioavailability in dog,In vivo,15145,,22224,,,BAO_0000218,,Autocuration,,9615.0,U,0,1,
13336,Rattus norvegicus,,CHEMBL874448,Bioavailability in rat (Sprague-Dawley) (male),In vivo,14080,,22224,,,BAO_0000218,,Autocuration,,10116.0,U,0,1,
13337,Primates,,CHEMBL629576,Bioavailability in monkey (dose 10 mg/kg i.d.),In vivo,11219,,22224,,,BAO_0000218,,Autocuration,,9443.0,U,0,1,
13338,Rattus norvegicus,,CHEMBL629577,Bioavailability in rat,In vivo,15145,,22224,,,BAO_0000218,,Autocuration,,10116.0,U,0,1,
13339,Rattus norvegicus,,CHEMBL629578,Bioavailability in rat,In vivo,15145,,22224,,,BAO_0000218,,Autocuration,,10116.0,U,0,1,
13340,Canis lupus familiaris,,CHEMBL629579,Bioavailability in dog (dose 3.0 mg/kg p.o.),In vivo,1202,,22224,,,BAO_0000218,,Autocuration,,9615.0,U,0,1,
13341,Canis lupus familiaris,,CHEMBL882958,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,In vivo,1202,,22224,,,BAO_0000218,,Autocuration,,9615.0,U,0,1,
13342,Pan troglodytes,,CHEMBL629580,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,In vivo,1202,,50505,,,BAO_0000218,,Intermediate,,9598.0,N,1,1,
13343,Eutheria,,CHEMBL629581,Bioavailability,In vivo,4026,,22224,,,BAO_0000218,,Autocuration,,9347.0,U,0,1,
13344,Saimiri,,CHEMBL629582,Bioavailability in squirrel monkey,In vivo,1492,,22224,,,BAO_0000218,,Autocuration,,9520.0,U,0,1,
13345,Canis lupus familiaris,,CHEMBL628522,Bioavailability was evaluated in dog,In vivo,12793,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13346,Cricetinae,,CHEMBL625432,Bioavailability was evaluated in hamster,In vivo,12793,,100712,,,BAO_0000218,,Intermediate,,10026.0,N,1,1,
13347,Rattus norvegicus,,CHEMBL625433,Bioavailability in rat,In vivo,12793,,22224,,,BAO_0000218,,Autocuration,,10116.0,U,0,1,
13348,Rattus norvegicus,1969.0,CHEMBL625434,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,In vivo,14793,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13349,Rattus norvegicus,1969.0,CHEMBL625435,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,In vivo,14793,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13350,Rattus norvegicus,,CHEMBL625436,Bioavailability in rat (dose 10 mg/kg p.o.),In vivo,14793,,22224,,,BAO_0000218,,Autocuration,,10116.0,U,0,1,
13351,Macaca fascicularis,,CHEMBL874588,Bioavailability was measured in cynomolgus monkeys.,In vivo,14731,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
13352,Mus musculus,,CHEMBL625437,Bioavailability was measured in nude mice.,In vivo,14731,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13353,Mustela putorius furo,,CHEMBL625438,Bioavailability in ferret (dose 10 mg/kg i.d.),In vivo,12187,,22224,,,BAO_0000218,,Autocuration,,9669.0,U,0,1,
13354,Simiiformes,,CHEMBL625439,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),In vivo,12187,,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
13355,Simiiformes,,CHEMBL625440,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",In vivo,12187,,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
13356,Simiiformes,,CHEMBL625441,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),In vivo,12187,,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
13357,Rattus norvegicus,,CHEMBL625442,Bioavailability in rat (dose 10 mg/kg i.d.),In vivo,12187,,22224,,,BAO_0000218,,Autocuration,,10116.0,U,0,1,
13358,Rattus norvegicus,,CHEMBL625443,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",In vivo,12187,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13359,,,CHEMBL625444,Bioavailability was determined; extremely poor,In vivo,17431,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13360,Mus musculus,,CHEMBL625445,% bioavailability in mice after oral administration of prodrug,In vivo,13318,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13361,Canis lupus familiaris,,CHEMBL625446,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13362,Canis lupus familiaris,,CHEMBL882960,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13363,Canis lupus familiaris,,CHEMBL625447,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13364,Canis lupus familiaris,,CHEMBL625448,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13365,Canis lupus familiaris,,CHEMBL625449,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13366,Canis lupus familiaris,,CHEMBL874589,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13367,Canis lupus familiaris,,CHEMBL625450,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13368,Canis lupus familiaris,,CHEMBL625451,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13369,Canis lupus familiaris,,CHEMBL626584,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13370,Canis lupus familiaris,,CHEMBL626585,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13371,Canis lupus familiaris,,CHEMBL626586,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13372,Canis lupus familiaris,,CHEMBL626587,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13373,Canis lupus familiaris,,CHEMBL626588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13374,Canis lupus familiaris,,CHEMBL626589,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13375,Canis lupus familiaris,,CHEMBL626590,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13376,Canis lupus familiaris,,CHEMBL626591,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13377,Canis lupus familiaris,,CHEMBL627181,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13378,Canis lupus familiaris,,CHEMBL628083,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13379,,,CHEMBL628084,IV clearance determined at an peroral dose of 15 mg/kg.,In vivo,15173,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13380,Hymenolepis nana,,CHEMBL628085,Mouse oral clearance was measured against Hymenolepiasis nana.,In vivo,7732,,50064,,,BAO_0000218,,Expert,,102285.0,N,1,1,
13381,Heligmosomoides polygyrus,,CHEMBL628086,Mouse oral clearance was measured against Nematospiroides dubius,In vivo,7732,,50545,,,BAO_0000218,,Expert,,6339.0,N,1,1,
13382,,,CHEMBL628087,Mouse oral clearance was measured against N. dubius; NT is Not Tested,In vivo,7732,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13383,Mus musculus,,CHEMBL628088,Mouse oral clearance was measured against N. nana; NT is Not Tested,In vivo,7732,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13384,,,CHEMBL628089,Mouse oral clearance was measured against N. nana; NT is Not Tested,In vivo,7732,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13385,,,CHEMBL628090,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,In vivo,8328,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13386,,,CHEMBL628091,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,In vivo,8328,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13387,,,CHEMBL628092,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,In vivo,8328,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13388,,,CHEMBL628093,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,In vivo,8328,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13389,,,CHEMBL875607,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,In vivo,8328,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13390,,,CHEMBL625710,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,In vivo,8328,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13391,,,CHEMBL625711,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,In vivo,8328,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13392,,,CHEMBL625712,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,In vivo,8328,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13393,,,CHEMBL625713,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,In vivo,8328,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13394,Canis lupus familiaris,,CHEMBL625714,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,In vivo,13376,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13395,Macaca mulatta,,CHEMBL625715,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,In vivo,13477,,50797,,,BAO_0000218,,Intermediate,,9544.0,N,1,1,
13396,Rattus norvegicus,,CHEMBL625716,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,In vivo,13477,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13397,Rattus norvegicus,,CHEMBL625717,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,In vivo,13477,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13398,Rattus norvegicus,,CHEMBL625718,Plasma clearance was determined for the compound in rats,In vivo,13313,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13399,Rattus norvegicus,,CHEMBL625719,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,In vivo,12504,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13400,Rattus norvegicus,,CHEMBL625720,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,In vivo,12504,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13401,Rattus norvegicus,,CHEMBL625721,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,In vivo,12504,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13402,Rattus norvegicus,,CHEMBL625722,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,In vivo,12504,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13403,Rattus norvegicus,,CHEMBL625723,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,In vivo,13129,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13404,Heligmosomoides polygyrus,,CHEMBL625724,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,In vivo,7732,,50545,,,BAO_0000218,,Intermediate,,6339.0,N,1,1,
13405,Heligmosomoides polygyrus,,CHEMBL625725,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,In vivo,7732,,50545,,,BAO_0000218,,Intermediate,,6339.0,N,1,1,
13406,Heligmosomoides polygyrus,,CHEMBL625726,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,In vivo,7732,,50545,,,BAO_0000218,,Intermediate,,6339.0,N,1,1,
13407,Heligmosomoides polygyrus,,CHEMBL875608,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,In vivo,7732,,50545,,,BAO_0000218,,Intermediate,,6339.0,N,1,1,
13408,Heligmosomoides polygyrus,,CHEMBL625727,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,In vivo,7732,,50545,,,BAO_0000218,,Intermediate,,6339.0,N,1,1,
13409,Rattus norvegicus,1088.0,CHEMBL625728,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,In vivo,9278,Urine,22224,,,BAO_0000218,,Autocuration,,10116.0,U,0,1,
13410,Rattus norvegicus,,CHEMBL625729,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,In vivo,9278,,22224,,,BAO_0000218,,Autocuration,,10116.0,U,0,1,
13411,Rattus norvegicus,,CHEMBL625730,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,In vivo,9278,,22224,,,BAO_0000218,,Autocuration,,10116.0,U,0,1,
13412,Rattus norvegicus,1088.0,CHEMBL625731,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,In vivo,9278,Urine,22224,,,BAO_0000218,,Autocuration,,10116.0,U,0,1,
13413,Rattus norvegicus,1088.0,CHEMBL626417,Urinary clearance was determined in rat at 25 mg/kg os dosage,In vivo,9278,Urine,22224,,,BAO_0000218,,Autocuration,,10116.0,U,0,1,
13414,Homo sapiens,1088.0,CHEMBL626418,Urinary clearance was determined at 100 mg/kg oral dosage in human,In vivo,9278,Urine,50587,,,BAO_0000218,,Intermediate,,9606.0,N,1,1,
13415,Canis lupus familiaris,1088.0,CHEMBL626419,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,In vivo,9278,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13416,Canis lupus familiaris,1969.0,CHEMBL626592,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,In vivo,5932,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13417,Rattus norvegicus,1969.0,CHEMBL626593,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,In vivo,5932,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13418,Rattus norvegicus,,CHEMBL626594,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,In vivo,5182,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13419,Canis lupus familiaris,,CHEMBL625035,Clearance rate in dogs,In vivo,10499,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13420,,,CHEMBL625036,Compound was measured for intrinsic clearance,In vitro,6051,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13421,,,CHEMBL625037,Calculated partition coefficient (clogP),,17508,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13422,,,CHEMBL625038,Calculated partition coefficient (clogP),,6228,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13423,,,CHEMBL625039,Calculated partition coefficient (clogP),,6231,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13424,,,CHEMBL625040,Calculated partition coefficient (clogP),,17740,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13425,,,CHEMBL625041,Calculated partition coefficient (clogP),,6495,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13426,,,CHEMBL625042,Calculated partition coefficient (clogP),,2171,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13427,,,CHEMBL874411,Partition coefficient of the compound,,3255,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13428,,,CHEMBL625043,Permeability,,6821,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13429,,,CHEMBL625044,Calculated partition coefficient (clogP),,2685,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13430,,,CHEMBL625045,Partition coefficient (logD),,17584,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13431,,,CHEMBL625046,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,13824,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13432,,,CHEMBL625047,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,13824,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13433,,,CHEMBL625048,Calculated partition coefficient (clogP),,16479,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13434,,,CHEMBL625049,Calculated partition coefficient (clogP),,11997,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13435,,,CHEMBL625050,Calculated logarithm of partition coefficient (P) was determined,,2988,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13436,,,CHEMBL625051,Calculated partition coefficient (clogP),,931,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13437,,,CHEMBL874412,Calculated partition coefficient (clogP),,4381,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13438,,,CHEMBL625052,Calculated partition coefficient (clogP),,4397,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13439,,,CHEMBL625053,Calculated partition coefficient (clogP),,5889,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13440,,,CHEMBL623250,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,,6154,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13441,,,CHEMBL623251,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,,6154,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13442,,,CHEMBL623252,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,,6154,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13443,,,CHEMBL623253,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,,6154,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13444,,,CHEMBL623254,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,,6154,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13445,,,CHEMBL623255,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,,6154,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13446,,,CHEMBL626831,Percent degradation of compound at a pH of 1 over a 18 hr period,,6887,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13447,,,CHEMBL877494,Percent degradation of compound at pH of 1 over an 18 hr period,,6887,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13448,,,CHEMBL626832,Delta Logarithm of Partition Coefficient value was determined.,,14116,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13449,,,CHEMBL626833,Delta logPoct-cyc,,11137,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13450,,,CHEMBL626834,Lipophilicity estimated on reversed phase TLC,,7230,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
13451,,,CHEMBL626835,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,,15741,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13452,,,CHEMBL626836,Delta logPoct-cyc,,9663,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13453,,,CHEMBL626837,Change in logarithm of partition coefficient of the compound,,9663,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13454,,,CHEMBL626838,Delta logD (pH 6.5),,13807,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13455,,,CHEMBL626839,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",,13807,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
13456,,,CHEMBL626840,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,,17425,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13457,,,CHEMBL626841,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),,12143,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13458,,,CHEMBL626842,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,,12608,,22224,,,BAO_0000219,,Autocuration,,,U,0,1,
13459,,,CHEMBL626843,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,,12608,,22224,,,BAO_0000219,,Autocuration,,,U,0,1,
13460,Rattus norvegicus,,CHEMBL626844,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,,8649,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13461,Rattus norvegicus,,CHEMBL877495,Amount of deuterium retained was reported after normal workup in rats,,8649,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13462,Rattus norvegicus,,CHEMBL626845,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,,8649,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13463,Rattus norvegicus,,CHEMBL626846,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,,8649,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13464,Rattus norvegicus,,CHEMBL626847,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,8649,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13465,Rattus norvegicus,,CHEMBL628677,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,8649,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13466,Rattus norvegicus,,CHEMBL628678,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,,8649,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13467,,,CHEMBL628679,Compound was subjected to electrochemical oxidation,,9659,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13468,,,CHEMBL628680,Compound was subjected to photochemical oxidation,,9659,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13469,,,CHEMBL628681,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,,9659,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13470,,,CHEMBL628682,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,,9659,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13471,,,CHEMBL628683,Oxidation of compound by methemoglobin in presence of hydroperoxide,,9659,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13472,Rattus norvegicus,,CHEMBL628684,Percent diffusion through fuzzy rat skin after 48 h of incubation,,9607,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13473,,,CHEMBL877501,Dissociation constant (pKa),,7057,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13474,,,CHEMBL628685,Dissociation constant value of the compound; ND means not determined.,,7057,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
13475,Rattus norvegicus,178.0,CHEMBL628686,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,,7911,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13476,Rattus norvegicus,178.0,CHEMBL628687,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,7911,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13477,Rattus norvegicus,,CHEMBL628688,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,,7911,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13478,Rattus norvegicus,,CHEMBL628689,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,7911,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13479,Rattus norvegicus,2107.0,CHEMBL628690,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,,7911,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13480,Rattus norvegicus,2107.0,CHEMBL629363,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,7911,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13481,Rattus norvegicus,2106.0,CHEMBL629364,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,,7911,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13482,Rattus norvegicus,2106.0,CHEMBL629365,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,7911,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13483,Rattus norvegicus,,CHEMBL629366,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,,7911,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13484,Rattus norvegicus,1088.0,CHEMBL629367,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,,7911,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13485,Rattus norvegicus,1988.0,CHEMBL629368,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,7911,Feces,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13486,Rattus norvegicus,1088.0,CHEMBL877502,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,7911,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13487,Mus musculus,2037.0,CHEMBL629369,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,,13792,Cerebellum,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13488,Mus musculus,955.0,CHEMBL629370,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,,13792,Brain,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13489,Simiiformes,1088.0,CHEMBL629371,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",,8133,Urine,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
13490,Simiiformes,1088.0,CHEMBL626276,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,8133,Urine,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
13491,Simiiformes,1088.0,CHEMBL626277,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,8133,Urine,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
13492,Simiiformes,1088.0,CHEMBL631250,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,8133,Urine,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
13493,Rattus norvegicus,1088.0,CHEMBL631251,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13494,Rattus norvegicus,1088.0,CHEMBL631252,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13495,Rattus norvegicus,1088.0,CHEMBL631253,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13496,Rattus norvegicus,1088.0,CHEMBL631254,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13497,Rattus norvegicus,1088.0,CHEMBL631255,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13498,Rattus norvegicus,1088.0,CHEMBL631256,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13499,Rattus norvegicus,1088.0,CHEMBL631257,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13500,Rattus norvegicus,1088.0,CHEMBL628009,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13501,Rattus norvegicus,1088.0,CHEMBL628010,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13502,Rattus norvegicus,1088.0,CHEMBL628011,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13503,Rattus norvegicus,1088.0,CHEMBL628012,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13504,Rattus norvegicus,1088.0,CHEMBL628013,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13505,Rattus norvegicus,1088.0,CHEMBL628014,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13506,Canis lupus familiaris,1088.0,CHEMBL628015,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",,8133,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13507,Canis lupus familiaris,1088.0,CHEMBL628016,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,8133,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13508,Canis lupus familiaris,1088.0,CHEMBL874461,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",,8133,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13509,Canis lupus familiaris,1088.0,CHEMBL628017,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,8133,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13510,Canis lupus familiaris,1088.0,CHEMBL628018,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,8133,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13511,Canis lupus familiaris,1088.0,CHEMBL628019,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,8133,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13512,Canis lupus familiaris,1088.0,CHEMBL628020,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,8133,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13513,Canis lupus familiaris,1088.0,CHEMBL628021,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,8133,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13514,Canis lupus familiaris,1088.0,CHEMBL628022,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,8133,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13515,Canis lupus familiaris,1088.0,CHEMBL628023,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,8133,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13516,Simiiformes,1088.0,CHEMBL628024,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,8133,Urine,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
13517,Simiiformes,1088.0,CHEMBL628025,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",,8133,Urine,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
13518,Simiiformes,1088.0,CHEMBL628026,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,8133,Urine,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
13519,Simiiformes,1088.0,CHEMBL628027,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,8133,Urine,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
13520,Simiiformes,1088.0,CHEMBL628028,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,8133,Urine,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
13521,Rattus norvegicus,1088.0,CHEMBL628029,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13522,Rattus norvegicus,1088.0,CHEMBL628030,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13523,Rattus norvegicus,1088.0,CHEMBL628031,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13524,Rattus norvegicus,1088.0,CHEMBL628032,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13525,Rattus norvegicus,1088.0,CHEMBL628033,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13526,Rattus norvegicus,1088.0,CHEMBL628034,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13527,Rattus norvegicus,1088.0,CHEMBL628035,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13528,Rattus norvegicus,1088.0,CHEMBL628036,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13529,Rattus norvegicus,1088.0,CHEMBL874462,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13530,Canis lupus familiaris,,CHEMBL628037,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13531,Canis lupus familiaris,,CHEMBL628123,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13532,Canis lupus familiaris,,CHEMBL628124,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13533,Canis lupus familiaris,,CHEMBL628125,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13534,Canis lupus familiaris,,CHEMBL628126,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13535,Canis lupus familiaris,,CHEMBL628127,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13536,Canis lupus familiaris,,CHEMBL628128,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13537,Canis lupus familiaris,,CHEMBL628129,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13538,Canis lupus familiaris,,CHEMBL628130,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13539,Canis lupus familiaris,,CHEMBL628131,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13540,Canis lupus familiaris,,CHEMBL628132,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13541,Canis lupus familiaris,,CHEMBL628133,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13542,Canis lupus familiaris,,CHEMBL628134,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13543,Canis lupus familiaris,,CHEMBL628135,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13544,Canis lupus familiaris,,CHEMBL628136,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13545,Canis lupus familiaris,,CHEMBL628137,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13546,Canis lupus familiaris,,CHEMBL628138,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13547,Canis lupus familiaris,,CHEMBL628139,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13548,Canis lupus familiaris,,CHEMBL628140,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13549,Canis lupus familiaris,,CHEMBL628141,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13550,Canis lupus familiaris,,CHEMBL628142,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13551,Canis lupus familiaris,,CHEMBL628143,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13552,Canis lupus familiaris,,CHEMBL628144,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13553,Canis lupus familiaris,,CHEMBL628145,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13554,Canis lupus familiaris,,CHEMBL628146,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13555,Canis lupus familiaris,,CHEMBL625355,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13556,Canis lupus familiaris,,CHEMBL625356,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13557,Canis lupus familiaris,,CHEMBL625357,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13558,Canis lupus familiaris,,CHEMBL625527,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13559,Canis lupus familiaris,,CHEMBL875473,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13560,Canis lupus familiaris,,CHEMBL625528,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,In vivo,9025,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13561,Rattus norvegicus,,CHEMBL626304,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,In vivo,9025,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13562,Canis lupus familiaris,1637.0,CHEMBL624138,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,In vivo,9025,Artery,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13563,,,CHEMBL624139,Calculated partition coefficient (clogP),,6448,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13564,,,CHEMBL624140,Calculated partition coefficient (clogP),,17221,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13565,,,CHEMBL624141,Calculated partition coefficient (clogP),,6545,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13566,,,CHEMBL624142,Calculated partition coefficient (clogP),,577,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13567,,,CHEMBL624143,Calculated partition coefficient (clogP),,6285,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13568,,,CHEMBL624144,Calculated partition coefficient (clogP),,6500,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13569,,,CHEMBL624145,Calculated partition coefficient (clogP),,6716,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13570,,,CHEMBL624146,Calculated partition coefficient (clogP),,13658,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13571,,,CHEMBL624147,Calculated partition coefficient (clogP),,6549,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13572,,,CHEMBL883123,Calculated partition coefficient (clogP) (MacLogP),,14685,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13573,,,CHEMBL624148,Partition coefficient (logP),,6893,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13574,,,CHEMBL874416,Kinetic parameter was determined,,3687,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13575,,,CHEMBL624149,Calculated partition coefficient (clogP),,4207,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13576,,,CHEMBL624150,Calculated partition coefficient (clogP),,4626,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13577,,,CHEMBL624151,Lipophilicity was determined,,1021,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
13578,,,CHEMBL624152,Lipophilicity was determined,,3777,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
13579,,,CHEMBL622139,Lipophilicity was determined,,17533,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
13580,,,CHEMBL622140,Calculated partition coefficient (clogP),,6524,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13581,,,CHEMBL622141,Lipophilicity was determined,,17533,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
13582,,,CHEMBL622142,Lipophilicity in octanol-water,,6480,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
13583,,,CHEMBL622143,Calculated partition coefficient (clogP),,17606,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13584,,,CHEMBL622144,Octanol-water partition coefficient was determined,,6863,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13585,,,CHEMBL877473,Partition coefficient (logP),,1356,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13586,,,CHEMBL622145,Calculated partition coefficient (clogP),,3326,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13587,,,CHEMBL622146,Partition coefficient was determined; ND means not determined,,1356,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13588,,,CHEMBL622147,Calculated partition coefficient (clogP),,12984,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13589,,,CHEMBL622148,Partition coefficient of the compound,,17363,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13590,,,CHEMBL883124,Permeability was determined,,6827,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13591,,,CHEMBL622149,The compound was evaluated for the partition coefficient,,261,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13592,,,CHEMBL622150,Partition coefficient (logP),,2685,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13593,,,CHEMBL622151,The lipophilicity was reported,,414,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
13594,,,CHEMBL622152,logarithm of the octanol-water partition coefficient for the compound,,15769,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13595,,,CHEMBL622153,Clogp value was determined,,17248,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13596,,,CHEMBL877474,Clp at a dose of 1.5 mg/kg,In vivo,16935,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13597,,,CHEMBL622154,Clp at a dose of 2.0 mg/kg,In vivo,16935,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13598,,1969.0,CHEMBL622155,"Clp, plasma clearance at a dose of 10 mg/kg",In vivo,14832,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13599,,1969.0,CHEMBL622156,"Clp, plasma clearance at a dose of 50 mg/kg",In vivo,14832,Plasma,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13600,Rattus norvegicus,1969.0,CHEMBL622157,Compound was tested for plasma clearance in rat,In vivo,2399,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13601,Rattus norvegicus,1969.0,CHEMBL622158,Compound was tested for plasma clearance in rat; Not determined,In vivo,2399,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13602,Rattus norvegicus,,CHEMBL622807,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,In vivo,6227,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13603,Macaca mulatta,,CHEMBL622808,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,In vivo,6227,,50797,,,BAO_0000218,,Intermediate,,9544.0,N,1,1,
13604,,,CHEMBL622809,Plasma clearance by iv administration at a dose 0.003 ug/mL,In vivo,5623,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13605,,,CHEMBL622810,Plasma clearance determined,In vivo,4854,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13606,Cricetinae,,CHEMBL876653,Plasma clearance after iv administration at 3 mg/kg in hamster,In vivo,4493,,100712,,,BAO_0000218,,Intermediate,,10026.0,N,1,1,
13607,Cricetinae,,CHEMBL622811,Plasma clearance after iv administration at 4 mg/kg in hamster,In vivo,4493,,100712,,,BAO_0000218,,Intermediate,,10026.0,N,1,1,
13608,Rattus norvegicus,,CHEMBL622986,Rate of clearance in rat was determined,In vivo,14956,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13609,Rattus norvegicus,1969.0,CHEMBL622987,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,In vivo,15372,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13610,Rattus norvegicus,1969.0,CHEMBL622988,Total plasma clearance after iv dose of 5.10 mg/kg in rats,In vivo,15372,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13611,Rattus norvegicus,1969.0,CHEMBL622989,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,In vivo,15372,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13612,Rattus norvegicus,1969.0,CHEMBL622990,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,In vivo,15372,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13613,Simiiformes,1969.0,CHEMBL622991,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,In vivo,15604,Plasma,22224,,,BAO_0000218,,Autocuration,,314293.0,U,0,1,
13614,Rattus norvegicus,1969.0,CHEMBL622227,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,In vivo,15604,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13615,Canis lupus familiaris,1969.0,CHEMBL622228,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,In vivo,15604,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13616,Rattus norvegicus,,CHEMBL622229,Clpl value in rat,In vivo,14964,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13617,Cavia porcellus,,CHEMBL622230,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,In vivo,15240,,50512,,,BAO_0000218,,Intermediate,,10141.0,N,1,1,
13618,Rattus norvegicus,,CHEMBL622231,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,In vivo,16449,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13619,Macaca fascicularis,,CHEMBL622232,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,In vivo,16449,,100710,,,BAO_0000218,,Intermediate,,9541.0,N,1,1,
13620,,,CHEMBL622233,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,In vivo,12902,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13621,,,CHEMBL622234,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,In vivo,12902,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13622,,,CHEMBL622235,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,In vivo,12902,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13623,,,CHEMBL622236,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,In vivo,12902,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13624,,,CHEMBL622237,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,In vivo,12902,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13625,,,CHEMBL877482,Cmax in minutes at a po dose of 10.0(pmol/g/h).,In vivo,12902,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13626,,,CHEMBL622238,Cmax in minutes at a po dose of 20.0(pmol/g/h).,In vivo,12902,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13627,,,CHEMBL622239,Cmax in minutes at a po dose of 40.0(pmol/g/h).,In vivo,12902,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13628,,178.0,CHEMBL622240,Cmax was calculated as maximum concentration reached in the blood,In vivo,11149,Blood,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13629,,178.0,CHEMBL622241,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,In vivo,11149,Blood,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13630,Rattus norvegicus,,CHEMBL631013,Cmax was determine after peroral administration at 10 mpk in Rat,In vivo,5669,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13631,Macaca mulatta,,CHEMBL631014,Cmax was determine after peroral administration at 10 mpk in Rhesus,In vivo,5669,,50797,,,BAO_0000218,,Intermediate,,9544.0,N,1,1,
13632,Canis lupus familiaris,,CHEMBL631015,Cmax was determine after peroral administration at 10 mpk in dog,In vivo,5669,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13633,Rattus norvegicus,,CHEMBL631016,Cmax was determine after peroral administration at 160 mpk in Rat,In vivo,5669,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13634,Rattus norvegicus,,CHEMBL631017,Cmax was determine after peroral administration at 20 mpk in Rat,In vivo,5669,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13635,Rattus norvegicus,,CHEMBL631018,Cmax was determine after peroral administration at 50 mpk in Rat,In vivo,5669,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13636,,,CHEMBL631019,Cmax was determined,In vivo,4236,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
13637,Mus musculus,955.0,CHEMBL875761,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,,13792,Brain,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13638,Mus musculus,955.0,CHEMBL631020,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,,13792,Brain,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13639,Mus musculus,955.0,CHEMBL631669,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,,13792,Brain,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13640,Mus musculus,955.0,CHEMBL631670,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,,13792,Brain,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13641,Mus musculus,2435.0,CHEMBL631671,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,,13792,Striatum,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13642,Rattus norvegicus,178.0,CHEMBL631672,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,,8418,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13643,Rattus norvegicus,178.0,CHEMBL631673,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,,8418,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13644,Rattus norvegicus,178.0,CHEMBL631856,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,,8418,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13645,Rattus norvegicus,178.0,CHEMBL631857,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,,8418,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13646,Rattus norvegicus,178.0,CHEMBL631858,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,,8418,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13647,Rattus norvegicus,178.0,CHEMBL631859,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,,8418,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13648,Rattus norvegicus,178.0,CHEMBL631860,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,,8418,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13649,Rattus norvegicus,178.0,CHEMBL631861,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,,8418,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13650,Rattus norvegicus,178.0,CHEMBL631862,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,,8418,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13651,Rattus norvegicus,178.0,CHEMBL631863,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,,8418,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13652,Rattus norvegicus,178.0,CHEMBL631864,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,,8418,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13653,Rattus norvegicus,178.0,CHEMBL631865,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,,8418,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13654,Rattus norvegicus,178.0,CHEMBL631866,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,,8418,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13655,Rattus norvegicus,178.0,CHEMBL629360,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,,8418,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13656,Rattus norvegicus,178.0,CHEMBL629361,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,,8418,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13657,Rattus norvegicus,178.0,CHEMBL629362,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,,8418,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13658,Rattus norvegicus,178.0,CHEMBL630740,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,,8418,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13659,Rattus norvegicus,178.0,CHEMBL630741,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,,8418,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13660,Rattus norvegicus,178.0,CHEMBL630742,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,,8418,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13661,Rattus norvegicus,,CHEMBL630743,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,,8418,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13662,Rattus norvegicus,,CHEMBL630744,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,,8418,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13663,Rattus norvegicus,,CHEMBL630745,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,,8418,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13664,Rattus norvegicus,,CHEMBL630746,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,,8418,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13665,Rattus norvegicus,,CHEMBL630747,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,,8418,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13666,Rattus norvegicus,,CHEMBL630748,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,,8418,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13667,Rattus norvegicus,,CHEMBL632056,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,,8418,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13668,Rattus norvegicus,,CHEMBL632057,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,,8418,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13669,Rattus norvegicus,,CHEMBL632058,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,,8418,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13670,Rattus norvegicus,,CHEMBL632059,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,,8418,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13671,Rattus norvegicus,,CHEMBL632060,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,,8418,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13672,Rattus norvegicus,,CHEMBL632061,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,,8418,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13673,Rattus norvegicus,,CHEMBL629207,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,,8418,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13674,Rattus norvegicus,,CHEMBL629208,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,,8418,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13675,Rattus norvegicus,,CHEMBL629209,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,,8418,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13676,Rattus norvegicus,,CHEMBL629210,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,,8418,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13677,Rattus norvegicus,,CHEMBL629211,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,,8418,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13678,Rattus norvegicus,,CHEMBL629212,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,,8418,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13679,Rattus norvegicus,,CHEMBL629213,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,,8418,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13680,Rattus norvegicus,1088.0,CHEMBL629214,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13681,Rattus norvegicus,1088.0,CHEMBL629215,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13682,Rattus norvegicus,1088.0,CHEMBL635154,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",,8133,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13683,Rattus norvegicus,,CHEMBL629216,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13684,Rattus norvegicus,,CHEMBL629217,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13685,Rattus norvegicus,,CHEMBL629218,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13686,Rattus norvegicus,,CHEMBL629219,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13687,Rattus norvegicus,,CHEMBL629220,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13688,Rattus norvegicus,,CHEMBL629221,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13689,Rattus norvegicus,,CHEMBL631127,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13690,Rattus norvegicus,,CHEMBL631128,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13691,Rattus norvegicus,,CHEMBL631129,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13692,Rattus norvegicus,,CHEMBL631130,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13693,Rattus norvegicus,,CHEMBL631131,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13694,Rattus norvegicus,,CHEMBL631132,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13695,Rattus norvegicus,,CHEMBL631133,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13696,Rattus norvegicus,,CHEMBL631134,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13697,Rattus norvegicus,,CHEMBL875120,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13698,Rattus norvegicus,,CHEMBL631135,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13699,Rattus norvegicus,,CHEMBL631136,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13700,Rattus norvegicus,,CHEMBL631137,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13701,Rattus norvegicus,,CHEMBL631138,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13702,Rattus norvegicus,,CHEMBL631139,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13703,Rattus norvegicus,,CHEMBL631140,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13704,Rattus norvegicus,,CHEMBL631141,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13705,Rattus norvegicus,,CHEMBL631142,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13706,Rattus norvegicus,,CHEMBL631143,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13707,Rattus norvegicus,,CHEMBL631144,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,6996,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13708,Canis lupus familiaris,,CHEMBL631145,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13709,Canis lupus familiaris,,CHEMBL631146,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13710,Canis lupus familiaris,,CHEMBL631147,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13711,Canis lupus familiaris,,CHEMBL631148,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13712,Canis lupus familiaris,,CHEMBL631149,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13713,Canis lupus familiaris,,CHEMBL631150,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13714,Canis lupus familiaris,,CHEMBL631151,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13715,Canis lupus familiaris,,CHEMBL631152,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13716,Canis lupus familiaris,,CHEMBL631443,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13717,Canis lupus familiaris,,CHEMBL631444,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13718,Canis lupus familiaris,,CHEMBL631445,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13719,Canis lupus familiaris,,CHEMBL631446,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13720,Canis lupus familiaris,,CHEMBL631447,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13721,Canis lupus familiaris,,CHEMBL631448,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13722,Canis lupus familiaris,,CHEMBL631449,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13723,Canis lupus familiaris,,CHEMBL631450,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13724,Canis lupus familiaris,,CHEMBL629724,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,6996,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13725,Mus musculus,14.0,CHEMBL629725,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,9716,Zone of skin,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13726,Mus musculus,14.0,CHEMBL629726,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,9716,Zone of skin,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13727,Mus musculus,2106.0,CHEMBL629727,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,9716,Spleen,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13728,Mus musculus,2106.0,CHEMBL630404,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,9716,Spleen,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13729,Mus musculus,2106.0,CHEMBL630405,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,9716,Spleen,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13730,Mus musculus,2106.0,CHEMBL630406,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,9716,Spleen,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13731,Mus musculus,945.0,CHEMBL630407,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,9716,Stomach,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13732,Mus musculus,945.0,CHEMBL630573,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,9716,Stomach,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13733,Mus musculus,945.0,CHEMBL630574,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,9716,Stomach,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13734,Mus musculus,945.0,CHEMBL630575,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,9716,Stomach,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13735,Mus musculus,,CHEMBL630576,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,9716,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13736,Mus musculus,,CHEMBL630577,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,9716,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13737,Mus musculus,,CHEMBL630578,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,9716,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13738,Mus musculus,,CHEMBL630579,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",In vivo,9716,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13739,Mus musculus,2113.0,CHEMBL630580,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),,12192,Kidney,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13740,Mus musculus,2113.0,CHEMBL630581,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,,12192,Kidney,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13741,Mus musculus,2113.0,CHEMBL630582,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),,12192,Kidney,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13742,Mus musculus,,CHEMBL630583,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,,12192,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13743,Mus musculus,,CHEMBL630584,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),,12192,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13744,Mus musculus,,CHEMBL630585,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,,12192,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13745,Mus musculus,,CHEMBL630586,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),,12192,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13746,Mus musculus,,CHEMBL630587,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,,12192,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13747,Mus musculus,,CHEMBL630588,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),,12192,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13748,Mus musculus,,CHEMBL630589,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,,12192,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13749,Mus musculus,,CHEMBL630590,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),,12192,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13750,,1988.0,CHEMBL630591,Removal of 238-Plutonium(IV) in feces at 24 h,,12192,Feces,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13751,,1988.0,CHEMBL630592,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),,12192,Feces,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13752,,,CHEMBL630593,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,,12192,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13753,,,CHEMBL630594,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),,12192,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13754,,1088.0,CHEMBL630595,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),,12192,Urine,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13755,,1088.0,CHEMBL630596,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),,12192,Urine,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13756,,1088.0,CHEMBL630597,Removal of 238-Plutonium(IV) in urine after 0-24 h,,12192,Urine,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13757,,1088.0,CHEMBL630598,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),,12192,Urine,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13758,,1088.0,CHEMBL630599,Removal of 238-Plutonium(IV) in urine after 0-4 h,,12192,Urine,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13759,,1088.0,CHEMBL630600,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),,12192,Urine,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13760,,1088.0,CHEMBL630601,Removal of 238-Plutonium(IV) in urine after 4-24 h,,12192,Urine,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13761,,1088.0,CHEMBL630602,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),,12192,Urine,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13762,,1088.0,CHEMBL630603,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),,12192,Urine,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13763,,1088.0,CHEMBL630604,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),,12192,Urine,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13764,Rattus norvegicus,178.0,CHEMBL624869,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13765,Rattus norvegicus,178.0,CHEMBL624870,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13766,Rattus norvegicus,178.0,CHEMBL623189,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,12017,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13767,Rattus norvegicus,178.0,CHEMBL623190,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13768,Rattus norvegicus,178.0,CHEMBL623191,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13769,Rattus norvegicus,,CHEMBL623192,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13770,Rattus norvegicus,,CHEMBL623193,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13771,Rattus norvegicus,,CHEMBL623194,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,12017,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13772,Rattus norvegicus,,CHEMBL623195,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13773,Rattus norvegicus,,CHEMBL623196,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13774,Rattus norvegicus,,CHEMBL623197,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,,11836,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13775,Rattus norvegicus,,CHEMBL623198,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,11836,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13776,Rattus norvegicus,,CHEMBL623199,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,11836,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13777,Rattus norvegicus,2385.0,CHEMBL623200,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,,11836,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13778,Rattus norvegicus,2385.0,CHEMBL623201,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,,11836,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13779,Rattus norvegicus,2385.0,CHEMBL623202,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,,11836,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13780,Rattus norvegicus,2385.0,CHEMBL623203,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,,11836,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13781,Rattus norvegicus,2385.0,CHEMBL623204,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,,11836,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13782,Rattus norvegicus,2385.0,CHEMBL623205,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,,11836,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13783,Rattus norvegicus,2385.0,CHEMBL623206,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,11836,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13784,Rattus norvegicus,2385.0,CHEMBL623207,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,,11836,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13785,Rattus norvegicus,2385.0,CHEMBL623208,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,,11836,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13786,Rattus norvegicus,2385.0,CHEMBL623209,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,11836,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13787,Rattus norvegicus,2385.0,CHEMBL623210,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,11836,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13788,Rattus norvegicus,,CHEMBL623211,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,11836,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13789,Rattus norvegicus,995.0,CHEMBL623212,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,11836,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13790,,,CHEMBL623213,Tested in vitro for intrinsic activity relative to quinpirole,,12640,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13791,,,CHEMBL623214,"Relative ion enhancement, determined in pulsed ultrafiltration",,14218,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13792,,,CHEMBL623215,% ionization at the pH 7.4 at 37 degree Centigrade,,11296,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13793,,,CHEMBL623216,Percentage ionization was measured,,10929,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13794,Bos taurus,,CHEMBL623217,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,,13841,,50591,,,BAO_0000218,,Intermediate,,9913.0,N,1,1,
13795,,,CHEMBL623218,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,,10431,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13796,,,CHEMBL623913,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,,10431,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13797,,,CHEMBL623914,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,,10431,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13798,,,CHEMBL623915,Compound was evaluated for the partition coefficient in octanol/water,,8826,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13799,,,CHEMBL624080,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),,8826,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13800,,,CHEMBL624081,Equilibrium constant measured by the pulse radiolysis at pH 7,,9884,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13801,Homo sapiens,,CHEMBL624082,In vitro hydrolytic rate constant determined in human blood,,9827,,50587,,,BAO_0000218,,Intermediate,,9606.0,N,1,1,
13802,Homo sapiens,,CHEMBL625054,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,,10009,,50587,,,BAO_0000218,,Intermediate,,9606.0,N,1,1,
13803,,,CHEMBL877485,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,,10009,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13804,Mus musculus,,CHEMBL625055,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,,10009,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13805,Mus musculus,,CHEMBL625056,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,,10009,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13806,Homo sapiens,,CHEMBL625057,In vitro oxidation of compound in presence of human plasma,,10009,,50587,,,BAO_0000218,,Intermediate,,9606.0,N,1,1,
13807,,,CHEMBL625058,In vitro oxidation of compound in presence of hydrogen peroxide,,10009,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13808,Mus musculus,,CHEMBL625059,In vitro oxidation of compound in presence of mouse brain homogenate,,10009,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13809,Mus musculus,,CHEMBL629536,In vitro oxidation of compound in presence of mouse liver homogenate,,10009,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13810,Rattus norvegicus,,CHEMBL629537,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13811,Rattus norvegicus,,CHEMBL629538,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13812,Rattus norvegicus,,CHEMBL629539,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13813,Rattus norvegicus,,CHEMBL874445,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13814,Rattus norvegicus,,CHEMBL629540,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13815,Rattus norvegicus,,CHEMBL629541,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13816,Rattus norvegicus,,CHEMBL629542,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13817,Rattus norvegicus,,CHEMBL630243,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13818,Rattus norvegicus,,CHEMBL630244,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13819,Rattus norvegicus,,CHEMBL630245,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13820,Rattus norvegicus,,CHEMBL630246,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13821,Rattus norvegicus,,CHEMBL630247,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13822,Rattus norvegicus,,CHEMBL630248,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13823,Rattus norvegicus,178.0,CHEMBL630249,Biodistribution in rat blood at 240 minutes after dose administration.,In vivo,13100,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13824,Rattus norvegicus,178.0,CHEMBL630250,Biodistribution in rat blood at 30 minutes after dose administration.,In vivo,13100,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13825,Rattus norvegicus,178.0,CHEMBL630251,Biodistribution in rat blood at 360 minutes after dose administration.,In vivo,13100,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13826,Rattus norvegicus,178.0,CHEMBL630252,Biodistribution in rat blood at 3 hr after dose administration.,In vivo,13100,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13827,Rattus norvegicus,178.0,CHEMBL630408,Biodistribution in rat blood at 60 minutes after dose administration.,In vivo,13100,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13828,Rattus norvegicus,2037.0,CHEMBL630409,Biodistribution in rat cerebellum at 120 minutes after dose administration.,In vivo,13100,Cerebellum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13829,Rattus norvegicus,2037.0,CHEMBL874446,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,In vivo,13100,Cerebellum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13830,Rattus norvegicus,2037.0,CHEMBL630410,Biodistribution in rat cerebellum at 15 minutes after dose administration.,In vivo,13100,Cerebellum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13831,Rattus norvegicus,2037.0,CHEMBL630411,Biodistribution in rat cerebellum at 240 minutes after dose administration.,In vivo,13100,Cerebellum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13832,Rattus norvegicus,2037.0,CHEMBL630412,Biodistribution in rat cerebellum at 30 minutes after dose administration.,In vivo,13100,Cerebellum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13833,Rattus norvegicus,2037.0,CHEMBL630413,Biodistribution in rat cerebellum at 360 minutes after dose administration.,In vivo,13100,Cerebellum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13834,Rattus norvegicus,2037.0,CHEMBL630414,Biodistribution in rat cerebellum at 3 hr after dose administration.,In vivo,13100,Cerebellum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13835,Rattus norvegicus,2037.0,CHEMBL630415,Biodistribution in rat cerebellum at 60 minutes after dose administration.,In vivo,13100,Cerebellum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13836,Rattus norvegicus,,CHEMBL630416,Biodistribution in rat cortex at 120 minutes after dose administration.,In vivo,13100,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13837,Rattus norvegicus,,CHEMBL630417,Biodistribution in rat cortex at 1440 minutes after dose administration.,In vivo,13100,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13838,Rattus norvegicus,,CHEMBL630418,Biodistribution in rat cortex at 15 minutes after dose administration.,In vivo,13100,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13839,Rattus norvegicus,,CHEMBL630419,Biodistribution in rat cortex at 240 minutes after dose administration.,In vivo,13100,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13840,Rattus norvegicus,,CHEMBL630420,Biodistribution in rat cortex at 30 minutes after dose administration.,In vivo,13100,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13841,Rattus norvegicus,,CHEMBL630421,Biodistribution in rat cortex at 360 minutes after dose administration.,In vivo,13100,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13842,Rattus norvegicus,,CHEMBL630422,Biodistribution in rat cortex at 3 hr after dose administration.,In vivo,13100,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13843,Rattus norvegicus,,CHEMBL630423,Biodistribution in rat cortex at 60 minutes after dose administration.,In vivo,13100,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13844,Rattus norvegicus,948.0,CHEMBL630424,Biodistribution in rat heart at 120 minutes after dose administration.,In vivo,13100,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13845,Rattus norvegicus,948.0,CHEMBL630425,Biodistribution in rat heart at 15 minutes after dose administration.,In vivo,13100,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13846,Rattus norvegicus,948.0,CHEMBL629462,Biodistribution in rat heart at 240 minutes after dose administration.,In vivo,13100,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13847,Rattus norvegicus,948.0,CHEMBL630426,Biodistribution in rat heart at 30 minutes after dose administration.,In vivo,13100,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13848,Rattus norvegicus,948.0,CHEMBL630427,Biodistribution in rat heart at 360 minutes after dose administration.,In vivo,13100,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13849,Rattus norvegicus,948.0,CHEMBL625877,Biodistribution in rat heart at 3 hr after dose administration.,In vivo,13100,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13850,Rattus norvegicus,948.0,CHEMBL625878,Biodistribution in rat heart at 60 minutes after dose administration.,In vivo,13100,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13851,Rattus norvegicus,10000000.0,CHEMBL625879,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,In vivo,13100,Hippocampus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13852,Rattus norvegicus,10000000.0,CHEMBL625880,Biodistribution in rat hippocampus at 240 minutes after dose administration.,In vivo,13100,Hippocampus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13853,Rattus norvegicus,10000000.0,CHEMBL625881,Biodistribution in rat hippocampus at 30 minutes after dose administration.,In vivo,13100,Hippocampus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13854,Rattus norvegicus,10000000.0,CHEMBL625882,Biodistribution in rat hippocampus at 360 minutes after dose administration.,In vivo,13100,Hippocampus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13855,Rattus norvegicus,10000000.0,CHEMBL625883,Biodistribution in rat hippocampus at 15 minutes after dose administration.,In vivo,13100,Hippocampus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13856,Rattus norvegicus,2113.0,CHEMBL625884,Biodistribution in rat kidney at 120 minutes after dose administration.,In vivo,13100,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13857,Rattus norvegicus,2113.0,CHEMBL625885,Biodistribution in rat kidney at 1440 minutes after dose administration.,In vivo,13100,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13858,Rattus norvegicus,2113.0,CHEMBL628649,Biodistribution in rat kidney at 15 minutes after dose administration.,In vivo,13100,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13859,Rattus norvegicus,2113.0,CHEMBL628650,Biodistribution in rat kidney at 240 minutes after dose administration.,In vivo,13100,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13860,Rattus norvegicus,2113.0,CHEMBL628651,Biodistribution in rat kidney at 30 minutes after dose administration.,In vivo,13100,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13861,Rattus norvegicus,2113.0,CHEMBL628652,Biodistribution in rat kidney at 360 minutes after dose administration.,In vivo,13100,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13862,Rattus norvegicus,2113.0,CHEMBL628653,Biodistribution in rat kidney at 60 minutes after dose administration.,In vivo,13100,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13863,Rattus norvegicus,2107.0,CHEMBL628654,Biodistribution in rat liver at 120 minutes after dose administration.,In vivo,13100,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13864,Rattus norvegicus,2107.0,CHEMBL628655,Biodistribution in rat liver at 1440 minutes after dose administration.,In vivo,13100,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13865,Rattus norvegicus,2107.0,CHEMBL625238,Biodistribution in rat liver at 15 minutes after dose administration.,In vivo,13100,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13866,Rattus norvegicus,2107.0,CHEMBL625239,Biodistribution in rat liver at 240 minutes after dose administration.,In vivo,13100,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13867,Rattus norvegicus,2107.0,CHEMBL625240,Biodistribution in rat liver at 30 minutes after dose administration.,In vivo,13100,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13868,Rattus norvegicus,2107.0,CHEMBL625241,Biodistribution in rat liver at 360 minutes after dose administration.,In vivo,13100,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13869,Rattus norvegicus,2107.0,CHEMBL625242,Biodistribution in rat liver at 60 minutes after dose administration.,In vivo,13100,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13870,Rattus norvegicus,2048.0,CHEMBL874587,Biodistribution in rat lung at 120 minutes after dose administration.,In vivo,13100,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13871,Rattus norvegicus,2048.0,CHEMBL625405,Biodistribution in rat lung at 1440 minutes after dose administration.,In vivo,13100,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13872,Rattus norvegicus,2048.0,CHEMBL625406,Biodistribution in rat lung at 15 minutes after dose administration.,In vivo,13100,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13873,Rattus norvegicus,2048.0,CHEMBL625407,Biodistribution in rat lung at 240 minutes after dose administration.,In vivo,13100,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13874,Rattus norvegicus,2048.0,CHEMBL625408,Biodistribution in rat lung at 30 minutes after dose administration.,In vivo,13100,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13875,Rattus norvegicus,2048.0,CHEMBL625409,Biodistribution in rat lung at 360 minutes after dose administration.,In vivo,13100,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13876,Rattus norvegicus,1515.0,CHEMBL625410,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,,12361,Thoracic aorta,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13877,Rattus norvegicus,1515.0,CHEMBL625411,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,,12361,Thoracic aorta,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13878,Rattus norvegicus,1515.0,CHEMBL625412,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,,12361,Thoracic aorta,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13879,Rattus norvegicus,1515.0,CHEMBL625413,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,,12361,Thoracic aorta,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13880,Rattus norvegicus,1515.0,CHEMBL625414,Percent of maximal contractile response to compound in rat thoracic aorta strips v,,12361,Thoracic aorta,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13881,Rattus norvegicus,1515.0,CHEMBL625415,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,,12361,Thoracic aorta,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13882,Rattus norvegicus,1515.0,CHEMBL625416,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,,12361,Thoracic aorta,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13883,Rattus norvegicus,1088.0,CHEMBL625417,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,,12712,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13884,Rattus norvegicus,1988.0,CHEMBL625418,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,,7415,Feces,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13885,Rattus norvegicus,1088.0,CHEMBL625419,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,,7415,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13886,Rattus norvegicus,,CHEMBL625420,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,,7415,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13887,Rattus norvegicus,,CHEMBL626996,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,,7415,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13888,Rattus norvegicus,1988.0,CHEMBL626997,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",,7415,Feces,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13889,Rattus norvegicus,1088.0,CHEMBL626998,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",,7415,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13890,Rattus norvegicus,,CHEMBL626999,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",,7415,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13891,Mus musculus,,CHEMBL627000,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,,8050,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13892,Mus musculus,,CHEMBL627001,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,,8050,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13893,Mus musculus,,CHEMBL627002,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,,8050,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13894,Mus musculus,,CHEMBL627003,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,,8050,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13895,Mus musculus,1088.0,CHEMBL627004,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,,8050,Urine,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13896,Mus musculus,1088.0,CHEMBL627005,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,,8050,Urine,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13897,Mus musculus,1088.0,CHEMBL874594,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,,8050,Urine,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13898,Mus musculus,1088.0,CHEMBL627006,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,,8050,Urine,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13899,Mus musculus,1088.0,CHEMBL627007,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,,8050,Urine,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13900,Mus musculus,1088.0,CHEMBL627884,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,,8050,Urine,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13901,Mus musculus,1088.0,CHEMBL627885,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,,8050,Urine,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13902,Mus musculus,1088.0,CHEMBL627886,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,,8050,Urine,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13903,Mus musculus,1088.0,CHEMBL627887,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,,8050,Urine,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13904,Mus musculus,1088.0,CHEMBL627888,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,,8050,Urine,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13905,Mus musculus,1088.0,CHEMBL628057,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,,8050,Urine,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13906,Mus musculus,1088.0,CHEMBL627405,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,,8050,Urine,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
13907,Canis lupus familiaris,1088.0,CHEMBL627406,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13908,Canis lupus familiaris,1088.0,CHEMBL627407,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13909,Canis lupus familiaris,1088.0,CHEMBL627408,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13910,Canis lupus familiaris,1088.0,CHEMBL627409,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13911,Canis lupus familiaris,1088.0,CHEMBL875486,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13912,Canis lupus familiaris,1088.0,CHEMBL627410,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13913,Canis lupus familiaris,1088.0,CHEMBL627411,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13914,Canis lupus familiaris,1088.0,CHEMBL627412,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13915,Canis lupus familiaris,1088.0,CHEMBL627413,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13916,Canis lupus familiaris,1088.0,CHEMBL627414,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13917,Canis lupus familiaris,1088.0,CHEMBL627415,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13918,Canis lupus familiaris,1088.0,CHEMBL627416,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13919,Canis lupus familiaris,1088.0,CHEMBL627417,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13920,Canis lupus familiaris,1088.0,CHEMBL627418,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13921,Canis lupus familiaris,1088.0,CHEMBL627419,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13922,Canis lupus familiaris,1088.0,CHEMBL627320,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13923,Canis lupus familiaris,1088.0,CHEMBL627321,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
13924,Rattus norvegicus,2113.0,CHEMBL627322,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13925,Rattus norvegicus,2113.0,CHEMBL627323,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13926,Rattus norvegicus,2113.0,CHEMBL627491,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,12017,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13927,Rattus norvegicus,2113.0,CHEMBL627492,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13928,Rattus norvegicus,2113.0,CHEMBL627493,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13929,Rattus norvegicus,2107.0,CHEMBL627494,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13930,Rattus norvegicus,2107.0,CHEMBL627495,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13931,Rattus norvegicus,2107.0,CHEMBL627496,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,12017,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13932,Rattus norvegicus,2107.0,CHEMBL627497,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13933,Rattus norvegicus,2107.0,CHEMBL627498,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13934,Rattus norvegicus,2048.0,CHEMBL627499,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13935,Rattus norvegicus,2048.0,CHEMBL627500,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13936,Rattus norvegicus,2048.0,CHEMBL627501,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,12017,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13937,Rattus norvegicus,2048.0,CHEMBL625616,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13938,Rattus norvegicus,2048.0,CHEMBL625617,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13939,Rattus norvegicus,2385.0,CHEMBL625618,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13940,Rattus norvegicus,2385.0,CHEMBL625619,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13941,Rattus norvegicus,2385.0,CHEMBL625620,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,12017,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13942,Rattus norvegicus,2385.0,CHEMBL625621,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13943,Rattus norvegicus,2385.0,CHEMBL625622,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13944,Rattus norvegicus,2106.0,CHEMBL625788,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13945,Rattus norvegicus,2106.0,CHEMBL625789,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13946,Rattus norvegicus,2106.0,CHEMBL625790,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,12017,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13947,Rattus norvegicus,2106.0,CHEMBL625791,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13948,Rattus norvegicus,2106.0,CHEMBL622334,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13949,Rattus norvegicus,2046.0,CHEMBL622335,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13950,Rattus norvegicus,2046.0,CHEMBL622336,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13951,Rattus norvegicus,2046.0,CHEMBL622337,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,12017,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13952,Rattus norvegicus,2046.0,CHEMBL622338,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13953,Rattus norvegicus,2046.0,CHEMBL622339,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13954,Rattus norvegicus,,CHEMBL624153,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13955,Rattus norvegicus,,CHEMBL628430,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13956,Rattus norvegicus,,CHEMBL628431,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,12017,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13957,Rattus norvegicus,,CHEMBL628432,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13958,Rattus norvegicus,,CHEMBL628433,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13959,Rattus norvegicus,2106.0,CHEMBL628434,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",In vivo,12017,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13960,Rattus norvegicus,2106.0,CHEMBL626789,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",In vivo,12017,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13961,Rattus norvegicus,2106.0,CHEMBL626790,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",In vivo,12017,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13962,Rattus norvegicus,2106.0,CHEMBL626791,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",In vivo,12017,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13963,Rattus norvegicus,2106.0,CHEMBL626792,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",In vivo,12017,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13964,Rattus norvegicus,2106.0,CHEMBL626793,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",In vivo,12017,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13965,Rattus norvegicus,,CHEMBL627436,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13966,Rattus norvegicus,,CHEMBL627437,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13967,Rattus norvegicus,,CHEMBL627438,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13968,Rattus norvegicus,,CHEMBL627439,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13969,Rattus norvegicus,,CHEMBL627440,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13970,Rattus norvegicus,,CHEMBL627602,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13971,Rattus norvegicus,,CHEMBL627603,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13972,Rattus norvegicus,,CHEMBL627604,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13973,Rattus norvegicus,,CHEMBL627605,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13974,Rattus norvegicus,,CHEMBL627606,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13975,Rattus norvegicus,,CHEMBL627607,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13976,Rattus norvegicus,,CHEMBL627608,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13977,Rattus norvegicus,,CHEMBL627609,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13978,Rattus norvegicus,,CHEMBL627610,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13979,Rattus norvegicus,,CHEMBL627611,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13980,Rattus norvegicus,,CHEMBL627612,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
13981,,,CHEMBL627613,Octanol:water partition coefficient is evaluated,,8362,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
13982,,,CHEMBL627614,Partition coefficient in 1-octanol/water system,,8257,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
13983,,,CHEMBL627615,Partition coefficient in 1-octanol/water system measured using radio active compounds,,8257,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
13984,,,CHEMBL627616,Partition coefficient in octanol/water system was determined,,9468,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
13985,,,CHEMBL627617,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,,9468,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
13986,,,CHEMBL627618,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,,10568,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13987,,,CHEMBL627619,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",,10568,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13988,,,CHEMBL627620,Pseudo-first-order rate constant of the compound,,15359,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13989,,,CHEMBL627621,Pseudo-first-order rate constant with 1-min time point,,15359,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13990,,,CHEMBL627622,Pseudo-first-order rate constant without 1-min time point,,15359,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13991,,,CHEMBL627623,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,,10431,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13992,,,CHEMBL627624,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,,10431,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13993,,,CHEMBL627625,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,,10431,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13994,,,CHEMBL628523,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,,15704,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13995,,,CHEMBL628524,The alkaline hydrolysis second order rate constant(K OH) of the compound,,15287,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13996,,,CHEMBL628525,The efflux rate constant of the compound,,7516,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13997,,,CHEMBL625732,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,12973,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13998,,,CHEMBL625733,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,12973,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
13999,,,CHEMBL625734,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,12973,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14000,,,CHEMBL625913,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,,12973,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14001,,,CHEMBL625914,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,,8696,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14002,,,CHEMBL625915,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,,15052,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14003,,,CHEMBL625916,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,,15052,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14004,,,CHEMBL625917,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),,10503,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14005,,,CHEMBL625918,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14006,,,CHEMBL625919,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14007,,,CHEMBL625920,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14008,,,CHEMBL874453,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14009,,,CHEMBL625921,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",,8354,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14010,,,CHEMBL625922,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,,10503,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14011,,,CHEMBL625923,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14012,,,CHEMBL625924,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14013,,,CHEMBL625925,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14014,,,CHEMBL625926,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14015,Rattus norvegicus,2048.0,CHEMBL627704,Biodistribution in rat lung at 60 minutes after dose administration.,In vivo,13100,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14016,Rattus norvegicus,,CHEMBL627705,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,In vivo,13100,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14017,Rattus norvegicus,,CHEMBL627706,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,In vivo,13100,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14018,Rattus norvegicus,,CHEMBL627707,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,In vivo,13100,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14019,Rattus norvegicus,,CHEMBL627708,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,In vivo,13100,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14020,Rattus norvegicus,,CHEMBL628361,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,In vivo,13100,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14021,Rattus norvegicus,,CHEMBL628362,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,In vivo,13100,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14022,Rattus norvegicus,2435.0,CHEMBL628363,Biodistribution in rat striatum at 120 minutes after dose administration.,In vivo,13100,Striatum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14023,Rattus norvegicus,2435.0,CHEMBL628364,Biodistribution in rat striatum at 1440 minutes after dose administration.,In vivo,13100,Striatum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14024,Rattus norvegicus,2435.0,CHEMBL628365,Biodistribution in rat striatum at 15 minutes after dose administration.,In vivo,13100,Striatum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14025,Rattus norvegicus,2435.0,CHEMBL874454,Biodistribution in rat striatum at 240 minutes after dose administration.,In vivo,13100,Striatum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14026,Rattus norvegicus,2435.0,CHEMBL628531,Biodistribution in rat striatum at 30 minutes after dose administration.,In vivo,13100,Striatum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14027,Rattus norvegicus,2435.0,CHEMBL628532,Biodistribution in rat striatum at 360 minutes after dose administration.,In vivo,13100,Striatum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14028,Rattus norvegicus,2435.0,CHEMBL628533,Biodistribution in rat striatum at 3 hr after dose administration.,In vivo,13100,Striatum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14029,Rattus norvegicus,2435.0,CHEMBL628534,Biodistribution in rat striatum at 60 minutes after dose administration.,In vivo,13100,Striatum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14030,Rattus norvegicus,2046.0,CHEMBL628535,Biodistribution in rat thyroid at 120 minutes after dose administration.,In vivo,13100,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14031,Rattus norvegicus,2046.0,CHEMBL628536,Biodistribution in rat thyroid at 1440 minutes after dose administration.,In vivo,13100,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14032,Rattus norvegicus,2046.0,CHEMBL628537,Biodistribution in rat thyroid at 15 minutes after dose administration.,In vivo,13100,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14033,Rattus norvegicus,2046.0,CHEMBL628538,Biodistribution in rat thyroid at 240 minutes after dose administration.,In vivo,13100,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14034,Rattus norvegicus,2046.0,CHEMBL628539,Biodistribution in rat thyroid at 30 minutes after dose administration.,In vivo,13100,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14035,Rattus norvegicus,2046.0,CHEMBL630297,Biodistribution in rat thyroid at 360 minutes after dose administration.,In vivo,13100,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14036,Rattus norvegicus,2046.0,CHEMBL630298,Biodistribution in rat thyroid at 60 minutes after dose administration.,In vivo,13100,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14037,Rattus norvegicus,955.0,CHEMBL630299,Biodistribution in rest of brain of rat 120 minutes after dose administration.,In vivo,13100,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14038,Rattus norvegicus,955.0,CHEMBL628094,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,In vivo,13100,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14039,Rattus norvegicus,955.0,CHEMBL628095,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,In vivo,13100,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14040,Rattus norvegicus,955.0,CHEMBL874648,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,In vivo,13100,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14041,Rattus norvegicus,955.0,CHEMBL628096,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,In vivo,13100,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14042,Rattus norvegicus,955.0,CHEMBL628097,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,In vivo,13100,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14043,Rattus norvegicus,955.0,CHEMBL628098,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,In vivo,13100,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14044,,,CHEMBL628099,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",,13331,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14045,,,CHEMBL628100,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,13331,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14046,,,CHEMBL628101,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),,13331,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14047,,,CHEMBL628102,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",,13331,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14048,,,CHEMBL628103,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",,13331,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14049,,,CHEMBL628104,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,13331,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14050,,,CHEMBL628105,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",,13331,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14051,,,CHEMBL628106,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",,13331,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14052,Rattus norvegicus,1088.0,CHEMBL628107,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,10086,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14053,,1088.0,CHEMBL628108,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,10086,Urine,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14054,Rattus norvegicus,1088.0,CHEMBL628109,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,10086,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14055,,1088.0,CHEMBL625299,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,10086,Urine,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14056,Rattus norvegicus,1088.0,CHEMBL625300,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,,10086,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14057,Rattus norvegicus,1088.0,CHEMBL625301,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,,10086,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14058,Rattus norvegicus,1088.0,CHEMBL625302,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,,10086,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14059,Rattus norvegicus,1088.0,CHEMBL874649,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,,10086,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14060,Rattus norvegicus,,CHEMBL625303,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,,13248,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14061,Rattus norvegicus,,CHEMBL625463,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,,13248,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14062,Homo sapiens,2107.0,CHEMBL625464,In vitro metabolism in human liver microsomes,,14527,Liver,50587,,,BAO_0000218,,Intermediate,,9606.0,N,1,1,
14063,Homo sapiens,,CHEMBL625465,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,,3008,,50587,,,BAO_0000218,,Intermediate,,9606.0,N,1,1,
14064,Canis lupus familiaris,1088.0,CHEMBL625466,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14065,Canis lupus familiaris,1088.0,CHEMBL625467,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14066,Rattus norvegicus,1088.0,CHEMBL625468,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14067,Rattus norvegicus,1088.0,CHEMBL625469,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14068,Rattus norvegicus,1088.0,CHEMBL625470,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14069,Rattus norvegicus,1088.0,CHEMBL632418,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14070,Rattus norvegicus,1088.0,CHEMBL627250,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14071,Rattus norvegicus,1088.0,CHEMBL627251,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14072,Rattus norvegicus,1088.0,CHEMBL627252,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14073,Rattus norvegicus,1088.0,CHEMBL627253,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14074,Rattus norvegicus,1088.0,CHEMBL627254,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14075,Rattus norvegicus,1088.0,CHEMBL875471,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14076,Rattus norvegicus,1088.0,CHEMBL627255,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14077,Rattus norvegicus,1088.0,CHEMBL627256,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14078,Rattus norvegicus,1088.0,CHEMBL627257,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14079,Rattus norvegicus,1088.0,CHEMBL627258,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14080,Rattus norvegicus,1088.0,CHEMBL627259,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14081,Rattus norvegicus,1088.0,CHEMBL627260,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14082,Rattus norvegicus,1088.0,CHEMBL623256,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14083,Rattus norvegicus,1088.0,CHEMBL874413,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14084,Rattus norvegicus,1088.0,CHEMBL623257,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14085,Rattus norvegicus,1088.0,CHEMBL623258,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14086,Rattus norvegicus,1088.0,CHEMBL623259,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14087,Rattus norvegicus,1088.0,CHEMBL623260,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14088,Rattus norvegicus,1088.0,CHEMBL623261,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14089,Rattus norvegicus,1088.0,CHEMBL623262,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14090,Rattus norvegicus,1088.0,CHEMBL623263,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14091,Rattus norvegicus,1088.0,CHEMBL623264,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14092,Rattus norvegicus,1088.0,CHEMBL623265,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14093,Rattus norvegicus,1088.0,CHEMBL623266,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14094,Rattus norvegicus,1088.0,CHEMBL623267,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14095,Rattus norvegicus,1088.0,CHEMBL623268,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14096,Rattus norvegicus,1088.0,CHEMBL623269,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14097,Rattus norvegicus,1088.0,CHEMBL623270,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14098,Rattus norvegicus,1088.0,CHEMBL623271,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14099,Rattus norvegicus,1088.0,CHEMBL623272,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14100,Rattus norvegicus,1088.0,CHEMBL623273,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14101,Rattus norvegicus,1088.0,CHEMBL623274,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14102,Rattus norvegicus,1088.0,CHEMBL874414,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14103,Rattus norvegicus,1088.0,CHEMBL623275,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14104,Rattus norvegicus,1088.0,CHEMBL629150,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14105,Rattus norvegicus,1088.0,CHEMBL623276,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14106,Rattus norvegicus,1088.0,CHEMBL623277,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14107,Rattus norvegicus,1088.0,CHEMBL623112,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14108,Rattus norvegicus,1088.0,CHEMBL623113,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14109,Rattus norvegicus,1088.0,CHEMBL623800,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14110,Rattus norvegicus,1088.0,CHEMBL623801,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14111,Rattus norvegicus,2106.0,CHEMBL623802,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",In vivo,12017,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14112,Rattus norvegicus,995.0,CHEMBL623803,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14113,Rattus norvegicus,995.0,CHEMBL623970,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14114,Rattus norvegicus,995.0,CHEMBL623971,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Uterus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14115,Rattus norvegicus,178.0,CHEMBL623972,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),In vivo,14045,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14116,Rattus norvegicus,178.0,CHEMBL623973,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),In vivo,14045,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14117,Rattus norvegicus,178.0,CHEMBL623974,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),In vivo,14045,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14118,Rattus norvegicus,178.0,CHEMBL623975,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),In vivo,14045,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14119,Rattus norvegicus,955.0,CHEMBL623976,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),In vivo,14045,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14120,Rattus norvegicus,955.0,CHEMBL623977,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),In vivo,14045,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14121,Rattus norvegicus,955.0,CHEMBL623978,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),In vivo,14045,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14122,Rattus norvegicus,955.0,CHEMBL623979,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),In vivo,14045,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14123,Rattus norvegicus,,CHEMBL623980,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),In vivo,14045,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14124,Rattus norvegicus,,CHEMBL623981,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),In vivo,14045,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14125,Rattus norvegicus,,CHEMBL626278,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),In vivo,14045,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14126,Rattus norvegicus,,CHEMBL626279,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),In vivo,14045,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14127,Mus musculus,,CHEMBL626280,Biodistribution in mice bladder plus excreted urine was determined,In vivo,14045,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14128,Mus musculus,,CHEMBL626281,"Percentage biodistribution in mouse blood, 10 minutes post injection",,14045,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14129,Mus musculus,,CHEMBL626282,"Percentage biodistribution in mouse blood, 30 minutes post injection",,14045,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14130,Mus musculus,,CHEMBL626283,"Percentage biodistribution in mouse blood, 5 minutes post injection",,14045,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14131,Mus musculus,,CHEMBL626284,"Percentage biodistribution in mouse blood, 60 minutes post injection",,14045,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14132,Mus musculus,955.0,CHEMBL626285,"Percentage biodistribution in mouse brain, 10 minutes post injection",,14045,Brain,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14133,Mus musculus,955.0,CHEMBL626286,"Percentage biodistribution in mouse brain, 30 minutes post injection",,14045,Brain,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14134,Mus musculus,955.0,CHEMBL626287,"Percentage biodistribution in mouse brain, 5 minutes post injection",,14045,Brain,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14135,Mus musculus,955.0,CHEMBL626288,"Percentage biodistribution in mouse brain, 60 minutes post injection",,14045,Brain,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14136,Mus musculus,,CHEMBL626289,"Percentage biodistribution in mouse heart, 10 minutes post injection",,14045,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14137,Mus musculus,,CHEMBL626290,"Percentage biodistribution in mouse heart, 30 minutes post injection",,14045,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14138,Mus musculus,,CHEMBL626291,"Percentage biodistribution in mouse heart, 5 minutes post injection",,14045,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14139,Mus musculus,,CHEMBL839888,"Percentage biodistribution in mouse heart, 60 minutes post injection",,14045,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14140,Mus musculus,160.0,CHEMBL626292,"Percentage biodistribution in mouse intestine, 10 minutes post injection",,14045,Intestine,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14141,Mus musculus,160.0,CHEMBL626293,"Percentage biodistribution in mouse intestine, 30 minutes post injection",,14045,Intestine,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14142,Mus musculus,160.0,CHEMBL626294,"Percentage biodistribution in mouse intestine, 5 minutes post injection",,14045,Intestine,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14143,Mus musculus,160.0,CHEMBL626295,"Percentage biodistribution in mouse intestine, 60 minutes post injection",,14045,Intestine,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14144,Mus musculus,2107.0,CHEMBL627659,"Percentage biodistribution in mouse liver, 10 minutes post injection",,14045,Liver,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14145,Mus musculus,2107.0,CHEMBL627660,"Percentage biodistribution in mouse liver, 30 minutes of post injection",,14045,Liver,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14146,Mus musculus,2107.0,CHEMBL627661,"Percentage biodistribution in mouse liver, 5 minutes post injection",,14045,Liver,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14147,Mus musculus,2107.0,CHEMBL627662,Biodistribution in mice liver at 60 minutes of post injection,In vivo,14045,Liver,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14148,Mus musculus,2048.0,CHEMBL627663,Biodistribution in mice lungs at 10 min of post injection,In vivo,14045,Lung,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14149,Mus musculus,,CHEMBL627664,"Percentage biodistribution in mouse lung, 30 minutes post injection",,14045,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14150,Mus musculus,,CHEMBL627665,"Percentage biodistribution in mousee lung, 5 minutes post injection",,14045,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14151,Mus musculus,2048.0,CHEMBL627666,Biodistribution in mice lungs at 60 min of post injection,In vivo,14045,Lung,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14152,Mus musculus,2106.0,CHEMBL627667,Percentage biodistribution in mouse spleen,,14045,Spleen,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14153,Mus musculus,945.0,CHEMBL627668,Percentage biodistribution in mouse stomach,,14045,Stomach,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14154,Mus musculus,1088.0,CHEMBL627669,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,,11745,Urine,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14155,,1255.0,CHEMBL627670,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,In vivo,13257,Urinary bladder,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14156,,178.0,CHEMBL627671,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,In vivo,13257,Blood,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14157,,1474.0,CHEMBL627672,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,In vivo,13257,Bone element,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14158,,,CHEMBL627673,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,In vivo,13257,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14159,,2113.0,CHEMBL627674,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,In vivo,13257,Kidney,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14160,,2107.0,CHEMBL627675,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,In vivo,13257,Liver,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14161,,2048.0,CHEMBL627676,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,In vivo,13257,Lung,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14162,,2385.0,CHEMBL627677,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,In vivo,13257,Muscle tissue,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14163,,,CHEMBL627678,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",,8354,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14164,Rattus norvegicus,1977.0,CHEMBL627679,Affinity for protein binding expressed as association constant in fresh rat serum,,7095,Serum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14165,,,CHEMBL627680,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,12185,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14166,,,CHEMBL627681,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,12185,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14167,,,CHEMBL627682,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,12185,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14168,,,CHEMBL627683,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,12185,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14169,,,CHEMBL627684,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,,12686,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14170,,,CHEMBL874441,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,12686,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14171,,,CHEMBL627685,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,,12686,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14172,,,CHEMBL627686,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,12686,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14173,,,CHEMBL627687,Apparent rate constant Koff for inactivation of dTMP synthase.,,8057,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14174,,,CHEMBL627688,The irreversible inhibitor activity by second order rate equation.,,15778,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14175,Rattus norvegicus,,CHEMBL628038,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,,12375,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14176,Rattus norvegicus,,CHEMBL628039,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,,12375,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14177,Rattus norvegicus,,CHEMBL628040,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,,12375,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14178,,,CHEMBL628041,Dissociation rate calculated from the first-order equation using t1/2 value,,13588,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14179,,,CHEMBL630226,The compound was tested for Binding constant against DNA,,15039,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14180,,,CHEMBL628042,First order rate constant for cyclization of the compound,,9500,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14181,,,CHEMBL625232,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,10014,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14182,,,CHEMBL625233,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,10014,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14183,,,CHEMBL625979,Hydrolysis rate constant was determined,,568,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14184,,,CHEMBL625980,Observed first order rate constant,,10026,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14185,,,CHEMBL625981,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,10281,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14186,,,CHEMBL625982,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,10281,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14187,,,CHEMBL625983,Second-order rate constant for attack on PNPA at 25 degree Centigrade,,9680,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14188,,,CHEMBL625984,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14189,,,CHEMBL625985,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14190,,,CHEMBL625986,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14191,,,CHEMBL625987,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14192,,,CHEMBL625988,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14193,,,CHEMBL625989,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14194,,,CHEMBL625990,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14195,,,CHEMBL625991,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14196,,,CHEMBL625992,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14197,,,CHEMBL625993,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14198,,,CHEMBL631973,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14199,,,CHEMBL632143,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14200,,,CHEMBL632144,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14201,,,CHEMBL632145,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14202,,,CHEMBL632146,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14203,,,CHEMBL632147,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14204,,,CHEMBL632148,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14205,,,CHEMBL632149,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14206,,,CHEMBL632150,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14207,,,CHEMBL632151,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14208,Homo sapiens,,CHEMBL632152,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,,3008,,50587,,,BAO_0000218,,Intermediate,,9606.0,N,1,1,
14209,Homo sapiens,,CHEMBL632153,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,4509,,50587,,,BAO_0000218,,Intermediate,,9606.0,N,1,1,
14210,Homo sapiens,,CHEMBL632154,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,4509,,50587,,,BAO_0000218,,Intermediate,,9606.0,N,1,1,
14211,Human herpesvirus 1,,CHEMBL632155,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,,8613,,50602,,,BAO_0000218,,Intermediate,,10298.0,N,1,1,
14212,Human herpesvirus 1,,CHEMBL632156,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,,8613,,50602,,,BAO_0000218,,Intermediate,,10298.0,N,1,1,
14213,Human herpesvirus 1,,CHEMBL632157,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,,8613,,50602,,,BAO_0000218,,Intermediate,,10298.0,N,1,1,
14214,Human herpesvirus 1,,CHEMBL632158,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,,8613,,50602,,,BAO_0000218,,Intermediate,,10298.0,N,1,1,
14215,Human herpesvirus 1,,CHEMBL632159,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,,8613,,50602,,,BAO_0000218,,Intermediate,,10298.0,N,1,1,
14216,Human herpesvirus 1,,CHEMBL626305,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,,8613,,50602,,,BAO_0000218,,Intermediate,,10298.0,N,1,1,
14217,Human herpesvirus 1,,CHEMBL626306,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,,8613,,50602,,,BAO_0000218,,Intermediate,,10298.0,N,1,1,
14218,Human herpesvirus 1,,CHEMBL626307,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,,8613,,50602,,,BAO_0000218,,Intermediate,,10298.0,N,1,1,
14219,Human herpesvirus 1,,CHEMBL626308,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,,8613,,50602,,,BAO_0000218,,Intermediate,,10298.0,N,1,1,
14220,Human herpesvirus 1,,CHEMBL626479,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,,8613,,50602,,,BAO_0000218,,Intermediate,,10298.0,N,1,1,
14221,Human herpesvirus 1,,CHEMBL626480,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,,8613,,50602,,,BAO_0000218,,Intermediate,,10298.0,N,1,1,
14222,,,CHEMBL626481,Calculated partition coefficient (clogP) (MlogP),,6021,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
14223,,,CHEMBL626482,Equipotent potent ratio relative to carbachol (nicotinic activity),,9348,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14224,Canis lupus familiaris,,CHEMBL626483,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",,15592,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14225,Canis lupus familiaris,,CHEMBL626484,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",,15592,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14226,,,CHEMBL626485,Solubility at pH 7.4 in micro g/mL;NA denotes available,,15592,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
14227,,,CHEMBL626486,Solubility at pH 7.4 in micro g/mL;NA denotes not available,,15592,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
14228,,,CHEMBL626487,Solubility at pH 7.4 in ug/mL;NA denotes not available,,15592,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
14229,Canis lupus familiaris,1969.0,CHEMBL626488,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,In vivo,15592,Plasma,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14230,Rattus norvegicus,1977.0,CHEMBL626489,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,,7095,Serum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14231,,,CHEMBL626490,Area under the MAP curve measured over 5 min; ND means Not determined,,16618,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14232,,,CHEMBL626491,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,,16835,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
14233,,,CHEMBL626492,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,,15284,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
14234,,,CHEMBL626493,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,,15750,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14235,Rattus norvegicus,,CHEMBL626494,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,In vivo,16618,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14236,,,CHEMBL626495,Half life after oral tested,In vivo,16618,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14237,Rattus norvegicus,1969.0,CHEMBL626496,Half life was determined in plasma of rat; NT indicates not tested,,15812,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14238,Rattus norvegicus,,CHEMBL626497,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,In vivo,16618,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14239,,,CHEMBL626498,Oral bioavailability after oral tested,In vivo,16618,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14240,Rattus norvegicus,,CHEMBL626499,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),,13098,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14241,Rattus norvegicus,,CHEMBL626500,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),,13098,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14242,Rattus norvegicus,1969.0,CHEMBL626501,half life was determined in plasma of rat; NT indicates not tested,,15812,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14243,Rattus norvegicus,1969.0,CHEMBL626502,half life was determined in plasma of rat; NT means not tested,,15812,Plasma,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14244,Rattus norvegicus,,CHEMBL626503,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14245,Rattus norvegicus,,CHEMBL626504,Mean sodium excretion in rats (Control/Drug treatment value); inactive,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14246,Rattus norvegicus,,CHEMBL626505,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14247,Rattus norvegicus,,CHEMBL626506,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14248,Rattus norvegicus,,CHEMBL626507,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14249,Rattus norvegicus,,CHEMBL626508,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14250,Rattus norvegicus,,CHEMBL626509,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14251,Rattus norvegicus,,CHEMBL875480,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14252,Rattus norvegicus,,CHEMBL626510,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14253,Rattus norvegicus,,CHEMBL626511,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14254,Rattus norvegicus,,CHEMBL626512,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14255,Rattus norvegicus,,CHEMBL628208,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14256,Rattus norvegicus,,CHEMBL628209,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14257,Rattus norvegicus,,CHEMBL628210,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14258,Rattus norvegicus,,CHEMBL628211,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14259,Rattus norvegicus,,CHEMBL628212,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14260,Rattus norvegicus,,CHEMBL628213,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14261,Rattus norvegicus,1088.0,CHEMBL628214,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14262,Rattus norvegicus,1088.0,CHEMBL628215,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14263,Rattus norvegicus,1088.0,CHEMBL628216,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14264,Rattus norvegicus,1088.0,CHEMBL626595,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14265,Rattus norvegicus,1088.0,CHEMBL626596,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14266,Rattus norvegicus,1088.0,CHEMBL626597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14267,Rattus norvegicus,1088.0,CHEMBL626598,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14268,Rattus norvegicus,1088.0,CHEMBL622242,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14269,Rattus norvegicus,1088.0,CHEMBL622243,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14270,Rattus norvegicus,1088.0,CHEMBL622244,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14271,Rattus norvegicus,1088.0,CHEMBL622245,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14272,Rattus norvegicus,1088.0,CHEMBL622246,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14273,Rattus norvegicus,1088.0,CHEMBL622247,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14274,Rattus norvegicus,1088.0,CHEMBL622248,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14275,Rattus norvegicus,1088.0,CHEMBL877483,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14276,Rattus norvegicus,1088.0,CHEMBL622249,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14277,Canis lupus familiaris,1088.0,CHEMBL622250,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14278,Canis lupus familiaris,1088.0,CHEMBL622251,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14279,Canis lupus familiaris,1088.0,CHEMBL622252,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14280,Canis lupus familiaris,1088.0,CHEMBL622253,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14281,Canis lupus familiaris,1088.0,CHEMBL622254,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14282,Canis lupus familiaris,1088.0,CHEMBL622255,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14283,Canis lupus familiaris,1088.0,CHEMBL622256,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14284,Canis lupus familiaris,1088.0,CHEMBL622257,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14285,Canis lupus familiaris,1088.0,CHEMBL622258,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14286,Canis lupus familiaris,1088.0,CHEMBL622259,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14287,Canis lupus familiaris,1088.0,CHEMBL622927,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14288,Canis lupus familiaris,1088.0,CHEMBL622928,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14289,Canis lupus familiaris,1088.0,CHEMBL622929,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14290,Canis lupus familiaris,1088.0,CHEMBL623182,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14291,Canis lupus familiaris,1088.0,CHEMBL623183,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14292,Rattus norvegicus,1088.0,CHEMBL623184,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14293,Rattus norvegicus,1088.0,CHEMBL623185,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14294,Rattus norvegicus,1088.0,CHEMBL877484,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14295,Rattus norvegicus,1088.0,CHEMBL627274,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14296,Rattus norvegicus,1088.0,CHEMBL623186,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14297,Rattus norvegicus,1088.0,CHEMBL623187,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14298,Rattus norvegicus,1088.0,CHEMBL623188,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14299,Rattus norvegicus,1088.0,CHEMBL628055,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14300,Rattus norvegicus,1088.0,CHEMBL628056,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14301,Rattus norvegicus,1088.0,CHEMBL628200,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14302,Rattus norvegicus,1088.0,CHEMBL628201,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14303,Rattus norvegicus,1088.0,CHEMBL628202,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14304,Rattus norvegicus,1088.0,CHEMBL628203,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14305,Rattus norvegicus,1088.0,CHEMBL628204,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14306,Rattus norvegicus,1088.0,CHEMBL628205,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14307,Rattus norvegicus,1088.0,CHEMBL628206,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14308,,2367.0,CHEMBL628207,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),In vivo,13257,Prostate gland,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14309,,2367.0,CHEMBL627220,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,In vivo,13257,Prostate gland,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14310,,2385.0,CHEMBL627221,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,In vivo,13257,Muscle tissue,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14311,,2367.0,CHEMBL627222,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),In vivo,13257,Prostate gland,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14312,,,CHEMBL627223,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,In vivo,13257,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14313,,2385.0,CHEMBL632062,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,In vivo,13257,Muscle tissue,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14314,,2106.0,CHEMBL632063,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,In vivo,13257,Spleen,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14315,,1255.0,CHEMBL632064,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,In vivo,13257,Urinary bladder,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14316,,178.0,CHEMBL632065,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,In vivo,13257,Blood,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14317,,1474.0,CHEMBL632066,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,In vivo,13257,Bone element,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14318,,,CHEMBL632067,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,In vivo,13257,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14319,,2113.0,CHEMBL629188,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,In vivo,13257,Kidney,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14320,,2107.0,CHEMBL629189,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,In vivo,13257,Liver,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14321,,2048.0,CHEMBL629190,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,In vivo,13257,Lung,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14322,,2385.0,CHEMBL629191,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,In vivo,13257,Muscle tissue,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14323,,2367.0,CHEMBL629192,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),In vivo,13257,Prostate gland,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14324,,2385.0,CHEMBL629193,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,In vivo,13257,Muscle tissue,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14325,,2367.0,CHEMBL629194,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),In vivo,13257,Prostate gland,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14326,,,CHEMBL629195,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,In vivo,13257,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14327,,2385.0,CHEMBL629373,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,In vivo,13257,Muscle tissue,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14328,,2106.0,CHEMBL629374,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,In vivo,13257,Spleen,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14329,,2367.0,CHEMBL629375,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,In vivo,13257,Prostate gland,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14330,,1255.0,CHEMBL629376,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,In vivo,13257,Urinary bladder,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14331,,178.0,CHEMBL629377,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,In vivo,13257,Blood,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14332,,1474.0,CHEMBL629378,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,In vivo,13257,Bone element,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14333,,,CHEMBL629379,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,In vivo,13257,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14334,,2113.0,CHEMBL629151,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,In vivo,13257,Kidney,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14335,,2107.0,CHEMBL629152,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,In vivo,13257,Liver,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14336,,2048.0,CHEMBL629153,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,In vivo,13257,Lung,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14337,,2385.0,CHEMBL629154,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,In vivo,13257,Muscle tissue,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14338,,2367.0,CHEMBL629155,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),In vivo,13257,Prostate gland,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14339,,2367.0,CHEMBL629156,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,In vivo,13257,Prostate gland,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14340,,2385.0,CHEMBL629157,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,In vivo,13257,Muscle tissue,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14341,,2367.0,CHEMBL629158,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),In vivo,13257,Prostate gland,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14342,,,CHEMBL629159,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,In vivo,13257,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14343,,2385.0,CHEMBL629160,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,In vivo,13257,Muscle tissue,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14344,,2106.0,CHEMBL629161,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,In vivo,13257,Spleen,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14345,,1255.0,CHEMBL629162,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,In vivo,13257,Urinary bladder,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14346,,178.0,CHEMBL629163,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,In vivo,13257,Blood,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14347,,1474.0,CHEMBL629164,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,In vivo,13257,Bone element,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14348,,,CHEMBL629165,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,In vivo,13257,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14349,,2107.0,CHEMBL629166,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,In vivo,13257,Liver,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14350,,2048.0,CHEMBL629167,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,In vivo,13257,Lung,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14351,,2385.0,CHEMBL629168,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,In vivo,13257,Muscle tissue,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14352,,,CHEMBL629169,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,,2193,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14353,,,CHEMBL629170,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,,2193,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14354,,,CHEMBL631153,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,,2193,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14355,,,CHEMBL875121,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,,2193,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14356,,,CHEMBL631154,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,,2193,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14357,,,CHEMBL631155,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,,2193,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14358,,,CHEMBL631156,Hydrolysis rate constant was determined,,568,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14359,,,CHEMBL631157,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",,9680,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14360,,,CHEMBL631158,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,9680,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14361,,,CHEMBL631159,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,9680,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14362,,,CHEMBL631160,Observed second order rate constant,,10026,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14363,,,CHEMBL631161,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,10281,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14364,,,CHEMBL631162,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,10014,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14365,,,CHEMBL630313,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,10014,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14366,,,CHEMBL630314,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,9680,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14367,,,CHEMBL630315,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,9680,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14368,,,CHEMBL630316,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14369,,,CHEMBL630986,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14370,,,CHEMBL630987,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14371,,,CHEMBL630988,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14372,,,CHEMBL630989,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14373,,,CHEMBL630990,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14374,,,CHEMBL630991,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14375,,,CHEMBL630992,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14376,,,CHEMBL630993,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14377,,,CHEMBL630994,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14378,Rattus norvegicus,,CHEMBL630995,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,,10014,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14379,,,CHEMBL629252,Association constant for compound at 31 degree C was determined,,9962,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14380,,,CHEMBL629253,Calculated antagonist equilibrium dissociation constant of the compound,,12029,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14381,,,CHEMBL629944,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,,12029,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14382,Cavia porcellus,3126.0,CHEMBL629945,Dissociation constants vs LTE4 on guinea pig trachea,,10583,Trachea,50512,,,BAO_0000218,,Intermediate,,10141.0,N,1,1,
14383,,,CHEMBL629946,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",,568,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14384,,,CHEMBL629947,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",,568,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14385,,,CHEMBL629948,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",,568,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14386,,,CHEMBL856024,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",,568,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14387,,,CHEMBL629949,Affinity constant KD value was derived from TMP,,7493,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14388,,,CHEMBL629950,Apparent dissociation (binding) rate constant was evaluated,,8371,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14389,,,CHEMBL630127,Dissociation constant (KD) of the compound,,13114,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
14390,,,CHEMBL630128,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,,15515,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
14391,,,CHEMBL630129,Dissociation constant from ESR titration experiments,,522,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
14392,,,CHEMBL630130,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),,13888,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14393,,,CHEMBL875234,Dissociation constant was evaluated.,,2616,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
14394,,,CHEMBL630131,Dissociation constant was reported,,3798,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
14395,Rattus norvegicus,,CHEMBL630132,Dissociation constant was determined in rat pituitary cells.,,8731,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14396,,,CHEMBL630133,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,,11892,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14397,,,CHEMBL630134,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,,11892,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14398,,,CHEMBL630135,Equilibrium dissociation constant of the compound,,2582,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14399,,,CHEMBL630136,Equilibrium dissociation constant was determined,,11892,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14400,,,CHEMBL630137,Kinetic constant KD was evaluated,,13396,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14401,,,CHEMBL630138,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,,603,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14402,,,CHEMBL630139,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,,15673,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14403,,,CHEMBL630140,Rate constant for hydrolysis in aqueous acetone.,,10368,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14404,,,CHEMBL875235,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,,14228,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14405,Rattus norvegicus,,CHEMBL876439,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14406,Rattus norvegicus,,CHEMBL630605,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14407,Rattus norvegicus,,CHEMBL630606,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14408,Rattus norvegicus,,CHEMBL630607,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14409,Rattus norvegicus,,CHEMBL630608,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14410,Rattus norvegicus,,CHEMBL630609,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14411,Rattus norvegicus,,CHEMBL630610,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14412,Rattus norvegicus,,CHEMBL630611,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14413,Rattus norvegicus,,CHEMBL629552,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14414,Rattus norvegicus,,CHEMBL629733,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14415,Rattus norvegicus,,CHEMBL629734,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14416,Rattus norvegicus,,CHEMBL629735,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14417,Rattus norvegicus,,CHEMBL629736,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14418,Rattus norvegicus,,CHEMBL629737,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14419,Rattus norvegicus,,CHEMBL629738,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14420,Rattus norvegicus,,CHEMBL629739,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14421,Rattus norvegicus,,CHEMBL629740,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14422,Rattus norvegicus,,CHEMBL629741,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14423,Rattus norvegicus,,CHEMBL629742,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14424,Rattus norvegicus,,CHEMBL629743,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14425,Rattus norvegicus,,CHEMBL629744,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14426,Rattus norvegicus,,CHEMBL629745,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14427,Rattus norvegicus,,CHEMBL629746,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14428,Rattus norvegicus,,CHEMBL629747,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14429,Rattus norvegicus,,CHEMBL629748,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14430,Rattus norvegicus,,CHEMBL629749,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14431,Rattus norvegicus,,CHEMBL629750,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14432,Rattus norvegicus,,CHEMBL629751,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14433,Rattus norvegicus,,CHEMBL629752,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14434,Rattus norvegicus,,CHEMBL629753,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14435,Rattus norvegicus,,CHEMBL629754,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14436,Rattus norvegicus,,CHEMBL629755,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14437,Rattus norvegicus,,CHEMBL629756,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14438,Rattus norvegicus,,CHEMBL629757,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14439,Rattus norvegicus,,CHEMBL629758,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14440,Rattus norvegicus,,CHEMBL629759,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14441,Rattus norvegicus,,CHEMBL629760,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14442,Rattus norvegicus,,CHEMBL876443,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,11510,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14443,Canis lupus familiaris,,CHEMBL629761,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,,8310,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14444,Canis lupus familiaris,,CHEMBL629762,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,,8310,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14445,Mus musculus,,CHEMBL629763,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,8310,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14446,Mus musculus,,CHEMBL629764,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,8310,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14447,Mus musculus,,CHEMBL629765,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,8310,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14448,Mus musculus,,CHEMBL629766,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,,8310,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14449,Mus musculus,,CHEMBL629767,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,8310,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14450,Canis lupus familiaris,,CHEMBL629768,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,,8310,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14451,Mus musculus,,CHEMBL629769,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,,8310,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14452,Canis lupus familiaris,,CHEMBL629770,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,,8310,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14453,Canis lupus familiaris,,CHEMBL629771,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,,8310,,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14454,Mus musculus,,CHEMBL629772,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,8310,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14455,Mus musculus,,CHEMBL629773,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,8310,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14456,Mus musculus,,CHEMBL625455,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,8310,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14457,Mus musculus,,CHEMBL625456,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,,8310,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14458,Mus musculus,,CHEMBL625457,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,,8310,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14459,Rattus norvegicus,1088.0,CHEMBL625458,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14460,Rattus norvegicus,1088.0,CHEMBL625459,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14461,Rattus norvegicus,1088.0,CHEMBL875483,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14462,Rattus norvegicus,1088.0,CHEMBL634779,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14463,Rattus norvegicus,1088.0,CHEMBL625460,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14464,Rattus norvegicus,1088.0,CHEMBL626117,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14465,Rattus norvegicus,1088.0,CHEMBL626118,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14466,Rattus norvegicus,1088.0,CHEMBL628342,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14467,Rattus norvegicus,1088.0,CHEMBL628343,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14468,Rattus norvegicus,1088.0,CHEMBL628344,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14469,Rattus norvegicus,1088.0,CHEMBL628345,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14470,Rattus norvegicus,1088.0,CHEMBL628346,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14471,Rattus norvegicus,1088.0,CHEMBL628347,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14472,Rattus norvegicus,1088.0,CHEMBL628348,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14473,Rattus norvegicus,1088.0,CHEMBL628349,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14474,Rattus norvegicus,1088.0,CHEMBL875611,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14475,Rattus norvegicus,1088.0,CHEMBL628350,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14476,Rattus norvegicus,1088.0,CHEMBL628351,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14477,Rattus norvegicus,1088.0,CHEMBL628352,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14478,Rattus norvegicus,1088.0,CHEMBL628353,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14479,Rattus norvegicus,1088.0,CHEMBL628354,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14480,Rattus norvegicus,1088.0,CHEMBL626667,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14481,Rattus norvegicus,1088.0,CHEMBL626668,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14482,Rattus norvegicus,1088.0,CHEMBL626669,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14483,Rattus norvegicus,1088.0,CHEMBL626670,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14484,Rattus norvegicus,1088.0,CHEMBL626671,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14485,Rattus norvegicus,1088.0,CHEMBL626672,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14486,Rattus norvegicus,1088.0,CHEMBL626673,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14487,Rattus norvegicus,1088.0,CHEMBL626674,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14488,Rattus norvegicus,1088.0,CHEMBL626675,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14489,Rattus norvegicus,1088.0,CHEMBL626676,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14490,Rattus norvegicus,1088.0,CHEMBL626677,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14491,Rattus norvegicus,1088.0,CHEMBL626678,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14492,Rattus norvegicus,1088.0,CHEMBL626679,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14493,Rattus norvegicus,1088.0,CHEMBL875612,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14494,Rattus norvegicus,1088.0,CHEMBL626680,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14495,Rattus norvegicus,1088.0,CHEMBL626681,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14496,Rattus norvegicus,1088.0,CHEMBL626682,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14497,Rattus norvegicus,1088.0,CHEMBL626683,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14498,Rattus norvegicus,1088.0,CHEMBL626684,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14499,Rattus norvegicus,1088.0,CHEMBL626685,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14500,Rattus norvegicus,1088.0,CHEMBL626686,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14501,Rattus norvegicus,1088.0,CHEMBL626687,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14502,Rattus norvegicus,1088.0,CHEMBL624978,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14503,Rattus norvegicus,1088.0,CHEMBL624979,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14504,Rattus norvegicus,1088.0,CHEMBL624980,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14505,Rattus norvegicus,1088.0,CHEMBL624981,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14506,Canis lupus familiaris,1088.0,CHEMBL624982,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14507,,2367.0,CHEMBL627564,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),In vivo,13257,Prostate gland,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14508,,2367.0,CHEMBL627565,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),In vivo,13257,Prostate gland,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14509,,,CHEMBL627566,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,In vivo,13257,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14510,,2385.0,CHEMBL627567,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,In vivo,13257,Muscle tissue,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14511,,2106.0,CHEMBL627568,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,In vivo,13257,Spleen,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14512,,2113.0,CHEMBL627569,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,In vivo,13257,Kidney,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14513,,1255.0,CHEMBL627570,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,In vivo,13257,Urinary bladder,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14514,,178.0,CHEMBL627571,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,In vivo,13257,Blood,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14515,,1474.0,CHEMBL627572,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,In vivo,13257,Bone element,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14516,,,CHEMBL627573,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,In vivo,13257,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14517,,2113.0,CHEMBL627574,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,In vivo,13257,Kidney,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14518,,2107.0,CHEMBL627575,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,In vivo,13257,Liver,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14519,,2048.0,CHEMBL627576,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,In vivo,13257,Lung,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14520,,2385.0,CHEMBL627577,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,In vivo,13257,Muscle tissue,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14521,,2367.0,CHEMBL627578,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),In vivo,13257,Prostate gland,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14522,,2367.0,CHEMBL627579,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,In vivo,13257,Prostate gland,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14523,,2385.0,CHEMBL627580,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,In vivo,13257,Muscle tissue,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14524,,2367.0,CHEMBL627581,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),In vivo,13257,Prostate gland,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14525,,,CHEMBL627582,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,In vivo,13257,,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14526,,2385.0,CHEMBL627583,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,In vivo,13257,Muscle tissue,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14527,,2106.0,CHEMBL627584,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,In vivo,13257,Spleen,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14528,,2367.0,CHEMBL627585,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,In vivo,13257,Prostate gland,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14529,,2385.0,CHEMBL627586,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,In vivo,13257,Muscle tissue,22224,,,BAO_0000218,,Autocuration,,,U,0,1,
14530,Rattus norvegicus,,CHEMBL627587,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,In vivo,15413,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14531,Rattus norvegicus,,CHEMBL627588,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,In vivo,15413,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14532,Rattus norvegicus,,CHEMBL628250,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,In vivo,15413,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14533,Rattus norvegicus,,CHEMBL628251,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,In vivo,15413,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14534,Rattus norvegicus,10000000.0,CHEMBL628252,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,In vivo,15413,Hippocampus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14535,Rattus norvegicus,10000000.0,CHEMBL628253,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,In vivo,15413,Hippocampus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14536,Rattus norvegicus,1898.0,CHEMBL628254,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,In vivo,15413,Hypothalamus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14537,Rattus norvegicus,1898.0,CHEMBL877493,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,In vivo,15413,Hypothalamus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14538,Rattus norvegicus,,CHEMBL628255,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,In vivo,15413,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14539,Rattus norvegicus,,CHEMBL628256,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,In vivo,15413,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14540,Rattus norvegicus,10000000.0,CHEMBL628257,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,In vivo,15413,Hippocampus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14541,Rattus norvegicus,1898.0,CHEMBL628258,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,In vivo,15413,Hypothalamus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14542,Rattus norvegicus,,CHEMBL628259,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,In vivo,15413,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14543,Rattus norvegicus,,CHEMBL628429,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,In vivo,15413,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14544,Rattus norvegicus,10000000.0,CHEMBL626862,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,In vivo,15413,Hippocampus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14545,Rattus norvegicus,1898.0,CHEMBL626863,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,In vivo,15413,Hypothalamus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14546,Rattus norvegicus,2037.0,CHEMBL625886,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,In vivo,15413,Cerebellum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14547,Rattus norvegicus,2037.0,CHEMBL625887,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,In vivo,15413,Cerebellum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14548,Rattus norvegicus,,CHEMBL625888,Biodistribution of the [11C]-radiolabeled compound in rat cortex,In vivo,15413,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14549,Rattus norvegicus,,CHEMBL625889,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,In vivo,15413,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14550,Rattus norvegicus,10000000.0,CHEMBL625890,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,In vivo,15413,Hippocampus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14551,Rattus norvegicus,10000000.0,CHEMBL625891,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,In vivo,15413,Hippocampus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14552,Rattus norvegicus,1898.0,CHEMBL625892,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,In vivo,15413,Hypothalamus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14553,Rattus norvegicus,1898.0,CHEMBL625893,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,In vivo,15413,Hypothalamus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14554,Rattus norvegicus,2037.0,CHEMBL625894,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,In vivo,15413,Cerebellum,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14555,Rattus norvegicus,,CHEMBL625895,Biodistribution of the [18F]-radiolabeled compound in rat cortex,In vivo,15413,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14556,,,CHEMBL625896,Reaction rate parameter value for phosphate with transfer with respect to ATP,,12404,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14557,,,CHEMBL625897,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",,568,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14558,,,CHEMBL625898,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,568,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14559,,,CHEMBL625899,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,568,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14560,,,CHEMBL626124,Reaction rate parameter value for phosphate with transfer with respect to ATP,,12404,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14561,Escherichia coli,,CHEMBL628500,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,,7624,,50212,,,BAO_0000218,,Intermediate,,562.0,N,1,1,
14562,Rattus norvegicus,,CHEMBL857856,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",,7624,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14563,Rattus norvegicus,,CHEMBL628501,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",,7624,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14564,,,CHEMBL628502,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",,4643,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14565,,,CHEMBL628503,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,,11532,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14566,,,CHEMBL628504,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,,11018,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14567,,,CHEMBL628505,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,2276,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14568,,,CHEMBL874452,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",,2276,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14569,,,CHEMBL628506,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",,2276,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14570,,,CHEMBL628507,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,2276,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14571,,,CHEMBL628508,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",,2276,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14572,,,CHEMBL628509,Michaelis constant (KM) was evaluated,,8949,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14573,,,CHEMBL628510,Reaction rate parameter value for phosphate with transfer with respect to ATP,,12404,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14574,,,CHEMBL628511,Substrate concentration for half maximal velocity was reported for rat hexokinase I,,7625,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14575,,,CHEMBL628512,Substrate concentration for half maximal velocity was reported for rat hexokinase II,,7625,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14576,,,CHEMBL628513,Substrate concentration for half maximal velocity was reported for rat hexokinase III,,7625,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14577,,,CHEMBL628514,Substrate concentration for half maximal velocity was reported for yeast hexokinase,,7625,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14578,,,CHEMBL628515,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,,12908,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14579,,,CHEMBL628516,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,,10368,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14580,,,CHEMBL628517,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,13108,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14581,,,CHEMBL628518,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,13108,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14582,,,CHEMBL628519,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,,15217,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14583,,,CHEMBL628520,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,,15217,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14584,,,CHEMBL628521,Binding constant was determined,,10933,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14585,,,CHEMBL630443,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,,2363,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14586,,,CHEMBL630444,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,,2363,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14587,,,CHEMBL857732,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,,2276,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14588,,,CHEMBL630445,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,,14915,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
14589,,,CHEMBL630446,Catalytic rate constant of the compound,,8847,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14590,,,CHEMBL630447,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,,15357,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14591,,,CHEMBL630448,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),,2869,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14592,,,CHEMBL630449,Catalytic rate constant against phospholipase A2 was determined,,3484,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14593,,,CHEMBL630450,"Compound was evaluated for catalytic constant, Kcat",,1373,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14594,,,CHEMBL630451,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,,8142,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14595,,,CHEMBL630452,Kcat calculated from 0.693/T1/2,,14131,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14596,,,CHEMBL630453,Kcat was determined,,17269,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14597,,,CHEMBL630454,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,,3485,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14598,,,CHEMBL630455,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,,3485,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14599,,,CHEMBL631487,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,,3485,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14600,,,CHEMBL631488,Kcat value was determined,,5962,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14601,,,CHEMBL876440,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,,3133,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14602,,,CHEMBL631489,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,,3133,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14603,,,CHEMBL857742,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,2276,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14604,,,CHEMBL631490,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",,2276,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14605,,,CHEMBL631491,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",,2276,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14606,,,CHEMBL631492,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,2276,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14607,,,CHEMBL631493,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",,2276,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14608,,,CHEMBL631494,Kinetic parameter for rate of conversion to PABA was determined,,4892,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14609,,,CHEMBL631495,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,3133,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14610,Rattus norvegicus,1988.0,CHEMBL631496,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,11488,Feces,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14611,Rattus norvegicus,1088.0,CHEMBL631497,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,11488,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14612,Rattus norvegicus,1088.0,CHEMBL631498,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,11488,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14613,Rattus norvegicus,1088.0,CHEMBL629776,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,11488,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14614,Rattus norvegicus,1088.0,CHEMBL629777,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,11488,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14615,Rattus norvegicus,1088.0,CHEMBL629778,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,11488,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14616,Rattus norvegicus,,CHEMBL630456,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,,11488,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14617,Rattus norvegicus,,CHEMBL630457,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,,11488,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14618,Rattus norvegicus,,CHEMBL630458,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,,11488,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14619,Rattus norvegicus,,CHEMBL630459,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,,11488,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14620,Rattus norvegicus,,CHEMBL630460,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,,11488,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14621,Rattus norvegicus,,CHEMBL876550,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,,11488,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14622,Rattus norvegicus,,CHEMBL630461,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,,11488,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14623,Rattus norvegicus,,CHEMBL630462,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,,11488,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14624,Rattus norvegicus,,CHEMBL630463,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,,11488,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14625,Rattus norvegicus,,CHEMBL630464,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,,11488,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14626,Rattus norvegicus,,CHEMBL630465,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,,11488,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14627,Rattus norvegicus,,CHEMBL630466,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,,11488,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14628,Rattus norvegicus,,CHEMBL630467,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,,11488,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14629,Rattus norvegicus,,CHEMBL630633,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,,11488,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14630,Rattus norvegicus,,CHEMBL630634,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,,11488,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14631,Rattus norvegicus,,CHEMBL630635,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,,11488,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14632,Rattus norvegicus,,CHEMBL630636,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,,11488,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14633,Rattus norvegicus,,CHEMBL630637,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,,11488,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14634,Oryctolagus cuniculus,1988.0,CHEMBL630638,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,7132,Feces,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
14635,Oryctolagus cuniculus,1988.0,CHEMBL630639,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,7132,Feces,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
14636,Oryctolagus cuniculus,1988.0,CHEMBL630640,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,7132,Feces,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
14637,Oryctolagus cuniculus,1988.0,CHEMBL876551,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,7132,Feces,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
14638,Oryctolagus cuniculus,1088.0,CHEMBL630641,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",,7132,Urine,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
14639,Oryctolagus cuniculus,1088.0,CHEMBL630642,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,7132,Urine,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
14640,Oryctolagus cuniculus,1088.0,CHEMBL630643,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,7132,Urine,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
14641,Oryctolagus cuniculus,1088.0,CHEMBL630644,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,7132,Urine,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
14642,Oryctolagus cuniculus,1088.0,CHEMBL630645,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,7132,Urine,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
14643,Oryctolagus cuniculus,1988.0,CHEMBL625599,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,7132,Feces,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
14644,Oryctolagus cuniculus,1988.0,CHEMBL625600,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,7132,Feces,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
14645,Oryctolagus cuniculus,1988.0,CHEMBL625601,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,7132,Feces,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
14646,Oryctolagus cuniculus,1988.0,CHEMBL625602,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,7132,Feces,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
14647,Oryctolagus cuniculus,1088.0,CHEMBL627470,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",,7132,Urine,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
14648,Oryctolagus cuniculus,1088.0,CHEMBL627471,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,7132,Urine,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
14649,Oryctolagus cuniculus,1088.0,CHEMBL627472,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,7132,Urine,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
14650,Oryctolagus cuniculus,1088.0,CHEMBL627473,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,7132,Urine,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
14651,Oryctolagus cuniculus,1088.0,CHEMBL627474,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,7132,Urine,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
14652,Rattus norvegicus,178.0,CHEMBL627475,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,13925,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14653,Rattus norvegicus,178.0,CHEMBL627476,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,13925,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14654,Canis lupus familiaris,1088.0,CHEMBL627477,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14655,Canis lupus familiaris,1088.0,CHEMBL627478,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14656,Canis lupus familiaris,1088.0,CHEMBL627479,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14657,Canis lupus familiaris,1088.0,CHEMBL627480,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14658,Canis lupus familiaris,1088.0,CHEMBL627481,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14659,Canis lupus familiaris,1088.0,CHEMBL627482,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14660,Canis lupus familiaris,1088.0,CHEMBL627483,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14661,Canis lupus familiaris,1088.0,CHEMBL875636,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14662,Canis lupus familiaris,1088.0,CHEMBL625764,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14663,Canis lupus familiaris,1088.0,CHEMBL625765,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14664,Canis lupus familiaris,1088.0,CHEMBL625766,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14665,Canis lupus familiaris,1088.0,CHEMBL625767,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14666,Canis lupus familiaris,1088.0,CHEMBL625768,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14667,Canis lupus familiaris,1088.0,CHEMBL625769,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14668,Canis lupus familiaris,1088.0,CHEMBL625770,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14669,Canis lupus familiaris,1088.0,CHEMBL625771,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14670,Canis lupus familiaris,1088.0,CHEMBL625772,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14671,Canis lupus familiaris,1088.0,CHEMBL625773,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,12582,Urine,50588,,,BAO_0000218,,Intermediate,,9615.0,N,1,1,
14672,Rattus norvegicus,1088.0,CHEMBL625774,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14673,Rattus norvegicus,1088.0,CHEMBL625775,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14674,Rattus norvegicus,1088.0,CHEMBL625776,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14675,Rattus norvegicus,1088.0,CHEMBL625777,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14676,Rattus norvegicus,1088.0,CHEMBL625778,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14677,Rattus norvegicus,1088.0,CHEMBL625779,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14678,Rattus norvegicus,1088.0,CHEMBL625780,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14679,Rattus norvegicus,1088.0,CHEMBL625781,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14680,Rattus norvegicus,1088.0,CHEMBL875637,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14681,Rattus norvegicus,1088.0,CHEMBL626473,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14682,Rattus norvegicus,1088.0,CHEMBL626474,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14683,Rattus norvegicus,1088.0,CHEMBL626475,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14684,Rattus norvegicus,1088.0,CHEMBL626476,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14685,Rattus norvegicus,1088.0,CHEMBL634397,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14686,Rattus norvegicus,1088.0,CHEMBL626477,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14687,Rattus norvegicus,1088.0,CHEMBL631069,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14688,Rattus norvegicus,1088.0,CHEMBL631070,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14689,Rattus norvegicus,1088.0,CHEMBL631071,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14690,Rattus norvegicus,1088.0,CHEMBL631072,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14691,Rattus norvegicus,1088.0,CHEMBL631073,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14692,Rattus norvegicus,1088.0,CHEMBL631074,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14693,Rattus norvegicus,1088.0,CHEMBL631075,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14694,Rattus norvegicus,1088.0,CHEMBL631725,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14695,Rattus norvegicus,1088.0,CHEMBL631726,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14696,Rattus norvegicus,1088.0,CHEMBL631727,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14697,Rattus norvegicus,1088.0,CHEMBL631728,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14698,Rattus norvegicus,1088.0,CHEMBL631729,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14699,Rattus norvegicus,1088.0,CHEMBL631730,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14700,Rattus norvegicus,1088.0,CHEMBL631731,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14701,Rattus norvegicus,1088.0,CHEMBL631910,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14702,Rattus norvegicus,10000000.0,CHEMBL631911,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,In vivo,15413,Hippocampus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14703,Rattus norvegicus,1898.0,CHEMBL631912,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,In vivo,15413,Hypothalamus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14704,Rattus norvegicus,1898.0,CHEMBL631913,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,In vivo,15413,Hypothalamus,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14705,Rattus norvegicus,178.0,CHEMBL631914,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14706,Rattus norvegicus,178.0,CHEMBL631915,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14707,Rattus norvegicus,178.0,CHEMBL875778,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,12017,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14708,Rattus norvegicus,178.0,CHEMBL631916,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14709,Rattus norvegicus,178.0,CHEMBL631917,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14710,Rattus norvegicus,178.0,CHEMBL631918,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14711,Rattus norvegicus,178.0,CHEMBL631919,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14712,Rattus norvegicus,178.0,CHEMBL631920,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,12017,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14713,Rattus norvegicus,178.0,CHEMBL631921,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14714,Rattus norvegicus,178.0,CHEMBL631922,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14715,Rattus norvegicus,178.0,CHEMBL631923,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,12017,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14716,Rattus norvegicus,,CHEMBL631924,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14717,Rattus norvegicus,,CHEMBL630234,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14718,Rattus norvegicus,,CHEMBL630235,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,12017,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14719,Rattus norvegicus,,CHEMBL630236,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14720,Rattus norvegicus,,CHEMBL630237,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14721,Rattus norvegicus,,CHEMBL630238,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14722,Rattus norvegicus,,CHEMBL630239,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14723,Rattus norvegicus,,CHEMBL630303,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,12017,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14724,Rattus norvegicus,,CHEMBL630304,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14725,Rattus norvegicus,,CHEMBL630305,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14726,Rattus norvegicus,2113.0,CHEMBL630306,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14727,Rattus norvegicus,2113.0,CHEMBL630307,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14728,Rattus norvegicus,2113.0,CHEMBL630308,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,12017,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14729,Rattus norvegicus,2113.0,CHEMBL630309,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14730,Rattus norvegicus,2113.0,CHEMBL629309,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14731,Rattus norvegicus,2113.0,CHEMBL629993,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14732,Rattus norvegicus,2113.0,CHEMBL629994,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14733,Rattus norvegicus,2113.0,CHEMBL629995,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,12017,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14734,Rattus norvegicus,2113.0,CHEMBL631993,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14735,Rattus norvegicus,2113.0,CHEMBL631994,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14736,Rattus norvegicus,2113.0,CHEMBL631995,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14737,Rattus norvegicus,2107.0,CHEMBL631996,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,12017,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14738,Rattus norvegicus,2107.0,CHEMBL631997,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14739,Rattus norvegicus,2107.0,CHEMBL631998,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14740,Rattus norvegicus,2107.0,CHEMBL631999,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14741,Rattus norvegicus,2107.0,CHEMBL632000,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,12017,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14742,Rattus norvegicus,2107.0,CHEMBL632001,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14743,Rattus norvegicus,2107.0,CHEMBL874424,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14744,Rattus norvegicus,2107.0,CHEMBL632002,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14745,Rattus norvegicus,2107.0,CHEMBL632003,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14746,,,CHEMBL632004,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,3133,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14747,,,CHEMBL632005,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,,2742,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14748,,,CHEMBL632006,Compound was tested for amidase rate in the presence of N62C screen enzyme,,2742,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14749,,,CHEMBL632007,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,,2742,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14750,,,CHEMBL632008,Compound was tested for amidase rate in the presence of S166C screen enzyme,,2742,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14751,,,CHEMBL632009,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,,2742,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14752,,,CHEMBL632010,Compound was tested for esterase rate in the presence of N62C screen enzyme,,2742,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14753,,,CHEMBL857750,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,,2742,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14754,,,CHEMBL632011,Compound was tested for esterase rate in the presence of S166C screen enzyme,,2742,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14755,,,CHEMBL632012,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,2276,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14756,,,CHEMBL632013,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,2276,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14757,,,CHEMBL632014,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",,2276,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14758,,,CHEMBL629622,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,2276,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14759,,,CHEMBL629623,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,2276,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14760,,,CHEMBL629624,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",,2276,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14761,,,CHEMBL629625,Ratio of Kcat to that of Km was determined,,17269,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14762,,,CHEMBL629626,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,2276,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14763,,,CHEMBL629627,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,2276,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14764,,,CHEMBL629628,"Compound was evaluated for constant, Kd",,15917,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14765,,,CHEMBL629629,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,,10933,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14766,,,CHEMBL629630,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,,10933,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14767,,,CHEMBL856030,Dissociation Constant of compound determined,,14293,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14768,,,CHEMBL629631,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,,6698,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14769,,,CHEMBL629632,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,,6698,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14770,,,CHEMBL629633,Dissociation constant of compound with Fructose was determined,,4318,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
14771,,,CHEMBL629634,Dissociation constant of compound with Fructose was determined; Not determined,,4318,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
14772,,,CHEMBL629635,Dissociation constant of compound with Lactulose was determined,,4318,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
14773,,,CHEMBL629636,Dissociation constant of compound with Lactulose was determined; Not determined,,4318,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
14774,,,CHEMBL629637,Dissociation constant of the Compound,,14959,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
14775,,,CHEMBL629638,Dissociation constant by non-linear regression analysis,,5913,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
14776,,,CHEMBL629639,Dissociation constant was determined,,14218,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
14777,,,CHEMBL629640,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,,10689,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
14778,,,CHEMBL629641,Dissociation constant was determined,,13925,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
14779,,,CHEMBL631344,Dissociation constant was determined,,16359,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
14780,Rattus norvegicus,2385.0,CHEMBL631345,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,,10944,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14781,,,CHEMBL631346,The dissociation constant determined by fluorescence displacement assay,,11080,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14782,,,CHEMBL631524,kd value surface plasmon resonance (SPR) method,,17805,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14783,Rattus norvegicus,2385.0,CHEMBL631525,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,,10944,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14784,,,CHEMBL631526,First dissociation constant of the binding of compound to V30M TTR,,16645,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14785,,,CHEMBL631527,Second dissociation constant of the binding of compound to V30M TTR,,16645,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14786,,,CHEMBL631528,"Compound was evaluated for equilibrium constant, Ke",,7793,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14787,,1898.0,CHEMBL631529,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,,12199,Hypothalamus,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14788,,1898.0,CHEMBL631530,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,,12199,Hypothalamus,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14789,,,CHEMBL631531,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,,9680,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14790,,,CHEMBL631532,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,,9680,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14791,,,CHEMBL631533,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,,9680,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14792,Mus musculus,,CHEMBL876552,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,13758,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14793,Mus musculus,,CHEMBL631534,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,13758,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14794,Mus musculus,,CHEMBL631535,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,13758,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14795,Mus musculus,,CHEMBL631536,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,13758,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14796,Mus musculus,,CHEMBL631537,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,,13758,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14797,Mus musculus,,CHEMBL631538,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,13758,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14798,Mus musculus,,CHEMBL631539,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,,13758,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14799,Mus musculus,,CHEMBL631540,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,13758,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14800,Rattus norvegicus,,CHEMBL625637,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,14393,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14801,Rattus norvegicus,,CHEMBL625638,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,14393,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14802,Rattus norvegicus,,CHEMBL625639,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,15078,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14803,Rattus norvegicus,955.0,CHEMBL625640,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,13925,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14804,Rattus norvegicus,955.0,CHEMBL625641,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,13925,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14805,Rattus norvegicus,948.0,CHEMBL625642,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,13925,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14806,Rattus norvegicus,948.0,CHEMBL625643,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,13925,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14807,Rattus norvegicus,2113.0,CHEMBL625644,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,13925,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14808,Rattus norvegicus,2113.0,CHEMBL625645,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,13925,Kidney,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14809,Rattus norvegicus,2107.0,CHEMBL625646,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,13925,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14810,Rattus norvegicus,2107.0,CHEMBL625647,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,13925,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14811,Rattus norvegicus,2048.0,CHEMBL625648,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,13925,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14812,Rattus norvegicus,2048.0,CHEMBL625649,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,In vivo,13925,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14813,Rattus norvegicus,2385.0,CHEMBL625650,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,13925,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14814,Rattus norvegicus,2385.0,CHEMBL625651,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,13925,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14815,Rattus norvegicus,14.0,CHEMBL625652,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,13925,Zone of skin,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14816,Rattus norvegicus,14.0,CHEMBL625653,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,13925,Zone of skin,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14817,Rattus norvegicus,2106.0,CHEMBL625654,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,13925,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14818,Rattus norvegicus,2106.0,CHEMBL625655,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,In vivo,13925,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14819,Rattus norvegicus,178.0,CHEMBL625656,Biodistribution of Compound in rat blood after 15 minutes of administration,In vivo,9712,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14820,Rattus norvegicus,178.0,CHEMBL625657,Biodistribution of Compound in rat blood after 2 minutes of administration,In vivo,9712,Blood,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14821,Rattus norvegicus,955.0,CHEMBL625658,Biodistribution of Compound in rat brain after 15 minutes of administration,In vivo,9712,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14822,Rattus norvegicus,955.0,CHEMBL625659,Biodistribution of Compound in rat brain after 2 minutes of administration,In vivo,9712,Brain,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14823,Rattus norvegicus,948.0,CHEMBL625660,Biodistribution of Compound in rat heart after 15 minutes of administration,In vivo,9712,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14824,Rattus norvegicus,948.0,CHEMBL625661,Biodistribution of Compound in rat heart after 2 minutes of administration,In vivo,9712,Heart,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14825,Rattus norvegicus,2107.0,CHEMBL625662,Biodistribution of Compound in rat liver after 15 minutes of administration,In vivo,9712,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14826,Rattus norvegicus,2107.0,CHEMBL625663,Biodistribution of Compound in rat liver after 2 minutes of administration,In vivo,9712,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14827,Rattus norvegicus,2048.0,CHEMBL875621,Biodistribution of Compound in rat lung after 15 minutes of administration,In vivo,9712,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14828,Rattus norvegicus,2048.0,CHEMBL628382,Biodistribution of Compound in rat lung after 2 minutes of administration,In vivo,9712,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14829,Rattus norvegicus,2385.0,CHEMBL628383,Biodistribution of Compound in rat muscle after 15 minutes of administration,In vivo,9712,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14830,Rattus norvegicus,2385.0,CHEMBL628384,Biodistribution of Compound in rat muscle after 2 minutes of administration,In vivo,9712,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14831,Rattus norvegicus,,CHEMBL628385,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,,13925,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14832,Rattus norvegicus,,CHEMBL875753,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,,13925,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14833,Rattus norvegicus,,CHEMBL628386,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,,13925,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14834,Rattus norvegicus,,CHEMBL628387,Organ distribution in rat blood 2 minutes after intravenous injection,,6941,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14835,Rattus norvegicus,,CHEMBL628388,Organ distribution in rat blood 2 hr after intravenous injection,,6941,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14836,Rattus norvegicus,,CHEMBL628389,Organ distribution in rat blood 30 minutes after intravenous injection,,6941,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14837,Rattus norvegicus,,CHEMBL632756,Organ distribution in rat blood 30 min after intravenous injection,,6941,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14838,Rattus norvegicus,,CHEMBL628390,Organ distribution in rat brain 2 minutes after intravenous injection,,6941,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14839,Rattus norvegicus,,CHEMBL631811,Organ distribution in rat brain 2 hr after intravenous injection,,6941,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14840,Rattus norvegicus,,CHEMBL631812,Organ distribution in rat brain 30 minutes after intravenous injection,,6941,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14841,Rattus norvegicus,,CHEMBL631813,Organ distribution in rat heart 2 minutes after intravenous injection,,6941,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14842,Rattus norvegicus,,CHEMBL631814,Organ distribution in rat heart 2 hr after intravenous injection,,6941,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14843,Rattus norvegicus,,CHEMBL631815,Organ distribution in rat heart 30 minutes after intravenous injection,,6941,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14844,Rattus norvegicus,,CHEMBL631816,Organ distribution in rat kidney 2 minutes after intravenous injection,,6941,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14845,Rattus norvegicus,,CHEMBL875758,Organ distribution in rat kidney 2 hr after intravenous injection,,6941,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14846,Rattus norvegicus,,CHEMBL631817,Organ distribution in rat kidney 30 minutes after intravenous injection,,6941,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14847,Rattus norvegicus,2107.0,CHEMBL631818,Organ distribution in rat liver 2 minutes after intravenous injection,,6941,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14848,Rattus norvegicus,2107.0,CHEMBL631819,Organ distribution in rat liver 2 hr after intravenous injection,,6941,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14849,Rattus norvegicus,2107.0,CHEMBL631820,Organ distribution in rat liver 30 minutes after intravenous injection,,6941,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14850,Rattus norvegicus,,CHEMBL631821,Organ distribution in rat lung 2 minutes after intravenous injection,,6941,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14851,Rattus norvegicus,,CHEMBL631822,Organ distribution in rat lung 2 hr after intravenous injection,,6941,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14852,Rattus norvegicus,,CHEMBL631823,Organ distribution in rat lung 30 minutes after intravenous injection,,6941,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14853,Rattus norvegicus,2385.0,CHEMBL631824,Organ distribution in rat muscle 2 minutes after intravenous injection,,6941,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14854,Rattus norvegicus,2385.0,CHEMBL631825,Organ distribution in rat muscle 2 hr after intravenous injection,,6941,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14855,Rattus norvegicus,2385.0,CHEMBL631826,Organ distribution in rat muscle 30 minutes after intravenous injection,,6941,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14856,Mus musculus,,CHEMBL631827,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),In vivo,14439,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14857,Mus musculus,,CHEMBL631828,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),In vivo,14439,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14858,Mus musculus,,CHEMBL631829,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),In vivo,14439,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14859,Rattus norvegicus,1088.0,CHEMBL875759,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14860,Rattus norvegicus,1088.0,CHEMBL631830,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14861,Rattus norvegicus,1088.0,CHEMBL631831,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14862,Rattus norvegicus,1088.0,CHEMBL631832,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14863,Rattus norvegicus,1088.0,CHEMBL631833,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14864,Rattus norvegicus,1088.0,CHEMBL631834,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14865,Rattus norvegicus,1088.0,CHEMBL631835,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14866,Rattus norvegicus,1088.0,CHEMBL631836,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14867,Rattus norvegicus,1088.0,CHEMBL631837,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14868,Rattus norvegicus,1088.0,CHEMBL631838,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14869,Rattus norvegicus,1088.0,CHEMBL631839,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14870,Rattus norvegicus,1088.0,CHEMBL631840,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14871,Rattus norvegicus,1088.0,CHEMBL631841,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14872,Rattus norvegicus,1088.0,CHEMBL631842,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14873,Rattus norvegicus,1088.0,CHEMBL631843,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14874,Rattus norvegicus,1088.0,CHEMBL631844,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14875,Rattus norvegicus,1088.0,CHEMBL631845,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14876,Rattus norvegicus,1088.0,CHEMBL631846,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14877,Rattus norvegicus,1088.0,CHEMBL875760,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14878,Rattus norvegicus,1088.0,CHEMBL632199,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14879,Rattus norvegicus,1088.0,CHEMBL631847,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14880,Rattus norvegicus,1088.0,CHEMBL631848,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14881,Rattus norvegicus,1088.0,CHEMBL628707,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14882,Rattus norvegicus,1088.0,CHEMBL628708,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14883,Rattus norvegicus,1088.0,CHEMBL628709,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14884,Rattus norvegicus,1088.0,CHEMBL628710,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14885,Rattus norvegicus,1088.0,CHEMBL628711,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14886,Rattus norvegicus,1088.0,CHEMBL628712,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14887,Rattus norvegicus,1088.0,CHEMBL628713,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14888,Rattus norvegicus,1088.0,CHEMBL628714,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,12582,Urine,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14889,Rattus norvegicus,,CHEMBL628715,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",,7415,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14890,,,CHEMBL629179,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,,7313,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14891,,,CHEMBL629180,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,,7313,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14892,,,CHEMBL875108,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,,7313,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14893,,1235.0,CHEMBL629181,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,7570,Adrenal cortex,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14894,,1235.0,CHEMBL629182,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,7570,Adrenal cortex,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14895,,,CHEMBL629183,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,,7570,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14896,,,CHEMBL629184,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,,7570,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14897,,1235.0,CHEMBL629185,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,7570,Adrenal cortex,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14898,,1235.0,CHEMBL629186,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,,7570,Adrenal cortex,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14899,,,CHEMBL629187,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,,7570,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14900,,,CHEMBL629887,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,,7570,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14901,,,CHEMBL629888,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,,7570,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14902,,,CHEMBL629889,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,,7570,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14903,,1235.0,CHEMBL629890,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,,7570,Adrenal cortex,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14904,,,CHEMBL629891,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,,7570,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14905,,,CHEMBL629892,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,,7570,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14906,,1235.0,CHEMBL629893,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,7570,Adrenal cortex,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14907,,,CHEMBL629894,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,,7570,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14908,,,CHEMBL629895,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,,7570,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14909,Canis lupus familiaris,,CHEMBL875109,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",In vivo,14122,,22224,,,BAO_0000218,,Autocuration,,9615.0,U,0,1,
14910,Macaca fascicularis,,CHEMBL629896,Absolute bioavailability in male cynomolgus monkeys,In vivo,16449,,22224,,,BAO_0000218,,Autocuration,,9541.0,U,0,1,
14911,Rattus norvegicus,,CHEMBL629897,Absolute bioavailability in maleSprague-Dawley rats,In vivo,16449,,22224,,,BAO_0000218,,Autocuration,,10116.0,U,0,1,
14912,Rattus norvegicus,2107.0,CHEMBL629898,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,12017,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14913,Rattus norvegicus,2107.0,CHEMBL630057,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14914,Rattus norvegicus,2107.0,CHEMBL630058,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Liver,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14915,Rattus norvegicus,2048.0,CHEMBL630059,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14916,Rattus norvegicus,2048.0,CHEMBL630060,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14917,Rattus norvegicus,2048.0,CHEMBL630061,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,12017,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14918,Rattus norvegicus,2048.0,CHEMBL630062,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14919,Rattus norvegicus,2048.0,CHEMBL630063,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14920,Rattus norvegicus,2048.0,CHEMBL630064,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14921,Rattus norvegicus,2048.0,CHEMBL630065,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14922,Rattus norvegicus,2048.0,CHEMBL630066,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,12017,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14923,Rattus norvegicus,2048.0,CHEMBL630067,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14924,Rattus norvegicus,2048.0,CHEMBL630068,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Lung,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14925,Rattus norvegicus,2385.0,CHEMBL631113,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14926,Rattus norvegicus,2385.0,CHEMBL631114,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14927,Rattus norvegicus,2385.0,CHEMBL631115,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,12017,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14928,Rattus norvegicus,2385.0,CHEMBL631116,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14929,Rattus norvegicus,2385.0,CHEMBL630528,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14930,Rattus norvegicus,2385.0,CHEMBL630529,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14931,Rattus norvegicus,2385.0,CHEMBL630530,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14932,Rattus norvegicus,2385.0,CHEMBL630531,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,12017,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14933,Rattus norvegicus,2385.0,CHEMBL630532,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14934,Rattus norvegicus,2385.0,CHEMBL630533,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Muscle tissue,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14935,Mus musculus,178.0,CHEMBL630534,Biodistribution in normal mice blood after 120 hr,In vivo,15045,Blood,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14936,Mus musculus,178.0,CHEMBL630535,Biodistribution in normal mice blood after 24 hr,In vivo,15045,Blood,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14937,Mus musculus,178.0,CHEMBL630536,Biodistribution in normal mice blood after 4 hr,In vivo,15045,Blood,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14938,Mus musculus,10000001.0,CHEMBL630537,Biodistribution in normal mice bone after 120 hr,In vivo,15045,Bone,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14939,Mus musculus,10000001.0,CHEMBL630538,Biodistribution in normal mice bone after 24 hr,In vivo,15045,Bone,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14940,Mus musculus,10000001.0,CHEMBL630539,Biodistribution in normal mice bone after 4 hr,In vivo,15045,Bone,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14941,Mus musculus,948.0,CHEMBL630540,Biodistribution in normal mice heart after 120 hr,In vivo,15045,Heart,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14942,Mus musculus,948.0,CHEMBL630541,Biodistribution in normal mice heart after 24 hr,In vivo,15045,Heart,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14943,Mus musculus,948.0,CHEMBL630542,Biodistribution in normal mice heart after 4 hr,In vivo,15045,Heart,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14944,Mus musculus,2113.0,CHEMBL630543,Biodistribution in normal mice kidney after 120 hr,In vivo,15045,Kidney,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14945,Mus musculus,2113.0,CHEMBL630544,Biodistribution in normal mice kidney after 24 hr,In vivo,15045,Kidney,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14946,Mus musculus,2113.0,CHEMBL630545,Biodistribution in normal mice kidney after 4 hr,In vivo,15045,Kidney,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14947,Mus musculus,2107.0,CHEMBL630546,Biodistribution in normal mice liver after 120 hr,In vivo,15045,Liver,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14948,Mus musculus,2107.0,CHEMBL630547,Biodistribution in normal mice liver after 24 hr,In vivo,15045,Liver,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14949,Mus musculus,2107.0,CHEMBL630548,Biodistribution in normal mice liver after 4 hr,In vivo,15045,Liver,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14950,Mus musculus,2106.0,CHEMBL630549,Biodistribution in normal mice spleen after 120 hr,In vivo,15045,Spleen,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14951,Mus musculus,2106.0,CHEMBL630550,Biodistribution in normal mice spleen after 24 hr,In vivo,15045,Spleen,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14952,Mus musculus,2106.0,CHEMBL876426,Biodistribution in normal mice spleen after 4 hr,In vivo,15045,Spleen,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
14953,Rattus norvegicus,2106.0,CHEMBL630551,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14954,Rattus norvegicus,2106.0,CHEMBL630552,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14955,Rattus norvegicus,2106.0,CHEMBL630553,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,12017,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14956,Rattus norvegicus,2106.0,CHEMBL630554,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14957,Rattus norvegicus,2106.0,CHEMBL630555,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14958,Rattus norvegicus,2106.0,CHEMBL630556,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14959,Rattus norvegicus,2106.0,CHEMBL630557,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14960,Rattus norvegicus,2106.0,CHEMBL630558,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),In vivo,12017,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14961,Rattus norvegicus,2106.0,CHEMBL630559,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14962,Rattus norvegicus,2106.0,CHEMBL630560,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Spleen,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14963,Rattus norvegicus,2046.0,CHEMBL876427,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,In vivo,12017,Thyroid gland,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14964,Rattus norvegicus,,CHEMBL630561,The Kel values in female wistar rats.,,14941,,50597,,,BAO_0000218,,Intermediate,,10116.0,N,1,1,
14965,,,CHEMBL630562,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,,4646,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14966,,,CHEMBL630563,Hydrolysis rate constant of the compound,,8847,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14967,,,CHEMBL629673,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,,11778,,22229,,,BAO_0000100,,Autocuration,,,U,0,1,
14968,,,CHEMBL629674,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",,2363,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14969,,,CHEMBL629675,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",,2363,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14970,,,CHEMBL629676,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",,2363,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14971,,,CHEMBL629677,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",,2363,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14972,,,CHEMBL629678,Apparent inactivation rate constant was evaluated,,8371,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14973,,,CHEMBL629679,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,,14883,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14974,,,CHEMBL629680,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,,14883,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14975,,,CHEMBL629681,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,,4643,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14976,,,CHEMBL629682,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,,3519,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14977,,,CHEMBL629683,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,,10600,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14978,,,CHEMBL629684,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,,8501,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14979,,,CHEMBL629685,Dissociation constant was determined,,8505,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
14980,,,CHEMBL629686,Dissociation constant was determined,,9778,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
14981,,,CHEMBL872932,Dissociation constant at pH 7.4,,9778,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
14982,,,CHEMBL629687,Dissociation constant in presence of 1 mM dithiothreitol,,9778,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
14983,,,CHEMBL872931,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,13007,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14984,,,CHEMBL628151,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,13007,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14985,,,CHEMBL628152,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,13007,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14986,,,CHEMBL628153,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,13007,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14987,,,CHEMBL628154,Kinetic constant for aromatization of androstenedione,,11482,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14988,,,CHEMBL628155,Kinetic constant for aromatization of testosterone,,11482,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14989,,,CHEMBL628156,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,,2303,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14990,,,CHEMBL628157,Local inhibition constant was determined,,11964,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14991,Saccharomyces cerevisiae,,CHEMBL857533,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,,3140,,50347,,,BAO_0000218,,Intermediate,,4932.0,N,1,1,
14992,,,CHEMBL628158,Dissociation constant value of the compound,,10650,,22224,,,BAO_0000100,,Autocuration,,,U,0,1,
14993,,964.0,CHEMBL628159,In vitro permeability through cornea without epithelium,,4667,Cornea,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14994,,964.0,CHEMBL875616,In vitro permeability through intact cornea,,4667,Cornea,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14995,Oryctolagus cuniculus,964.0,CHEMBL628160,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,,9199,Cornea,50592,,,BAO_0000218,,Intermediate,,9986.0,N,1,1,
14996,,,CHEMBL628161,Rate of enzyme inactivation for the compound was determined,,11966,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14997,,964.0,CHEMBL628162,In vitro permeability through cornea without epithelium,,4667,Cornea,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14998,,964.0,CHEMBL628163,In vitro permeability through intact cornea,,4667,Cornea,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
14999,,,CHEMBL628164,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
15000,,,CHEMBL628165,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
15001,,,CHEMBL628166,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
15002,,,CHEMBL628167,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
15003,,,CHEMBL628168,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
15004,,,CHEMBL628169,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
15005,,,CHEMBL628170,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
15006,,,CHEMBL628171,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
15007,,,CHEMBL627434,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
15008,,,CHEMBL627435,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
15009,,,CHEMBL628110,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
15010,,,CHEMBL628111,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
15011,,,CHEMBL628112,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
15012,,,CHEMBL628260,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
15013,,,CHEMBL628261,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,,22224,,,BAO_0000019,,Autocuration,,,U,0,1,
15014,Mus musculus,,CHEMBL628262,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),In vivo,14439,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
15015,Homo sapiens,,CHEMBL628263,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,In vivo,14439,,50587,,,BAO_0000218,,Intermediate,,9606.0,N,1,1,
15016,Mus musculus,,CHEMBL628264,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),In vivo,14439,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
15017,Mus musculus,,CHEMBL628265,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),In vivo,14439,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
15018,Mus musculus,,CHEMBL628266,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),In vivo,14439,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
15019,Mus musculus,,CHEMBL628267,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),In vivo,14439,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
15020,Mus musculus,,CHEMBL628268,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,In vivo,14439,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
15021,Mus musculus,,CHEMBL628269,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),In vivo,14439,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
15022,Mus musculus,,CHEMBL628270,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),In vivo,14439,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
15023,Mus musculus,,CHEMBL628271,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),In vivo,14439,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
15024,Mus musculus,,CHEMBL628272,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),In vivo,14439,,50594,,,BAO_0000218,,Intermediate,,10090.0,N,1,1,
